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Abstract
Educational interventions for preventing vascular catheter 
bloodstream infections in critical care: evidence map, 
systematic review and economic evaluation
Geoff K Frampton,1* Petra Harris,1 Keith Cooper,1 Tracey Cooper,2 
Jennifer Cleland,3 Jeremy Jones,1 Jonathan Shepherd,1 Andrew Clegg,1 
Nicholas Graves,4 Karen Welch1 and Brian H Cuthbertson5
1Southampton Health Technology Assessments Centre (SHTAC), Faculty of Medicine,  
University of Southampton, Southampton, UK
2Department of Infection Prevention and Control, South London Healthcare NHS Trust, 
London, UK
3Division of Medical and Dental Education, School of Medicine, University of Aberdeen, 
Aberdeen, UK
4Institute of Health and Biomedical Innovation, Queensland University of Technology,  
Brisbane, Australia
5Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada
*Corresponding author
Background: Bloodstream infections resulting from intravascular catheters (catheter-BSI) in critical care 
increase patients’ length of stay, morbidity and mortality, and the management of these infections and 
their complications has been estimated to cost the NHS annually £19.1–36.2M. Catheter-BSI are thought 
to be largely preventable using educational interventions, but guidance as to which types of intervention 
might be most clinically effective is lacking.
Objective: To assess the effectiveness and cost-effectiveness of educational interventions for preventing 
catheter-BSI in critical care units in England.
Data sources: Sixteen electronic bibliographic databases – including MEDLINE, MEDLINE In-Process & 
Other Non-Indexed Citations, Cumulative Index to Nursing and Allied Health Literature (CINAHL), NHS 
Economic Evaluation Database (NHS EED), EMBASE and The Cochrane Library databases – were searched 
from database inception to February 2011, with searches updated in March 2012. Bibliographies of 
systematic reviews and related papers were screened and experts contacted to identify any 
additional references.
Review methods: References were screened independently by two reviewers using a priori selection 
criteria. A descriptive map was created to summarise the characteristics of relevant studies. Further 
selection criteria developed in consultation with the project Advisory Group were used to prioritise a subset 
of studies relevant to NHS practice and policy for systematic review. A decision-analytic economic model 
was developed to investigate the cost-effectiveness of educational interventions for preventing 
catheter-BSI.
AbSTrACT
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Results: Seventy-four studies were included in the descriptive map, of which 24 were prioritised for 
systematic review. Studies have predominantly been conducted in the USA, using single-cohort  
before-and-after study designs. Diverse types of educational intervention appear effective at reducing  
the incidence density of catheter-BSI (risk ratios statistically significantly < 1.0), but single lectures were not 
effective. The economic model showed that implementing an educational intervention in critical care units 
in England would be cost-effective and potentially cost-saving, with incremental cost-effectiveness ratios 
under worst-case sensitivity analyses of < £5000/quality-adjusted life-year.
Limitations: Low-quality primary studies cannot definitively prove that the planned interventions were 
responsible for observed changes in catheter-BSI incidence. Poor reporting gave unclear estimates of risk of 
bias. Some model parameters were sourced from other locations owing to a lack of UK data.
Conclusions: Our results suggest that it would be cost-effective and may be cost-saving for the NHS to 
implement educational interventions in critical care units. However, more robust primary studies are 
needed to exclude the possible influence of secular trends on observed reductions in catheter-BSI.
Study registration: The study is registered with PROSPERO as CRD42012001840.
Funding: The National Institute for Health Research Health Technology Assessment programme.
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Glossary
Catheter-associated bloodstream infection A primary laboratory-confirmed bloodstream infection in 
a patient with a central line at the time of (or within 48 hours prior to) the onset of symptoms, and which 
is not related to an infection from another site. Synonyms include central line-associated bacteraemia and 
central line-associated bloodstream infection.
Catheter-bloodstream infection (catheter-BSI) An umbrella term referring to catheter-associated 
bloodstream infections, catheter-related bloodstream infections or catheter-suspected bloodstream 
infections and their synonyms.
Catheter-related bloodstream infection Various definitions and terms are used, and sometimes 
confused, in the literature to describe a bloodstream infection that has developed as a consequence  
of an indwelling intravascular catheter. Bloodstream infections that are proven microbiologically to result 
from vascular catheter use are generally referred to as catheter-related bloodstream infections. For the 
purposes of this report, a definition as used in the Matching Michigan programme in England is provided 
(see Table 1).
Critical care unit A specially equipped hospital area designed for the specialised care of patients whose 
conditions are life-threatening and who require comprehensive care and constant monitoring. For the 
purposes of this report, synonymous with intensive care unit, including high-dependency units, but 
excluding step-down units.
Device-days The total number of days that patients have one or more vascular devices in a given period. 
Definitions vary depending on whether multiple vascular devices per patient are counted separately.
Incidence density The standardised incidence of infection. For the purposes of this report, standardised 
to the number of vascular device-days and expressed per 1000 device-days.
Incidence density risk ratio The ratio of incidence densities in study and comparator groups. Values of 
< 1 favour the study group; values of > 1 favour the comparator group.
Intensive care unit See Critical care unit.
Matching Michigan An infection prevention strategy adapted from the US Keystone ICU (‘Michigan’) 
project intervention and implemented in English NHS trusts in 2009.
ORION Guidelines for the transparent reporting of nosocomial infections, including a 22-item checklist 
and summary table.
STROBE Guidelines for the reporting of observational studies in epidemiology, including a 22-item 
checklist and supporting information with examples.
TREND Guidelines for the reporting of non-randomised evaluations of behavioural and public health 
interventions, including a 22-item checklist.
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BEME Best Evidence in Medical Education
BSI bloodstream infection
CABSI catheter-associated 
bloodstream infection
CDC Centers for Disease Control 
and Prevention
CEO chief executive officer
CFU colony-forming unit
CH/SSD chlorhexidine/silver sulfadiazine
CI confidence interval
CLAB central line-associated bacteraemia 
(synonymous with CABSI)
CLABSI central line-associated 
bloodstream infection 
(synonymous with CABSI)
CQI continuous quality improvement
CRBSI catheter-related 
bloodstream infection
CVC central venous catheter
CVL central venous line
ECDC European Centre for Disease 
Prevention and Control
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for Infection Control 
through Surveillance
HRG Healthcare Resource Group
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cost-effectiveness ratio
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Scientific summary
Background
Bloodstream infections resulting from the use of intravascular catheters (catheter-BSI) are the most 
frequent infections in critical care units in England. Catheter-BSI increase patients’ length of stay (LOS) in 
hospital and their risk of health complications and death, and impose a burden on health services in terms 
of bed occupancy and the additional costs of managing these infections and their complications. Annual 
costs to the NHS related to catheter-BSI in critical care units have been estimated at £19.1–36.2M. The 
majority of catheter-BSI are thought to be preventable using evidence-based educational interventions to 
ensure that doctors and nurses are committed to a culture of safety and follow best practice to achieve 
this. However, there is a lack of guidance as to which types of intervention might be most clinically 
effective and cost-effective in an NHS setting. We developed an evidence map, conducted a systematic 
review and performed an economic evaluation to assess the effectiveness and cost-effectiveness of 
educational interventions relevant to the prevention of catheter-BSI in critical care units in England.
Methods
Evidence map and systematic review of effectiveness
A two-stage process was followed: (1) development of a descriptive map of the key characteristics of 
studies evaluating educational interventions, followed by (2) a detailed systematic review of a subset 
of interventions.
Search strategies
Fifteen electronic bibliographic databases [including MEDLINE, MEDLINE In-Process & Other Non-Indexed 
Citations, Cumulative Index to Nursing and Allied Health Literature (CINAHL), EMBASE and Cochrane 
Collaboration databases] were searched from the period of database inception up to February 2011, 
with searches rerun in March 2012. Searches were not restricted by publication language. Bibliographies 
of systematic reviews and related papers were screened and experts contacted to identify additional 
published and unpublished references.
Study selection
Titles and abstracts were screened for eligibility by two reviewers independently using a priori pilot-tested 
criteria. Studies eligible for inclusion in the descriptive map were any primary research studies that included 
one or more planned educational interventions for preventing catheter-BSI, were conducted in critical care 
units, and reported the effect of the intervention(s) on the incidence density of catheter-BSI, mortality 
and/or LOS as an outcome. We defined education in a broad sense to include any means of information 
provision, and we defined catheter-BSI to include catheter-related and catheter-associated bloodstream 
infections (CABSIs) and their synonyms. Full papers were obtained for those titles and abstracts that 
appeared relevant and these were screened by two reviewers independently.
Descriptive map
Keywords were developed and systematically applied to included studies to produce a detailed map of 
the evidence base that was used to prioritise a subset of studies for inclusion in the systematic review in 
consultation with the project’s expert Advisory Group (AG).
Data extraction and quality assessment
Two reviewers independently extracted data from the studies included in the systematic review using 
a pilot-tested data extraction form and independently assessed studies for methodological quality, 
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including risk of bias using prespecified criteria. Differences in judgement were resolved by discussion and 
involvement of a third reviewer if necessary.
Data synthesis
Studies were synthesised narratively and considered for meta-analysis.
Economic evaluation
A systematic review was conducted to identify economic evaluations of educational interventions for 
preventing catheter-BSI in critical care. Thirteen electronic bibliographic databases [including MEDLINE, 
MEDLINE In-Process & Other Non-Indexed Citations, CINAHL, EMBASE, Cochrane Collaboration databases 
and NHS Economic Evaluation Database (NHS EED)] were searched from the period of database inception 
up to February 2011, with searches rerun in March 2012. References identified were screened according to 
a priori criteria. Full papers were obtained for those titles and abstracts that appeared relevant and these 
were screened by two reviewers independently.
A decision-analytic economic model was developed to compare the costs and consequences of a central 
venous catheter (CVC) care bundle for the prevention of catheter-BSI against current clinical practice. The 
CVC care bundle was defined based upon the ‘Keystone intensive care unit (ICU) project’ conducted in 
Michigan, USA, and the ‘Matching Michigan’ programme in England. The CVC care bundle encompassed 
five elements, together with education: optimal hand hygiene, chlorhexidine skin antisepsis, maximal 
barrier precautions for catheter insertion, choice of optimal insertion site, and prompt catheter removal. 
Current clinical practice was defined as critical care that did not implement a CVC care bundle.
The model follows hypothetical cohorts of patients from their admission to the critical care unit and 
incorporates their risk of catheter-BSI and hospital mortality. Estimates are made of the long-term survival 
of patients after discharge from critical care and the total costs and quality-adjusted life-years (QALYs) 
gained for both cohorts, from which the model determines the cost-effectiveness of the CVC care bundle. 
Model parameters were derived from a systematic search of the literature on the natural history and 
epidemiology of catheter-BSI, health-related quality of life (HRQoL) and costs. Costs were derived from 
primary data from previous studies and NHS unit costs. The analysis was conducted from the perspective 
of the NHS and Personal Social Services, and has a lifetime horizon. Uncertainty around the model results 
was investigated through the use of deterministic and probabilistic sensitivity analyses.
Results of the evidence map and systematic review 
of effectiveness
A descriptive map of 74 studies meeting the inclusion criteria was produced. The results illustrate a 
predominance of North American trials of educational interventions. Studies have been conducted at a 
range of spatial and temporal scales with diverse types of educational intervention, ranging from individual 
short lectures conducted in single critical care units to multiyear regional-scale interventions that involved 
continuous quality improvement (CQI) approaches in over 100 critical care units. Nearly all studies used 
uncontrolled before-and-after study designs, with only two randomised controlled trials (RCTs) included.
Discussion with the project’s AG enabled the prioritisation of a policy-relevant subset of studies for 
systematic review. To be included, studies had to have a clearly reported prospective design; focus on adult 
critical care units; and provide a definition of their catheter-BSI outcome.
A total of 24 studies met the inclusion criteria for the systematic review. Twelve studies were conducted 
in the USA, with only one in the UK. Nine studies were judged to be at high risk of bias. However, 
owing to poor reporting of the methodology, the majority of studies were judged to be at unclear risk 
of bias. Most studies did not report their methods of data collection. Quality criteria were not used to 
exclude studies from data synthesis but were taken into consideration when discussing whether studies 
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provided convincing evidence of clinical effectiveness. Owing to the wide heterogeneity of intervention 
types included in the systematic review, meta-analysis was inappropriate. Instead, incidence density risk 
ratios (RRs) with 95% confidence intervals (incidence of catheter-BSI expressed per 1000 catheter-days) 
calculated for each of the interventions were compared in a narrative synthesis.
Studies included in the systematic review were predominantly uncontrolled before-and-after studies.  
None of the controlled studies demonstrated clinical effectiveness. Assuming that observed changes in 
catheter-BSI rates in before-and-after studies were caused by the intended interventions, 12 of the  
24 studies included in the systematic review reported interventions that appeared to be effective at 
reducing the incidence density of catheter-BSI (incidence density RRs statistically significantly < 1.0), 
six studies reported interventions that were clearly not effective, three lacked convincing evidence of 
effectiveness and three provided insufficient data to calculate incidence density RRs. Overall, there was 
no clear evidence that particular types of education were any more or less effective at reducing incidence 
densities of catheter-BSI. Interventions that included checklists, performance feedback and/or infection 
surveillance feedback were sometimes, but not always, clinically effective. An exception is that single 
lectures on infection prevention practices conducted in individual critical care units (assessed in two 
studies) were not clinically effective. Few studies reported effects of interventions on mortality or LOS,  
and no clear patterns were evident for these outcomes.
Nineteen studies reported qualitative or quantitative information on intervention processes including 
compliance of critical care staff with evidence-based practices. Starting compliance at study inception 
was highly variable. In the RCT, lack of initial data collection infrastructure appears to have been a barrier 
to effective implementation. Although evidence is limited to few studies, inappropriate staff attitudes 
appear to be a potential barrier to effective implementation of evidence-based practices for preventing 
catheter-BSI.
Of the interventions judged in the systematic review to be clinically effective, a regional-scale CQI 
programme conducted in 37 critical care units in Australia (the ‘CLAB ICU project’) was considered most 
relevant to current NHS practice. Clinical effectiveness data from this intervention were used to inform the 
economic model.
Results of the economic evaluation
Systematic review of cost-effectiveness studies
Three economic evaluations of educational interventions for prevention of catheter-BSI were included. 
However, none was appropriate for estimating the cost-effectiveness of an educational intervention for 
prevention of catheter-BSI in NHS critical care units in England.
Modelled cost-effectiveness analysis
The results from the model showed that the CVC care bundle would save 0.8 catheter-BSI and 0.3 lives 
compared with current clinical practice (per 100 patients admitted to the critical care unit), with an 
increased survival of 3.6 years and 2.7 QALYs. The incremental cost was –£573 per QALY gained and 
–£1976 per catheter-BSI averted, with negative values resulting from the CVC care bundle being both 
more effective and less costly than existing clinical practice (i.e. dominant). The cost saving largely arises 
from a reduction in the critical care LOS.
Robustness of the model results was tested using a range of sensitivity analyses as well as a scenario 
analysis to explore the effect of different patient starting ages. The CVC care bundle ranged from 
remaining cost saving to no longer being cost saving, but in all cases it would be considered cost-effective 
at the standard cost-effectiveness threshold of £20,000 per QALY (worst-case results were all of  
< £5000 per QALY). The greatest variation in the sensitivity analyses was associated with two variables – 
catheter-BSI incidence rate and additional length stay in critical care for patients with catheter-BSI.
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There is uncertainty in the model-based analysis relating to variation in implementation of the CVC care 
bundle, as some of the interventions included in the bundle (to be implemented on a regional or national 
basis) may already be partially implemented (by individual hospitals or critical care units). However, at the 
least favourable values tested in sensitivity analyses to reflect extremes of implementation (a relative risk of 
catheter-BSI with the CVC care bundle = 0.7 and baseline incidence density of 1 per 1000 catheter-days), 
the incremental cost-effectiveness ratio (ICER) remained below the threshold conventionally considered  
as cost-effective.
For England, with 90,000 critical care patients per year, the model estimates that implementing the  
CVC care bundle would reduce the number of catheter-BSI infections by > 700 [interquartile range (IQR)  
482–914] and save 270 lives (IQR 184–348 lives) per year. The yearly additional cost to implement  
the intervention used in England would be £1.4M (IQR £1.2M–£1.5M). However, if the intervention  
was implemented, not only would the cost of implementation be recouped but there would be a net 
saving from implementing the intervention of £1.5M, largely as a result of the savings in costs related to  
reduced LOS (£2.4M, IQR £1.4M–£3.3M). The CVC care bundle remains cost saving up to an annual 
implementation cost of £2.7M (equivalent to £30 per critical care patient).
Conclusions
Literature searches indicate that the evaluation of educational interventions for prevention of catheter-BSI 
is an active area of primary research. Economic evaluation suggests that an educational intervention based 
on a CVC care bundle implemented in critical care units in England would be more effective and less 
costly than current clinical practice, even after allowing for heterogeneity of baseline clinical practices and 
heterogeneity of implementation. However, there is a need for more rigorous primary research studies to 
be conducted, as the current evidence comes predominantly from uncontrolled before-and-after studies 
that may not convincingly distinguish intervention effectiveness from secular trends. Clinical practices are 
being addressed by a wide variety of different educational strategies that do not draw upon pedagogic, 
theoretical or conceptual frameworks, and, consequently, do not provide generalisable lessons to inform 
national guidelines. A co-ordinated and harmonised approach to the provision of education, with the 
involvement of educationalists in the design of research studies, would improve the generalisability and 
comparability of educational interventions. Improvements in the reporting of the primary studies are 
needed, to enable judgements about risk of bias and confounding. Definitions of catheter-related and 
CABSIs are used inconsistently and should be standardised.
Recommendations for practice
NHS organisations should carefully consider whether existing practice for preventing catheter-BSI may be 
improved by implementing educational interventions in critical care units either at local or regional scales. 
Although it is not possible to be specific about which type of intervention may be most appropriate, 
economic evaluation suggests that a variety of approaches could be cost-effective or cost-saving. 
Consideration should be given to the need to adopt standard definitions of CABSI and catheter-related 
bloodstream infection, and apply and report these consistently. When clinical practice is delivered within 
a research setting, for example if interventions are intended to be implemented into practice while 
their effectiveness is monitored, consideration should be given to ensuring that the research design is 
appropriate for cause–effect relationships to be determined. Co-ordinated collection of surveillance data 
on catheter-BSI, mortality and LOS in critical care units, and the resources required to implement and 
sustain an intervention, would be helpful to inform future economic evaluations.
Recommendations for research
Future evaluations of educational interventions for preventing catheter-BSI should be rigorously designed 
to enable causal relationships to be established and any influences of secular trends on outcomes to 
be controlled. Appropriate designs could include RCTs and interrupted time series. When developing 
educational interventions for prevention of catheter-BSI, consideration should be given to: basing 
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interventions on robust educational and behavioural theory; involving educationalists; including process 
evaluations; and integrating a cost-effectiveness evaluation. Development of educational interventions 
for preventing catheter-BSI (and other infections) is likely to benefit from being co-ordinated at a national 
level, to ensure that valid and reliable pedagogical approaches are used, which are generalisable and 
inform national guidelines. Researchers should be encouraged to clearly report research studies of 
educational interventions to provide greater confidence about the validity and generalisability of the 
results and to fully identify the risks of bias and confounding. Updates to this review may help to clarify 
the extent of the growing evidence base and to ensure that the quality controls recommended above, if 
implemented, are effective.
Study registration
This study is registered with PROSPERO as CRD42012001840.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National 
Institute for Health Research.

DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
1
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Chapter 1 Background
Intravascular catheters are used for the administration of medication, fluids, blood products and parenteral nutrition, as well as for patient monitoring,1 but they are an important cause of bloodstream 
infections (BSIs).2–4 The most frequently used type of intravascular catheter is a central venous catheter 
(CVC), also referred to as a central line. A CVC is defined as an intravascular device that terminates in one 
of the great veins, or in or near to the right atrium, and includes peripherally inserted central catheters 
(PICCs), haemodialysis catheters and parenteral nutrition catheters. Insertion sites for CVCs are usually the 
jugular, subclavian and femoral veins, although femoral insertion may be associated with higher risk of 
BSIs than insertions at other sites.5 Intravascular catheters vary in the material from which they are made, 
the presence or absence of antimicrobial or anticoagulant coatings, the number of lumens present and 
whether they are tunnelled, and these variables may have an important bearing on the risk of BSI.6
Four distinct pathways may be identified in the infection process of catheter-BSI. The two major 
pathways are the external and internal bacterial colonisation of the catheter surface, both eventually 
leading to catheter-tip colonisation, with the potential for subsequent bacteraemia. Additional pathways 
include microbial contamination of the infusate and direct mechanical introduction of pathogens into 
the bloodstream.7 A wide variety of microorganisms may cause catheter-BSI, including, among others, 
Staphylococcus aureus, Staphylococcus epidermidis8 and enterococci.9 Catheter-BSI result from inadequate 
hygiene and suboptimal catheter management procedures. These include inadequate hand hygiene by 
hospital staff; inadequate skin hygiene at the site of patients’ catheter insertion; suboptimal location of 
catheters; and unnecessary placement of catheters.6 Other risk factors are the patient’s age and underlying 
disease,6 and the duration of catheterisation.10
Bloodstream infections arising from the placement of vascular catheters (catheter-BSI) are a particular 
problem in critical care units owing to the high frequency of intravascular catheter placement and 
increased susceptibility to infections among critical care patients.11 The latest (2011) point prevalence 
survey in England,12 showed that 64% of all patients with a BSI had a vascular access device in the 
48 hours prior to onset of infection, and 59.3% of critical care patients received a CVC compared with 
5.9% of other hospital patients. A 1-month audit in a hospital in England found that 65% of patients 
in the critical care unit required a CVC, whereas in surgical and renal wards the proportion ranged from 
3.5% to 25%.13
Prevalence of catheter-bloodstream infection
Prevalence of catheter-BSI is usually standardised to the number of CVC-days, and is typically expressed 
as the incidence density per 1000 CVC-days, although the definition of a device-day varies (multiple 
concurrent vascular catheters in the same patient are often not counted separately14). According to 
the 2011 point prevalence survey in England, intravascular catheter placement accounted for 29% of 
hospital-acquired BSI.12 Unpublished data from presentations about the ‘Matching Michigan’ programme 
in England15–17 (described further below) reported an incidence density of catheter-BSI of 3.7 per 1000 
CVC-days for a subset of 19 critical care units in northern England sampled in mid-2009. The most 
recent published incidence density data available for the UK are from the Intensive Care Unit Associated 
Infection (ICUAI) National Surveillance Programme (NSP), based on data from May 2009 until January 2010 
for 19 critical care units in Scotland. The NSP reported a catheter-BSI incidence density of 0.7 per 1000 
CVC-days.18 A 2009 report of the European Centre for Disease Prevention and Control (ECDC) estimated 
prevalence of catheter-BSI to be 4.3 per 1000 CVC-days, based on aggregated data from 12 European 
countries, which included some data from England.19
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There is evidence that prevalence of BSI associated with vascular catheters has decreased as a result of 
national and local infection prevention programmes in several countries. For example, in the USA the 
Institute for Healthcare Improvement’s ‘100,000 Lives Campaign (2005–6) and ‘5 Million Lives’ Campaign 
(2006–8) were among a number of programmes that recruited a large number of hospitals and promoted 
(among other objectives) strategies for the prevention of catheter-BSI. The most recent data available from 
the US Centers for Disease Control and Prevention (CDC)20 show that a 58% decrease in the prevalence 
of catheter-BSI occurred from 2001 to 2009. The point prevalence surveys conducted in England indicate 
a decline in the overall prevalence of BSI in recent years but the data are difficult to interpret owing to 
changes that occurred in the sampling methodology.12
Definitions and diagnosis of catheter-bloodstream infection
Various definitions and terms are used, and sometimes confused, in the literature to describe a BSI that has 
developed as a consequence of an indwelling intravascular catheter. Laboratory-confirmed bloodstream 
infections (LCBSIs) which are proven microbiologically to result from vascular catheter use are generally 
referred to as catheter-related bloodstream infections (CRBSIs). In the absence of microbiological testing 
and after ruling out other possible sources, BSIs that appear to be linked to vascular catheter use are 
referred to as catheter-associated bloodstream infections (CABSIs). The gold standard for diagnosis of 
CRBSI is isolation of the same microorganism from a peripheral blood culture as that obtained from the 
tip of the removed catheter.21 As many patients suspected of having a BSI will not have their catheter 
removed, and quantitative blood cultures are not universally performed, alternative definitions to CRBSI 
that do not require catheter removal are often used (i.e. CABSI), and these overestimate the true incidence 
of CRBSI. The most widely cited definitions of CABSI and CRBSI are the surveillance definitions of the 
US Centers for Disease Control and Prevention (CDC) National Nosocomial Infection Surveillance System 
(NNIS), which operated up to 2004, and the CDC National Healthcare Safety Network (NHSN) which 
replaced the NNIS in 2005. The latest CDC guidelines on defining and diagnosing CABSI and CRBSI, 
endorsed by the Infectious Diseases Society of America, were reported by Mermel and colleagues.22 
Recently, stringent definitions of CABSI and CRBSI, based on the CDC definitions, have been developed for 
use in the ‘Matching Michigan’ programme in England17 (see Table 1). As we describe below (see Current 
prevention of catheter-bloodstream infections in the NHS), Matching Michigan was a programme for 
prevention of catheter-BSI in critical care units in England that has direct relevance to NHS practice.
For the purposes of this report, we follow the definitions of CABSI, CRBSI and catheter-suspected BSIs,  
as defined in the Matching Michigan programme (Table 1), and these definitions are collectively referred  
to as catheter-BSI.
Diagnosis of CRBSI is made in various ways, depending upon both local clinical practice and, for infection 
surveillance purposes, the definition of infection in use. The use of different definitions of infections can 
dramatically alter the reported infection rate unless they are aligned with clinical practice. For example, if 
clinical practice is not to send a CVC line tip to the laboratory for culture, or to draw only a single set of 
percutaneous cultures, then any definition requiring catheter-tip culture or more than one set of cultures 
will never be met, potentially giving an artificially low infection rate.
Impact of catheter-bloodstream infection on patients and 
health services
Catheter-BSI increase patients’ discomfort and length of stay (LOS) in hospital23 and their risk of health 
complications and death.24 Catheter-BSI can trigger a range of responses from systemic sepsis through to 
septic shock and multiple organ failure. Metastatic infection may lead to septic thrombosis, endocarditis 
and septic arthritis.25 Further complications may include acute respiratory distress syndrome, disseminated 
intravascular coagulation and acute renal failure.26
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Robust data on mortality, quality of life (QoL) and long-term prognosis specifically related to catheter-BSI 
are not available for the UK. Recent estimates of the mortality rates of patients with catheter-BSI in critical 
care units in France, Germany and Italy ranged from 11% to 17.1%.27 Estimates of the additional LOS 
per catheter-BSI episode in UK critical care units have ranged from 1.9 days27 to 11 days.23 In 2006 the 
National Audit Office estimated the additional cost of a BSI to be £6209 per patient.28 The most recent 
(2009) estimate of the financial impact for the NHS suggests that annual costs related to catheter-BSI in 
critical care units are £19.1–36.2M.27
Educational interventions for preventing  
catheter-bloodstream infection
Educational interventions for preventing catheter-BSI have been trialled in critical care settings in many 
countries and vary considerably in their content and complexity. They range from the provision of simple 
fact sheets and posters29 to complex interventions comprising multiple behavioural components.30 
Educational approaches also include continuous quality improvement (CQI), which engages front-line staff 
in cycles of iterative problem solving, with decision-making based on real-time process measurements.31 
Interventions differ in the number and duration of education components, whether they are didactic 
or interactive, and whether infection surveillance feedback and performance feedback are also present. 
Interventions that contain several different elements which together aim to achieve a particular outcome 
TABLE 1 Definitions of BSIs used in the ‘Matching Michigan’ programme in England (source: J Bion; dated 
20 November 2009)
Infection type Definition 
LCBSI The patient has one or more recognised pathogens cultured from one blood culture
If the microorganism is a common skin organism [i.e. diphtheroids (Corynebacterium spp.), 
Bacillus spp. (not B. anthracis), Propionibacterium spp., coagulase-negative staphylococci 
(excludes sensitive S. aureus), viridans-group streptococci, Aerococcus spp. or Micrococcus spp.], 
then . . .
 z It must have been cultured from two or more blood cultures drawn on separate occasions, or 
from one blood culture in a patient in whom antimicrobial therapy has been started, and
 z The patient has one of the following: fever of > 38 °C, chills or hypotension
CABSI Criteria above must be met for LCBSI, and:
 z The presence of one or more CVCs at the time of the blood culture, or up to 48 hours 
following removal of the CVC and:
 z The signs and symptoms and positive laboratory results including the pathogen cultured from 
the blood are not primarily related to an infection at another site
CRBSI Criteria above must be met for LCBSI, and:
 z The presence of one or more CVCs at the time of the blood culture, or up to 48 hours 
following removal of the CVC, and
 z One of the following:
1. a positive semiquantitative (> 15 CFUs/catheter segment) or quantitative (> 10³ CFU/ml  
or > 10³ CFU/catheter segment) culture whereby the same organism (species and 
antibiogram) is isolated from blood sampled from the CVC or from the catheter tip, and 
peripheral blood;
2. simultaneous quantitative blood cultures with a > 5 : 1 ratio of CVC vs. peripheral
Catheter-suspected BSI Negative blood cultures in the presence of parenteral antimicrobials, and
 z Clinical evidence of a systemic response to infection, and
 z Clinical condition improves following removal of CVC, and
 z No other likely source of infection
CFU, colony-forming unit.
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are referred to as ‘multifaceted’, ‘multicomponent’ or ‘bundled’ interventions.32 A care bundle is defined 
as a small set of practices that have been individually proven to improve patient outcomes and when 
implemented together are expected to result in better outcomes than when implemented individually.33
Multifaceted educational interventions that have been developed for preventing catheter-BSI include the 
Michigan Keystone ICU project in the USA34 and the NHS ‘High Impact’ CVC care bundle.28 These include, 
among others, specific components for ensuring appropriate staff behaviour for hand hygiene, patient skin 
hygiene, choice of catheter type and insertion site, and catheter ongoing care.
In general, educational interventions involve encounters between teachers and learners for one or more of 
the following purposes: to raise awareness; to enhance or improve knowledge; or to change behaviour.35 
Educational interventions for preventing catheter-BSI ideally should include behaviour modification 
components underpinned by relevant theory.36
We defined educational interventions as those that contain any element of information provision intended 
to influence catheter-BSI outcomes (i.e. by changing health-care workers’ behaviour). Included within 
this definition are checklists, and information feedback to health-care workers. We distinguish between 
infection surveillance feedback whereby staff are informed in real time of catheter-BSI incidence rates, 
and performance feedback whereby staff are informed of their compliance with evidence-based practices 
or progress with learning goals. According to our definition, educational interventions are not limited 
to purely educational practices but may also include non-educational activities, such as the provision of 
supplies. Such interventions may be described as providing ‘components beyond education’.37
Current prevention of catheter-bloodstream infections  
in the NHS
Catheter-BSI are believed to be largely preventable following work in the UK that has successfully reduced 
the number of cases of methicillin-resistant S. aureus (MRSA) BSI. It has been proposed that the majority of 
catheter-BSI could be prevented using evidence-based educational interventions to ensure that doctors and 
nurses are committed to a culture of safety and follow best practice to achieve this.26,38
Evidence-based practices that are recommended for prevention of catheter-BSI include selection of an 
appropriate catheter type; avoidance of the femoral insertion site; antimicrobial cleansing of the insertion 
site; use of maximal sterile barrier precautions and aseptic technique (gloves, mask, hat, patient drapes) 
during catheter insertion; and use of a sterile semipermeable transparent dressing to allow observation of 
the insertion site.6,39
To address the prevention of catheter-BSI, the NHS has developed ‘Saving Lives’ tools,40 which include 
‘high-impact’ care bundles for CVCs and peripheral intravenous cannula.28 The High Impact No. 1 CVC 
bundle consists of actions for preventing catheter-BSI in relation to CVC insertion (Table 2) and CVC 
ongoing care (Table 3). These bundles are based on ‘epic2’ guidelines,39 which stress the importance 
of education of hospital staff for successful implementation of infection control programmes. Similar 
guidelines produced by the US CDC also strongly emphasise the need for education and training in 
evidence-based practices for preventing catheter-BSI.6 However, in both the epic2 guidelines39 and US 
guidelines6 there is a lack of evidence on the types of educational interventions that are most appropriate 
and effective, and the guidelines do not make any recommendations that specifically relate to critical care 
settings. Following a recommendation in the Darzi Report,41 during 2009–11 the UK National Patient 
Safety Agency implemented an initiative known as ‘Matching Michigan’38,42 to prevent catheter-BSI. 
Matching Michigan was based on a regional-scale intervention that had successfully reduced catheter-BSI 
incidence density in the Keystone ICU project, conducted in 103 critical care units in Michigan, USA.34 
However, the original study in the USA34 was not randomised and did not assess the importance of the 
education strategy in the effectiveness of the overall care bundle.
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TABLE 2 Central venous catheter insertion actions in the High Impact No. 1 CVC bundle28
Catheter type Single lumen unless indicated otherwise
Consider antimicrobial impregnated catheter if duration of 1–3 weeks and risk of 
CRBSI high
Insertion site Subclavian or internal jugular
Skin preparation Preferable use 2% chlorhexidine gluconate in 70% isopropyl alcohol and allow  
to dry
If patient has a sensitivity use a single-patient-use povidone–iodine application
Personal protective equipment Gloves are single-use items and should be removed and discarded immediately after 
the care activity
Eye/face protection is indicated if there is a risk of splashing with blood or  
body fluids
Hand hygiene Decontaminate hands before and after each patient contact
Use correct hand hygiene procedure
Aseptic technique Gown, gloves and drapes, as indicated, should be used for the insertion of  
invasive devices
Dressing Use a sterile, transparent, semipermeable dressing to allow observation of  
insertion site
Safe disposal of sharps Sharps container should be available at point of use and should not be overfilled;  
do not disassemble needle and syringe; do not pass sharps from hand to hand
Documentation Date of insertion should be recorded in notes
TABLE 3 Central venous catheter ongoing care actions recommended in the High Impact No. 1 CVC bundle28
Hand hygiene Decontaminate hands before and after each patient contact
Use correct hand hygiene procedure
Catheter site inspection Regular observation for signs of infection, at least daily
Dressing An intact, dry, adherent transparent dressing should be present
Catheter access Use aseptic technique and swab ports or hub with 2% chlorhexidine gluconate in 
70% isopropyl alcohol prior to accessing the line for administering fluids or injections
Administration set replacement Following administration of blood, blood products – immediately
Following total parenteral nutrition – after 24 hours (72 hours if no lipid)
With other fluid sets – after 72 hours
No routine catheter placement.
The Matching Michigan programme in England recruited 240 adult and 40 paediatric critical care units, 
with 97% of acute health trusts in England participating. Technical components of the Matching Michigan 
programme were a data collection system for infection surveillance; CVC insertion checklist; CVC trolley 
inventory; catheter-BSI fact sheet; and Department of Health High Impact bundles.28 Matching Michigan 
also included non-technical strategies, which were to develop a culture of safety; facilitate learning  
from incidents; foster teamwork and collaborations; and develop executive and clinical partnerships.  
The Matching Michigan programme ran for 2 years and ended in 2011. Preliminary results of audits from 
individual participating trusts are starting to appear at conferences15–17 and in online presentations, but, to 
date, a detailed formal analysis of findings from Matching Michigan has not been published.
bACkGrOuND
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Evidence from existing reviews
A number of narrative reviews have suggested that educational interventions including care bundles may 
be effective at preventing catheter-BSI in various health-care settings,7,43–46 but no systematic reviews 
have specifically investigated the effectiveness of educational interventions for preventing catheter-BSI in 
critical care units. The most relevant systematic reviews in related areas have investigated interventions for 
preventing catheter-BSI (not limited to educational interventions or critical care);47 bundled behavioural 
interventions to control health care-associated infections (not limited to education, catheter-BSI or critical 
care);30 interventions for preventing catheter-BSI in critical care (not limited to education or behavioural 
interventions);48 educational interventions for preventing health care-associated infections (not limited 
to educational or behavioural interventions, catheter-BSI or critical care);37 and features of educational 
interventions that impact on competence in aseptic insertion technique and maintenance of CVCs by 
health-care workers (not limited to catheter-BSI or critical care).49 Some of these systematic reviews 
included primary research studies relevant to the scope of our current evidence synthesis but the most 
recent of these reviews49 did not include any studies published after August 2008.
None of the systematic reviews referred to above included economic analyses. Most of the available 
information on the economic impact of catheter-BSI in critical care is from work conducted in the USA.50,51 
A recent brief narrative review of epidemiological studies27 provides an insight into the economic burden of 
catheter-BSI in critical care in European countries including the UK but, owing to a shortage of information 
on costs, its findings are based on numerous assumptions and uncertainties.
Objectives
The overall aim of this evidence synthesis is to provide a rigorous evaluation of the clinical effectiveness 
and cost-effectiveness of educational interventions that are relevant to the NHS for preventing  
catheter-BSI in critical care units in England. The types of intervention that could be relevant appear diverse,  
but the quantity, quality and relevance of the primary clinical effectiveness and cost-effectiveness  
studies are unclear. To address these uncertainties the current project has the following specific objectives:
1. To create an evidence map summarising all potentially relevant primary research studies. This is 
necessary as a first step to clarify the quantity, quality and potential relevance to NHS policy and 
practice of the existing primary research studies.
2. To conduct a systematic review of a subset of studies in the evidence map considered most relevant to 
inform NHS policy and practice for prevention of catheter-BSI in critical care.
3. To conduct a systematic review of cost-effectiveness studies. This is necessary to clarify the quality and 
relevance of any existing studies of the cost-effectiveness of interventions for preventing catheter-BSI 
and may help to inform the structure of a decision-analytic economic model.
4. To develop a decision-analytic model to determine and compare cost-effectiveness of relevant groups 
of interventions and settings. This would utilise data on clinical effectiveness from Objective 2 and,  
if appropriate, relevant methodology and model parameters identified from Objective 3.
5. Based on the information provided from Objectives 1–4, to identify future research needs and consider 
the implications of implementing educational interventions for preventing catheter-BSI that are 
relevant to service users in the NHS.
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Chapter 2 Methods for the mapping exercise and 
systematic review of clinical effectiveness
The a priori methods for systematically reviewing the evidence of clinical effectiveness and  cost-effectiveness are described in the research protocol (see Appendix 1). The protocol was sent  
to our expert Advisory Group (AG) for comment. Minor amendments were made as appropriate,  
but none of the comments we received identified specific problems with the methods of the review. 
Methods outlined in our protocol are briefly summarised below.
Search strategy
A sensitive search strategy was developed and refined by an experienced information scientist  
(see Appendix 2).
Searches for clinical effectiveness literature were undertaken from inception of databases to January/
February 2011. No trial or study filter and no language restrictions were included in the search strategy.
The strategies were applied during February 2011 to the following databases:
 z MEDLINE (Ovid; searched 1948 to 19 January 2011)
 z Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations (searched to 1 February 2011)
 z EMBASE (Ovid; searched to 25 January 2011)
 z BIOSIS (searched 1969 to 2011)
 z Health Management Information Consortium (HMIC) (searched on 1 February 2011)
 z CINAHL EBSCOhost (searched on 2 February 2011)
 z Cochrane Central Register of Controlled Trials (CCRCT) (searched on 2 January 2011)
 z Cochrane Database of Systematic Reviews (CDSR) (searched on 2 January 2011)
 z Cochrane Database of Abstracts of Reviews of Effects (DARE) (searched on 3 February 2011)
 z Education Resources Information Center (ERIC) (searched from 1966)
 z Web of Science databases (searched to 1 February 2011):
 | Science Citation Index Expanded (SCIE) (searched from 1970)
 | Social Sciences Citation Index (SSCI) (searched from 1970)
 | Arts & Humanities Citation Index (A&HCI) (searched from 1975)
 | Conference Proceedings Citation Index – Science (CPCI-S) (searched from 1990)
 | Conference Proceedings Citation Index – Social Science & Humanities (CPCI-SSH) (searched 
from 1990).
In addition, we hand-searched reference lists of the papers retrieved and relevant systematic reviews for 
potential additional studies. Experts on the project AG were also asked to identify additional published and 
unpublished references. All search results were downloaded into a Reference Manager database version 
12.0.3 (Thomson ResearchSoft, San Francisco, CA, USA). Searches were rerun using the same search 
strategies in March 2012 to identify any new primary research published during March 2011 to  
March 2012, which might impact on the findings of the report.
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Inclusion criteria for descriptive mapping (stage 1)
The purpose of the mapping exercise was to facilitate a description of the evidence base so that a subset 
of policy-relevant studies from the map could be identified and subjected to a detailed systematic review. 
The following inclusion/exclusion criteria were applied to the references identified by the above search 
strategy to select studies eligible for inclusion in the evidence map:
 z Population Patients in critical care with any type of vascular catheter (including CVCs, arterial 
catheters, cannula). Critical care was defined as any critical or intensive care unit (ICU), including  
high-dependency units but excluded general or specialist (e.g. cardiac, neurological, surgical)  
non-critical units. Patients with urinary or other non-vascular catheters were only included if vascular 
catheters were also present. Studies solely on patients with urinary or other non-vascular catheters 
were excluded.
 z Design Interventional studies based on primary research.
 z Intervention(s) Educational interventions with an objective to reduce or prevent catheter-BSI.  
An educational intervention was defined as any intervention that aimed to prevent catheter-BSI and  
(1) included at least an element of factual information provision related to that aim; (2) was described 
by the authors as educational; or (3) was described by the authors as behavioural. Checklists were 
eligible as an educational tool. Interventions that did not target catheter-BSI (e.g. interventions for 
hand hygiene alone or for infection surveillance) were excluded; provision of factual information was 
also excluded if it was unrelated to prevention of catheter-BSI.
 z Outcomes Primary outcomes were BSIs, mortality or LOS associated with, related to, or suspected to 
result from intravascular catheter use. BSIs unrelated to vascular catheter use were excluded, as were 
non-vascular infections (e.g. urinary tract, organ space or skin). The following secondary outcomes 
were not used for study selection but were to be extracted from studies at the data collection stage if 
at least one primary outcome was reported: staff reaction to education; attitudes; knowledge; skills; 
compliance with interventions; and process evaluations (quantitative or qualitative descriptions of 
intervention processes, facilitators or barriers).
Study selection for descriptive mapping
Titles and abstracts of records identified by the bibliographic searches conducted in January/February 
2011 were assessed independently by two reviewers for potential eligibility, using a pilot tested selection 
worksheet containing the above selection criteria (see Appendix 3). Any disagreements between the 
reviewers were resolved through discussion and in some cases with recourse to a third reviewer. Full-text 
papers were obtained for all titles and abstracts that met the selection criteria or were unclear. The full-text 
papers were then assessed independently by two reviewers using the same study selection worksheet. Any 
further disagreements between the reviewers were resolved through discussion and in some cases recourse 
to a third reviewer. Papers published in languages other than English were each assessed by at least one 
native or competent speaker of the publication language together with a member of the systematic 
review team.
In addition to the selection of primary research studies described above, any potentially relevant 
systematic reviews identified during title and abstract screening were obtained as full-text versions for 
detailed inspection.
Owing to lack of time, any new studies identified from the updated searches in March 2012 were not 
formally included in the evidence synthesis but their potential implications for interpretation of the 
evidence synthesis findings are considered in the discussion (see Chapter 7).
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The process of descriptive mapping
As mentioned above, the purpose of the mapping exercise was to facilitate a description of the evidence 
base so that a subset of policy-relevant studies from the map could be identified and subjected to a 
detailed systematic review. This approach has been found to be useful in previously published  
systematic reviews.52–54
Studies that met the selection criteria reported above were coded on the basis of their key characteristics 
using a classification instrument developed by the project team. The classification instrument (see 
Appendix 4) consisted of a standard list of keywords for capturing information on critical care specialties, 
vascular devices used, types of intervention used, study designs, outcomes and the educational 
strategies and topics covered. The classification instrument was provided in an Microsoft Excel (Microsoft 
Corporation, Redmond, WA, USA) worksheet, together with instructions on how to interpret and apply 
the keywords, and was piloted by each member of the project team on three studies. Some amendments 
were made to both the keywords and the instructions to establish good inter-reviewer reliability within 
the team. Once finalised, the instrument was applied to the included studies by one or two reviewers 
depending on the publication language. Studies published in English were classified by one reviewer. 
Studies published in a language other than English were classified jointly by two reviewers, at least 
one of whom was a competent speaker of the publication language. A random sample of 40% of all 
the completed classifications was then checked independently by a further reviewer to ensure good 
inter-reviewer reliability.
Inclusion criteria for the systematic review (stage 2)
Once all of the studies had been classified, analysis was performed to construct the descriptive map  
(for results of the map, see Chapter 3).
The results of the descriptive map were presented to the AG in September 2011 for discussion. The group 
assisted us in prioritising a subset of studies for systematic review that most closely resemble current UK 
practice, and which are most likely to address current policy and practice needs for preventing catheter-BSI 
in critical care. Suggestions for systematic review study selection criteria were provided by seven members 
of the AG and 11 members of the project team, and these were discussed at a face-to-face meeting of the 
project team in October 2011.
Numerous potential selection criteria for the systematic review were discussed. These included limiting 
the systematic review to particular study designs; geographical regions; types of catheter; population age 
groups; types of educational approaches; or levels of study quality. A detailed description of the issues 
discussed is available from the authors upon request.
Based on the discussion, the inclusion criteria for the systematic review were set as follows:
 z Population Adults (i.e. excluding neonatal and paediatric critical care units)
 z Design Clearly reported as prospective
 z Outcomes Studies had to provide a definition of catheter-BSI (including any definitions given in the 
publication or accompanying supplementary material or hyperlinks).
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Study selection for the systematic review
Once the criteria for the systematic review had been set, all of the studies classified in the map were 
rechecked by one reviewer to ensure that the keywords regarding the population, design and outcomes 
were accurate. Studies from the map which met the three inclusion criteria reported above for population, 
design and outcomes were then entered into the full systematic review.
Data extraction in the systematic review
A data extraction and quality assessment form was devised for the systematic review based on a 
standard template used by the project team for other systematic reviews. The template was adapted to 
take into account the reporting standards recommended by the TREND Statement for reporting non-
randomised studies of behavioural interventions;55 a Best Evidence in Medical Education (BEME) Guide for 
systematically reviewing educational interventions;56 and the ORION Statement for reporting intervention 
studies of nosocomial infections.57 The form was piloted on a subset of the studies to ensure good  
inter-reviewer reliability. Data from each study included in the systematic review were then extracted 
by one reviewer and were checked by a second reviewer. Any disagreements between reviewers were 
resolved by consensus or if necessary by arbitration by a third reviewer. The completed data extraction 
forms can be seen in Appendix 5.
Quality assessment
Using criteria specified a priori, we assessed two aspects of the quality of the included studies: (1) risk 
of bias, which identifies methodological deficiencies in studies that could lead to systematic errors in 
outcomes and (2) the reporting of the methods used to collect data, which was identified by the project 
AG as an important aspect of study quality that should be assessed.
Risk of bias
The concept of risk of bias indicates whether study outcomes are likely to be valid and, hence, whether 
they may be trusted in the data synthesis.58 Project scoping searches indicated that before-and-after 
studies were likely to be the most frequent research approach used for evaluating the effectiveness of 
educational interventions for preventing catheter-BSI. Our quality assessment criteria therefore focused 
on before-and-after studies, with additional criteria provided for assessing the quality of randomised 
controlled trials (RCTs), where appropriate. Risk of bias criteria have been established by the Cochrane 
Collaboration for RCTs58 and could, in principle, be adapted or developed for assessing some aspects of 
bias in non-randomised studies.59 Before-and-after studies without a concurrent control group may be 
particularly at risk of performance bias, as investigators may be unable to isolate effects of their intended 
changes in health-care practice (e.g. implementation of an intervention) from other changes that could 
influence patient outcomes (e.g. intrahospital, regional or national changes in health-care practices or 
policies). Before-and-after studies may also be at risk of selection bias if the population characteristics of 
the intervention and comparator (baseline) groups differ systematically, and attrition bias if availability of 
data differs between the intervention and comparator groups.
Specific criteria for assessing risk of bias have not been published for before-and-after studies.  
We developed assessment criteria for risk of selection bias, performance bias and attrition bias (Table 4), 
based on the general format of the Cochrane risk of bias tool, in which risk of bias is judged either as  
low, high or unclear.58 Judgements of ‘unclear’ risk of bias were made if insufficient information was  
reported to assess a given risk of bias criterion. The risk of bias criteria were agreed by the review team  
and then applied independently by two reviewers to the studies included in the systematic review.  
The criteria were revised in light of disagreements between the reviewers’ judgements. The final risk of 
bias criteria (see Table 4) are intended to assist interpretation of the current data synthesis [see Chapter 4, 
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TABLE 4 Risk of bias criteria used to assess before-and-after studies
Type of bias Criteria for judgement of ‘low’ Criteria for judgement of ‘high’
Selection bias risk: systematic 
differences between groups
Characteristics of the patient groups 
were similar in the baseline and 
intervention periods, or any differences 
would be unlikely to influence risk of 
catheter-BSI 
Characteristics of the patient groups 
differed between the baseline and 
intervention periods to an extent that 
could influence risk of catheter-BSI
Performance bias risk: effects of other 
concurrent intervention(s)
Outcomes are interpretable in relation 
to a specified intervention 
Outcomes could be explained by more 
than one intervention 
Performance bias risk: other 
concurrent staff or policy changes
Baseline and intervention periods were 
similar in staff numbers and expertise; 
patient management policies (at 
hospital or critical care unit levels);  
and critical care unit infrastructure 
(e.g. bed numbers)
There were notable differences 
between the baseline and intervention 
periods in staff numbers or expertise; 
in patient management policies; and/
or critical care unit infrastructure 
Performance bias risk: outcome 
assessment not blinded
Staff involved in blood sampling and 
culturing were unaware they were in a 
research study
Staff involved in blood sampling and 
culturing were aware they were in a 
research study
Performance bias risk: outcome 
definition or measurement differences 
between groups
Methods for taking blood for cultures 
and/or criteria for diagnosing  
catheter-BSI did not differ between 
baseline and intervention periods
Methods for taking blood for cultures 
and/or criteria for diagnosing  
catheter-BSI were different in baseline 
and intervention periods
Attrition bias risk: imbalances between 
groups in missing data
Patient population clearly described 
and the numbers of patients who 
provided primary outcome data agree 
with the described population for 
baseline and intervention periods 
Availability of primary outcome 
data differed between baseline and 
intervention periods; and/or reasons 
for missing data related to intervention 
effectiveness
Synthesis of effectiveness (primary outcomes)] and may not be applicable outside this current systematic 
review. It should be recognised that assessment of risk of bias is an imperfect science, as subjectivity of 
interpretation and inter-reviewer disagreements occur even with the well-established Cochrane risk of bias 
criteria for RCTs.60
For RCTs, we applied the risk of bias criteria listed in Table 4 to before-and-after comparisons within each 
study arm so as to enable comparisons with the non-randomised studies; and we also assessed risks of 
selection bias according to the adequacy of randomisation and allocation concealment, according to the 
standard Cochrane risk of bias criteria for RCTs.58
In addition to the risks of selection, performance and attrition bias reported above which we assessed 
using the criteria specified a priori (see Table 4), any other possible sources of bias noted by the 
reviewers in the primary studies were recorded at the data collection stage, in a free text field of the data 
extraction form.
Reporting of data collection in the primary studies
We recorded whether the methods of data collection were reported for clinical outcomes, infection 
surveillance and staff performance. Judgements were agreed by two reviewers and were recorded as yes, 
no, partly or unclear, together with an explanatory statement, in the data extraction form for each study. 
If data collection processes were reported, we also recorded whether they were shown to be validated 
and reliable.
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Data synthesis
Studies were synthesised narratively following a structured approach similar to one proposed by  
Rodgers and colleagues.61 In addition to the narrative synthesis, we explored the possibility of calculating 
pooled-effect estimates across independent studies in meta-analysis, taking into consideration 
methodological similarities and differences between the studies.
The primary review outcome was incidence density of catheter-BSI, expressed as the number of  
catheter-BSI per 1000 catheter-days. Effects were expressed as incidence density risk ratios (RRs) with  
95% confidence intervals (CIs), for comparisons between intervention and baseline periods in the  
before-and-after studies. If a RR and CI were not reported for a primary study, we calculated these 
from catheter-BSI incidence data and the corresponding number of catheter-days, using the method of 
Kirkwood and Sterne.62 In cases when catheter-BSI incidence and catheter-days were not reported, we 
sought these data from the study investigators. All secondary review outcomes (including compliance 
and process evaluations) were synthesised narratively. For all steps of the data synthesis, calculations and 
narrative syntheses were conducted by one reviewer and were then checked by a second reviewer.
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Chapter 3 Results of the mapping exercise
Results of the literature search
The process for identifying relevant references and selecting studies for the evidence map is shown in 
Figure 1. After excluding duplicates, we identified a total of 5013 potentially relevant references. Of these, 
we excluded 4805 references, as their titles and/or abstracts clearly did not meet the selection criteria. 
Reviewer agreement at the title and abstract screening step was 99% [Cohen’s kappa (κ) = 0.90].  
Sixty-seven of the records not initially excluded were conference abstracts. These were found to provide 
too little information to contribute to the keyword mapping exercise and were subsequently excluded. We 
retrieved the full-text publications for the remaining 141 records for inspection. These included 12  
non-English-language publications, which we translated from Spanish,63–69 French,70–72 German73 and 
Swedish.74 Following this selection process, 79 of the full-text records describing 74 primary research 
studies were included in the evidence map.34,50,51,64,65,68–70,75–146
Characteristics of the studies
Geographical locations
Of the 74 primary research studies reporting educational interventions for preventing catheter-BSI which 
we included in the evidence map, most (65%) have been conducted in North America. Seven studies 
have been conducted in Spain (10%),64,65,68,69,121,122,127 five in Brazil (7%),108,109,112,118,132 two each in 
Argentina,129,130 France,70,117 Switzerland,94,144 and the UK,110,128 and one each in Australia,83 Belgium,111 
Canada,119 Italy,120 South Korea142 and Mexico.103 The UK studies were conducted in Northern Ireland128 and 
Scotland110 in paediatric and adult critical care units, respectively. No multinational studies were identified.
Spatial and temporal scales
Most (58) studies (78%) were conducted in single hospitals, with 40 of the studies (54%) conducted in 
single critical care units. Of the included studies, 11 were conducted in 10 or more critical care units.34,68,82, 
83,85,91,107,115,133,140,141 The largest study conducted was the Michigan Keystone ICU project,34 which included 
103 critical care units in 67 hospitals in Michigan, USA.
The duration of interventions ranged from < 1 day to 7 years. In approximately one-quarter of the studies 
the intervention duration was unclear owing to inadequate or ambiguous reporting (Figure 2).
Study designs
The designs of the interventional studies are summarised in Table 5, based on a classification system 
proposed by the Cochrane Collaboration.58,59 The order of study designs in Table 5 reflects a hierarchy of 
the reliability of evidence, with risk of bias likely to be lower in well-conducted RCTs than in cohort studies.
The most frequently used study design, in 48 studies (65%), was a prospective before-and-after study  
(see Table 5). Eight studies81,96,111,116,134,137,141,142 were historically controlled before-and-after studies.  
Three studies68,136,145 were controlled trials but only two of these were randomised.136,145 Speroff and 
colleagues136 conducted a cluster RCT in the USA, in which 60 hospitals were randomised to either a virtual 
collaborative quality improvement (QI) programme or a toolkit-based approach for preventing catheter-BSI. 
Khouli and colleagues145 conducted a RCT in the USA in which medical residents were randomised in a 
simulation laboratory to simulation-based plus video training for CVC insertion or video training alone. 
Palomar-Martinez and colleagues68 conducted a study in Spain in which 17 critical care units received 
either an intervention based on the Michigan Keystone ICU project or served as controls. Two studies  
used an interrupted time series approach.88,115 In the remaining 13 of the 74 studies (18%) the design  
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FIGURE 1 Process for selecting studies in the evidence map.
5013 titles and abstracts identified
Title and abstract screening:
4805 records excluded
62 papers excluded (listed in Appendix 6, Full-text
records excluded from the evidence map)
Population not relevant (n =  6)
Intervention not relevant (n = 10)
Relevant outcomes not reported (n = 12)
Study design not relevant (n = 34)
141 full-text papers obtained
(12 translated to English)
208 potentially eligible
references
79 papers reporting 74 studies
included in evidence map
67 conference abstracts excluded
(listed in Appendix 6, Conference
abstracts excluded from the
evidence map)
FIGURE 2 Duration of interventions.
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was judged unclear, either because it was unclear whether pre-intervention groups were selected 
prospectively or retrospectively (four studies100,106,120,121), or because too little information about the study 
methods was reported to classify the design (nine studies78,80,82,90,101,102,105,113,125).
Critical care specialties
The majority of studies were in adult medical, surgical and cardiac critical care units (Table 6).  
The specialties were not described consistently in the studies and in some cases were unclear. Numbers  
in Table 6 do not sum to 74, as some studies covered multiple specialties.
Intravascular devices
The studies in general provided very little information about the vascular devices used. Sixty-nine studies 
(93%) referred to central lines or CVCs. Five studies65,94,105,117,131 stated that they included arterial catheters 
TABLE 5 Study designs
Study design (Cochrane classification59) No. (rounded %) of studies (n = 74)
Before-and-after study – prospective 48 (65)
Design unclear  9 (12)
Before-and-after study – historically controlled  8 (11)
Controlled trial (including RCT, quasi-RCT, non-randomised)  3 (4)
Interrupted time series (controlled or uncontrolled)  2 (3)
Before-and-after study – unclear whether prospective  4 (5)
ITS, interrupted time series.
TABLE 6 Critical care specialties
Specialty as described by the study authors No. of studies
Medical 20
Medical–surgical 18
Surgical 18
Cardiac/coronary 17
Neonatal 11
Paediatric  8
Neurological/neurosurgical  9
Trauma  6
General or mixed  4
Burn  1
Other  6
Not reported or unclear  7
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as well as CVCs, and one study51 specifically excluded arterial catheters. Many of the studies did not 
report the insertion site (64% of the studies), lumen material (95%), whether antimicrobial-impregnated 
catheters were used (74%) or the number of lumens used (91%) (Table 7). Comparisons between studies 
are problematic, as unreported differences in vascular devices could contribute to interstudy differences 
in catheter-BSI incidence rates. Only three studies83,90,131 reported catheter-BSI data separately for different 
types of vascular catheter.
Description and definition of catheter-bloodstream infection
In 36 of the 74 studies (49%) the authors described BSIs as catheter-associated (CABSI) and in 31 of the 
studies (42%) the authors described BSIs as catheter-related (CRBSI). Four studies70,104,117,125 described BSIs 
in other ways and the remaining three studies80,86,118 provided no description for the infection data they 
presented. Twenty-eight of the 74 studies (38%) provided a definition of catheter-BSI within their report 
and 56 studies (76%) cited a reference to a definition. Most of the studies defined catheter-BSI according 
to criteria of the US CDC NNIS, which operated up to 2004, or the CDC NHSN, which replaced the NNIS in 
2005. Although the CDC definitions have changed through time, studies continued to cite old versions.  
For example, at least seven studies published since 2005 referred to infection definitions published in 1988.
Aims of the studies
Most (57) of the 74 studies (77%) stated that their aim was specifically to prevent catheter-BSI in critical 
care. The remaining studies mostly aimed to prevent catheter-BSI together with ventilator-associated 
pneumonia (VAP),82,102,128,136 together with VAP and urinary tract infections (UTIs),86,104,114,117,130,137 or 
together with VAP and sepsis prevention.91,101 Five studies89,93,94,118,120 each included prevention of  
catheter-BSI as part of a more general aim (Table 8).
TABLE 7 Vascular device characteristics potentially associated with risk of catheter-BSI
Device characteristics No. (rounded %) of studies (n = 74)
Insertion site
Fully reported 15 (20)
Partly reported 12 (16)
Not reported 47 (64)
Lumen material
Fully reported  4 (5)
Partly reported  0 (0)
Not reported 70 (95)
Lumen coating/impregnation
Fully reported 13 (18)
Partly reported  6 (8)
Not reported 55 (74)
Lumen number
Fully reported  3 (4)
Partly reported  4 (5)
Not reported 67 (91)
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Types of educational intervention
Of the 74 studies, 25 (34%) provided information on development or testing of their interventions but 
only three77,102,119 (4%) reported that their interventions were based on educational theory.
The most frequently addressed clinical practices were hand hygiene (49 studies), catheter insertion site 
preparation (typically providing guidance on the use of chlorhexidine or povidone–iodine) (45 studies),  
use of full barrier precautions (43 studies), and catheter insertion site selection (typically discouraging  
use of the femoral site) (36 studies). The studies were variable in the extent to which they reported the  
clinical practices addressed by their interventions, and it was not always clear which clinical practices  
were included in education. For example, of the 49 studies with interventions that targeted hand  
hygiene behaviour, only 37 studies mentioned explicitly that intervention included education about hand 
hygiene (Table 9).
Twenty-two studies (30%) reported interventions that were purely educational and 52 studies (70%) 
reported that their interventions contained components beyond education (e.g. provision of antiseptic,  
or a catheter supplies cart).
The educational forum types (approaches to education delivery) are summarised in Table 10. Studies 
often gave rather general descriptions of educational approaches in which specific details were not 
reported. For this reason, the numbers of studies that used particular educational forum types may have 
been underestimated.
Thirty-one studies (42%) reported infection surveillance feedback and 36 studies (49%) reported 
performance feedback, but in nine studies79,80,85,115,118,119,125,128,142 it was unclear whether feedback 
approaches were used. In several studies, feedback approaches that were described as being part of an 
intervention also appear to have been used during the pre-intervention period.50,87,136,138,139
Characteristics of the educational approaches are summarised in Table 11 and also may have been 
underestimated owing to incomplete reporting by the study authors. Active learning approaches that reinforced 
education delivery by repeated information provision, testing and assessment and/or feedback approaches were 
reported in 49 of the 74 studies (66%), but in 18 studies (24%) it was unclear whether active or passive  
(non-reinforced) educational approaches were used. It is difficult to draw firm conclusions about the use of 
didactic and interactive educational approaches because often teaching sessions were described too superficially 
TABLE 8 Aims of the interventions
Aim No. (rounded %) of studies (n = 74)
Specifically to prevent catheter-BSI 57 (77)
Other aims
Prevention of catheter-BSI and VAP  4 (5)
Prevention of catheter-BSI and VAP and UTI  6 (8)
Prevention of catheter-BSI and VAP and sepsis  2 (3)
Prevention of MRSA, catheter-BSI, VAP and UTI  1 (1)
Prevention of VAP, pressure ulcer, UTI, VAP, deep vein thrombosis  1 (1)
Prevention of ICU-acquired infections including catheter-BSI  1 (1)
Prevention of nosocomial infections including catheter-BSI  1 (1)
Identification of risk factors for catheter-BSI  1 (1)
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TABLE 9 Clinical infection prevention practices reported, listed in order of the number of studies that 
addressed them
Clinical practice
Included in 
intervention
Specified 
as target of 
education
Hand hygiene 49 37
Catheter insertion site preparation, management, and/or ongoing care 45 29
Barrier precautions – full 43 28
Catheter insertion site selection (e.g. avoidance of femoral site) 36 24
Checklist (principally about catheter insertion) 35  5
Dressing care (hygiene, removal, replacement) 33 23
Catheter need review (e.g. daily inspection; removal of unnecessary catheters) 30 17
Barrier precautions – specific (e.g. drapes, gloves, gown) 27 20
Unspecified aseptic or sterile technique 22 19
Catheter device ongoing management (e.g. flushing; hub care, including ‘scrub the hub’) 20 19
Dressing selection (e.g. antimicrobial biopatch) 19 13
Infection prevention and/or control (including evidence-based practice; guidelines) 15 15
Central line cart use 15  1
Catheter (re)placement procedure (e.g. use of ultrasound or radiography;  
avoidance of guidewires) 10  8
Epidemiology of BSIs  8  8
Catheter type selection (e.g. lumen number, chemical impregnation)  5  4
Documentation and auditing of processes  5  3
Team approach to catheter care  5  4
Administration of intravenous medication or infusate  4  4
Blood draw and/or culture technique  4  4
Measurement and/or definition of infection  4  4
Catheter-BSI risk factors  2  2
Responsibilities of health-care workers  1  1
Complications of vascular catheter insertion  1  1
Isolation and contact precautions  1  1
Educational topic(s) not reported or unclear (only a very general or vague  
description was provided)
16 16
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TABLE 10 Educational forum types (approaches to educational delivery)
Education forum No. of studies
Checklist 35
Lecture(s), course(s) or workshop(s) 29 (+ one unclear)a
Printed material (leaflet, pamphlet, magazine, book, course documents) 27
Discussion group(s) 20
Poster 18
Audiovisual (video or slide show) 12
Fact sheet 11
Electronic teaching materials (multimedia resources on CD, DVD, computer, internet) 12
Champion/opinion leader (= group based) 11 (+ one unclear)
Practical demonstration of catheter technique or related activity 10
Face-to-face meetings 9
Self-study 8
Skills practice 8 (+ one unclear)
Goal sheet 7
Virtual learning (computer-mediated instruction) 6
Supervision 6
Conference calls 5
Reminders 4
Simulation 3
Mentoring, shadowing or coaching 3
Information label 2
One or more component(s) of the educational forum unclear 16
Education materials not reported or unclear 34
a Number of lectures/workshops/courses not fully deductible in 17 of these studies.
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for us to be sure of their approach. At least 31 of the studies (42%) used an interactive approach to learning 
which encourages self-discovery of information. Of the 74 studies, 21 studies (28%) made it clear that their 
educational sessions were mandatory, 46 studies (62%) conducted at least some of the training in-service, and 
group-based education appears to have been more frequently used than individual training (see Table 11).
Knowledge of the providers and recipients of the education (Table 12) and the intensity (concentration) of 
education (Table 13) is important for determining the resources that would be required if the intervention 
were to be replicated in another setting. Only 27 of the studies (36%) provided full information on who 
delivered the education, whereas 47 of the studies (64%) fully reported the intended recipients. In 42 of 
the studies (57%) it was unclear how many educational sessions were used and in 54 (73%) it was unclear 
how much time the educational sessions occupied.
TABLE 11 Characteristics of educational approaches used
Education characteristics No. (rounded %) of studies (n = 74)
Mode of learning
Passive  7 (9)
Active 25 (34)
Both passive and active 24 (32)
Unclear 18 (24)
Mode of information presentation
Didactic  7 (9)
Interactive 15 (20)
Both didactic and interactive 16 (22)
Unclear 36 (49)
Participation in educational sessions
Mandatory 21 (28)
Voluntary  4 (5)
Unclear 49 (66)
Location of education/training
In service 46 (62)
External, residential  0 (0)
External, non-residential  4 (5)
Unclear 24 (32)
Contact type
Individual based 10 (14)
Group based 38 (51)
Both individual and group based 13 (18)
Unclear 13 (18)
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
21
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Concurrent changes in clinical practice, policy or infrastructure in addition to the intended intervention 
for preventing catheter-BSI were evident in 17 studies (23%). These included changes in the use of 
antimicrobial catheters, mechanical ventilation and/or UTI prevention bundles, hand hygiene programmes, 
staffing or critical care bed number. Where such changes occurred it would be difficult to isolate the 
effects of the intended intervention for prevention of catheter-BSI. Only 7 of the 74 studies (9%) 
explicitly stated that other concurrent interventions or changes in patient care did not occur during a 
study.70,77,85,86,121,122,145
Mapping exercise: summary of results
Seventy-four studies were identified that have investigated the effectiveness of educational interventions 
for preventing catheter-BSI in critical care. The majority of research has involved uncontrolled  
before-and-after studies conducted in the USA, predominantly local-scale studies in single critical care 
TABLE 12 Education providers and recipients
Category No. (rounded %) of studies (n = 74)
Education providers 
Fully reported 27 (36)
Partly reported 12 (16)
Unclear 35 (47)
Education recipients
Fully reported 47 (64)
Partly reported 10 (14)
Unclear 17 (23)
TABLE 13 Concentration of education
Educational sessions No. (rounded %) of studies (n = 74)
Frequency 
Fully reported 12 (16)
Partly reported 20 (27)
Unclear 42 (57)
Duration
Fully reported  6 (8)
Partly reported 14 (19)
Unclear 54 (73)
Both frequency and duration fully reported  6 (8)
Frequency and duration both unclear 33 (45)
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units but also some regional-scale studies with up to 103 critical care units. Very limited information is 
available for the UK. Approximately half of the studies described catheter-BSI as CABSI and the other half 
as CRBSI, with few other descriptions reported. The most commonly targeted clinical practices were hand 
hygiene, preparation of the insertion site and the use of maximal sterile barrier precautions, with a wide 
variety of educational approaches used to address these. Interventions containing components beyond 
education were reported approximately twice as frequently as interventions consisting of education alone. 
Few studies reported the intensity of education they provided, which makes it difficult to determine 
resource requirements.
The evidence map highlights that secondary synthesis of educational interventions for preventing  
catheter-BSI is a complex area requiring appraisal of educational/behavioural strategies, complex 
interventions and non-randomised studies.
As mentioned earlier in Chapter 2 (see The process of descriptive mapping), the results of the mapping 
exercise were discussed with the project’s AG to identify studies relevant to NHS practice and policy for 
prevention of catheter-BSI. Various different inclusion criteria for the systematic review were discussed, 
based on the findings of the map. These discussions led to the identification of the following inclusion 
criteria for the systematic review:
 z Population Adults (i.e. excluding neonatal and paediatric critical care units).
 z Design Clearly reported as prospective.
 z Outcomes Studies had to provide a definition of catheter-BSI (including any definitions given in the 
publication or accompanying supplementary material or hyperlinks).
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Chapter 4 Results of the systematic review of 
clinical effectiveness
The inclusion criteria for the systematic review were chosen through discussion with the project’s  AG, to prioritise studies that were likely to be of most relevance to current NHS policy and  
practice for preventing catheter-BSI in critical care units in England. The agreed inclusion criteria  
specified that studies should have assessed interventions in adult critical care units; used  
and clearly reported a prospective study design; and provided a definition of catheter-BSI.  
Twenty-four34,50,51,68,83,87,93,94,97,98,103,108–110,117,122,126,129,130,135,136,138,139,144 of the 74 studies included in the 
evidence map met these criteria and were included in the systematic review (Figure 3). Below, we describe 
the key characteristics of these 24 studies, before going on to consider their methodological quality and 
the effectiveness of their educational interventions for the prevention of catheter-BSI.
Characteristics of the included studies
The current systematic review focuses on studies of adult critical care units, with prospective designs, 
and which provided definitions of catheter-BSI, but in other respects the characteristics of the included 
studies are broadly representative of those included in the evidence map (Table 14). Half of the studies 
were conducted in the USA, and the majority used single-cohort before-and-after designs. One of the 
two UK studies in the evidence map was excluded from the systematic review because it was conducted 
in neonatal critical care units,128 and one of the two RCTs in the evidence map was excluded from the 
systematic review because it did not provide a definition of catheter-BSI.145 The systematic review includes 
studies conducted at different spatial and temporal scales, and involving different types of education, 
either focusing on education alone, or including additional intervention strategies beyond education  
(see Table 14). Further details of the study characteristics are presented below.
Study designs
The 24 studies included in the systematic review had the following designs. Most (20) were prospective 
before-and-after studies and these involved either single critical care units,50,51,87,93,94,97,108,110,138 multiple 
critical care units for which results were pooled across the units,34,83,98,126,129,130,135,139 or multiple critical 
care units for which results were presented separately for each unit.103,109,122,144 One RCT136 was based on 
clusters, with hospitals randomised to interventions, but implementation was at the level of the critical  
care unit, comparing ‘Virtual Collaborative’ and ‘Toolkit’ CQI programmes in 60 critical care units.  
One non-randomised study68 compared a CQI intervention and control (no intervention) in 17 critical care 
units. The remaining two studies83,117 were single-cohort CQI programmes without a true baseline period in 
which data from early in the intervention period served as the baseline (Table 15).
Populations
Characteristics of the critical care patient populations were generally reported superficially. Only 10 out 
of the 24 studies (42%)50,87,93,103,109,110,129,136,139,144 reported the age and/or sex of their patient population 
(Table 16). The youngest patients reported were on average in their early 40s, in the studies by DuBose  
and colleagues93 and Higuera and colleagues.103 The oldest critical care population group reported  
was in the study by Rosenthal and colleagues,129 in which the mean age was close to 72 years. Where 
reported, the studies included mixed-sex populations, with the proportion of men ranging from  
46% to 79%. Only one study mentioned the patients’ ethnicity, stating that 94% of the population was 
Caucasian.139 Comorbidities were reported inconsistently, with some studies providing considerable detail 
and others providing no information (see data extractions in Appendix 5). In most studies the population 
characteristics either did not differ between the intervention and comparator groups or were not reported. 
Where differences between groups were evident we considered the risk of bias (reported below).
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TABLE 14 Comparison of key study characteristics between the systematic review and evidence map
Study characteristic
No. (rounded %) of studies included 
in the evidence map (n = 74)
No. (rounded %) of studies included 
in the systematic review (n = 24)
Conducted in the USA 48 (65) 12 (50)
Conducted in the UK  2 (3)  1 (4)
Prospective before-and-after study 40 (54) 20 (83)
RCT  2 (3)  1 (4)
Design unclear 13 (18)  0
Education alone 22 (30) 14 (58)
Components beyond education 52 (70) 10 (42)
Short term (≤ 12 months) 32 (43) 13 (54)
Long term (> 12 months) 21 (28) 11 (46)
Duration unclear 21 (28)  0
FIGURE 3 Process for selecting studies for inclusion in the systematic review.
74 studies included in the evidence map
(from Figure 1)
24 studies included in the
systematic review
50 studies (listed in Appendix 6, Full-text records
excluded from the clinical effectiveness
systematic review) were excluded for the
following reasons: 
Population not adult (n = 18)
Study design retrospective or unclear (n = 24)
Infection definition not reported (n = 39)
(numbers do not add up to 50 as some studies
met multiple exclusion criteria)
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TABLE 15 Summary of study characteristics
Study (publication year)
Country (no.: specialty of critical care units) [duration of 
intervention]. Intervention summary Study design
Burrell;83 CEC146  
(2010, 2011)
Australia (37: not reported; included paediatric units at two hospitals) 
[18 months]. CQI programme based on principles of the Michigan 
Keystone ICU intervention,34 including a ‘clinician bundle’ (hand 
hygiene, barrier precautions and sterile technique) and a patient 
bundle (skin preparation, patient draping and imaging catheter 
positioning during insertion) with performance feedback and infection 
surveillance feedback; aimed at ICU staff (staff grades not specified)
Single cohort without 
true baseline period 
Coopersmith (2002)50 USA (1: surgical/burn/trauma) [6 months]. Multimodal education on 
CVC care and unspecified topics including in-services, posters and 
fact sheets, self-study and performance feedback; aimed at critical 
care nurses and also non-critical care staff
Prospective before-
and-after study
Coopersmith (2004)87 USA (1: surgical) [15 months]. Multimodal education including 
lectures, self-study, practical demonstration, in-services and pictures 
of CVC maintenance, with broad topic coverage; aimed at nurses
Prospective before-
and-after study
DuBose (2008)93 USA (1: trauma) [3 months]. Daily quality rounds checklist with 2 
out of 16 checklist items relevant to CRBSI prevention; aimed at ICU 
fellows, residents and medical students
Prospective before-
and-after study
Eggimann (2000),94 
(2005)95
Switzerland (1: medical) [up to 6 years]. Education based 
on 30-minute slideshows, bedside in-services and practical 
demonstration; aimed at all critical care staff (physicians, nurses and 
nursing assistants)
Prospective before-
and-after study
Galpern (2008)97 USA (3: medical and surgical (mixed across three locations), one 
cardiac) [19 months]. Central line bundle including discussion 
sessions about CVC access and care, checklist, infection surveillance 
feedback, performance feedback and catheter cart; aimed at all ICU 
staff (physicians and nurses)
Prospective before-
and-after study
Guerin (2010)98 USA (2: medical, surgical) [1 year]. Post-insertion central line care 
bundle including 4-hour hands-on practical sessions on CVC access 
and care followed by competence evaluation; included performance 
feedback and provision of an intravenous therapy team; aimed at all 
critical care unit nursing staff
Prospective before-
and-after study
Higuera (2005)103 Mexico (2: medical surgical, neurosurgical) [9 months]. Process 
control intervention including 1-hour classes and provision of CDC 
infection control guidelines, with performance feedback and the 
provision of alcohol hand rub; aimed at ICU nurses, ancillary staff 
and physicians
Prospective before-
and-after study
Lobo (2005)108 Brazil (2: medical) [8 months + 12 months’ follow-up]. Multimodal 
education with infection surveillance feedback, including posters and fact 
sheets with emphasis on hand hygiene; aimed at all critical care staff
Prospective before-
and-after study
Lobo (2010)109 Brazil (2: medical) [9 months]. Two educational interventions with 
performance feedback and infection surveillance feedback: ICU A – 
monthly lectures and monthly questionnaire, ICU B – single lecture, 
unspecified duration; aimed at all critical care staff
Prospective before-
and-after study
Longmate (2011)110 Scotland (1: medical surgical) [up to 36 months]. CQI programme 
(including VAP prevention) incorporating checklist, infection 
surveillance feedback and performance feedback; aimed at critical 
care nurses and trainee doctors
Prospective before-
and-after study
Misset (2004)117 France (1: medical surgical) [unclear, ~ 5–6 years]. CQI programme 
(including VAP and UTI prevention) based on infection surveillance 
feedback; aimed at all ICU staff (nurses and residents)
Single cohort without 
true baseline period
Palomar Martinez (2010)68 Spain (17: not reported) [3 months]. Pilot study evaluating the 
feasibility of national implementation of a CQI intervention based on 
the Michigan Keystone ICU intervention34
Non-randomised 
controlled trial, 
historical baseline 
continued
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TABLE 15 Summary of study characteristics (continued)
Study (publication year)
Country (no.: specialty of critical care units) [duration of 
intervention]. Intervention summary Study design
Perez Parra (2010)122 Spain (3: medical, general post surgery, cardiac post surgery) 
[15–20 minutes + 9 months’ follow-up]. Short (15-minute) lecture on 
approaches for CVC care and maintenance; aimed at all critical care 
staff, with post-test 6 months after intervention
Prospective before-
and-after study
Pronovost (2006),34 
(2008),124 (2010)123
USA (103: including medical, cardiac surgical, neurological surgical, 
cardiac medical, trauma and one paediatric) [up to 3 years]. CQI 
programme (Michigan Keystone ICU project) using a checklist, 
presentations and meetings, fact sheet, infection surveillance 
feedback and catheter supplies cart; aimed at ‘ICU colleagues’ 
(unspecified)
Prospective before-
and-after study; 
some ICUs without 
true baseline period
Render (2006)126 USA (8: medical) [unclear; data reported for 1 year]. Continuous 
QI programme based on work/learning/reporting cycles, including 
performance feedback and infection surveillance feedback; aimed at 
ICU nurses and physicians
Prospective before-
and-after study
Rosenthal (2003)129 Argentina (4: cardiac, medical-surgical) [8–10 months]. Unspecified 
education and performance feedback; aimed at health-care workers 
(unspecified). The education period (1–2 months) was followed by a 
performance feedback period (7–8 months)
Prospective before-
and-after study
Rosenthal (2005)130 Argentina (2: cardiac, medical surgical) [17 months]. Daily 1-hour 
educational classes and discussion groups for 1 week, followed by 
performance feedback during the remainder of the intervention 
period to enhance hand hygiene compliance; aimed at health-care 
workers (nurses, physicians and ancillary staff)
Prospective before-
and-after study
Sherertz (2000)135 USA (7: general medical and surgical + 1 step down unit) [3 days 
in each of 2 years]. Hands-on 1-day course on infection control 
practices and procedures including simulation and performance 
feedback; aimed at third year medical students and physicians 
completing their first postgraduate year. Course run on 3 days  
in June 1996 and 3 days in June 1997, with follow-up to  
December 1997
Prospective before-
and-after study
Speroff (2011)136 USA (60: not reported, but included two paediatric per arm) 
[18 months]. Hospitals randomised to Virtual Collaborative and 
Toolkit CQI approaches (including VAP prevention), with access to 
interactive web seminars for both groups. Virtual collaborative: 
monthly educational and troubleshooting conference calls, individual 
coaching and electronic mailing list (designed to stimulate interaction 
among teams). Toolkit: based on evidence based guidelines, fact 
sheets, review of QI and teamwork methods, educational on-line 
tutorials and standardised data collection/charting tools. Included 
performance feedback
RCT
Wall (2005)138 USA (1: medical) [2 years]. CQI programme involving real time 
feedback of infection rates and compliance with insertion practice, 
based on use of checklist, supervision of insertions, and web-based 
tutorial with competence assessment; aimed at ICU house staff 
(proceduralists) and nursing staff (as observers of procedures)
Prospective before-
and-after study
Warren (2003)139 USA (2: medical, surgical) [3 months + 10 months’ follow-up]. 
Multimodal education including lectures, self-study, bedside 
teaching, in-services, staff meetings, posters and fact sheets and 
performance feedback, with broad topic coverage; aimed at nurses 
and physicians
Prospective before-
and-after study
Warren (2004)51 USA (1: medical) [1 month + 23 months’ follow-up]. Multimodal 
education including lectures, self-study, bedside teaching, discussion 
groups, posters and fact sheets and performance feedback, with broad 
topic coverage; aimed at nurses and physicians
Prospective before-
and-after study
Zingg (2009)144 Switzerland (5: medical, trauma, cardiovascular, general surgery) 
[5 months]. Multimodal education including interactive training 
modules and video demonstrations focusing on hand hygiene and 
vascular catheter care; aimed at nurses and physicians
Prospective before-
and-after study
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The critical care specialties most frequently reported were medical, surgical and cardiac. Three of the 
regional-scale studies33,83,136 were not conducted entirely in adult critical care units but we judged the 
studies to have met the population inclusion criterion for the systematic review because the proportion of 
non-adult critical units was small. Burrell and colleagues83 included two paediatric critical care units  
(95% were adult units), Pronovost and colleagues35 included one paediatric unit (99% were adult units) 
and Speroff and colleagues136 included two paediatric units in each study arm (93% were adult units). 
Palomar Martinez and colleagues68 appeared to focus on adult critical care but did not state this explicitly 
(the study authors were contacted but had not clarified this at the time of writing).
Vascular devices
All 24 studies included in the systematic review reported that they used CVCs, but it was not always clear 
whether other catheter types were also used. Misset and colleagues117 included arterial catheters, whereas 
Warren and colleagues51 specifically excluded these. Antimicrobial impregnated catheters were used 
routinely by DuBose and colleagues93 and Warren and colleagues139 but were not used by Sherertz and 
colleagues135 or Warren and colleagues.51 Longmate and colleagues110 specified that their default catheters 
were non-impregnated and had four or five lumens, whereas Guerin and colleagues98 used antimicrobial-
impregnated catheters unless patients were hypersensitive to them. Coopersmith and colleagues50,87 used 
four-lumen antimicrobial-impregnated catheters before their educational intervention but stated that their 
‘accessibility was limited’ after the implementation of education (we discuss the implications of this for risk 
of bias below). The only other studies that reported lumen characteristics were by Wall and colleagues,138 
who used triple-lumen catheters; Render and colleagues,126 who specified that 60% of the catheters were 
multilumen; and Misset and colleagues,117 who specified that single-lumen or multilumen catheters were 
used as clinically required.
Definitions of bloodstream infections
Of the 24 studies, 12 defined their infections as, or equivalent to, catheter-associated (CABSI), 11 defined 
their infections as, or equivalent to, catheter-related (CRBSI), and the remaining study117 gave an unclear 
definition (Table 17). Only eight studies provided definitions that agree with those of the Matching 
Michigan programme. In one of these studies, by Palomar Martinez and colleagues,68 definitions equivalent 
to CABSI and CRBSI were both accepted but were not separated when reporting the results (see Table 17). 
In support of their reported infection definitions, 28 of the studies also cited published references to 
definitions of CABSI or CRBSI. However, the most frequently-cited of these references, by Garner and 
colleagues,147 does not actually define CABSI or CRBSI.
TABLE 16 Patient characteristics in 10 studies that reported patients’ age and/or sex
Study Age (years) (mean unless stated) Sex (% male)
Coopersmith (2002)50 Not reported Baseline 59.8; intervention 55.3
Coopersmith (2004)87 Baseline 54.5; intervention 57.4 Baseline 49.4; intervention 56.9
DuBose (2008)93 Baseline 41.1; intervention range 40.3–41.6 Baseline 73.0; intervention range 67.0–78.9
Higuera (2005)103 Baseline 44.32; intervention 45.91 Baseline 45.5; intervention 48.2
Lobo (2010)109 ICU A: baseline 54; intervention 53 ICU A: baseline 62; intervention 43
ICU B: baseline 55; intervention 51 ICU B: baseline 49; intervention 50
Longmate (2011)110 Not reported Baseline 56.1; intervention range 55.5–56.2
Rosenthal (2003)129 Baseline 71.98; intervention 71.91 Baseline 48.8; intervention 53.6
Speroff (2011)136 Not reported Baseline: virtual collaborative group 50.3; 
toolkit group 49.7
Warren (2003)139 Overall study period 67 Overall study period: 52
Zingg (2009)144 Median: baseline 62; intervention 61 Baseline 64; intervention 67
rESuLTS Of THE SYSTEMATIC rEVIEw Of CLINICAL EffECTIVENESS
28
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Types of educational intervention
The types of educational approach used in the 24 included studies are summarised in Table 15. As noted in 
the protocol (see Appendix 1), educational interventions were defined in a broad sense to capture any  
type of information provision relating to the prevention of catheter-BSI by critical care staff, including the 
use of checklists, performance feedback and information surveillance feedback. Fourteen of the studies 
(58%)50,51,87,93,94,108,109,122,129,130,135,138,139,144 used interventions that we classified as purely educational. These 
ranged from the provision of single lectures109,122 to multimodal combinations of bedside teaching,51,94,139 
in-services 50,87,94,139 self-study,50,51,139 practical demonstrations,87,94,144 slide shows or videos,94,144 
lectures,51,87,109,139 discussion groups or classes,51,130 supervision,138 simulations,135 and/or posters and fact 
sheets50,51,87,108,139 (see Table 15). In one study129 the educational approach was not reported and it is 
possible that other studies may not have fully reported all of the educational approaches that they used. 
These purely educational interventions were all implemented at a local scale, mostly in single critical 
care units.
TABLE 17 Comparison of catheter-associated and CRBSI definitions in the primary studies with definitions used in 
the Matching Michigan programme in England
Study Reported definition Consistent with Matching Michigan definitions?
Burrell (2011)83,146 CABSI Yes – CABSI
Coopersmith (2002)50 CRBSI No
Coopersmith (2004)87 CRBSI No
DuBose (2008)93 CRBSI No
Eggimann (2000),94 (2005)95 CRBSI No
Galpern (2008)97 CABSI No
Guerin (2010)98 CABSI Yes – CABSI
Higuera (2005)103 CABSI No
Lobo (2005)108 CABSI Yes – CABSI
Lobo (2010)109 CABSI No
Longmate (2011)110 CRBSI No
Misset (2004)117 Unclear No
Palomar Martinez (2010)68 CRBSI Yes – met either CRBSI or CABSI but not reported 
separately
Perez Parra (2010)122 CABSI No
Pronovost (2006),34 (2008),124 (2010)123 CRBSI No
Render (2006)126 CRBSI No
Rosenthal (2003)129 CABSI Yes – some met CABSI
Rosenthal (2005)130 CABSI Yes – CABSI
Sherertz (2000)135 CRBSI No
Speroff (2011)136 CABSI Yes – CABSI
Wall (2005)138 CRBSI No
Warren (2003)139 CABSI No
Warren (2004)51 CABSI Yes – CABSI
Zingg (2009)144 CRBSI No
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A total of 1034,68,83,97,98,103,110,117,126,136 of the 24 studies (42%) were classified as having intervention 
components beyond education (a classification previously used by Safdar and Abad37 in a systematic 
review of interventions for preventing health care-associated infections). These studies included some of 
the educational approaches referred to above but, in addition, they used changes in equipment (e.g. the 
provision of a catheter supplies cart or alcohol for skin antisepsis) or infrastructure (e.g. the provision of 
a team). Five34,68,83,126,136 of these studies implemented their interventions at a regional scale, in 8,126 17,68 
37,83 60136 or 10334 critical care units (see Table 15). These regional-scale studies included the Michigan 
‘Keystone ICU’ project conducted in the USA;34,123,124 the ‘CLAB ICU’ project,83 which sought to replicate 
aspects of the Keystone ICU project in Australia; the ‘Bacteraemia Zero’ project,68 which sought to replicate 
aspects of the Keystone ICU project in Spain, and the RCT referred to above, which compared Virtual 
Collaborative and Toolkit approaches in the USA.136 Four of these interventions could be described as  
CQI programmes34,83,126,136 in which iterative improvements in clinical practices became embedded over  
time, whereas the fifth68 was a short (3-month) pilot study of a CQI programme. A further two CQI 
programmes were implemented at a local scale in individual critical care units in France117 and Scotland.110 
The remaining three studies97,98,103 that implemented interventions with components beyond education 
at a local scale (in one to three critical care units) included a catheter insertion care bundle,97 a catheter 
ongoing care bundle,98 and an educational intervention with provision of alcohol hand rub.103
The duration of interventions included in the systematic review ranged from a brief 15-minute lecture 
reported by Perez Parra and colleagues122 to up to 6 years in the case of a multimodal educational 
intervention reported by Eggimann and colleagues94,95 (see Table 15). With the exception of  
five studies,51,108,122,135,139 the studies monitored effects of the interventions on catheter-BSI incidence density 
only during the period of intervention implementation, without post-intervention follow-up. This reflects an 
intention in many of the studies that the interventions would become embedded into routine clinical practice.
Formal and informal education
Formal education implies that participants set aside some time for structured learning, for example to 
participate in classes, lectures, seminars, view slide shows, or take self-study modules. Informal education 
may involve passive information dissemination, for example in-service discussions during daily rounds, 
posters, newsletters, or supervision. The distinction is important from the perspective of resource provision 
since staff engaging in formal learning will be taken away from their critical care duties. Nearly all of the 
educational interventions contained formal education components (Table 18), implying that staff cover 
would need to be provided for those staff participating in an intervention. However, the concentration 
of the education (duration and frequency of sessions and whether they were periodically reinforced) was 
rarely reported (see data extraction forms in Appendix 5).
Educational theory
None of the 24 included studies specified an educational or behavioural theory. Pronovost and 
colleagues124 referred to the ‘4E’ framework proposed by Heifetz, in which the technical aspects  
(i.e. scientific evidence; definitions of measures standardised across hospitals) are classed as education and 
evaluation, whereas the adaptive elements (i.e. implementation of measures; interventions modified to fit 
the local context of a clinical area) are classed as engagement and execution. The authors stated only that 
the technical functions in the study were centralised.
Comparison of educational interventions with UK practice
The Matching Michigan programme is reflective of current NHS practice for preventing catheter-BSI  
(see Chapter 1) and educational interventions included in the systematic review shared some of the  
approaches used in Matching Michigan to varying degrees (Table 19). Of the 24 included studies,  
11 studies34,68,83,93,97,108–110,126,136,138 used checklists to improve compliance with best practices for prevention  
of catheter-BSI. Three studies34,83,98 empowered their staff to halt CVC insertion procedures if protocols for 
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infection prevention were not followed. Fourteen studies34,50,83,87,97,108–110,117,126,130,136,138,139 included infection 
surveillance feedback in their interventions, in which catheter-BSI incidence rates were reported to critical care 
staff at regular intervals, either at meetings or using posters or fact sheets. However, for six of these studies, 
infection surveillance feedback was already in place during the baseline period and would not explain any 
differences in catheter-BSI incidence densities observed between baseline and intervention periods. Fourteen 
studies involved interventions that provided some form of performance feedback to the critical care unit 
staff. The feedback primarily provided information on compliance with interventions or specific intervention 
components (e.g. hand hygiene110), but in some studies feedback was given on problems encountered109  
or on staff competence assessed through tests of knowledge or skills, with staff required to repeat training 
if satisfactory scores were not achieved.50,51,98 In three studies68,122,139 the critical care staff were given tests or 
questionnaires, but it is unclear whether the results were fed back to the staff.
TABLE 18 Formal education approaches used in the primary studies 
Study Type of education Main formal education method used
Burrell (2011)83,146 Formal + informal Workshops
Coopersmith (2002)50 Formal 10-page self-study module
Coopersmith (2004)87 Formal + informal Lectures
DuBose (2008)93 Unclear –
Eggimann (2000),94 (2005)95 Formal Slide shows
Galpern (2008)97 Informal –
Guerin (2010)98 Formal 4-hour mandatory training
Higuera (2005)103 Formal 1-hour classes
Lobo (2005)108 Formal Monthly classes
Lobo (2010)109 Formal Lectures
Longmate (2011)110 Formal Self-guided education, including slide show
Misset (2004)117 Unclear –
Palomar Martinez (2010)68 Formal + informal ‘Kick-off’ meeting, online course
Perez Parra (2010)122 Formal 15-minute lecture
Pronovost (2006),34 (2008),124 
(2010)123
Formal + informal PowerPoint (Microsoft Corporation, Redmond, WA, USA) 
presentation
Render (2006)126 Formal + informal 1.5-day ‘kick-off’ session of lectures/presentations – 
unclear if involved all staff 
Rosenthal (2003)129 Formal Unclear, other than education and training provided
Rosenthal (2005)130 Formal 1-hour educational classes (repeated)
Sherertz (2000)135 Formal Classes on basic principles, plus skills station training
Speroff (2011)136 Formal Interactive web seminars
Wall (2005)138 Formal Web-based tutorial but not compulsory to complete
Warren (2003)139 Formal 45-minute lectures, and self-study module
Warren (2004)51 Formal 45-minute lectures, and self-study module
Zingg (2009)144 Formal + informal 45-minute classroom teaching sessions
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Clinical practices recommended in the Department of Health ‘High Impact Intervention No. 1’ for CVC 
insertion and maintenance28 (see Tables 2 and 3) and used in Matching Michigan were included to varying 
degrees in the primary studies (Table 20). Where studies had two interventions,109,136 the interventions 
within each study did not differ in the clinical practices addressed and have been summarised together in 
Table 20. The most frequently addressed of the recommended clinical practices were hand hygiene prior to 
patient contact, and the use of maximal sterile barrier precautions and antiseptic insertion site preparation. 
Only three studies93,129,139 did not address hand hygiene practices, although in five studies68,97,122,130,135 there 
was ambiguity as to whether hand hygiene was prior to or after contact with the patient (see Table 20). 
TABLE 19 Strategies used in educational interventions for prevention of catheter-BSI compared with the  
Matching Michigan programme 
Study Checklist
Staff 
empowerment
Infection 
surveillance 
feedback
Performance 
feedback
Burrell (2011)83 • • • •
Coopersmith (2002)50 (•) •
Coopersmith (2004)87 (•)
DuBose (2008)93 •
Eggimann (2000)94
Galpern (2008)97 • • •
Guerin (2010)98 • •
Higuera (2005)103 •
Lobo (2005)108 • •
Lobo (2010)109 • • •
Longmate (2011)110 • • •
Misset (2004)117 •
Palomar Martinez (2010)68 • ? ?
Perez Parra (2010)122 ?
Pronovost (2006)34 • • •
Render (2006)126 • • •
Rosenthal (2003)129 •
Rosenthal (2005)130 (•) •
Sherertz (2000)135 •
Speroff (2011)136 • (•) •
Wall (2005)138 • (•) •
Warren (2003)139 (•) ?
Warren (2004)51 ? •
Zingg (2009)144
Matching Michigan • • • •
•, Included in intervention; (•), Included in both intervention and baseline; ?, Unclear if system was already in place 
before the educational intervention.
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TABLE 20 Evidence-based practices specified the UK ‘High Impact Intervention No. 1’ for CVC insertion and  
maintenance28 that were included in the primary studies
Study
CVC insertion practices CVC ongoing care practices
Hand hygiene
Maximal 
barrier 
precautions
Skin 
preparation
Insertion 
site 
selection Dressing
Documentation 
(date of 
insertion)
Hand hygiene
Site inspection 
(daily) Dressing 
Catheter need 
review
Catheter 
access
Administration 
set replacement
No routine 
catheter 
replacement
Before 
contact
After 
contact
Before 
contact
After 
contact
Burrell (2011)83 • • • • • • • • • • •
Coopersmith (2002)50 • ? ? ? •
Coopersmith (2004)87 • ? ? ? ? ? ? 
DuBose (2008)93 •
Eggimann (2000)94 • • • • • • • • • • • •
Galpern (2008)97 ° ° • • • •
Guerin (2010)98 • • • • • • • • •
Higuera (2005)103 • • • • •
Lobo (2005)108 • • • • • • • • • • • •
Lobo (2010)109 • • • ? ? ° • • ° • •
Longmate (2011)110 • • • • • • ? • • •
Misset (2004)117 • • • • • • • ? •
Palomar Martinez 
(2010)68
° ° • • • ° ° •
Perez Parra (2010)122 ° ° • • ° ° ? •
Pronovost (2006)34 • • • • • • • •
Render (2006)126 • • • • •
Rosenthal (2003)129 • • •
Rosenthal (2005)130 ° °
Sherertz (2000)135 ° ° • • ° ° ° °
Speroff (2011)136 • • • • • • •
Wall (2005)138 • • • •
Warren (2003)139 • • • •
Warren (2004)51 • • • • • • • • • • •
Zingg (2009)144 • • • • • •
Matching Michigan • • • • • • • • •
•, included in intervention; °, included in intervention but timing unclear in relation to patient contact (before or after) 
and/or care phase (device insertion or maintenance); ?, unclear whether included in intervention (limited information 
reported, or mentioned only as an outcome or an assessment/examination item).
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TABLE 20 Evidence-based practices specified the UK ‘High Impact Intervention No. 1’ for CVC insertion and  
maintenance28 that were included in the primary studies
Study
CVC insertion practices CVC ongoing care practices
Hand hygiene
Maximal 
barrier 
precautions
Skin 
preparation
Insertion 
site 
selection Dressing
Documentation 
(date of 
insertion)
Hand hygiene
Site inspection 
(daily) Dressing 
Catheter need 
review
Catheter 
access
Administration 
set replacement
No routine 
catheter 
replacement
Before 
contact
After 
contact
Before 
contact
After 
contact
Burrell (2011)83 • • • • • • • • • • •
Coopersmith (2002)50 • ? ? ? •
Coopersmith (2004)87 • ? ? ? ? ? ? 
DuBose (2008)93 •
Eggimann (2000)94 • • • • • • • • • • • •
Galpern (2008)97 ° ° • • • •
Guerin (2010)98 • • • • • • • • •
Higuera (2005)103 • • • • •
Lobo (2005)108 • • • • • • • • • • • •
Lobo (2010)109 • • • ? ? ° • • ° • •
Longmate (2011)110 • • • • • • ? • • •
Misset (2004)117 • • • • • • • ? •
Palomar Martinez 
(2010)68
° ° • • • ° ° •
Perez Parra (2010)122 ° ° • • ° ° ? •
Pronovost (2006)34 • • • • • • • •
Render (2006)126 • • • • •
Rosenthal (2003)129 • • •
Rosenthal (2005)130 ° °
Sherertz (2000)135 ° ° • • ° ° ° °
Speroff (2011)136 • • • • • • •
Wall (2005)138 • • • •
Warren (2003)139 • • • •
Warren (2004)51 • • • • • • • • • • •
Zingg (2009)144 • • • • • •
Matching Michigan • • • • • • • • •
•, included in intervention; °, included in intervention but timing unclear in relation to patient contact (before or after) 
and/or care phase (device insertion or maintenance); ?, unclear whether included in intervention (limited information 
reported, or mentioned only as an outcome or an assessment/examination item).
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Generally, fewer studies addressed practices related to CVC ongoing care than practices related to CVC 
insertion. When interpreting Table 20, it is important to bear in mind that authors of the primary studies 
might not have reported all of the clinical practices that their interventions addressed, as studies were 
variable in the amount of detail they provided about their methods.
The most comprehensive interventions in terms of the number of evidence-based clinical practices they 
included were education-only local-scale interventions reported by Eggimann and colleagues,94 Lobo and 
colleagues108 and Warren and colleagues,51 and regional-scale interventions with components beyond 
education reported by Burrell and colleagues83 and Pronovost and colleagues.34 Among these studies, the 
Burrell study (the CLAB ICU project)83 appears most relevant to current UK clinical practice, as it sought to 
replicate the Keystone ICU project at a regional scale.
Summary of study characteristics
Twenty-four studies were included in the systematic review. Most studies were conducted in medical, 
surgical and cardiac critical care units but the studies provided little information about their study 
populations and the vascular devices used. Where reported, patients’ ages ranged from early 40s to  
early 70s. Half of the studies were conducted in the USA,34,50,51,87,93,97,98,126,135,136,138,139 with only one  
study conducted in the UK110 (a CQI programme in a single critical care unit in Scotland). The majority 
of studies used a single-cohort uncontrolled before-and-after design, with only one RCT included. The 
interventions evaluated in the studies were diverse in their educational approaches, ranging from single 
lectures in single critical care units to regional-scale CQI programmes in up to 103 critical care units. 
Fifty-eight per cent of the interventions reported were purely educational and 42% included components 
beyond education. Nearly all interventions included formal education approaches that would take  
staff away from bedside patient care. The interventions varied in the extent to which they addressed 
evidence-based clinical practices relevant to the NHS for preventing catheter-BSI. Most interventions 
focused on catheter insertion rather than catheter ongoing care, with hand hygiene, maximal barrier 
precautions and antiseptic preparation of the insertion site being the most frequently addressed practices. 
Different educational approaches, which were unique to individual studies, were used to address the 
same clinical practices. Although studies had to provide a definition of catheter-BSI to be included in 
the systematic review, only eight studies provided definitions consistent with those used in the NHS for 
the Matching Michigan programme. Two of the regional-scale interventions68,83 aimed to replicate the 
Keystone ICU project intervention in different countries, and, of these, the CLAB ICU project83 appears 
most relevant to NHS practice, although it was conducted in an Australian health-care setting.
Assessment of clinical effectiveness
Quality assessment: risk of bias
The included primary studies were difficult to assess for risk of bias because in most cases insufficient 
information was reported, resulting in a judgement of ‘unclear’ (Table 21). Methodological information 
supporting the judgements reached by the reviewers is given in the data extraction forms (see Appendix 5). 
When interpreting risk of bias it is important to bear in mind that, as judgements of bias are constrained 
by the availability of information, studies classified as having high or low risk of bias may not necessarily be 
at greater or lower risk of bias than those studies classified as unclear.
Studies judged to be at high risk of bias
Three studies68,109,144 were judged to be at high risk of selection bias, as the numbers of patient-days and 
CVC-days were consistently lower in the intervention period than in the pre-intervention period;109 baseline 
incidence of catheter-BSI was higher in control than in intervention critical care units;68 or the McCabe 
rapid fatality score, number of trauma patients and number of patients who had a CVC inserted were 
statistically significantly higher in the intervention than in the baseline period.144
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TABLE 21 Quality assessment: risk of bias – criteria adapted for before-and-after studies
Study
Selection 
bias risk 
(systematic 
differences 
between 
groups)
Performance 
bias risk 
(effects 
of other 
concurrent 
intervention/s)
Performance 
bias risk 
(other 
concurrent 
staff/policy 
changes)
Performance 
bias risk 
(outcome 
assessment 
not blinded)
Performance 
bias risk 
(outcome 
definition or 
measurement 
differences 
between 
groups)
Attrition 
bias risk 
(imbalances 
between 
groups in 
missing 
data)
Burrell (2011)83 Unclear Unclear Unclear Unclear Unclear Unclear
Coopersmith 
(2002)50
Unclear Unclear High High High Unclear
Coopersmith 
(2004)87
Unclear Unclear High Unclear Unclear Unclear
DuBose (2008)93 Unclear Unclear Unclear High Low Unclear
Eggimann (2000),94 
(2005)95
Low Low Low Unclear Unclear Low
Galpern (2008)97 Unclear Low Unclear Unclear Unclear Unclear
Guerin (2010)98 Unclear Unclear Unclear Unclear Unclear Unclear
Higuera (2005)103 Low Unclear Unclear Unclear Unclear Unclear
Lobo (2005)108 Unclear Unclear Unclear Unclear Unclear Unclear
Lobo (2010)109 High High Unclear Unclear Unclear Unclear
Longmate (2011)110 Unclear Unclear Unclear High Unclear Unclear
Misset (2004)117 Unclear Unclear Low Unclear Unclear Unclear
Palomar Martinez 
(2010)68
High High Unclear Unclear Unclear Unclear
Perez Parra (2010)122 Unclear Low Unclear Unclear Low Unclear
Pronovost (2006),34 
(2008),124 (2010)123
Unclear Unclear Unclear Unclear Unclear Unclear
Render (2006)126 Unclear Unclear Unclear Unclear Unclear Unclear
Rosenthal (2003)129 Unclear High Unclear Unclear Unclear Unclear
Rosenthal (2005)130 Unclear High Unclear Unclear Unclear Unclear
Sherertz (2000)135 Unclear Unclear Unclear Unclear Unclear Unclear
aSperoff (2011) 
(RCT)136
Unclear Unclear Unclear Unclear Unclear Unclear
Wall (2005)138 Unclear Unclear Unclear Unclear Unclear Unclear
Warren (2003)139 Low Unclear Unclear Unclear Unclear Unclear
Warren (2004)51 Unclear Unclear Unclear High Unclear Unclear
Zingg (2009)144 High Unclear Unclear Unclear Unclear Low
a Risk of bias criteria for the RCT refer to comparisons between baseline and intervention periods within each arm 
(assessment of randomisation and allocation concealment are reported separately in the text).
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Four studies68,109,129,130 were judged to be at high risk of performance bias owing to a potential influence 
of other concurrent or overlapping interventions as the planned intervention overlapped with different 
hand hygiene interventions;129,130 staff in a critical care unit receiving one intervention moved to a different 
critical care unit receiving another intervention;109 or staff in control critical care units were able to attend 
training for the intervention.68
Two studies50,87 were judged to be at high risk of performance bias owing to staff or policy changes 
because they reported changes in antibiotic prescribing patterns and accessibility of quadruple-lumen 
catheters,50 or reported that the number of ICU beds was higher in the intervention period (six beds;  
33% increase).87
Four studies50,51,93,110 were judged to be at high risk of performance bias because critical care staff assessing 
outcomes (the staff collecting and culturing blood samples and analysing the results) were not blinded. 
The remaining 19 studies did not report whether the staff were blinded but it seems unlikely that authors 
would have blinded study participants without reporting so.
One study50 was judged to be at high risk of performance bias, as the authors implied that there was a 
procedural difference in diagnosis and/or reporting of infections between the baseline and intervention 
periods (it was stated that treatment of catheter colonisation could have accounted for a large number of 
documented infections in the pre-intervention time period).
Studies judged to be at low risk of bias
Studies were judged to be at low risk of bias if their population characteristics did not appear to differ 
between baseline and intervention periods94,103,139 (low selection bias risk); they stated that no other 
concurrent interventions were conducted,94,97,122 or no changes in critical care structure or staffing 
occurred94,117 that could potentially affect catheter-BSI incidence; they stated that catheter-BSI definitions 
and diagnosis procedures did not change93,122 (low performance bias risk); or missing data were deducible 
and did not appear to differ between baseline and intervention periods94,144 (low attrition bias risk).
Risk of bias in randomised controlled trials
Only one RCT, by Speroff and colleagues,136 was included in the systematic review. In addition to the 
risk of bias criteria reported above for before-and-after studies, which we used to assess before-and-
after comparisons within each of the RCT arms, we assessed the risk of selection bias, according to the 
adequacy of randomisation and allocation concealment, using the Cochrane Collaboration criteria for 
risk of bias in RCTs.58 The RCT136 was judged to be at unclear risk of selection bias because insufficient 
information was provided about the methods of random sequence generation and allocation concealment.
Other bias risk
Information collected in the data extraction forms (see Appendix 5) suggests that studies may have been at 
risk of self-reporting bias (study outcomes were reported directly by the investigators without independent 
checking). For example, self-reporting of outcomes was routine110,136 or dependent upon staff availability;83 
an audit tool and intervention were implemented by the same team that designed them;87 the study 
co-ordinator who was involved in delivering an intervention checked data sheets for missing items and 
errors;129 and it was assumed that nurses accurately captured information and completed a checklist for 
every insertion, without formal validity and reliability analyses.138
In three studies110,117,136 the intervention as reported by the authors was not intended solely for the 
prevention of catheter-BSI: Longmate and colleagues110 reported an intervention for preventing CRBSI, 
VAP and MRSA; Misset and colleagues117 reported an intervention for preventing CRBSI, VAP and UTIs; 
and Speroff and colleagues136 reported two interventions, each for preventing both central line-associated 
bloodstream infection (CLABSI) and VAP. In these studies, clinical effectiveness must be evaluated for the 
intervention as a whole, as effects of the individual intervention components that target the different types 
of infections are not separable.
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Reporting of data collection in the primary studies
Of the 24 primary studies,34,50,51,68,83,87,93–95,97,103,108–110,117,122–124,126,129,130,135,136,138,139,144,146 none provided full 
details of their data collection processes. The most detailed descriptions of data collection were reported 
by Burrell and colleagues83 and Wall and colleagues,138 but even their descriptions were incomplete. Burrell 
and colleagues83,146 stated that data entry was manual, with an infection nurse checking data on each 
form. Collected data were received and collated by the Clinical Excellence Commission. Missing and invalid 
data were followed up and validity of reported central line-associated bacteraemia (CLAB) were confirmed 
with individual critical care units. However, many critical care units did not have microbiological support 
and reported CLAB through discussion with senior critical care staff, while improved understanding of 
surveillance definitions versus clinical definitions led to some CLAB cases being reclassified. Wall and 
colleagues138 reported that upon completing a checklist, a nurse detached the top page (with all items 
readable) and dropped it in a secure lockbox. The second page remained on the patient’s chart with the 
sensitive items blacked out. The infection control practitioners collected the checklists daily and scanned 
the de-identified forms into a pre-established computerised database using scanning software which read 
pre-established fields on the checklist into a spreadsheet database. These data were stored on a secure 
computer at the Center for Clinical Improvement for future statistical analyses.
Only one94 of the 24 studies reported that their data collection approach was reliable (pre-tested and 
standardised in several pilot phases), for infection surveillance. One study98 mentioned that device-day data 
collected by critical care unit nursing staff were compared with data collected daily by the intravascular 
catheter management team to confirm the accuracy of data collection but did not provide any supporting 
data. Three studies110,136,138 stated explicitly that validity and/or reliability of the data collection method was 
not assessed. It seems improbable that validity and reliability of data collection would have been assessed 
in the remaining studies, as no mention was made in the publications.
Summary of quality assessment
Overall, the methodological quality of the 24 included primary studies was difficult to assess owing to 
limited or unclear reporting of study populations and research methods. Nine studies50,51,68,87,93,109,110,129,130 
were judged to be at high risk of bias, but, as risk of bias could be assessed only for well-reported studies, 
the extent of risks of bias among the studies may have been underestimated. Several different types of 
data were collected in the primary studies, including infection surveillance information, results of tests and 
assessments, and information on patient outcomes. However, none of the included studies fully reported 
its data collection methods and the majority of studies did not report whether data collection approaches 
had been shown to be valid and/or reliable. In most cases the staff who were involved in data collection 
were not specified, and studies may have been at risk of self-reporting bias (we did not formally assess 
whether staff involved in data collection were independent, but the authors of five studies83,87,110,129,136 
implied that they were not).
Synthesis of effectiveness (primary outcomes)
It was inappropriate to calculate pooled-effect estimates for study outcomes, as the primary studies 
included in the systematic review varied considerably in their temporal and spatial scales, objectives, and 
in the structure and content of their interventions. The data from the primary studies were also considered 
unsuitable for exploration using meta-regression to identify potential explanatory variables for intervention 
effects, as the data requirements for the conduct and clear interpretation of meta-regression as described 
by Thompson and Higgins148 would not be met. Instead, we present a structured narrative synthesis below.
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It was not possible to identify studies that could be classed as ‘best’ or ‘worst’ in terms of methodological 
quality and risk of bias. We have therefore not used quality criteria to exclude any studies from the 
data synthesis. Instead, we summarise below the effectiveness for all studies, which provided relevant 
outcomes data. Issues of quality and bias identified above that could influence the interpretation of clinical 
effectiveness for specific studies are highlighted on a case-by-case basis.
Incidence density of catheter-bloodstream infection
In 10 studies, insufficient data were reported for the calculation of incidence density RRs with 95% CIs 
or there were ambiguities in the published data,83,93,94,97,117,126,130,135,136,138 and we attempted to contact 
the authors for clarification. Six authors responded with information, three did not respond and one 
responded stating that relevant data were not available. Data that were provided by the study authors in 
response to us contacting them are indicated in Appendix 7.
To enable comparisons of clinical effectiveness among the included interventions, incidence density RRs 
with their 95% CIs are displayed in forest plots, with the interventions grouped according to their spatial 
and temporal scales: regional-scale interventions (see Figure 4), local-scale interventions of duration 
≤ 12 months (see Figure 5), and local-scale interventions of duration of > 12 months (see Figure 6). Within 
each forest plot, studies are ordered by effect size (larger effects of interventions relative to comparators 
are indicated by smaller incidence density RRs). As this is a narrative synthesis, pooled-effect estimates 
are not displayed in the forest plots. The amount of information available varied considerably among the 
studies, with some studies providing RRs for more than one intervention scenario or time period (multiple 
within-study effect estimates are not statistically independent but are included in the forest plots, as 
pooled-effect estimates are not calculated). The full data used in calculating RRs, including the baseline 
and intervention catheter-BSI incidence densities for each study, are given in Appendix 7.
Educational interventions were classified either as effective at reducing catheter-BSI incidence density, 
lacking convincing evidence for effectiveness, or ineffective according to the following criteria:
 z Effective The incidence density RR for intervention compared with comparator (baseline) was  
< 1.0 and the 95% CI of the RR did not include 1.0.
 z Ineffective The 95% CI of the incidence density RR for intervention compared with comparator 
(baseline) included 1.0.
 z Lack of convincing evidence for effectiveness Effectiveness was marginal, or serious limitations of the 
study methodology cast doubt on the reliability of the results (explanations are provided below on a 
case-by-case basis).
Regional-scale interventions
Five studies34,68,83,126,136 investigated regional-scale CQI interventions (Figure 4; for the full data see 
Appendix 7, Data for forest plot: regional-scale interventions). These studies included the Keystone ICU 
project,34,123,124 the ‘CLAB ICU’ project,83,146 which sought to replicate aspects of the Keystone ICU project 
in Australia, and the ‘Bacteraemia Zero’ project,68 which sought to replicate aspects of the Keystone ICU 
project in Spain. Three of the studies used uncontrolled before-and-after designs, whereas two (a RCT by 
Speroff and colleagues136 and the non-randomised controlled study by Palomar Martinez and colleagues68) 
included two parallel comparison groups of critical care units (virtual collaborative and toolkit groups136 
or intervention and control groups68). The study by Palomar Martinez and colleagues68 reported historical 
baseline data on infection incidence for 3 years prior to the prospective intervention (2004–6), of which we 
report only the 2006 data, as these are most directly relevant for comparison with the study period (2007) 
(for full data see the data extraction form in Appendix 5). All of the regional-scale studies calculated the 
number of device-days based on presence/absence of vascular catheters, which does not take into account 
the number of concurrent catheters that a patient may have.
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FIGURE 4 Incidence density RRs (± 95% CI) for regional-scale interventions (multiple catheters per patient not 
counted separately in device-days). a, CI not calculable.
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Clinically effective interventions (with unclear risk of bias)
Assuming that effects displayed in the forest plots reflect those of the planned interventions, the CLAB 
ICU project83,146 and Keystone ICU project34,123,124 interventions appear to have been effective in reducing 
catheter-BSI incidence densities relative to baseline, although both studies had unclear risk of bias (Box 1). 
The Keystone ICU project achieved a reduction in catheter-BSI incidence density after 3 months, which 
subsequently persisted through the 36-month intervention monitoring period. The CLAB ICU project 
achieved a reduction in catheter-BSI incidence density after 6 months, which was mostly sustained until 
the end of the 18-month intervention monitoring period (statistically significant in quarters 3, 5 and 6) 
(see Figure 4). These studies both have some relevance to clinical practices for prevention of catheter-BSI in 
critical care in the NHS and are considered in more detail below.
Clinically ineffective interventions
The two interventions implemented in the RCT by Speroff and colleagues136 were clearly not effective 
at reducing catheter-BSI incidence density, as acknowledged by the study authors (Box 2). During the 
18-month study period, catheter-BSI incidence density for the virtual collaborative intervention actually 
increased relative to baseline (see Figure 4).
Process evaluation conducted by Speroff and colleagues136 (discussed below: see Process evaluations, 
facilitators and barriers) indicated that adoption of intervention components was consistently 
higher in the virtual collaborative intervention arm than the toolkit approach arm, suggesting that 
failure of the interventions to reduce catheter-BSI incidence was not simply related to the extent of 
intervention implementation.
Interventions lacking convincing evidence for effectiveness
The two remaining regional-scale interventions, by Render and colleagues126 and Palomar Martinez and 
colleagues,68 appear at first sight to have been effective at reducing the incidence densities of catheter-BSI. 
However, upon closer inspection the findings of these studies are difficult to interpret.
Published data for the study by Render and colleagues126 indicate an incidence density RR below 1.0 
but the publication did not provide a CI or sufficient data for us to calculate one. Further data obtained 
on request from the author (see Appendix 7, Data for forest plot: regional-scale interventions) enabled 
 z CQI programme conducted in 103 critical care units in the USA: the Keystone ICU project (duration of up 
to 36 months). Targeted clinicians’ use of hand washing, full barrier precautions during CVC insertion, 
skin cleansing with chlorhexidine, avoiding the femoral site, and removing unnecessary catheters; 
included checklist, presentations and meetings, fact sheet, infection surveillance feedback and catheter 
supplies cart.34,123,124
 z CQI programme conducted in 37 critical care units in Australia: the CLAB ICU project (duration of up 
to 18 months). Based on principles of the Michigan Keystone ICU project, including a ‘clinician bundle’ 
(hand hygiene, barrier precautions and sterile technique) and a patient bundle (skin preparation, 
patient draping and imaging catheter positioning during insertion); also included a checklist, infection 
surveillance feedback and catheter supplies cart.83,146
BOX 1 Regional-scale interventions at unclear risk of bias that appear effective at reducing the incidence density 
of catheter-BSI
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us to calculate an incidence density RR with a 95% CI, but the CI indicates lack of effectiveness (see 
Figure 4). On balance, the available information for the study by Render and colleagues126 does not provide 
convincing evidence that the intervention was effective at reducing the incidence density of catheter-BSI 
(see Box 2).
The results of the Bacteraemia Zero project reported by Palomar Martinez and colleagues68 are difficult  
to interpret because incidence density RRs were significantly lower than 1.0 both for the intervention  
and control groups of critical care units, with a larger effect (smaller RR) evident in the control group  
(see Figure 4). The Palomar Martinez study68 is notable in that we judged it to be at high risk of selection 
bias because the control group had higher baseline incidence density of catheter-BSI than the intervention 
group. We also judged this study to be at high risk of performance bias because staff in control critical care 
units were able to attend intervention group meetings at which intervention information and materials 
were disseminated. On balance, this 3-month pilot study by Palomar Martinez and colleagues68 does not 
provide convincing evidence of effectiveness of their CQI programme at reducing the incidence density of 
catheter-BSI.
Local-scale interventions of up to 12 months in duration
Twelve studies investigated local-scale interventions of up to 12 months’ duration. Of these, 10 
studies50,51,98,103,108,109,122,129,139,144 provided sufficient data for the calculation of incidence density RRs 
(Figure 5; for the full data, see Appendix 7, Data for forest plot: local-scale interventions of duration up 
to 12 months). These studies all calculated the number of device-days based on the presence/absence of 
vascular catheters, which does not distinguish multiple concurrent catheters in a patient. The educational 
interventions were diverse and included single lectures on practices related to CVC care;109,122 structured 
and interactive education modules focusing on hand hygiene and CVC care144 multimodal education of 
various types with performance feedback;50,51,103,129,139 multimodal education with infection surveillance 
feedback;108 and a post-insertion central line care bundle.98 Three of these studies each involved a single 
critical care unit;50,51,108 three studies involved multiple critical care units and reported results pooled across 
the units;98,129,139 and four studies presented results separately for different critical care units.103,109,122,144 
Lobo and colleagues109 compared a single lecture in one critical care unit (‘ICU A’) with a tailored 
continuous educational intervention in another critical care unit (‘ICU B’) located at the same hospital, 
whereas Higuera and colleagues,103 Perez Parra and colleagues122 and Zingg and colleagues144 compared 
results from different critical care units which had received similar interventions (see Figure 5).
Not effective: CQI programme conducted in 60 critical care units in the USA during 18 months. Hospitals 
were randomised to Virtual Collaborative and Toolkit CQI approaches (including VAP prevention), with access 
to interactive web seminars for both groups. Virtual collaborative: monthly educational and troubleshooting 
conference calls, individual coaching and electronic mailing list (designed to stimulate interaction among 
teams). Toolkit: based on evidence based guidelines, fact sheets, review of QI and teamwork methods, 
educational online tutorials and standardised data collection/charting tools136 (note that hospitals were 
randomised but implementation was at the level of critical care units).
Lack of convincing evidence for effectiveness: Continuous QI programme, duration approximately 1 year, 
in a single cohort of eight critical care units in the USA, based on work/learning/reporting cycles, including 
performance feedback and infection surveillance feedback.126
Lack of convincing evidence for effectiveness: Three-month pilot study based on the Michigan Keystone ICU 
intervention, evaluating the feasibility of national implementation of a CQI intervention in 17 critical care 
units in Spain, with units allocated non-randomly to either intervention or control groups – the Bacteraemia 
Zero project68 (this study was judged to be at high risk of selection and performance bias).
BOX 2 Regional-scale interventions that were not effective at reducing the incidence density of catheter-BSI  
or lack convincing evidence for effectiveness
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FIGURE 5 Incidence density RRs (± 95% CI) for local-scale interventions of up to 12 months in duration (multiple 
catheters per patient not counted separately in device-days). a, Confidence interval not calculable.
Study
Guerin 201098
Zingg 2009144
Rosenthal
2003129
Coopersmith 200250
Warren 2003139
Higuera 2005103
Warren 200451
Lobo 2005108
Perez Parra
2010122
Lobo
2010109
Comparison
Intervention (12 months) vs. baseline
Total (5 ICUs), intervention (5 months) vs. baseline
Medical ICU, intervention (5 months) vs. baselinea
Surgical ICU, intervention (5 months) vs. baselinea
Medical-surgical ICU, intervention (9 months) vs. baseline
Neurosurgical ICU, intervention (9 months) vs. baseline
Performance feedback (7–8 months) vs. education (1–2 months)
Both education + performance feedback vs. baseline
Education (1–2 months) vs. baseline
Intervention (6 months) vs. baseline
Intervention (3 months) + follow-up (10 months) vs. baseline
Intervention (1 month) + follow-up (23 months) vs. baseline
Intervention (8 months) vs. baseline
Post-intervention follow-up (12 months) vs. baseline
Follow up (12 months) vs. intervention
Total (2 ICUs), intervention (9 months) vs. baseline
General ICU, single lecture + follow-up (9 months) vs. baseline
Cardiac ICU, single lecture + follow-up (9 months) vs. baseline
Medical ICU, single lecture + follow-up (9 months) vs. baseline
ICU B, single lecture + follow-up (9 months) vs. baseline
ICU A, continuous intervention (9 months) vs. baseline
Total (3 ICUs), single lecture + follow-up (9 months) vs. baseline
0.00 0.50 1.00 2.00 2.50
Favours comparatorFavours intervention
1.50
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
43
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Clinically effective interventions (with unclear or high risk of bias)
Assuming that effects displayed in the forest plots reflect those of the planned interventions, seven of the 
interventions50,51,98,103,129,139,144 would appear to have been effective in reducing the incidence density of 
catheter-BSI (Box 3), as incidence density RRs were significantly below 1.0 (see Figure 5). The studies by 
Coopersmith and colleagues50 and Warren and colleagues51 were judged to be at high risk of performance 
bias because the authors stated that the staff assessing outcomes were not blinded to the intervention. 
However, it seems unlikely that staff would have been blinded in any of the other studies, although this 
was not reported. Two studies50,129 were judged to be at high risk of performance bias for other reasons. 
Effects of the educational intervention implemented by Coopersmith and colleagues50 appear to have 
been confounded with changes in antibiotic prescribing practice and availability of four-lumen catheters, 
whereas effects of the educational intervention implemented by Rosenthal and colleagues129 overlapped 
with a separate hand washing intervention. One study by Zingg and colleagues144 was judged to be at 
high risk of selection bias, as the study characteristics of the population differed between the baseline and 
intervention periods.
In two103,129 of the seven studies that appeared clinically effective, further caution on interpretation is 
required. In the study by Rosenthal and colleagues129 incidence density RRs were significantly < 1.0 for 
education or education and performance feedback periods together but not for the performance feedback 
period alone. These results are difficult to interpret because the education and performance feedback 
 z Multimodal education including self-study, in-services and performance feedback in one critical care 
unit in the USA for 6 months, with broad topic coverage aimed at nurses; included infection surveillance 
feedback but this was also present in the baseline period.50
 z Multimodal education including self-study and performance feedback, with broad topic coverage aimed 
at nurses and physicians in two critical care units in one hospital in the USA for 3 months; included 
infection surveillance feedback but this was also present in the baseline period.139
 z Multimodal education including self-study and performance feedback, with broad topic coverage aimed 
at nurses and physicians in one critical care unit in the USA for 1 month; unclear whether included 
infection surveillance feedback.51
 z Multimodal education focusing on hand hygiene and vascular catheter care aimed at nurses and 
physicians in five critical care units in one hospital in Switzerland for 5 months144 (this study was judged  
to be at high risk of selection bias, as population characteristics differed between baseline and  
study periods).
 z Unspecified education (1–2 months) followed by performance feedback (7–8 months) in four critical care 
units in two hospitals in Argentina129) (this study was judged to be at high risk of performance bias as the 
effects of the intervention appear to be confounded with those of a separate hand-washing intervention; 
also, as mentioned in the text, only the education phase can be reliably interpreted; this study also had 
relatively high baseline incidence density of catheter-BSI).
 z Process control intervention in two critical care units in one hospital in Mexico for 9 months, including 
1-hour classes and provision of CDC infection control guidelines, with performance feedback and the 
provision of alcohol hand rub103 (note that this study had relatively high baseline incidence density of 
catheter-BSI and effectiveness was not demonstrated in all participating critical care units).
 z Post-insertion central line care bundle in two critical care units in one hospital in the USA for 12 months, 
including 4-hour hands-on practical sessions on CVC access and care followed by competence evaluation; 
included performance feedback and provision of an intravenous therapy team.98
BOX 3 Local-scale interventions of up to 12 months’ duration and at unclear (or, where stated, high) risk of bias 
that appear effective at reducing the incidence density of catheter-BSI
rESuLTS Of THE SYSTEMATIC rEVIEw Of CLINICAL EffECTIVENESS
44
NIHR Journals Library www.journalslibrary.nihr.ac.uk
periods were sequential, and performance feedback may not have been independent of the effects of the 
preceding education. Interpretation should therefore be restricted to the education phase, which itself 
appeared to be clinically effective, although this was only monitored for 1–2 months (see Figure 5). In the 
study by Higuera and colleagues103 the intervention was effective when data for two critical care units 
were pooled but found to be effective in only one of the units when they were analysed separately (see 
Figure 5). It is notable that the medical–surgical critical care unit had a higher baseline incidence density of 
catheter-BSI per 1000 catheter-days (57.4) than the neurosurgical critical care unit (32.8). These baseline 
incidence densities and also the baseline catheter-BSI incidence density in the study by Rosenthal and 
colleagues129 (45.9 per 1000 catheter-days) are higher than typically found in European studies.
For these seven studies50,51,98,103,129,139,144 that appeared to be effective at reducing incidence of  
catheter-BSI (albeit with the caveats noted above), statistical significance indicated by the CIs of RRs in 
Figure 5 is consistent with the primary study publications, which, in all cases, claimed that effects of the 
interventions at reducing catheter-BSI incidence were statistically significant.
Two51,139 of the studies that appeared effective at reducing catheter-BSI incidence (see Box 3) reported 
post-intervention follow-up monitoring, which may provide an indication of the longer-term persistence 
or attenuation of intervention effectiveness. Warren and colleagues139 conducted 10 months of follow-up 
after a 3-month intervention; and Warren and colleagues51 conducted 23 months of follow-up after 
an intervention of about 1 month. Although the RRs based on the whole follow-up period appear 
encouraging, monthly data provided for the latter study51 (data extraction form – see Appendix 5) show 
that incidence densities varied considerably from month to month, and returned to baseline levels within 
the first 3 months of the 23-month follow-up period.
Clinically ineffective interventions
For two109,122 of the local-scale short-term studies, the 95% CIs for the RRs indicate that the reduction 
in catheter-BSI incidence density was not statistically significant (see Figure 5). In contrast, the primary 
publications for these studies both claimed statistically significant effects of the interventions.109,122  
Lobo and colleagues109 based their conclusion on incidence data rather than incidence density.  
Perez Parra and colleagues122 stated that they initially conducted a Wilcoxon rank sum test and then to 
control for (unspecified) confounding effects of external events and (unspecified) secular trends that 
occurred during the study period they used a Poisson regression approach. The statistical significance 
reported122 varied among the critical care units (overall: p = 0.3; general post surgical: p = 0.05; cardiac 
post surgical: p = 0.12; medical: p = 0.31) and it is not clear to which of the analytical approaches the 
p-values refer. On balance, we conclude that these two studies were not effective at reducing  
catheter-BSI incidence density (see Figure 5 and Box 4) and the claims of statistical significance in the 
primary publications do not provide sufficient grounds for us to alter our conclusion.
Interventions lacking convincing evidence for effectiveness
The intervention reported by Lobo and colleagues108 has a RR bordering on statistical non-significance 
(upper limit of the 95% CI 0.97) and a non-significant RR for the follow-up period suggesting that the 
intervention was only briefly effective (see Box 4) at reducing the incidence of catheter-BSI (see Figure 5). 
The publication for this study did not report statistical significance.108
Local-scale interventions of more than 12 months in duration
Seven studies87,94,95,97,110,138 investigated local scale interventions of > 12 months in duration, of which 
five provided sufficient data for the calculation of incidence density RRs (Figure 6: for the full data see 
Appendix 7.3, Data for forest plot: local-scale interventions of duration of > 12 months). The studies were 
all conducted in single critical care units, apart from one which involved three units.97 The interventions 
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FIGURE 6 Incidence density RRs (± 95% CI) for local-scale interventions of more than 12 months in duration 
(multiple catheters per patient not counted separately in device-days unless stated).
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Not effective: Single lecture (15 minutes with 9 months of follow-up) on approaches for CVC care and 
maintenance, with performance feedback, aimed at all staff in three critical care units in one hospital 
in Spain.122
Not effective: Single lecture (unspecified duration, with 9 months of follow-up) on CVC care aimed at all 
critical care staff in a single critical care (‘ICU B’) unit in Brazil109 (this study was judged to be at high risk of 
selection bias and performance bias).
Not effective: Continuous tailored education including lectures on CVC care and hand hygiene, posters, 
colourful labels, and infection surveillance feedback aimed at all critical care staff in a single critical  
care unit (‘ICU A’) in Brazil for 9 months109 (this study was judged to be at high risk of selection bias and 
performance bias).
Lack of convincing evidence for effectiveness: Multimodal education with emphasis on hand hygiene, aimed 
at all staff in two critical care units in one hospital in Brazil for 8 months, included infection surveillance 
feedback.108
BOX 4 Local-scale interventions of up to 12 months’ duration that were not effective at reducing the incidence 
density of catheter-BSI or lack convincing evidence for effectiveness
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included multimodal education with slide shows and bedside in-services, repeated for up to 6 years;94,95 
multimodal education with self-study, bedside in-services and performance feedback over 15 months;87 
a central line bundle deployed over 19 months, including checklist, infection surveillance feedback, 
performance feedback and catheter supplies cart;97 a CQI programme implemented over 3 years, including 
checklist, infection surveillance feedback and performance feedback;110 and a CQI programme focused on 
real-time performance feedback over 2 years, including a checklist, supervision of insertions and  
web-based tutorial with competence assessment.138
Three87,97,138 of these five studies calculated the number of device-days based on presence/absence of 
vascular catheters, which does not distinguish multiple concurrent catheters in a patient. Eggimann and 
colleagues94 and Longmate and colleagues110 calculated the number of device-days in two ways: based 
on the presence/absence of vascular catheters; and by counting each concurrent catheter as a separate 
device-day. In both studies the incidence density RRs were similar for both methods of calculating the 
device-days (see Figure 6).
Clinically effective interventions (with unclear risk of bias)
Assuming that effects displayed in the forest plots reflect those of the planned interventions, three of 
the interventions conducted by Eggimann and colleagues,94,95 Longmate and colleagues110 and Galpern 
and colleagues97 appear effective in reducing the incidence density of catheter-BSI (Box 5), with incidence 
density RRs significantly lower than 1.0 (see Figure 6). Exceptions were that the RRs were not significantly 
different from 1.0 on all of the monitoring dates reported by Eggimann and colleagues94,95 and Longmate 
and colleagues.110 Data from the Eggimann study94,95 suggest that the intervention was effective for the 
initial 3 years of implementation but not consistently so thereafter. Data from the Longmate study110 
suggest that the intervention did not become effective at reducing catheter-BSI until the third year of 
implementation (see Figure 6). The publications reporting these three studies94,95,97,110 either claimed 
statistically significant intervention effects97,110 or did not mention the statistical significance of effects.94,95
The study by Longmate and colleagues110 was judged to be at high risk of performance bias, as the 
authors stated that the staff assessing outcomes were not blinded. However, as mentioned above, it is 
unlikely that staff would have been blinded in any of the other studies, although this was not reported. 
The other studies were judged to be mostly at unclear risk of bias, although (as mentioned in the section 
on quality assessment above) the Eggimann study94 was judged to be at low risk of bias for four of seven 
bias domains assessed (the other three were judged unclear).
 z Multimodal education based on 30-minute slide shows and bedside in-services aimed at all critical care 
staff (physicians, nurses and nursing assistants) in one critical care unit in Switzerland for up to 6 years.94,95
 z Central line bundle including discussion sessions about CVC access and care, checklist, infection 
surveillance feedback, performance feedback and catheter cart; aimed at all staff (physicians and nurses) 
in three critical care units in the USA for 19 months.97
 z CQI programme (including VAP prevention) incorporating a CVC insertion bundle with checklist, infection 
surveillance feedback and performance feedback; aimed at ICU nurses and trainee doctors in one critical 
care unit in Scotland for up to 3 years.110
BOX 5 Local-scale interventions of > 12 months’ duration and at unclear risk of bias that appear effective at 
reducing the incidence density of catheter-BSI
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Clinically ineffective interventions
Two87,138 of the five studies that implemented local-scale interventions of > 12 months’ duration, by 
Coopersmith and colleagues87 and Wall and colleagues,138 were not effective at reducing catheter-BSI 
incidence density (Box 6), as the incidence density RRs were not significantly different from 1.0 (see 
Figure 6). Coopersmith and colleagues87 acknowledged that effects of their intervention were not 
statistically significant. Among possible reasons for the lack of success of the intervention, Coopersmith 
and colleagues87 suggested that that diffuseness of the educational message may have been a contributory 
factor and that ideally didactic education should be specifically targeted to support best clinical practices. 
Wall and colleagues138 did not report the statistical significance of the effectiveness of their real-time 
process feedback approach for reducing catheter-BSI. The number of infections appeared to decrease 
dramatically (from 25 per 24 months to 6 per 24 months),138 but there was also a marked decrease in the 
number of CVC-days during the study, which explains the lack of statistical significance when intervention 
effects are analysed in terms of the incidence density of catheter-BSI.
Overview of intervention effects on catheter-BSI incidence density
Assuming that the incidence density RRs reflect those of the planned interventions, then a range of 
different types of educational intervention would appear to have been effective at reducing catheter-BSI 
incidence in critical care units (Boxes 1, 3 and 5). A key proviso is that some studies were judged to be at 
high risk of specific types of bias, but risk of bias was generally unclear and it is not possible to objectively 
classify the studies on bias risk. The interventions that appeared effective, subject to the caveats above, 
include regional-scale CQI programmes34,83 or a local-scale CQI programme;110 local-scale multimodal 
education with or without performance feedback and infection surveillance feedback;50,51,94,103,129,139,144 a 
catheter insertion bundle;97 and a catheter ongoing care bundle.98 However, single lectures on CVC care 
and infection prevention were not effective as a means of reducing catheter-BSI incidence densities.109,122 
There is no clear evidence to suggest that regional-scale studies were more effective than local-scale 
studies, or that short-term studies (up to 12 months’ duration) had different effectiveness than  
long-term studies (exceeding 12 months’ duration). All three groups of studies (regional scale, local scale 
short-term and local-scale long-term) contain examples of effective interventions (Boxes 1, 3 and 5)  
and ineffective interventions (Boxes 2, 4 and 6). The studies included in the systematic review provide 
no clear evidence that performance feedback and/or infection surveillance feedback were influential in 
achieving effectiveness. Among the 12 interventions classed as clinically effective, eight (67%) included 
performance feedback,50,51,83,97,98,103,110,129 four (33%) included infection surveillance feedback,34,83,97,110 three 
(25%) included both types of feedback83,97,110 and two (17%) did not include either type of feedback.94,144 
Among the eight interventions that were not classed as clinically effective, the respective proportions were 
similar: four (50%) included performance feedback,109,126,136,138 three (38%) included infection surveillance 
feedback,108,109,126 two (25%) included both types of feedback109,126 and one (13%) did not include either 
type of feedback.122 Apart from single lectures being ineffective, there appears to be no clear evidence 
 z Multimodal education on CVC care and unspecified topics, including self-study, in-services and 
performance feedback, with broad topic coverage aimed at nurses and other staff in one critical care 
unit in the USA for 15 months; included infection surveillance feedback but this was also present in the 
baseline period87 (this study was judged to be at high risk of performance bias).
 z CQI programme involving real time feedback of infection rates and compliance with insertion practice, 
based on use of checklist, supervision of insertions, and web-based tutorial with competence assessment; 
aimed at ICU house staff (proceduralists) and nursing staff (as observers of procedures) in one critical  
care unit in the USA for 2 years; note that infection surveillance feedback was also present in the  
baseline period.138
BOX 6 Local-scale interventions of more than 12 months’ duration that were not effective at reducing the 
incidence density of catheter-BSI
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that interventions which included components beyond education (e.g. provision of antiseptic or a catheter 
supplies cart) were more or less effective than interventions that consisted of education alone.
Most studies did not separately count multiple vascular catheters per patient when calculating the  
number of device-days. In two studies that compared different approaches for calculating the number 
of device-days, the calculation approach used did not appear to influence the incidence density RR for 
catheter-BSI.
Mortality
Five studies94,103,110,139,144 reported mortality as an outcome but they did not specifically report mortality due 
to catheter-BSI or its sequelae.
Only one of these studies110 reported mortality specifically for critical care patients with CVCs (those 
patients in the critical care unit for > 2 days with a CVC for at least part of their critical care stay). Mortality 
rates significantly decreased during the study period, being 21.2% during the baseline period, and 20.9% 
and 16% during years 3 and 4 of the intervention, respectively (year 3 vs. 1, p = 0.328; year 4 vs. 1, 
p = 0.013).
Three94,103,144 of the five studies reported unadjusted mortality rates for critical care patients. Of these, 
two reported that there were no statistically significant differences between the baseline and intervention 
periods.94,144 An exception was that mortality due to cardiac arrest was significantly more frequent during 
the intervention period of one study94 (p < 0.05). The third study103 reported statistically significantly lower 
rates of unadjusted mortality per 1000 critical care unit discharges during the intervention period than the 
baseline period (64/132 = 48.5% and 111/338 = 32.8%), respectively [RR = 0.68 (95% CI 0.50 to 0.91), 
p = 0.01].
The remaining study139 reported that mortality for an ambiguous population (‘in-hospital mortality rate for 
catheterised patients’) did not differ significantly between the baseline and intervention periods.
In summary, insufficient data are available for us to draw any firm conclusions about the effects of the 
educational interventions, or the effects of catheter-BSI, on rates of mortality among patients in critical 
care units.
Length of stay
Seven studies50,94,109,110,117,139,144 reported LOS. One of these studies110 explicitly stated that their LOS data 
were for critical care unit patients who had vascular catheters. One study144 compared LOS in patients with 
and without CRBSI. For the remaining five studies LOS data appear to refer to all critical care unit patients, 
not limited to those with vascular catheters.
Longmate and colleagues110 reported both mean and median lengths of stay for patients who were in 
the critical care unit for > 2 days and had a CVC for at least part of their critical care stay. Mean (± SD) 
lengths of stay significantly increased [5.4 ± 3.9 days during year 1 (baseline period), 5.3 ± 3.7 days during 
intervention year 3, and 5.9 ± 3.7 days during intervention year 4] (differences from baseline, p > 0.05). 
The corresponding median [interquartile range (IQR)] lengths of stay decreased, and were, respectively,  
9.7 (4–20) days, 8.9 (4–13) days and 6.0 (3–11) days (differences from baseline, p < 0.05).
Zingg and colleagues144 reported median overall LOS for patients in five critical care units, during a 
4-month baseline and 5-month intervention period. LOS was statistically significantly longer during the 
intervention period. The median (IQR) LOS for baseline and intervention periods respectively were  
3 (2–7) days and 4 (2–9) days – difference, p < 0.001. Corresponding mean LOS during these periods  
were 5.9 days and 7.5 days, respectively. Zingg and colleagues also reported that median (IQR) LOS was  
15.5 (10–25) days in patients with CRBSI and 5 (3–12) days in patients without CRBSI (difference reported 
as 10.5 days).
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In summary, two studies110,144 reported length of critical care unit stay in relevant populations of  
patients with CVCs. One study,144 a 9-month education intervention by Zingg and Colleagues, reported 
significantly longer duration of stay during the intervention period, whereas the other, a 4-year continuous 
QI programme by Longmate and colleagues,110 found significantly shorter duration of stay in the 
intervention period. In addition, Zingg and colleagues144 reported that the median LOS for critical care 
patients with CRBSI was 10.5 days longer than for critical care unit patients without CRBSI (reported as 
15.5 and 5 days, respectively).
Synthesis of process (secondary outcomes)
Attitudes
One of the included studies by Sherertz and colleagues135 reported staff attitudes as a quantitative 
outcome. The proportions of postgraduate year 1 physicians-in-training who perceived a need for 
povidone–iodine, gloves, gowns and full sterile drapes increased significantly following a formal one-day 
education course (full data are in the data extraction form – see Appendix 5). However, incidence density 
RRs could not be calculated for this study135 so its clinical effectiveness at reducing catheter-BSI incidence 
density is unclear.
Four studies68,83,110,122 mentioned qualitative observations relating to the attitudes of critical care staff 
towards evidence-based infection prevention practices. Burrell and colleagues83 observed that some 
clinicians considered the incidence of CLAB in New South Wales to be low and doubted the value of 
the project, as existing Australian practice was felt to be equal to or better than the methods informing 
the project. Some clinicians doubted the evidence even with supportive CDC guidelines. Hat-wearing 
was a contentious element of the physician bundle: clinicians cited lack of evidence for hat use and four 
critical care units elected to omit their use as standard practice for CVC insertion.83 The remaining studies 
provided only brief mention of staff attitudes. Longmate and colleagues110 reported that two consultant 
clinicians doubted the need for full aseptic technique for CVC insertion, although this was resolved after 
evidence sharing. Perez Parra and colleagues122 reported that staff incorrectly assumed that small drapes 
were sufficient for catheter-BSI prevention, although it is not clear whether they were referring to the 
baseline or intervention period. Palomar Martinez and colleagues68 reported that some practitioners 
expressed dissatisfaction with chlorhexidine for skin antisepsis and doubted its effectiveness.
Although limited in detail and lacking quantitative analysis, these observations of the attitudes of critical 
care staff highlight that staff may be liable to question the need for evidence-based infection prevention 
practices, even when presented with supporting evidence.
Knowledge
Two50,122 of the included studies indirectly reported improvements in knowledge, expressed as changes 
in the proportion of staff with correct test scores50 or the percentage of correctly answered questions.122 
In the latter study, the test questions most often answered incorrectly (fewer than 50% correct) were 
those about the need for full sterile barriers during CVC insertion and on the choice of antiseptic for 
skin disinfection.122 These studies suggest that educational interventions can improve critical care staff 
knowledge of infection prevention practices but they did not report the types of knowledge gained 
through participation in the interventions.
Compliance
Compliance with evidence-based practices for preventing catheter-BSI was reported in 19 out of the  
24 included studies.
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Compliance with hand hygiene
Seven studies reported compliance with hand hygiene behaviour (Table 22). They all reported 
improvements in compliance relative to baseline, although these were not statistically significant in all 
cases. In most of the studies hand hygiene compliance rates did not reach 100% during educational 
interventions. In one study, the change was modest (final compliance 30%) and non-significant, possibly 
because hand hygiene was not a specific target of the education.87
TABLE 22 Compliance with hand hygiene during study baseline and intervention periods
Study
Baseline 
compliance (%)
Intervention 
compliance (%)
RR (95% CI); statistical 
significance Comments
Coopersmith (2004)87 17 30 p > 0.99
Higuera (2005)103 62 84.9 RR = 1.37 (1.21 to 1.51); 
p = 0.0000
Before patient contact
Lobo (2005)108 100 100 Not reported CVC insertion
5 61 RR = 12.78 (3.24 to 50.42); 
P < 0.001
Before manipulation
38 43 RR = 1.14 (0.69 to 1.90); 
p = 0.6
After manipulation
45 68 RR = 1.50 (0.95 to 2.37); 
p = 0.072
Before dressing
Lobo (2010)109 (data 
for interventions 
in two critical care 
units – ‘ICU A’ and 
‘ICU B’)
35 81 RR = 2.32 (1.62 to 3.32); 
p = 0.370
ICU A, before CVC handling
19 84 RR = 4.42 (2.63 to 7.43); 
p < 0.001
ICU A, after CVC handling
15 48 RR = 3.20 (1.33 to 7.72); 
p = 0.008
ICU B, before CVC handling
9 55 RR = 6.00 (1.95 to 18.44); 
p < 0.001
ICU B, after CVC handling
28 98 RR = 3.50 (2.24 to 5.47); 
p < 0.001
ICU A, before CVC dressing
34 96 RR = 2.82 (1.91 to 4.17); 
p < 0.001
ICU A, after CVC dressing
6 76 RR = 12.50 (3.22 to 48.56); 
p < 0.001
ICU B, before CVC dressing
27 64 RR = 2.33 (1.26 to 4.31); 
p < 0.006
ICU B, after CVC dressing
Rosenthal (2005)130 23.1 64.5 RR = 2.79 (2.46 to 3.17); 
p < 0.0001
Wall (2005)138 73 94, 89 Not reported For last 2 quarters
Zingg (2009)144 59.1 65 p = 0.466 Overall compliance
22.5 42.6 p = 0.003 Correct hand disinfection
26 45 p = 0.007 Before patient contact
21 56 p < 0.001 After patient contact
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Five103,108,109,130,144 of the studies that achieved statistically significant improvements in compliance had 
specified hand hygiene as a main108,109,130 or joint103,144 component of their education. High baseline 
variability in compliance rates is notable, both within and between the studies. For example, Lobo and 
colleagues108 found baseline compliance with hand hygiene at CVC insertion was already 100% but 
compliance with hand hygiene before line manipulation was only 5%. Overall, these findings suggest that 
hand hygiene behaviour in relation to the insertion and management of CVCs is complex and variable, 
and can differ considerably between the stages of intravascular catheter site preparation, insertion and 
ongoing management. Owing to the relatively small number of studies that reported hand hygiene 
compliance it is unclear whether the degree of compliance with hand hygiene practices had any bearing 
on the effectiveness of the interventions for preventing catheter-BSI.
Compliance with barrier precautions
None of the seven studies87,108,109,126,135,138 that measured compliance with barrier precautions (Table 23) had 
specified this as a target behaviour change, although most of the studies included an element of education 
about sterile barrier precautions in their interventions. Compliance with barrier precautions was highly 
variable at baseline, ranging from 0% to 100%. Final compliance with barrier precautions after study 
interventions ranged from 65% to 100%, indicating improvement, but this was reported to be statistically 
significant for only two out of eight comparisons.
The studies appeared to differ in their ability to detect statistically significant changes in compliance.  
A 30% increase in compliance with maximal sterile barrier use was not significant (p = 0.29) in one study,87 
whereas a 21% increase in compliance with sterile drape use was significant (p < 0.001) in another 
study.135 Wall and colleagues138 reported that a decline in compliance with maximal barrier precautions 
during the intervention period was caused by lack of use of patient drapes. Compliance with maximal 
barrier precautions improved after the team purchased new sterile kits pre-packaged with drapes, and 
confirmed providers had completed a tutorial. Wall and colleagues138 also mentioned that use of the 
femoral site, compared with other insertion sites, was associated with statistically significant lower 
compliance with hand washing, chlorhexidine skin antisepsis and maximal barrier precautions.
TABLE 23 Compliance with barrier precautions during study baseline and intervention periods
Study Barrier type
Baseline 
compliance (%)
Intervention 
compliance (%)
RR (95% CI); statistical 
significance
Coopersmith (2004)87 Maximal barriers  50  80 p = 0.29
Lobo (2005)108 Maximal barriers, CVC 
insertion
 91 100 RR = 0.91 (0.80 to 1.04); 
p = 0.147
Wall (2005)138 Maximal barriers, for last 
quarter
 68  86 Not reported
Lobo (2005)108 Glove use at CVC manipulation  40  98 RR = 2.36 (1.64 to 3.40); 
p < 0.001
Glove use at CVC dressing  97  97 RR = 1.00 (0.91 to 1.10); 
p = 1.0.
Lobo (2010)109 Glove use at CVC insertion 
and dressing
100 100 Not reported
Render (2006)126 Large sterile drapes   0  83 Not reported
Sherertz (2000)135 Sterile drapes  44  65 p < 0.001
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Compliance with dressing management
None of the six studies that measured compliance with dressing management (Table 24) explicitly specified 
this was a target behaviour, although dressing care was clearly stated as a topic in the educational 
interventions of the studies by Coopersmith and colleagues,87 Higuera and colleagues103 and Lobo and 
colleagues.109 Compliance with various aspects of CVC dressing care ranged from 11% to 84% at baseline 
and improved to 21% to 97% after interventions, with the improvements all being reported to be 
statistically significant, although compliance with correct dating of CVC dressings reached only 21% after 
the intervention by Coopersmith and colleagues.87 In the study by Rosenthal and colleagues,129 compliance 
with placing gauze dressings and with checking the condition of dressings both increased by a greater 
degree following performance feedback than following education alone. However, as these intervention 
components were implemented sequentially, the effects of performance feedback may not have been 
independent of the education.
Compliance with skin antisepsis prior to catheter insertion
Skin antisepsis prior to CVC insertion was a common element of the education in many of the studies 
included in the systematic review, but no studies specified explicitly that it was a target behaviour. Baseline 
rates of compliance with skin antisepsis ranged from 9% to 57% in the three studies that reported this 
outcome, and in all cases interventions resulted in improvements, with final compliance ranging from  
82% to 100%. The change was statistically significant in one study108 but significance was not reported  
in the other two studies126,138 (see Table 25).
Compliance with hub disinfection and catheter set dating
Compliance rates for line protection and hub disinfection were reported in two studies108,109 and ranged 
from 33% to 69% at baseline and were improved by interventions, with final compliance in the range 
82% to 98% (all improvements were reported statistically significant). However, there was a notable 
difference between two studies in compliance with the dating of intravenous administration sets, although 
in both cases increases in compliance occurred, which were statistically significant. Baseline compliance 
was only 0.57% and initially fell to 0% after education in the study by Rosenthal and colleagues129 but 
then reached 74% after a phase of performance feedback. In the study by Higuera and colleagues,103 
compliance with set dating rose from 40.69% to 93.85% (see Table 25).
TABLE 24 Compliance with dressing management during study baseline and intervention periods
Study Dressing action
Baseline 
compliance (%)
Intervention 
compliance (%) RR (95% CI); statistical significance
Coopersmith (2004)87 Dating dressing 11 21 p < 0.001
Rosenthal (2003)129 Placing gauze 53.02 56.21 (96.53)a RR = 1.06 (0.86 to 1.30); p = 0.64
RRb = 1.72 (1.40 to 2.10); p < 0.001
Higuera (2005)103 Placing gauze 84.21 97.87 RR = 1.16 (1.09 to 1.24); p = 0.0000
Rosenthal (2003)129 Checking 
condition
48.70 43.19 (89.56)a RR = 0.89 (0.67 to 1.17); p = 0.39
RRb = 2.07 (1.65 to 2.62); p < 0.001
Lobo (2005)108 Skin antisepsis 26 58 RR = 2.25 (1.15 to 4.39); p = 0.01
Lobo (2010)109 Skin antisepsis, 
ICU A
54 100 RR = 1.85 (1.43 to 2.39); p < 0.001
Skin antisepsis, 
ICU B
27 97 RR = 3.56 (2.03 to 6.23); p < 0.001
a During performance feedback phase.
b For education and performance feedback phases combined.
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Compliance with overall bundles
Three studies83,98,110 reported compliance with overall care bundles (Table 25). These were ‘patient’ and 
‘clinician’ bundles83 a CVC insertion bundle110 and a post-insertion care bundle.98 Compliance improved in 
the studies by Burrell and colleagues83 and Longmate and colleagues110 but was reported to be statistically 
significant only in the former study. The intervention by Guerin and colleagues98 did not appear to affect 
compliance with the CVC post-insertion care bundle. It is notable that compliance with all four bundles 
was already high at baseline, ranging from 74% to 94%, and improvements appeared modest (increases 
of only 7% and 11% in the Burrell study83 despite being statistically significant, and approximately 20% in 
the Longmate study110).
Burrell and colleagues83 demonstrated relationships between compliance with the two care bundles and 
the effectiveness of their CQI intervention at preventing catheter-BSI (central line-associated bacteraemia). 
Risk of catheter-BSI was reduced if insertion was conducted by physicians compliant in both bundles 
[RR = 0.5 (95% CI 0.4 to 0.8); p = 0.004], but risk was increased if insertion was conducted by physicians 
not compliant with the clinician bundle [RR = 1.62 (95% CI 1.1 to 2.4); p = 0.018]. Most (94.0%) cases of 
non-compliance with the clinician bundle were due to failure to wear a hat, mask and eyewear.
TABLE 25 Compliance with other activities during study baseline and intervention periods
Study Activity
Baseline 
compliance
Intervention 
compliance
RR (95% CI); statistical 
significance
Lobo (2005)108 Skin antisepsis at CVC insertion 9 100 RR = 11.0 (3.24 to 50.42); 
p < 0.001
Render (2006)126 Skin antisepsis at CVC insertion 42 82 Not reported
Wall (2005)138 Skin antisepsis at CVC insertion 57 100  
(last quarter)
Not reported
Rosenthal (2003)129 Dating i.v. admin set 0.57 0 (74)a p = 0.32
p < 0.001b
Higuera (2005)103 Dating i.v. admin set 40.69 93.85 RR = 2.34 (2.14 to 2.56); 
p = 0.0000
Lobo (2005)108 Line protection 69 98 RR = 1.38 (1.13 to 1.69);  
p < 0.001
Hub disinfection 33 93 RR = 2.74 (1.78 to 4.22); 
p < 0.001
Lobo (2010)109 Hub disinfection, CVC handling, 
ICU A
68 97 RR = 1.42 (1.19 to 1.69); 
p < 0.001
Hub disinfection, CVC handling, 
ICU B
44 82 RR = 1.80 (1.20 to 2.70); 
p < 0.004
Burrell (2011)83 Clinician bundle compliance 74 81 p = 0.0006; χ2 of slope = 11.71
Patient bundle compliance 81 92 p = 0.001; χ2 of slope = 108.34
Guerin (2010)98 CVC post-insertion bundle 
compliance
94 93 Not reported
Longmate (2011)110 CVC insertion bundle compliance 80 95–100 
(approximate)
Not reported
i.v., intravenous.
a During performance feedback phase.
b For education and performance feedback phases combined.
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Longmate and colleagues110 reported that all-or-nothing compliance with the CVC insertion bundle 
component of their CQI programme fluctuated between 80% and 100% during an 18-month period. 
The authors suggested that low initial compliance was attributed to a lack of checklist stickers early in the 
period; improved compliance later may have been due to introduction of a CVC insertion pack and the 
creation of subteam nurses to ‘own’ CVC processes, and also to greater scrutiny and follow up of episodes 
of incomplete compliance.110
In addition to the studies listed in Table 25, Speroff and colleagues136 provided extensive data on the 
adoption of various components of flexible QI interventions in critical care units of hospitals that had  
been randomised to toolkit-based and virtual collaborative QI approaches (full data are given in the  
data extraction form: see Appendix 5). Adoption of intervention components was consistently higher 
in virtual collaborative hospitals than toolkit hospitals. However, as mentioned above, neither of these 
intervention approaches was successful in reducing catheter-BSI incidence density relative to baseline.  
Risk of catheter-BSI appeared higher under the virtual collaborative (see Figure 4), which had the more 
frequent adoption of intervention tools and strategies, suggesting that failure to reduce catheter-BSI 
incidence density was not simply related to the extent of intervention implementation.
Further data on compliance with evidence-based practices were reported by Coopersmith and colleagues,50 
DuBose and colleagues,93 Lobo and colleagues,109 Palomar Martinez and colleagues,68 and Render and 
colleagues.126 These data (see Appendix 5) are not discussed here as they are based on very small or 
unclear sample sizes, or it is unclear to which study periods they refer.
Summary of compliance
Overall, nearly all of the studies that reported compliance with evidence-based infection prevention 
practices reported improvements relative to the baseline period, although the uncontrolled studies cannot 
definitively exclude an influence of secular trends. Most of the information on compliance relates to hand 
hygiene, barrier precautions and CVC dressing care. The studies are difficult to compare, however, as in 
some studies small changes in compliance were reported to be statistically significant, whereas in other 
studies large changes were reported not statistically significant. Interventions targeting specific behaviours 
appear more likely to improve compliance but this is difficult to assess critically as target behaviours were 
not always clearly specified in the primary studies. Baseline compliance rates varied considerably between 
studies and for hand hygiene they varied markedly between the different stages of CVC site preparation, 
insertion and ongoing care. It is not clear from these data whether compliance with evidence-based 
practices was an important mediator of intervention effectiveness at preventing catheter-BSI, as baseline 
compliance rates were often already high. An exception is the study by Burrell and colleagues,83 which 
found that compliance with two care bundles significantly reduced the risk of catheter-BSI.
Other secondary outcomes
Our systematic review protocol (see Appendix 1) specified two secondary outcomes that we would assess 
if reported in the primary studies: (1) the reaction of critical care staff to education and (2) critical care 
staff practical skills in relation to infection prevention. However, none of the 24 studies included in the 
systematic review reported these outcomes.
Process evaluations, facilitators and barriers
In addition to the assessments of attitudes, knowledge and compliance reported above, six 
studies34,68,83,110,126,136 provided qualitative observations relevant to understanding intervention processes, 
facilitators and barriers, although none of these studies carried out a full process evaluation.
Three of the CQI studies83,110,136 identified a lack of adequate infrastructure to support data collection 
and dissemination as being a barrier to successful implementation of the interventions. Burrell and 
colleagues83 stated that reliable baseline data did not exist prior to the project owing to variable reporting 
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mechanisms. Some critical care units were hesitant to accept previously reported rates, and inadequate 
staffing rates in some critical care units impacted on data capture rates. Difficulties were also encountered 
regarding data collection and associated information technology, such that the project team resorted to 
hard copy receipt of checklists. The lack of a continuous and sustainable data collection system involving 
cross-specialty collaboration was seen as a serious risk to sustainability of the CLAB ICU project principles. 
Speroff and colleagues136 commented that the lack of appropriate infrastructure to support data-driven 
QI was a significant barrier and that systematic standardised data collection was initially lacking in many 
of the study hospitals. Early effort was therefore needed to deploy a system-wide standardised infection 
control database registry. Longmate and colleagues110 reported that investigators were initially unable to 
reach agreement on a system – which had full support of both clinicians and data analysts – for collecting 
process measurements.
Three studies34,68,110 reported difficulties around the use of chlorhexidine for skin antisepsis. These related 
to difficulty in obtaining supplies (implying uneven compliance across critical care units)34,68 and the fact 
that chlorhexidine is colourless, making the skin area prepared with antiseptic difficult to see.68,110 In one 
study110 it was agreed that povidone–iodine could be used to colour the skin, followed by chlorhexidine.
Two studies68,136 commented that their interventions provided insufficient time for some components to be 
implemented. Speroff and colleagues136 reported that implementation of checklists was slow, suggesting 
that beneficial translation of desired changes may take more than 18 months to achieve. Palomar Martinez 
and colleagues68 reported that none of the critical care units was able to implement catheter equipment 
carts within the 3-month duration of their pilot study.
Other aspects of intervention process evaluation were identified in specific studies:
Burrell and colleagues83 reported difficulty in ensuring application of, and adherence to, infection 
surveillance definitions. They also commented that the CLAB ICU project methodology was based on 
a single successful collaborative (the Keystone ICU project) without a detailed analysis of all available 
evidence, which allowed criticism of methodology to be an excuse for non-compliance.
Palomar Martinez and colleagues68 reported that critical care staff were reluctant to take a test as part 
of the training for the CQI intervention, as the test was not mandatory, results were not anonymous and 
there was no credit given for participation in the training.
Pronovost and colleagues34 reported that the Keystone ICU project intervention was modestly more 
effective in small hospitals, with an incidence rate ratio of 0.97 (95% CI 0.96 to 0.99, p < 0.001) for 
each 100-bed decrease in the size of the hospital. Although Pronovost and colleagues34 did not conduct 
a detailed process evaluation during the Keystone ICU project, Dixon-Woods and colleagues149 developed 
an ex-post theory of the processes that contributed to the project’s success at preventing catheter-BSI. 
Although not noted by Dixon-Woods and colleagues,149 an important difference between the Keystone 
ICU project34 and other regional-scale CQI approaches that we reviewed68,83,110,136 could be that the 
Keystone ICU project was based on an established data collection system.
Render and colleagues126 provided a table of facilitators and barriers in their publication but it is unclear 
whether this was based on quantitative evidence. The study authors reported that after 6 months the 
project leader and project co-ordinator reviewed their detailed notes from the monthly reporting meetings 
to independently identify themes contributing to or delaying project success. The list of barriers and 
facilitators was then validated by the project leaders. However, the validation process was not explained.
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Summary of the systematic review of clinical effectiveness
Twenty-four studies were included in the systematic review, half of which were conducted in the USA and 
most of which used a single-cohort uncontrolled before-and-after design. The interventions were diverse 
in their educational approaches, ranging from single lectures in single critical care units to regional-scale 
CQI programmes in up to 103 critical care units. Most interventions focused on catheter insertion rather 
than catheter ongoing care, with hand hygiene, maximal barrier precautions and antiseptic preparation of 
the insertion site being the most frequently addressed clinical practices. Different educational approaches, 
which were unique to individual studies, were used to address the same clinical practice. Nearly all 
interventions included formal education approaches that would take staff away from bedside patient care. 
Definitions of CABSI and CRBSI were used inconsistently and two-thirds of the studies provided infection 
definitions that did not agree with those used in the NHS for the Matching Michigan programme. Most 
studies did not separately count multiple vascular catheters per patient when calculating the number of 
device-days, but where different approaches for calculating the number of device-days were compared the 
method of calculation did not appear to influence the incidence density RRs for catheter-BSI.
Data synthesis was conducted narratively, as it was inappropriate to statistically pool effects from the 
different types of educational interventions, which varied in their spatial and temporal scales and 
intervention complexity. Some studies were identified to be at high risk of bias but, owing to deficiencies 
in the reporting of study methods, risk of bias was generally unclear and could not be used as a criterion 
for objectively excluding studies from the data synthesis. Assuming that the RRs for incidence density of 
catheter-BSI reflect those of the planned interventions, 12 studies reported interventions that appeared 
clinically effective, eight studies reported interventions judged not to be clinically effective, or not to have 
provided convincing evidence of effectiveness, and four studies provided insufficient data for effectiveness 
of their interventions to be assessed. The interventions that appeared effective (subject to caveats about 
possible risks of bias and establishing cause and effect in before-and-after studies ) included local- and 
regional-scale CQI programmes; local-scale multimodal education with or without performance feedback 
and infection surveillance feedback; a catheter insertion bundle; and a catheter ongoing care bundle.
However, single lectures on CVC care and infection prevention in single critical care units were not 
effective. There was no evidence to suggest that the spatial or temporal scale, intervention complexity 
(education alone or with components beyond education) or the presence/absence of performance 
feedback and/or infection surveillance feedback had any appreciable influence on the incidence density 
of catheter-BSI. Too few studies provided information on mortality and LOS for effects of the educational 
interventions on these outcomes to be assessed.
Assessments of critical care staff attitudes, knowledge, compliance with clinical practices and other aspects 
of intervention processes identified several barriers or potential barriers to the successful implementation 
of educational interventions. Although limited in detail and lacking quantitative analysis, reports of the 
attitudes of critical care staff suggest that staff may be liable to question the need for evidence-based 
infection prevention practices, even when presented with supporting evidence. Most of the information on 
compliance with intervention practices was related to hand hygiene, barrier precautions and CVC dressing 
care. However, only one study had formally tested the influence of staff compliance on intervention 
effectiveness, finding that staff compliance with care bundles significantly reduced the risk of catheter-BSI. 
In several CQI programmes a lack of existing systems and infrastructure for data collection was reported to 
be a barrier to effective implementation of interventions. The availability of infrastructure at intervention 
inception seems to be a key difference between the Keystone ICU project which was based on an existing 
data collection system and the other CQI programmes, which appeared to have had to develop data 
collection systems for their interventions.
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At the time of writing this report, the only published UK study110 to have implemented an educational 
intervention for adult critical care patients was conducted in Scotland by Longmate and colleagues (the 
results of Matching Michigan in England had not been published and so could not be included in our 
evidence map or systematic review). The CQI programme110 included some elements of the Keystone ICU 
project but it differed from the Matching Michigan programme, in that it aimed to prevent VAP as well 
as catheter-BSI; it was conducted in a single critical care unit; it took 3 years to achieve effectiveness and 
the last year of the intervention overlapped with the Scottish Patient Safety Programme.110 The CLAB 
ICU project implemented by Burrell and colleagues83 in Australia appeared to be the most relevant of 
the clinically effective interventions to current NHS practice for prevention of catheter-BSI. CLAB ICU has 
similarities to Matching Michigan in England, as both programmes attempted to implement interventions 
based on the Keystone ICU project in new national settings. The CLAB ICU baseline incidence density 
of catheter-BSI was relatively low, consistent with the situation in English NHS trusts, and the starting 
infrastructure of the CLAB ICU study appears to have had some similarities with the English situation, 
as standard data collection strategies for infection surveillance appear not to have been in place at the 
start of CLAB ICU or Matching Michigan. An advantage of the CLAB ICU project, compared with most 
other studies included in the systematic review, is that the methods of the intervention were extensively 
reported. These are available in the published paper,83 project report146 and project website. Given the 
above considerations, the CLAB ICU project was used to provide some of the parameters used in the 
health economic model (see Chapter 6) to explore the cost-effectiveness of educational interventions for 
preventing catheter-BSI.
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Chapter 5 Systematic review of cost-effectiveness 
studies
A systematic review of the literature was conducted to identify and assess the current evidence base for the cost-effectiveness of educational interventions for preventing catheter-BSI and to inform the most 
appropriate approach for the de novo economic model (see Chapter 6).
Search strategy
A systematic literature search was undertaken to identify economic evaluations of educational 
interventions for preventing CRBSIs in critical care. Sensitive search strategies (shown in Appendix 2,  
Cost-effectiveness search strategy) were developed and tested by an experienced information scientist. 
These strategies were used to search the following electronic bibliographic databases:
 z MEDLINE (Ovid)
 z MEDLINE In-Process & Other Non-Indexed Citations
 z EMBASE (Ovid)
 z BIOSIS
 z Cochrane Central Register of Controlled Trials (CCRCT)
 z Cochrane Database of Systematic Reviews (CDSR)
 z Cochrane Database of Abstracts and Reviews of Effects
 z Cumulative Index to Nursing and Allied Health Literature (CINAHL) EBSCOhost
 z Web of Science databases:
 | Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI)
 | Arts & Humanities Citation Index (A&HCI)
 | Conference Proceedings Citation Index – Science (CPCI-S)
 | Conference Proceedings Citation Index – Social Science & Humanities (CPCI-SSH)
 z NHS Economic Evaluation Database [NHS EED via the Centre for Reviews and Dissemination (CRD)].
Searches were undertaken from inception of databases to February 2011 and updated in March 2012. 
Data from the studies that met the inclusion criteria were extracted and evaluated for quality and 
generalisability to the UK using a critical appraisal checklist.150 The included studies were then described 
in more detail, including discussion of the main issues arising from each of the studies. The full data 
extraction forms for the studies are shown in Appendix 8.
Inclusion criteria
Titles and (where available) abstracts of references identified by the search strategy were assessed for 
eligibility against our inclusion criteria (Table 26) by two health economists. Conference abstracts were 
not eligible for inclusion unless sufficient detail was provided for critical appraisal. Articles published 
in languages other than English were eligible for inclusion. Full papers of those records that appeared 
relevant on title or abstract were retrieved and independently screened by two health economists.  
Any differences in judgement were resolved through discussion.
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Quantity and quality of published research
A total of 767 potentially relevant articles were identified in the cost-effectiveness searches. Through 
inspecting the titles and abstracts of these articles, 759 non-relevant studies were excluded. The full-text 
records of the remaining eight studies were retrieved, but only three met all the inclusion criteria,76,151,152 
with the remaining five studies excluded because they were not full economic evaluations (Figure 7). 
A summary of the characteristics of the three included studies is given in Table 27 and the studies are 
described in more detail below.
The cost-effectiveness studies were assessed using a critical appraisal checklist as shown in Table 28. The 
checklist assesses the studies for quality and their generalisability to the UK; it was adapted by the review 
authors from checklists originally put together by Phillips and colleagues,150 Drummond and colleagues153 
and the National Institute for Health and Care Excellence (NICE) reference case requirements.154 The 
definition of catheter-BSI provided was CRBSI in two of the studies76,151 and CLAB in the third study.152
The three studies76,151,152 specified the decision problem, the study rationale and justified the comparator. 
A detailed description was given of the patient groups and the health-care settings were similar to those 
in the UK. The health-care systems in all studies differ to that of the UK and therefore the practices may 
not be generalisable to the UK. The structure of the models used in the studies76,151,152 reflect the disease 
process and the modelling methodologies seem appropriate.
TABLE 26 Inclusion criteria for the systematic review of cost-effectiveness studies
Study characteristic Inclusion criteria
Population Patients in critical care with vascular catheter(s)
Intervention Educational interventions with an objective to reduce or prevent CRBSIs
Outcomes BSIs or mortality associated with, related to, or suspected to result from catheter use
Design Full economic evaluations: cost-effectiveness, cost–utility, cost–benefit and cost–consequence
FIGURE 7 Identification of studies for inclusion in the systematic review of cost-effectiveness.
8 full-text papers obtained
767 titles and abstracts
identified
Title and abstract screening:
759 records excluded
5 papers excluded because
they were not full economic
evaluations (listed in Appendix 6,
Full-text records excluded from
the cost-effectiveness systematic
review)
3 papers describing 3 studies
assessed in cost-effectiveness review
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Cohen and colleagues76 and Bond and King152 did not base their effectiveness estimates on a systematic 
review, and did not use any instruments to measure health benefit. Halton and colleagues151 did both, 
using quality-adjusted life-years (QALYs) as a measure of health outcome. Data inputs for the model used 
in Cohen and colleagues76 and Halton and colleagues151 studies were adequately reported and justified, 
but not in the Bond and King152 study. Cohen and colleagues76 and Bond and King152 did not state the 
uncertainty surrounding the model and the included parameters, neither did they report any form of 
model validation, whereas Halton and colleagues151 reported both.
TABLE 27 Characteristics of economic evaluations 
Characteristics Halton151 Cohen76 Bond and King152
Publication year 2010 2010 2011
Country Australia USA USA
Funding source Queensland Health Quality 
and Safety programme and 
National Health and Medical 
Research Council
Not stated None
Study type Cost–utility analysis Cost–consequence analysis Cost-effectiveness analysis
Perspective Australian health-care payer United States health-care 
payer 
Not stated
Study population Adult critical care unit 
patients with a CVC
Adult patients with a CVC 
inserted in the MICU
Adult patients with a CVC
Intervention and 
comparator
Catheter care bundle vs. 
current practice 
Simulated education training 
in catheter insertion vs. no 
educational intervention
CVC educational intervention 
vs. no educational 
intervention
Intervention effect Reduction in the rate of 
CRBSI from 7.7 to 1.4 per 
1000 line-days over an 
18-month period, relative risk 
reduction of 0.34 (95% CI 
0.23 to 0.50)
Prevented 9.95 cases of 
CRBSI among patients in 
MICU, with 14 additional 
hospital days (including 12 
MICU days) gained
The number of CLAB was 
reduced from 4 to 2 per 
600 CVCs inserted in a 
hypothetical year
Intervention cost Unknown. A range of costs 
was used in the model
Total operating costs 
for training the medical 
residents, faculty and staff 
time, supplies and space 
rental were US$111,916
The total cost per patient was 
US$546 with the education 
intervention vs. US$392 
without the intervention
Currency base A$ (2006) US$ (2008) US$ (year not stated)
Model type, health states Markov model Regression model Decision-analytic model
Time horizon Lifetime 12 months Hospital stay
Baseline case results The base-case analysis shows 
that the care bundle is cost-
effective up to an 18-month 
nationwide implementation 
cost of A$4,349,730 when 
compared with current 
practice
The intervention was highly 
cost-effective with overall 
cost savings
If the educational 
intervention is effective, a 
small increase in cost can 
reduce complications
MICU, medical intensive care unit.
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Description and results of the published economic evaluations
Full data extracted from the published economic evaluations are given in the data extraction forms  
(see Appendix 8).
Halton and colleagues
Halton and colleagues151 conducted an economic evaluation of the effectiveness of a CVC care bundle for 
preventing CRBSI relative to current practice, which was defined as a non-bundled approach to central 
line management with the use of uncoated catheters. The study setting was an adult ICU in Australia. The 
intervention ran over an 18-month period. The CVC care bundle encompassed five elements: optimal hand 
hygiene, chlorhexidine skin antisepsis, maximal barrier precautions for catheter insertion, choice of optimal 
insertion site and prompt catheter removal. The intervention also included a programme to educate staff 
about clinical leadership and the risk of infection.
The total costs of implementing the intervention were estimated in two parts: the costs directly associated 
with the components of the intervention and the costs related to the monitoring, education and 
leadership activities. A Markov model was constructed and was used to estimate the cost-effectiveness 
of the CVC care bundle for different combinations of antimicrobial and uncoated catheters. The analysis 
was conducted from the Australian health-care payer perspective with the costs reported in Australian 
dollars at 2006 prices. The study used various sources including the published literature, primary data 
from studies, national statistics, population surveys and health-care databases to derive costs and the 
associated health benefits. The economic outcomes from the model were summarised in terms of QALYs 
and total costs.
TABLE 28 Critical appraisal checklist for the economic evaluations
No. Item
Halton 
2010151
Cohen 
201076
Bond and 
King152
 1 Is there a clear statement of decision problem? Yes Yes Yes
 2 Is the comparator routinely used in UK NHS? Yes Yes Yes
 3 Is the patient group in the study similar to those of interest in UK NHS? Yes Yes Yes
 4 Is the health-care system comparable that of the UK? No No No
 5 Is the setting comparable to that of the UK? Yes Yes Yes
 6 Is the perspective of the models clearly stated? Yes Yes No
 7 Is the study type appropriate? Yes Yes Yes
 8 Is the modelling methodology appropriate? Yes Yes Yes
 9 Is the model structure described and does it reflect the disease process? Yes Yes Yes
10 Are the assumptions about the model structure listed and justified? Unclear Unclear Yes
11 Are the data inputs for the model described and justified? Yes Yes Unclear
12 Is the effectiveness of the intervention established based on systematic review? Yes No No
13 Are health benefits measured in QALYs? Yes No No
14 Are health benefits measured using a standardised questionnaire? Yes No No
15 Are the resource costs described and justified? Yes Unclear No
16 Have the costs and outcomes been discounted? Yes No No
17 Has uncertainty been assessed? Yes No Yes
18 Has the model been validated? Yes No No
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Modelling approach
The structure of the model was based on the patient clinical pathway. A Markov state–transition decision 
model, which had previously been developed to evaluate the cost-effectiveness of antimicrobial CVCs in an 
Australian setting, was adapted.155 The Markov model consists of short- and long-term components: short 
term for the hospital stay and long term for the remainder of the patients’ life after hospital discharge. 
The patients enter the model with the CVC in situ. The short-term Markov model consists of daily cycles 
whereby patients may develop CRBSI, remain as an ICU patient with the CVC or have their catheter 
removed. Patients who develop CRBSI have an increased risk of death in hospital (Figure 8).
The daily probabilities of catheter removal and CRBSI were estimated by fitting a Weibull distribution to 
data from an epidemiological study of CVCs.156 In the long-term Markov model, the surviving cohort was 
followed for the remainder of their lifetimes. Utilities associated with different health states were assigned 
to cycles spent in the ICU and 6 months after discharge. Costs and QALYs were discounted using a  
rate of 3%.
Assumptions
Several assumptions were made in the model structure. It was assumed that the catheters were inserted 
or removed mainly within the ICUs and that no multiple catheterisations existed. ICUs were assumed to 
have an existing infection control procedure in place. The consequences of CRBSI were also assumed 
not to be dependent on age, disease severity or causative micro-organisms. As there was no information 
on reduction in QALYs among CRBSI survivors, the life expectancies among this group of patients were 
adjusted using Australian population QoL population norms.157
Catheter colonisation was not included in the model, as the authors considered that this event does not 
carry health or economic consequences. It was assumed that preferences exist among the clinicians for the 
use of antimicrobial CVCs. This assumption led to comparisons between the current standard of practice 
using antimicrobial-impregnated catheters and adoption of the CVC care bundle.
Effectiveness of intervention
The study used estimates of the effectiveness of a catheter care bundle from the Keystone ICU project,34 
which reported an 18-month intervention aimed at reducing the incidence of CRBSI in adult ICUs in 
Michigan, USA (as discussed in Chapter 4). The intervention focused on the clinicians’ use of five  
evidence-based procedures as highlighted by the US CDC. The intervention included a programme to 
educate staff about clinical leadership and risk of infection. The intervention reduced the risk of infection 
over 18 months with a relative risk of 0.34 (95% CI 0.23 to 0.5).
FIGURE 8 Markov model of the health states for ICU patients with a CVC.151
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Halton and colleagues151 estimated the effectiveness of each type of antimicrobial CVC from a systematic 
review of the literature conducted by Ramritu and colleagues.158 The relative risks of contracting CRBSI 
with the use of a chlorhexidine/silver sulfadiazine (CH/SSD)-coated catheter, and minocycline and 
rifampicin (MR)-coated catheter were 0.66 and 0.39, respectively.
Estimation of quality-adjusted life-years
The health outcome in the model was expressed in QALYs. The utility weight estimates used in the model 
were taken from several sources. A utility value of 0.66 for the ICU stay was derived from a previous study 
that examined the changes in QoL before and after intensive care.159 The study was a prospective cohort 
of 300 consecutive patients admitted to intensive care in a Scottish hospital. The SF-36 questionnaire was 
given to patients’ relatives to assess the patients’ health-related quality of life (HRQoL) before their current 
illness. The EQ-5D instrument was then used to elicit the patient’s QoL over a 12-month period.
Age-related utility values were derived from a population-based survey.157 The Australian Health Omnibus 
Survey was based on responses from a 3100 population using the Assessment of Quality of Life (AQoL) 
instrument. The data from the population based survey were stratified by age, gender and health status.
Estimation of costs
Halton and colleagues151 included costs associated with implementing the CVC care bundle and the costs of 
the monitoring, educational and leadership activities. The authors were not able to estimate the cost of the 
care bundle itself. The estimates of the resources associated with these activities were based on descriptions 
from the Keystone ICU project.34 The overall resource use estimate was based on time spent on the activities 
directed towards the implementation of the intervention. Time spent on activities such as mentoring by key 
personnel, lectures for the clinical staff and preparation of care bundle components were among the key 
resource estimates. The overall time spent was expressed in days and man-hours to the nearest minute.
The additional costs for the CH/SSD and MR catheters were A$11.64 and A$59.36, respectively, relative to 
uncoated catheters. Cost estimates for CRBSI were categorised into costs of CRBSI diagnostics, treatment 
and hospitalisation. Diagnostic costs for CRBSI were A$101.70 (per patient with CRBSI), based on an 
estimate from the Australian health-system database, whereas the cost for treatment was A$591.30. 
CRBSI was associated with increased hospitalisation costs and longer inpatient stays. These costs were 
for ICU bed-days (A$3021 per day) and hospital bed-days (A$843 per day). There were an extra 2.41 ICU 
days and 7.54 hospital days associated with each case of CRBSI. Other sources of cost and resource use 
estimates included a prior economic evaluation,160 and costing study.161
Cost-effectiveness results
As the cost of implementing a CVC care bundle in Australia was unknown, deterministic threshold 
analyses were conducted. The maximum cost for the care bundle was identified at which it would remain 
cost-effective (i.e. if the cost per QALY was less than the willingness-to-pay threshold of A$64,000). 
The baseline analyses show the benefits for the CVC care bundle or standard practice under different 
scenarios. The CVC care bundle was shown to be cost-effective up to a nationwide implementation cost  
of A$4,349,730 for an 18-month period (or A$94,559 per ICU) compared with current practice alone.  
For the strategy that includes CH/SSD and MR catheters, the CVC care bundle remains costs effective up  
to an implementation cost of A$2,287,400 and A$1,144,465, respectively, for the same period.
Sensitivity analyses
Sensitivity analyses were conducted to compare the CVC care bundle and different forms of vascular 
catheters used in current practice. The analyses included a pairwise comparison between current practice 
and the CVC care bundle; a three-way comparison between the CVC care bundle, the CH/SSD catheters 
and current practice; and a four-way comparison between the CVC care bundle, MR catheters, CH/SSD 
catheters and current practice.
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Summary of key issues
 z The study estimated the cost-effectiveness of a CVC care bundle relative to current practice in an 
Australian setting.
 z The structure of the model, assumptions and methods used in estimating the utility weights 
incorporated into the model were clearly stated.
 z One key limitation is that the study was not able to estimate the cost of the CVC care bundle.
Cohen and colleagues
Cohen and colleagues76 conducted a retrospective analysis of the costs from a simulation-based 
educational intervention in CVC insertion as a means of reducing CRBSI among patients in a medical 
intensive care unit (MICU) in Chicago, USA. The study estimated the financial implication of the 
educational intervention by comparing the rates of CRBSI during the intervention period (December 2006 
to November 2007) and the year before the intervention. The intervention included a 2-hour lecture, 
ultrasound training and organised practice with a CVC simulator, as well as feedback from an instructor. 
The education intervention involved emphasis on the core evidence-based protocol for reducing CRBSI, 
which includes hand washing, full sterile barrier technique, chlorhexidine skin preparation, avoidance of 
the femoral site and prompt CVC removal.
The cost-effectiveness model used regression analyses to estimate the costs from the non-randomised 
before-and-after study. The resources used and cost estimates for the intervention were derived from 
hospital cost accounting data. The costs included were the cost of the intervention and the associated 
costs for the hospital stay.
Modelling approach
Two statistical methods were used in the study: the propensity score matched case–control comparison 
method and the linear regression method. The trial data were analysed and regression models were used 
to derive estimates of cost and LOS for the intervention and control group, controlling for age, sex and 
Charlson score (an indicator of comorbidity). To give the intervention and the control group the same 
infection risk, a regression-based propensity score was used. Estimates of cost differences between the 
matched cases and controls were then derived.
Effectiveness of intervention
The effectiveness of the intervention was estimated retrospectively by comparing the CRBSI rates for the 
year before the intervention to the one after the simulation-based education. Using hospital accounting 
data, the incremental cost and LOS associated with MICU patients with a CVC and a CRBSI during the 
period were estimated.
A total of 477 patients who had a CVC inserted in the MICU during the period were included in the 
study. The baseline infection rate before the trial was 11 cases in 239 CVC patients, i.e. 4.2 per 100 MICU 
CVC admissions. After the medical residents had been fully trained, the infection rate was estimated 
to be 0.42 per 100 MICU CVC admissions. The study estimated that 9.95 CRBSI cases were prevented 
in the year after the intervention. Analysis of the data (for both statistical methods) gave an additional 
LOS for patients with CRBSI compared with those without CRBSI of 13.8–14.2 days for the hospital and 
12.1–12.2 days for the MICU.
Estimation of quality-adjusted life-years
Utility weights were not reported in the model and the study in general, and so QALYs were not estimated. 
The health benefit from the study had been estimated in terms of the number of CRBSI cases averted.
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Estimation of costs
The cost estimates in the study were sourced primarily from the hospital cost accounting data and include 
the costs of supplies, faculty and staff time and space rental (as outlined in the data extraction form:  
see Appendix 8).
All the reported costs were adjusted to 2008 US dollars. The cost to train 69 medical residents was 
US$111,916. The predicted annual cost to maintain the intervention was US$89,455. The additional cost 
estimates associated with CRBSI derived from the linear regression model and the risk-adjusted model 
were similar: US$82,005–82,730.
Cost-effectiveness results
The total annual estimated savings for the propensity score matched case–control comparison method 
and the linear regression method, respectively, were US$823,164 and US$815,950, 141 and 137 
patient hospital days, and 120 and 121 MICU days. The net annual saving in monetary terms from the 
intervention was estimated to be US$700,000. Based on the results, a 7 : 1 rate of return on investment 
was achieved with the intervention. The study did not report any results of sensitivity analysis.
Summary of key issues
 z Data were from a before-and-after study and may not be a true reflection of the intervention effect.
 z The intervention was limited to a particular hospital setting and was conducted for a limited duration. 
This makes it unclear if the findings are generalisable to other hospitals or countries.
 z The study did not consider longer-term follow-up.
 z The health outcomes of the study were not presented in QALYs.
Bond and King
Bond and King152 conducted an economic evaluation of the theoretical impact of an educational 
intervention to improve the safety of CVC insertion. The study setting was a health-care system that 
included a tertiary care centre, a community hospital and an emergency department in the USA. The 
educational intervention consisted of a CVC education course. It was a day-long programme with 
brief introductory lectures followed by hands-on procedural simulation in CVC insertion, using training 
mannequins, appropriate sterile procedures, ultrasound imaging and feedback from instructors. In 
addition, doctors and nurses were taught the Institute for Healthcare Improvement (IHI) bundle of barrier 
precautions and new processes to encourage, ensure and track compliance.
A decision-analytic model was constructed and was used to estimate the cost-effectiveness of the 
education intervention. The authors did not state the perspective of the analysis, nor the base year for 
the costs. The study used various sources including data from published primary studies. The results from 
the model were presented in US dollars in terms of net monetary benefits of the education intervention 
compared with no education.
Modelling approach
A decision-analytic model was constructed in TreeAge software version 1.5 (TreeAge Software Inc., 
Williamstown, MA, USA) and describes the duration of the hospital stay. The model starts with the need 
for a CVC, with a focus on non-emergent cases, defined as those where there was sufficient time to 
follow sterile precautions in CVC insertion. One cohort of patients receive the education intervention and 
the other does not. In each cohort, a proportion receive the CVC in the internal jugular, subclavian and 
femoral veins. Patients then either have no complications or mechanical complications, such as iatrogenic 
pneumothorax or CLAB. Patients who suffer a CLAB or mechanical complication have corresponding 
higher costs and mortality than those without.
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Effectiveness of intervention
The evaluation assumes that the educational intervention would reduce the rate of CLAB by 50% and 
reduce the rate of the mechanical complications by 25% in the base-case analysis. The study did not 
discuss the sources upon which these are based, nor the rationale behind their use. Patients with CLAB 
had an attributable mortality of 12%, compared with a baseline mortality risk of 10% for ICU patients, 
based on a review of studies.
Estimation of quality-adjusted life-years
Utility weights were not reported in the model and the study in general, and so QALYs were not estimated. 
The health benefit from the study had been estimated in terms of the number of CLAB cases averted.
Estimation of costs
The costs of the educational programme were presented but it is not clear how these were estimated or 
whether they were based upon an empirical study. The costs of the programme included the acquisition 
cost of mannequins and ultrasound technology, and the staff training time for the trainers and trainees. 
The cost of the programme was US$170,360 for the first year and an average of US$63,610 for the 
subsequent 4 years, for the health-care system described, in which 600 patients had CVCs inserted in 
each year.
The cost per CLAB case was US$16,350 based upon those reported by IHI; however, the full reference was 
not provided so we are unable to critique this cost. The mean excess cost of mechanical complications was 
US$17,312.
Cost-effectiveness results
The results were presented for the education intervention versus no intervention per individual with a CVC 
inserted in the ICU. The survival during the hospital stay was 89.9% for those in the education intervention 
cohort and 89.8% in the no-education intervention cohort. The costs with and without the education, 
based on the first year programme cost, were US$546 and US$392, respectively, i.e. an additional cost 
of US$154. For the health-care setting, the additional cost was US$92,400 to reduce the number of 
CLABs from 4.2 to 2.1. The study conducted a number of sensitivity analyses varying the programme cost, 
CLAB baseline rate and the intervention effectiveness. For the lower programme cost for years 2–5, the 
additional cost of the education intervention was US$44 per patient. Raising the CLAB rate to 5% gave a 
net monetary benefit of US$158 with an additional survival of 0.3%.
Summary of key issues
 z The study estimated the cost-effectiveness of a CVC education intervention relative to no education 
for a US health-care setting.
 z The model does not consider long-term follow-up beyond the hospital stay or include QALYs.
 z The derivation of some of the model parameter estimates is unclear, particularly the cost of the CLAB, 
and the effectiveness of the education intervention.
Published economic evaluations: summary of methods
 z A systematic review of cost-effectiveness studies identified three cost-effectiveness studies of 
educational interventions for preventing catheter-BSI in critical care.76,151,152 Two studies used a decision 
modelling approach and the other was a trial-based economic analysis.
 z Halton and colleagues151 used a Markov decision-analytic approach to model Australian patients with 
CRBSI over their lifetime and the health benefits associated with a CVC care bundle. The model did 
not include the cost of the care bundle.
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 z Cohen and colleagues76 used a trial-based cohort analysis to derive estimates of the costs and benefits 
associated with a simulation-based education intervention in a hospital in the USA. They used 
regression models to estimate the costs and health benefits for matched case and control groups with 
and without CRBSI. However, the intervention was limited to a particular hospital setting and for a 
short period of time.
 z Bond and colleagues152 used a Markov decision-analytic approach to evaluate effects of an educational 
intervention on CLAB among US patients. The model did not consider the long-term health benefit for 
the intervention.
 z None of the studies was considered appropriate to estimate the cost-effectiveness of educational 
interventions for preventing catheter-BSI in critical care units in the UK NHS.
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Chapter 6 Economic evaluation
We developed a new model to estimate the costs, benefits and cost-effectiveness of implementing a CVC care bundle for preventing catheter-BSI in adult patients in critical care units in England, 
compared against current clinical practice. The CVC care bundle in this analysis was defined based upon 
the Matching Michigan programme in England and the original US Keystone ICU project approach.34 
It encompassed five elements: optimal hand hygiene, chlorhexidine skin antisepsis, maximal barrier 
precautions for catheter insertion, choice of optimal insertion site, and prompt catheter removal. Current 
clinical practice was defined as critical care that did not implement a CVC care bundle. The model was 
populated with clinical effectiveness data from the study most relevant to Matching Michigan identified 
in our systematic review of clinical effectiveness (see Chapter 4). HRQoL data were derived from the 
published literature and cost data derived from published studies (where available), and from national and 
local NHS unit costs.
The economic evaluation was from the perspective of the NHS and Personal Social Services, as only these 
direct costs were included. The model estimates the costs during hospital stay and the lifetime benefits for 
the intervention and its comparator. The benefits were discounted at 3.5%, as recommended by NICE.154 
The base price year for the costs was 2011. The outcome of the economic evaluation is reported as the 
incremental cost per QALY gained.
Methods for cost-effectiveness modelling
Description of the model structure
A decision-analytic model was designed to estimate the cost-effectiveness of a CVC care bundle for 
preventing catheter-BSI in critical care units compared with remaining with current clinical practice. 
A diagram of the model is shown below (Figure 9). The model follows cohorts of patients from their 
admission to the critical care unit. The cohorts of patients compared are those who receive the CVC care 
bundle and those who receive current clinical practice. The numbers of critical care patients infected with 
catheter-BSI depend upon the catheter-BSI incidence rate, the proportion of patients with a CVC, and the 
effectiveness of the intervention (CVC care bundle or current clinical practice) for preventing infections. 
Patients may die during their hospital stay and the risk of mortality is greater for those with catheter-BSI. 
Furthermore, LOS will be greater for patients with catheter-BSI. The model estimates the number of people 
who contract catheter-BSI, those who die in hospital and the total LOS for the two cohorts. The long-term 
survival of patients after discharge from the critical care unit is estimated using a simple Markov model 
with states for alive and dead. Long-term QALYs are estimated for these patients using general population 
age-related HRQoL utility values. The model calculates the costs associated with LOS and the treatment 
and diagnosis of the catheter-BSI infections. There are also costs of implementing the CVC care bundle.
In the model, the total costs and discounted QALYs are calculated for both cohorts and thus the  
cost-effectiveness of the CVC care bundle is calculated:
Cost for bundle cohort − cost for current practice cohort
Cost effectiveness =
QALYs for bundle cohort −QALYs for current practice cohort
  (1)
The model is based on the following assumptions:
 z We assumed for the purposes of the model that CABSI and CRBSI are synonymous, and are collectively 
referred to as catheter-BSI. It is not possible to distinguish between the surveillance definition of 
catheter-associated BSI and the clinical definition of catheter-related BSI. Although in theory CABSI 
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overestimates the true incidence of CRBSI (for definitions see Chapter 1), our review of clinical 
effectiveness (see Chapter 4) and another systematic review21 found that the definitions are used 
interchangeably and inconsistently in primary research studies.
 z We assumed that there is no difference in mortality during the hospital stay following critical care 
discharge for patients who had catheter-BSI in the critical care unit compared with those who did 
not. We were unable to find any data for the mortality during the hospital stay following critical care 
discharge for these two groups.
 z We assumed that there was no difference in mortality after hospital discharge for those who had 
catheter-BSI in the critical care unit compared with those who did not.
The model does not consider the HRQoL of patients in critical care units, because the time spent in critical 
care is very small compared with the lifetime horizon, and therefore any QALY gains during this period are 
insignificant. In addition, non-fatal adverse events associated with catheter-BSI were included within the 
model as a cost, but not as a utility decrement.
The economic evaluation does not include non-tangible benefits or disbenefits associated with the 
intervention, such as changes to staff morale and public confidence in the health-care system.
Evaluation of uncertainty
There are uncertainties in the evaluation of the cost-effectiveness of the CVC care bundle. These reflect 
a lack of information about the content of interventions, their costs and resource use, and the extent to 
which they were implemented in primary research studies, as well as a general lack of information about 
the effects of catheter-BSI on patient survival and HRQoL. Uncertainty was evaluated using deterministic 
and probabilistic sensitivity analyses (PSAs). One-way deterministic sensitivity analyses (described 
below) were conducted to evaluate the influence of individual parameters on the model results and 
to test the robustness of the cost-effectiveness results to variations in the structural assumptions and 
parameter inputs.
Multiparameter uncertainty in the model was addressed using PSA.162 In the PSA, probability distributions 
were assigned to point estimates of all parameters used in the base-case analysis. The model was run for 
1000 iterations, with a different set of parameter values for each iteration, by sampling parameter values 
at random from their probability distributions. The uncertainty surrounding the cost-effectiveness of the 
CVC care bundle is represented according to the range of cost-effectiveness results. The parameters 
included in the PSA, the distribution used for sampling each parameter, and the upper and lower limits 
assumed for each variable are reported in Appendix 9.
FIGURE 9 Cost-effectiveness model for the CVC care bundle to prevent catheter-BSI.
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Model validation
The economic model was validated by checking the model structure, calculations and data inputs for 
technical correctness by an independent health economist. The structure was reviewed by two clinical 
experts for its appropriateness for the disease process and the treatments considered. The robustness of 
the model to changes in input values was tested using sensitivity analyses to ensure that any changes to 
the input values produced changes to the results of the expected direction and magnitude. Finally, the 
model results were compared with those from previous published cost-effectiveness analyses.
Data sources
Catheter-bloodstream infection epidemiology
Catheter-bloodstream infection incidence rate
Catheter-bloodstream infection incidence data were collected from critical care units in England during 
the Matching Michigan programme. Matching Michigan recruited 97% of the acute health-care trusts 
in England, representing 216 critical care units. The main elements of the scheme involved defining 
and measuring infections and then reporting results on a monthly basis.163 Although full data from the 
Matching Michigan programme were not available at the time of writing this report, the incidence per 
1000 catheter-days was reported as 3.7 at the start of the collecting period (May 2009). For the purposes 
of our analyses, we have used the incidence rate from before the introduction of the Matching Michigan 
intervention (Table 29) to reflect the baseline incidence density of catheter-BSI associated with current 
clinical practice.
Within the model, the incidence density per 1000 catheter-days was converted to the percentage of critical 
care patients who contracted catheter-BSI by assuming a mean stay in critical care with a CVC of 5 days.164
The proportion of patients with a central venous catheter
No estimate was found of the proportion of patients in critical care requiring a CVC in England (or 
anywhere else in the UK). However, a pilot surveillance study166 reported infection control data for nine 
hospitals in Irish critical care units between November 2010 and January 2011. The characteristics of 
the Irish units were assumed to be similar to those in the UK. The proportion of patients with a CVC 
was defined as the percentage of patients in the critical care unit who had one or more CVC inserted. 
Nationally, it was 71% and ranged between individual units from 49% to 96%.
Clinical effectiveness
Central venous care bundle effectiveness
At the time of constructing the model, full results of the Matching Michigan programme had not been 
published. An estimate of the effectiveness of the CVC care bundle was derived from our systematic 
review of clinical effectiveness (see Chapter 4). In this review the most relevant studies in terms of 
geographical scale for providing clinical effectiveness data were the five regional-scale projects34,68,83,126,136 
as they most closely resemble the regional multicentre approach used in Matching Michigan in England. 
We considered the ‘CLAB ICU’ study by Burrell and colleagues in Australia83 to be the most appropriate 
for the following reasons: (1) it appeared to closely reflect the strategic approach used in Matching 
Michigan in England (provision of a CVC insertion kit, checklist, infection surveillance feedback and staff 
empowerment among other components); (2) sufficient details of the intervention were reported for the 
intervention to be classified by the reviewers as reproducible based on the published information; (3) costs 
of the intervention were reported; (4) the intervention was, like Matching Michigan, specifically intended 
to replicate the original US Keystone ICU project approach34 in a new national setting. The study by Burrell 
and colleagues83 is reported in more detail in Chapter 4. Burrell and colleagues83 used a definition of CABSI 
during the hospital stay, rather than CRBSI, as used with other model parameters. However, as noted 
above, we assume that CABSI and CRBSI are synonymous and are collectively referred to as catheter-BSI.
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Burrell and colleagues83 reported a 60% reduction in the number of catheter-BSI in critical care,  
i.e. a relative risk of 0.4 compared with baseline clinical practice.
Our model compares a CVC care bundle against remaining with current clinical practice, where those 
elements from the CVC care bundle have not been implemented on a co-ordinated, national or regional 
basis. However, it may be the case that some hospitals (or individual critical care units) would have 
incorporated some elements of the CVC care bundle into current clinical practice, prior to implementation 
of a co-ordinated, national or regional programme. The baseline catheter-BSI incidence data used in the 
model, based on the rate reported in acute health-care trusts in England prior to the implementation of 
Matching Michigan, should reflect such partial implementation. It should also be noted that there may 
be variation in the degree to which aspects of the bundle are implemented between different hospitals. 
Similar variability would likely have been present in the regional-scale CLAB ICU project83 that provides an 
estimate of clinical effectiveness of the CVC care bundle.
Increased length of stay due to infection
Length of stay was reported in seven studies50,94,109,110,117,139,144 in our clinical effectiveness review (see 
Chapter 4). Only one of these studies, by Zingg and colleagues,144 reported LOS data separately for 
patients with and without catheter-BSI, and we have therefore additionally searched the literature for 
further supporting information on the additional LOS due to catheter-BSI.
TABLE 29 List of parameters included in the model
Parameter name Base case
Higher 
estimate
Lower 
estimate Source
Catheter-BSI epidemiology
Catheter-BSI incidence rate, per 1000 catheter-days for 
current clinical practice
3.7 5.0 1.3 NPSA163
Critical care mortality, no catheter-BSI 0.169 0.203 0.135 ICNARC 2011164
RR for critical care mortality due to catheter-BSI 3.25 3.6 2.7 Lambert et al.165
Proportion of patients with a CVC 0.71 0.96 0.49 ICCTG166
Costs
Ward bed-day, £ 246 295.2 196.8 HRG 2010/11167
Critical care bed-day, £ 1440 1171 1657 HRG 2010/11167
Catheter-BSI diagnosis and treatment costs, £ 518 622 415 Halton et al.151
CVC care bundle (per critical care patient), £ 15.48 20.13 10.84 Various 
Clinical effectiveness
Bundle effectiveness, RR 0.4 0.67 0.22 Burrell et al.83
Additional critical care LOS for catheter-BSI, days 1.5 2.5 0.0 Lambert et al.165
Additional ward LOS for catheter-BSI, days 5.13 8.68 1.58 Warren et al.168
Other parameters
Starting age, years 60 70 50 ICNARC164
Intercept Age coefficient
HRQoL utility coefficients 1.0604 –0.0043 Ward et al.169
HRG, Healthcare Resource Group; National Patient Safety Agency; ICCTG, Irish Critical Care Trials Group; ICNARC, 
Intensive Care National Audit & Research Centre.
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Estimates for increased LOS due to catheter-BSI vary widely in the literature. However, some of these 
studies170,171 have overestimated the additional LOS due to the acquired infection by ignoring the timing 
of the infection. This leads to ‘time-dependent bias’ in multiplicative hazard ratios. A more appropriate 
method to estimate LOS due to an infection is to use a multistate or longitudinal model that accounts for 
the time of the infection.170–172
Barnett and colleagues170 demonstrated the effect of time-dependent bias on LOS. They used a multistate 
model that accounted for the time of infection and compared that to a commonly used model that ignores 
the time of infection (a generalised linear model assuming a gamma distribution). They applied the two 
methods to a large prospective cohort of hospital admissions from Argentina and validated their results 
using a simulation study. The additional critical care LOS due to nosocomial infection was 11.23 days when 
ignoring time dependence and only 1.35 days after accounting for the time of infection. The simulation 
results showed that ignoring time dependence consistently overestimated the additional LOS.
We found four studies165,168,170,173 that used the appropriate methodology to estimate the additional 
LOS attributable to BSIs in the critical care unit. From these, we considered a study by Lambert and 
colleagues165 to be most relevant and appropriate as it was a large European study. Lambert and 
colleagues165 analysed data for 119,699 patients collected prospectively from 537 critical care units in 
10 participating countries during 2005–8, using a standard European protocol for the surveillance of 
infections [Hospitals In Europe Link for Infection Control through Surveillance (HELICS)-ICU].174 They 
assessed the excess mortality and critical care LOS associated with BSI (and pneumonia). They focused on 
the most frequent causative microorganisms for BSI and pneumonia (Acinetobacter baumannii, Escherichia 
coli, Pseudomonas aeruginosa and S. aureus). The risk of death in the critical care unit was modelled with 
a time-dependent regression model assuming proportional hazards, taking into account the indirect effect 
on mortality of (a potentially) extended stay due to the infection. The study165 reported analyses separately 
for infections caused by pathogens with and without antimicrobial resistance (sensitive or resistant). The 
time adjusted excess LOS for all four microorganisms varied from 1.1 days to 2.5 days for sensitive and 
resistant pathogens, respectively. The excess LOS for all patients was not reported and so we estimated the 
pooled population excess LOS using the proportions of patients with sensitive (71%) and resistant (29%) 
microorganisms, to give an estimate of 1.5 days.
We found one study168 that used the appropriate methodology to estimate the additional LOS attributable 
to catheter-BSI during hospital stay, after discharge from the critical care unit. Warren and colleagues168 
prospectively collected data on all patients admitted to the medical–surgical critical care units of the 
Missouri Baptist Medical Centre in St Louis during 1998–2000. They analysed data for patients who had 
required a CVC during their critical care stay. Two multiple regression models were created to evaluate 
hospital LOS and critical care LOS due to catheter-BSI using the backward stepwise method. Compared 
with non-infected patients, those patients with catheter-BSI had longer critical care and total hospital LOS. 
The unadjusted mean difference in overall LOS was 21.8 days for the critical care unit and 51.7 days for 
hospital stay. After controlling for confounding factors, the attributable critical care LOS due to  
catheter-BSI was 2.41 days and the attributable hospital LOS was 7.54 days (95% CI 3.99 to 11.09). 
Warren and colleagues168 used a definition of CABSI, rather than CRBSI but, as noted above, it is not 
possible to isolate the effect of using different definitions and therefore catheter-BSI used in the model 
does not distinguish between CABSI and CRBSI.
Critical care unit mortality
General population data for patients in UK critical care units are collated by the Intensive Care National 
Audit & Research Centre (ICNARC).163 The latest data available were for the period for April 2009 to 
March 2010, from 188 NHS critical care units with 96,810 patients admitted. The mean patient age was 
60.5 years and the mortality rate reported for critical care was 16.9%. Mean LOS in the unit was 5 days. 
The mean mortality rate during the hospital stay (outside the critical care unit) was 8.3%.
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As with estimates for LOS, estimates for the attributable mortality for catheter-BSI vary widely according to 
the methodology adopted. Mortality was reported in five studies94,103,110,139,144 in our clinical effectiveness 
review (see Chapter 4); however, none of the studies reported mortality data separately for patients with 
and without catheter-BSI. As with LOS, we considered the study by Lambert and colleagues165 to be the 
most appropriate. Their findings suggest that BSI caused by all four microorganisms treble the risk of 
mortality for patients in the critical care unit. The fully adjusted hazard ratios for critical care deaths were 
3.1 and 3.6 for sensitive and resistant microorganisms, respectively. We used the same method as for LOS 
to estimate an overall hazard ratio for critical care mortality of 3.25.
We found no evidence for any differences between mortality risks for patients with catheter-BSI during 
their hospital stay, outside the critical care unit, and therefore assumed there was no additional mortality 
risk during this period.
Estimation of costs
The costs included in the model were critical care unit and ward bed-day costs, catheter-BSI diagnostic 
and treatment costs and the cost of the CVC care bundle. The base year for the analysis was 2011; where 
necessary, costs were inflated to that year using the inflation indices from the Unit Costs of Health and 
Social Care.175
Critical care unit and ward bed-days
Critical care unit and ward bed-day costs were taken from Healthcare Resource Group (HRG) costs.176 The 
cost of a critical care bed-day was estimated based upon the cost for the number of organs supported 
(zero to six). We assumed that for our cohort of patients there would be the equivalent of an average 
of three organs supported (HRG code XC03Z), and we tested this assumption in the sensitivity analysis. 
The HRG bed-day cost for patients after they leave the critical care unit is dependent upon the reason 
for their critical care admission. We used the median cost for all non-elective inpatient (long-stay) excess 
bed-days reported.
Catheter-bloodstream infection diagnostic and treatment costs
Halton and colleagues151 estimated the consumable costs associated with catheter-BSI in Australia and 
these prices reflected the cost to Queensland Health decision-makers. These costs included the price of 
the catheters, catheter-BSI diagnosis (one catheter tip culture and two blood cultures) and catheter-BSI 
treatment. Treatment costs were a weighted average of the costs of standard regimens for causative 
organisms observed within the surveillance system: i.e. 2 weeks of vancomycin, 10 days of ticarcillin and 
clavulanate or 4 weeks of fluconazole. We converted these costs to UK pounds sterling (£) and inflated 
them to our analysis base year (exchange rate £1 = A$1.477).
Central venous catheter care bundle cost
The cost of the CVC care bundle used in the model refers to the additional costs – above those of current 
clinical practice – of implementing the bundle. For the purposes of the analysis the costs of current clinical 
practice are assumed to be zero. The cost of the CVC care bundle consists of the national programme 
and local implementation costs. The programme grant for implementing Matching Michigan in England 
was £1,750,000 for a 2-year period. The programme grant costs covered the costs of the support for 
central training days and web-based data collection tools, but did not cover any payments to local 
health professionals. Thus, the annual cost would be £875,000 per annum. The local training costs were 
calculated based on clinical advice we received about the implementation of Matching Michigan in one 
local centre. In this centre, one Band 6 nurse trained and monitored ICU staff in three critical care units 
and this took 20% whole time equivalent. Using the assumptions above, the CVC care bundle costs were 
estimated as £15.48 per patient attending critical care (see Table 29) and these are shown in Appendix 10. 
The CLAB ICU project,83 which provides our estimate of clinical effectiveness, included 37 critical care units 
at a total cost of A$508,831. Assuming critical care patient admissions were similar to those in the UK, this 
would equate to an average cost per critical care patient of about £15, which is consistent with the cost 
used for the CVC care bundle in our analysis.
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Estimation of health-related quality of life and long-term survival
The long-term survival of patients after discharge from the critical care unit was estimated based on 
England and Wales population mortality rates177 using a simple Markov model with states for alive and 
dead. Survival of patients after discharge from critical care is lower than for the general population as 
reported by Williams and Dobb.178 We multiplied the general population mortality rates by the relative 
risks of mortality reported in their study:178 2.9 in the first year and 1.5 thereafter. Long-term QALYs 
were estimated using general population utility values stratified for age as derived in a previous Health 
Technology Assessment (HTA) report for statins169 (utility = 1.0604 – 0.0043x, where x is the person’s 
age). We used the mean age of a critical care patient of 60 years, according to the ICNARC data.164 The 
calculated mean discounted life expectancy for a typical patient aged 60 years from hospital discharge was 
11.8 years, and the mean discounted QALY was 9.1.
Results of the modelling
This section reports the cost-effectiveness results for cohorts of 100 adult patients aged 60 years admitted 
to the critical care unit. The analysis evaluates a CVC care bundle compared with remaining with current 
practice, where current practice relates to the period before the introduction of the Matching Michigan 
programme. Results are presented for costs and QALYs for the CVC care bundle cohort and the current 
clinical practice cohort with undiscounted costs and health outcomes discounted at 3.5%.
The base-case results show that there are 0.79 fewer catheter-BSI in the CVC care bundle cohort than in 
the current clinical practice cohort (Table 30), a corresponding 0.3 fewer deaths during critical care, which 
leads to an increased survival of 3.55 years and 2.72 QALYs. The bundle dominates current practice, i.e. it 
is more effective and less costly. The cost savings are largely as a result of the savings from reduced LOS in 
the critical care unit. The incremental cost per QALY gained was –£573 (Table 31). The incremental cost per 
catheter-BSI averted was –£1976.
Sensitivity analysis
Deterministic sensitivity analysis
One-way deterministic sensitivity analyses were performed, in which model parameters were systematically 
and independently varied, using realistic minimum and maximum values. The sensitivity analyses 
TABLE 30 Summary of the model results for cohorts of 100 adult patients admitted to critical care
Outcome
Current 
practice
CVC care 
bundle Difference
Patients with catheter-BSI in critical care (per 100 adult critical care patients) 1.31 0.53 0.79
Total mortality, critical care unit (per 100 adult critical care patients) 17.40 17.10 0.30
Total survivors, hospital discharge (per 100 adult critical care patients) 74.30 74.60 0.30
Additional critical care LOS for catheter-BSI (days per 100 adult critical care patients) 1.97 0.79 –1.18
Additional ward LOS for catheter-BSI (days per 100 adult critical care patients) 6.74 2.70 –4.04
Discounted life-years 879 883 3.55
Discounted QALYs 674 677 2.72
Extra inpatient bed-day cost, £ 4494 1798 –2697
Cost diagnosis + treatment catheter-BSI, £ 681 272 –408
Intervention cost, £ 0 1548 1548
Total cost, £ 5175 3618 –1557
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investigated the effect of uncertainty around the model assumptions, structure and parameter values on 
the cost-effectiveness results to highlight the most influential parameters. The effects of uncertainty in 
multiple parameters were addressed using PSA (reported below). Where possible, the parameters were 
varied according to the ranges of their CIs, based on published estimates. Where these data were not 
available an alternative suitable range was chosen, based upon expert opinion. The same ranges were used 
in the deterministic analyses and PSA (see Appendix 9).
Tables 32–34 show the results of the deterministic sensitivity analyses for the incremental cost-effectiveness 
ratios (ICERs), incremental costs and incremental QALYs. As the ICERs are negative in the base case, 
some of the results appear counterintuitive owing to the nature of the cost-effectiveness ratio, and care 
is needed in their interpretation. As an example to illustrate the nature of a negative ICER, readers may 
consider two results from hypothetical cost-effectiveness analyses comparing two treatments: (1) a saving 
of £1000 and a gain of 0.5 QALYs (ICER = –£2000/QALY) and (2) the same saving and a gain of 1 QALY 
(ICER = –£1000/QALY). The negative ICERs would appear to suggest that (1) is more cost-effective than 
(2). However, (1) is actually less cost-effective than (2).
The cost-effectiveness results are robust to changes in all parameters in the deterministic sensitivity 
analysis. The cost-effectiveness estimates for the CVC care bundle vary from –£990 to £479 per QALY 
gained for all analyses (see Table 32). With the exception of catheter-BSI incidence rate and additional 
critical care LOS for patients with catheter-BSI, the model results are cost saving for all parameter values, 
and the results are most sensitive to changes in these two parameters. For changes to the values of the 
TABLE 31 Base-case cost-effectiveness results for cohorts of 100 adult patients admitted to critical care
Strategy Cost, £ Life-years QALYs ICER (£/QALY)
Current clinical practice 5175 879.3 674.0 –
CVC care bundle 3618 882.8 676.7 –
Difference –1557 3.55 2.72 –573
ICER, incremental cost-effectiveness ratio.
TABLE 32 Deterministic sensitivity analyses results for ICERs for cohorts of 100 adult critical care patients 
Parameter Baseline
Upper 
value
Lower 
value 
Upper 
value ICER 
(£/QALY)
Lower 
value ICER 
(£/QALY) Range (£)
Catheter-BSI incidence rate 3.7 5 1.3 –721 479 1200
Additional critical care LOS for catheter-BSI 1.5 2.5 0.001 –990 53 1043
CVC care bundle effectiveness 0.4 0.67 0.22 –107 –704 597
Additional ward LOS for catheter-BSI 5.13 8.68 1.58 –826 –320 506
Proportion of patients with CVC 0.71 0.96 0.49 –721 –317 404
Cost of CVC care bundle (per critical care 
patient), £
15.48 20.13 10.84 –402 –744 342
RR for critical care mortality due to catheter-BSI 3.25 3.6 2.7 –496 –758 262
Critical care mortality, no catheter-BSI 0.169 0.2028 0.1352 –477 –716 239
Critical care unit bed-day cost, £ 1440 1171 1657 –456 –667 212
Ward bed-day cost, £ 246 295 197 –646 –500 146
Catheter-BSI diagnosis and treatment cost, £ 518 622 415 –603 –543 60
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catheter-BSI incidence rate and the additional critical care LOS for patients with catheter-BSI, the  
cost-effectiveness estimates vary between –£721 and £479 and between –£990 and £53, respectively.
The most influential parameters on the incremental cost are the catheter-BSI incidence rate, the additional 
critical care LOS for patients with catheter-BSI and the CVC care bundle effectiveness (see Table 33). The 
incremental cost varies between –£2692 and £457 for all analyses. The most influential parameters on 
the incremental QALYs are the catheter-BSI incidence rate and the CVC care bundle effectiveness (see 
Table 34). The incremental QALYs vary between 0.96 and 3.68 for all analyses.
Probabilistic sensitivity analyses
In the PSA, all parameters were sampled probabilistically from an appropriate distribution162 using similar 
ranges as used in the deterministic sensitivity analyses (see Appendix 9). The parameters sampled were: 
catheter-BSI incidence rate, critical care mortality, catheter-BSI mortality risk, catheter utilisation, critical 
care unit and ward bed-day costs, treatment costs for catheter-BSI, critical care and ward LOS and CVC 
care bundle effectiveness and cost.
One thousand simulations were run. The PSA results are presented in Table 35 and show similar results to 
the deterministic analyses (see Tables 32–34) with an ICER of –£488 per QALY gained. The variability of the 
results is explored in more detail in Table 36, by showing the IQRs for model outputs. The CVC care bundle 
TABLE 33 Deterministic sensitivity analyses results for incremental costs for cohorts of 100 adult critical 
care patients
Parameter Baseline
Upper 
value
Lower 
value 
Upper value 
incremental 
cost, £
Lower value 
incremental 
cost, £ Range
Catheter-BSI incidence rate 3.7 5 1.3 –2648 £457 3105
Additional critical care LOS for catheter-BSI 1.5 2.5 0.001 –2692 £144 2836
CVC care bundle effectiveness 0.4 0.67 0.22 –160 –2488 2329
Proportion of patients with CVC 0.71 0.96 0.49 –2650 –595 2056
Additional ward LOS for catheter-BSI 5.13 8.68 1.58 –2245 –869 1376
Cost of CVC care bundle (per critical care 
patient), £
15.48 20.13 10.84 –1092 –2021 929
Critical care bed-day cost, £ 1440 1171 1657 –1239 –1814 575
Ward bed-day cost, £ 246 295 197 –1756 –1358 398
Catheter-BSI diagnosis and treatment cost, £ 518 622 415 –1639 –1475 163
TABLE 34 Deterministic sensitivity analysis results for incremental QALYs for cohorts of 100 adult critical 
care patients 
Parameter Baseline
Upper 
value
Lower 
value 
Upper value 
QALYs
Lower value 
QALYs Range
Catheter-BSI incidence rate 3.7 5 1.3 3.67 0.96 2.72
CVC care bundle effectiveness 0.4 0.67 0.22 1.50 3.53 2.04
Proportion of patients with CVC 0.71 0.96 0.49 3.68 1.88 1.80
Critical care mortality, no catheter-BSI 0.169 0.203 0.135 3.26 2.17 1.09
RR for critical care mortality due to catheter-BSI 3.25 3.6 2.7 3.67 0.96 2.72
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cost varies between £1377 and £1702, and this is offset by the savings from the inpatient bed-day cost 
(–£3647 to –£1553). The scatterplots and histogram for cost and health outcomes for the PSA are shown 
in Figures 10 and 11. The majority (83%) of the results show that the bundle is cost saving compared 
with current clinical practice. The cost-effectiveness of the bundle was < £5000 per QALY gained for all 
simulation results.
TABLE 35 Baseline PSA cost-effectiveness results 
Strategy
Cost, £ Life-years QALYs ICER (£/QALY)
Median IQR Median IQR Median IQR Median IQR
Current 
clinical 
practice
4903 3351–6831 878.9 865–894 673.7 663–685 – –
CVC care 
bundle
3489 2817–4462 882.7 868–897 676.6 666–688 – –
Difference –1414 –2582 to –293 3.78 2.43–4.58 2.90 1.83–3.51 –488 –827 to –131
TABLE 36 Summary of PSA cost-effectiveness results for the difference between the CVC care bundle cohort and 
the current clinical practice cohort
Outcome Median IQR
Patient with catheter-BSI in critical care (cases per 100 adult critical care patients) 0.76 0.54–1.02
Total mortality, critical care (cases per 100 adult critical care patients) 0.28 0.20–0.39
Additional critical care LOS for catheter-BSI (days per 100 adult critical care patients) –0.93 –1.60 to –0.49
Additional ward LOS for catheter-BSI (days per 100 adult critical care patients) –3.98 –5.81 to –2.63
Inpatient bed-day cost, £ –2358 –3647 to –1553
Intervention cost, £ 1542 1377–1702
FIGURE 10 Histogram of ICERs for CVC care bundle compared with current clinical practice from the PSA 
simulation runs.
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Scenario analyses
In addition to the sensitivity analyses, additional scenario analyses were undertaken to investigate the 
uncertainty in the model results for simultaneous changes to more than one parameter.
Effect of changing the age of patients in critical care
A scenario analysis was conducted for alternative mean starting ages for patients in the critical care unit, 
using the analysis described above (see the section ‘Estimation of HRQoL and long-term survival’).  
The calculated mean discounted life expectancy from hospital discharge for a typical patient of age 50  
and 70 years was 15.8 and 7.6 years respectively and the corresponding mean discounted QALY was  
12.6 and 5.6.
For a cohort of patients with mean age of 50 years, the cost-effectiveness is slightly improved at –£413 per 
QALY gained. At mean age of 70 years, the cost-effectiveness is slightly worse at –£926 per QALY gained.
Threshold analysis
Table 37 shows the results of a threshold analysis in which all parameters were varied until the CVC care 
bundle became more costly than the current clinical practice. For this scenario, the CVC care bundle would 
only be more expensive for any feasible changes to four of the parameters, and would remain cost saving 
TABLE 37 Model scenario analysis results
Parameter
Value at which CVC care bundle becomes more 
expensive than current practice
Catheter-BSI incidence, per 1000 catheter-days < 1.8
Proportion of patients with CVC < 0.35
CVC care bundle cost, per patient, £ > 30
CVC care bundle effectiveness > 0.7
FIGURE 11 Scatterplot for PSA.
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for the other parameters. The results show that the bundle would no longer be cost saving if the bundle 
cost per patient was > £30, the bundle effectiveness incidence density RR was > 0.7, the catheter-BSI 
incidence density of < 1.8 per 1000 catheter-days, or the proportion of critical care patients with a CVC  
of < 0.35.
Two-way sensitivity analysis comparing central venous catheter care bundle 
cost versus effectiveness
Figure 12 shows a two-way sensitivity analysis of the effect on the model results of simultaneously varying 
both bundle cost and bundle effectiveness. These results show that, even when using extreme values for 
the parameters, for example with a bundle effectiveness of 0.7 and bundle cost of £85 per critical care 
patient, the bundle (although no longer cost saving) remains cost-effective with an ICER of < £5000 per 
QALY gained.
Two-way sensitivity analysis comparing catheter-bloodstream incidence 
versus additional critical care length of stay
Figure 13 shows a two-way sensitivity analysis of the effect of simultaneously changing both catheter-BSI 
incidence and additional critical care LOS for catheter-BSI on the model results. These results show that 
FIGURE 12 Two-way sensitivity analysis comparing CVC care bundle cost vs. effectiveness.
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FIGURE 13 Two-way sensitivity analysis comparing CRBSI incidence vs. critical care additional LOS.
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even when using extreme values for the parameters, for example with an incidence density of  
1.0 catheter-BSI per 1000 catheter-days and no additional critical care LOS for catheter-BSI, the CVC care 
bundle is no longer cost-saving, but remains cost-effective with an ICER of < £2000 per QALY gained.
Two-way sensitivity analysis comparing catheter-bloodstream infection 
incidence versus bundle effectiveness
Figure 14 shows a two-way sensitivity analysis of the effect of simultaneously changing both catheter-BSI 
incidence and CVC bundle effectiveness on the model results. These results show that, even when using 
extreme values for the parameters, for example with a bundle effectiveness of 0.7 and incidence density of 
1.0 catheter-BSI per 1000 catheter-days, the bundle, although no longer cost saving, remains cost-effective 
with an ICER of about £3000 per QALY gained.
Estimating the cost of national implementation
The national costs and benefits of implementing the CVC care bundle were estimated using the model 
based on the total annual number of admissions to critical care units during 1 year (2009/10) (ICNARC). 
In that year, there were 96,810 admissions to 188 NHS adult general critical care units in England, Wales 
and Northern Ireland. Note that this may slightly underestimate the total number of admissions, as not all 
critical care units participated in the data collection. The results are shown in Table 38.
For England, with 90,000 critical care patients per year, the model estimates that implementing the CVC 
care bundle would reduce the number of catheter-BSI infections by > 700 (IQR 482–914) and save 270 
(IQR 184–348) lives per year. The yearly additional cost to implement the intervention used in England 
would be £1.4M (IQR £1.2M–£1.5M). However, if the intervention was implemented, not only would 
the cost of implementation be recouped, but also there would be a net saving from implementing the 
intervention of £1.5M, largely as a result of the savings in costs related to reduced LOS (£2.4M, IQR 
£1.4M–£3.3M). The CVC care bundle remains cost saving up to an annual implementation cost of £2.7M 
(equivalent to £30 per critical care patient).
FIGURE 14 Two-way sensitivity analysis comparing catheter-BSI incidence vs. bundle effectiveness.
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Summary of cost-effectiveness
We developed a decision-analytic model to assess the cost-effectiveness of a CVC care bundle compared 
with current clinical practice. The model followed cohorts of patients from their admission to critical care 
and estimated the associated costs, mortality and lifetime QALYs. The results from the model showed 
that the CVC care bundle saved 0.8 catheter-BSI and 0.3 lives per 100 patients admitted to critical care 
compared with current clinical practice, and led to an increased survival of 3.55 years and 2.72 QALYs.  
The CVC care bundle is more effective and less costly than current clinical practice, largely as a result of  
the saving from the reduced length of critical care stay.
The effects of a range of parameter values in the economic model were evaluated in sensitivity analyses. 
The model results were found to be robust to changes in the parameter values. The model results are most 
sensitive to changes in catheter-BSI incidence and the additional critical care LOS for catheter-BSI.
There is uncertainty in the model-based analysis relating to variation in implementation of the CVC care 
bundle. Some of the interventions included in the bundle (to be implemented on a regional or national 
basis) may already be partially implemented (by individual hospitals or ICUs). The effect of this would, all 
other things being equal, be to lower the baseline incidence of catheter-BSI (prior to regional or national 
implementation of the CVC care bundle). In addition, there is likely to be variation in the success or 
completeness of implementing the CVC care bundle which would be expected – all other things being 
equal – to result in a lower reduction in catheter-BSI following implementation. We conducted a two-way 
sensitivity analysis on these variables, which indicated that implementing the CVC care bundle was less 
cost-effective at lower catheter-BSI incidence density. However, even at the least favourable values tested 
(a relative risk of catheter-BSI with the CVC care bundle = 0.7 and baseline incidence density of 1.0 per 
1000 catheter-days) the ICER remained below the threshold conventionally considered as cost-effective.
The PSA estimated the probability that the CVC care bundle is cost-effective at different willingness-to-
pay thresholds. The majority (83%) of the results show that the CVC care bundle would be cost saving 
compared with current clinical practice.
TABLE 38 Base-case cost-effectiveness results extrapolated for all critical care units in England
Outcome
Current clinical 
practice
CVC care 
bundle Difference
Difference, 
25% percentile
Difference, 
75% percentile
No. of patients 90000 90000
Health outcomes 
Catheter-BSI cases 1182 473 709 482 914
Total critical care mortality 15,660 15,390 270 184 348
Additional critical care LOS due 
to catheter-BSI, days
1773 709 –1064 –1439 –439
Additional ward LOS due to 
catheter-BSI, days
6064 2426 –3639 –5232 –2365
Discounted life-years 879,665 882,856 3192 2183 4118
Discounted QALYs 674,267 676,713 2447 1673 3156
Costs
Inpatient bed-day cost, £ 4,045,018 1,618,007 –2,427,011 –3,282,553 –1,397,455
Intervention cost, £ 0 1,393,409 1,393,409 1,239,459 1,532,181
Total cost (£) 4,657,753 3,256,510 –1,401,243 –2,323,724 –263,726
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Chapter 7 Discussion
Discussion of the systematic review of clinical effectiveness
A wide range of educational approaches has been used in interventions for preventing catheter-BSI in 
critical care units. Results of updated literature searches (discussed further below) suggest that this is an 
active area of primary research. Many of the interventions appear to have potential relevance to NHS 
practice, as they addressed clinical practices for infection prevention recommended in the ‘epic2’ national 
evidence-based guidance for NHS hospitals in England39 to varying degrees. The intervention that has 
attracted the most attention and publicity is the Keystone ICU project, which achieved a reduction in 
catheter-BSI incidence density in 103 critical care units in the USA during 3 years of implementation.34,123,124 
Owing to the apparent success of the Keystone ICU project, there have been several attempts to replicate 
it in other countries, including the Matching Michigan programme in England, the CLAB ICU project in 
Australia83 and the Bacteraemia Zero project in Spain.68 Given that the Bacteraemia Zero project68 did 
not provide convincing evidence of effectiveness, and the Matching Michigan programme results had 
not been published, we considered the CLAB ICU project to be most relevant to NHS practice. As noted 
in Chapter 4, one of the interventions included in the systematic review was conducted in the UK (in 
Scotland) but this had limitations including delayed effectiveness at reducing catheter-BSI and overlap with 
a national patient safety programme, and the intervention appeared less relevant than the Australian CLAB 
ICU project to NHS practice.
Study designs
The only studies with concurrent control groups68,109,136 included in the systematic review did not 
demonstrate clinical effectiveness of their interventions. The entire evidence base for clinical effectiveness 
thus comes from single-cohort studies that would be classed as low quality according to the criteria for 
grading quality of evidence and strength of recommendations (GRADE).179
A problem with these poor-quality studies is that they cannot usefully inform infection prevention 
guidelines such as ‘epic2’, which need to be based on reliable evidence. More rigorous study designs are 
needed to enable the determination of cause–effect relationships. In the Bacteraemia Zero project, for 
example, the intervention was no more effective than the control (i.e. no-intervention group), but within 
the intervention group of critical care units catheter-BSI incidence density was significantly lower during 
the intervention period than at baseline. This example illustrates how potentially misleading single-cohort 
studies can be for deducing effectiveness, as they do not control for secular trends. It is important that 
the study design employed is appropriate for the research question and capable of determining causality. 
Although not always feasible, RCTs may be appropriate for, and have been used in, evaluations of the 
effectiveness of educational interventions.180 As there are often two or three levels of infrastructural 
organisation, i.e. critical care units grouped within hospitals, and hospitals grouped within regions, a 
cluster RCT design may be appropriate. Scales and colleagues181 provided an example of the utility of a 
cluster RCT approach for evaluating the effectiveness of a QI improvement programme on adoption of 
evidence-based practices in critical care units. An alternative approach to the use of concurrent control 
groups is to use an interrupted time series (ITS) design. An ITS design requires sufficiently fine resolution 
of temporal monitoring of outcomes (e.g. weekly or monthly) to enable detection of any changes in 
outcomes when an intervention is implemented, against any background secular trends. However, there 
is no clear consensus on how many temporal outcome assessments would be needed for a study to be 
classified as ITS. Only two88,115 of the 74 studies included in the evidence map (none of which was included 
in the systematic review) employed an ITS approach (a further study127 claimed to use an ITS approach but 
was reported as a single-cohort before-and-after study design).
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Study reporting
Studies that have been conducted need to be more clearly and fully reported. Guidance on the reporting 
of observational studies of educational interventions is available from several sources, including the 
STROBE checklist (strengthening the reporting of observational studies in epidemiology),182 the TREND 
checklist (improving the reporting quality of nonrandomised evaluations in behavioural and public health 
interventions)55 and the ORION statement (reporting intervention studies of nosocomial infections).57 
Item 7 in the STROBE checklist encourages study authors to report all potential confounders and effect 
modifiers. This item should be particularly emphasised by peer reviewed journals as, in this review, a 
failure of authors to disclose this information was a major reason why many primary studies were judged 
to be at unclear risk of performance bias. Another key deficiency in the primary studies was the failure to 
report whether valid and reliable data collection methods had been used. A potential problem with these 
checklists and statements is that when reporting non-randomised educational interventions for preventing 
catheter-BSI it may not be obvious which checklist(s) the authors should use. Our assessment of study 
quality suggested non-compliance of authors with the checklists and statements is frequent.
Populations
The eligibility criteria for the systematic review developed in consultation with the project AG focused on 
adult critical care patients, who make up the majority of the critical care population and were identified 
in the evidence map as having the most primary evidence. Neonatal critical care units were not specified 
in the systematic review eligibility criteria as they are very different to those of adult specialties and 
experience higher rates of BSI-related mortality.24 In practice it was not feasible for us to completely 
exclude children from the systematic review since some adult critical care specialties may include a small 
proportion of children, but the studies rarely reported this level of detail about their populations. Three of 
the regional-scale interventions34,83,136 were not conducted entirely in adult critical care units but we judged 
them to have met the population inclusion criterion for the systematic review because the proportion 
of paediatric critical units they included was small (in all cases < 9%), whereas a fourth regional-scale 
intervention did not explicitly state the population but we assumed it to be primarily adult.68 If we had 
strictly limited the systematic review to entirely adult critical care patients then we would have excluded 
several studies of relevance to NHS practice, notably the Keystone ICU project,34 CLAB ICU project83 and 
Bacteraemia Zero project.68
Primary outcomes
All 24 of the studies included in the systematic review reported the incidence of catheter-BSI but 10 
studies did not report sufficient data for us to calculate the incidence density RR and its 95% CI, and 
we therefore had to contact the study authors for this information. The incidence density expressed per 
1000 catheter-days is a common metric used to compare infection prevalence, but studies reporting 
catheter-BSI incidence density typically follow the NNIS and CDC approach,22 which does not count 
separately any individual catheters present in the same patient during a 24-hour period. A more precise 
definition employed by HELICS174 defines a catheter day as a patient having a single catheter for a whole 
or part 24-hour period, whereas two catheters for a part or whole 24-hour period would be defined as 
two device-days. Only two of the studies included in the systematic review94,110 used both definitions of 
catheter-days, enabling comparisons. The limited data available from these two studies suggest that the 
definition of catheter-days did not have an appreciable impact on incidence density RRs.
The temporal and spatial resolution of outcome assessments varied considerably among the studies, 
illustrating why standardisation to catheter-days is necessary to enable comparisons. Most studies reported 
incidence density RRs for the cumulative number of catheter-BSI and catheter-days registered during 
a single intervention period compared with a single baseline period. Where additional finer-resolution 
(e.g. monthly) data were also provided,50,51,103,109,122,139 (data in Appendix 5) these illustrated considerable 
short-term temporal variability in catheter-BSI incidence density that was not reflected in overall estimates 
for intervention and baseline periods. Studies which included multiple critical care units usually provided 
pooled estimates of catheter-BSI incidence density for all the units combined. Where catheter-BSI incidence 
density was also reported separately for different critical care units103,122,144 considerable spatial variability 
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in catheter-BSI incidence density was evident, which would be obscured when pooling incidence densities 
across units. We recommend that primary studies should always provide estimates of the temporal and 
spatial variability of their data when reporting outcomes.
Relatively limited data were provided about mortality and LOS in the primary studies. It would be helpful 
in future studies for records to be kept of the mortality and LOS for critical care patients with and without 
catheter-BSI, to clarify the burden of catheter-BSI in settings relevant to the NHS.
Secondary outcomes and process evaluations
The Medical Research Council (MRC) guidance on developing and evaluating complex interventions183 
stresses the importance of conducting process evaluations to help in understanding the reasons why 
complex interventions may or may not be effective. Assessments of attitudes, knowledge, compliance and 
other aspects of intervention processes identified several barriers or potential barriers to the successful 
implementation of the educational interventions included in the systematic review. Staff attitudes towards 
the need for evidence-based infection-prevention practices appear to be a barrier, as several studies 
reported staff resistance to the use of sterile drapes, gloves, masks and hats, with some staff questioning 
evidence-based guidance. In the CQI programmes a notable issue was a lack of existing systems and 
infrastructure for data collection. This seems to be an important difference between the Keystone ICU 
project, which was based on an existing data collection system, and the other CQI programmes that 
appeared to have had to develop data collection systems for their interventions. These observations of 
process improve understanding of potential facilitators and barriers to the successful implementation of 
educational interventions for preventing catheter-BSI but they were primarily based on ad hoc observations 
reported by the study authors, and it may be that other important facilitators or barriers were identified 
but not reported.
Educational approaches
Although many of the interventions included in the systematic review addressed similar sets of clinical 
practices, these were often addressed using very different, and often unclear, educational approaches. In 
many cases educational interventions were described superficially and it was difficult to tell whether all 
of the educational approaches used had been fully reported. Ideally, educational interventions should be 
reported in sufficient detail, and the resource requirements needed to implement the education elucidated, 
so they could be replicated. The information needed would include, for example, the total staff time 
involved and the cost of all materials, preferably itemised to allow interpretation of how costs might vary 
if intervention concentration (i.e. frequency and duration of sessions) were varied. The types of education 
should be clearly reported, as formal educational approaches that take staff away from bedside patient 
care will have associated opportunity costs. An example of good reporting of the education frequency/
duration and staffing requirements was provided by Zingg and colleagues.144 Educational interventions 
tend to evolve once they are implemented,149,184 so it is important that any differences between the 
intended and actual implementation are reported. Where possible, primary outcomes research studies 
should include an integral cost-effectiveness evaluation.
Instead of each intervention using its own unvalidated educational approach, as was the case in the 
studies we reviewed, there is a good case to be made for educational approaches to be developed in a 
more co-ordinated way so that they integrally support the national guidance on care bundles and can 
be deployed in a more consistent and similar manner. The educational interventions which we reviewed 
do not draw upon pedagogical, theoretical or conceptual frameworks that would enable understanding 
of why a particular approach works, or does not work. Consequently there are no generalisable lessons 
to inform the ‘epic2’ guidelines on which types of educational approach should be used in support of 
infection prevention practices. Unless some action is taken to effect a change, it seems likely that the 
current primary research activity in this area will continue to develop further ad hoc and unvalidated 
educational approaches. A necessary first step to address this issue would be to determine a responsible 
organisation for considering the harmonisation of educational approaches (e.g. an evidence-based-practice 
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guidelines development group). Involvement of educationalists in the design of interventions would help to 
ensure that the interventions are well supported by relevant theory and are reliable and generalisable.
Information feedback approaches
Infection surveillance feedback, in which results of infection surveillance are provided to health-care 
workers to inform their clinical practices, is thought to be an effective strategy for reducing nosocomial 
infection incidence.185 Our clinical effectiveness findings suggested that infection surveillance feedback 
and/or performance feedback were not essential for effecting reductions in catheter-BSI incidence density. 
However, the feedback approaches varied considerably among the primary studies, with some studies 
providing active feedback (e.g. at meetings), whereas others provided passive feedback (e.g. in wall charts) 
and none of the studies clearly reported the data collection methods used or whether they were valid and 
reliable. It may be that the interventions included in our systematic review were too heterogeneous in 
their intervention characteristics for any underlying influences of feedback approaches on catheter-BSI to 
have been detectable. For some studies, it became apparent only when the publications were scrutinised 
in detail that infection surveillance feedback was already practised in the pre-intervention period, 
and would therefore not explain any observed changes in catheter-BSI incidence when interventions 
were implemented.
Definitions of catheter-bloodstream infection
During the preparation of this report we identified citations to more than 15 different published sources 
of CDC definitions in support of CABSI or CRBSI. The most frequently cited publications containing CDC 
definitions were by Garner and colleagues,147 NNIS186 and Horan and colleagues.187 However, although two 
of these references define LCBSI,147,187 none of them actually defines CABSI or CRBSI. A systematic review 
on 191 studies of patients with cancer published by Tomlinson and colleagues in 201121 found that CABSI 
and CRBSI are defined inconsistently in primary research studies. Our findings (see Chapter 4) provide 
further evidence that CABSI and CRBSI are inconsistently defined in primary research. For the NHS, the 
definitions of CABSI and CRBSI that were used during Matching Michigan (see Table 1) appear appropriate 
and could be formally recommended for wider use.
Influence of updated literature searches on the clinical effectiveness results
Bibliographic searches, which were rerun in March 2012 using the original search strategy, identified 
933 potentially relevant new titles and abstracts published between February 2011 and March 2012, of 
which 19 full-text publications met the criteria for inclusion in the evidence map (see Appendix 6, Clinical 
effectiveness full-text records identified in search updates) and 12 potentially relevant new conference 
abstracts were identified (see Appendix 6, Clinical effectiveness conference abstracts identified in 
search updates).
Of the 19 new full-text publications, 18 reported 18 new primary research studies and one publication188 
reported on an existing study already in the evidence map.83 The new studies published during February 
2011 to March 2012 would increase the size of the evidence map from 74 studies to 92 studies (i.e. a 
24% increase), indicating that the evaluation of educational interventions for preventing catheter-BSI is 
an active area of research. This appears to be particularly the case for paediatric and neonatal critical care 
(60% increase and 36% increase, respectively).
Among the 18 new studies identified that would be eligible for inclusion in the evidence map, three 
studies would appear to also meet the inclusion criteria for the systematic review, although this was not 
assessed formally. Render and colleagues189 evaluated a regional-scale CQI programme conducted in 174 
critical care units in 123 hospitals in the USA, which was based on a centralised infrastructure to support 
the co-ordinated implementation of care bundles containing infection prevention learning modules and 
five evidence-based practices (hand hygiene, maximal barrier precautions, skin antisepsis, avoidance of 
femoral insertions, removal of unnecessary CVCs). Kim and colleagues190 evaluated a catheter care bundle 
in six critical care units in a hospital in the USA, including checklist, supplies cart, catheter need review, 
avoidance of the femoral site, staff empowerment to halt incorrect procedures, staff education, and 
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infection surveillance and performance feedback. Seddon and colleagues191 evaluated a CQI programme in 
a single critical care unit in New Zealand based on a care bundle, insertion and maintenance checklists and 
performance feedback but we noted that this intervention coincided with a major expansion of the critical 
care unit, which could be a confounding factor.
These three newly published studies all used before-and-after designs and claimed statistically significant 
reductions in the incidence density of catheter-BSI, although we did not check their calculations or 
methodological quality. The Render study189 is notable in being the largest study we have come across 
in terms of the number of critical care units involved (174 units were included). The Seddon study191 is 
notable in being the only study conducted in New Zealand. If these studies were, upon more rigorous 
scrutiny, shown to be clinically effective at preventing catheter-BSI then their findings would be broadly 
consistent with those of our systematic review which demonstrated both local-scale and regional-scale 
CQI programmes including CVC care bundles appear effective at preventing catheter-BSI. However, as 
with all the before-and-after studies, a key assumption is that the observed effects were a result of the 
planned interventions.
Searches of databases of ongoing research did not identify any other relevant primary research studies 
taking place up to May 2012.
In summary, the updated searches indicate that educational interventions for preventing catheter-BSI 
is an active area of research, but did not identify any new evidence that would appear to change the 
conclusions of our systematic review.
Findings from other systematic reviews
Systematic reviews of interventions for preventing health care-associated infections identified before this 
project commenced are summarised in Chapter 1. The most directly relevant and recent of these were 
published in 2008 by Safdar and Abad37 and in 2010 by Cherry and colleagues.49
Safdar and Abad37 conducted a systematic review of educational interventions for preventing health-care 
associated infections, not limited to catheter-BSI or critical care. Of 26 primary studies they included, 10 
were also included in our evidence map. The main conclusion from their systematic review, which was 
limited to English-language publications, was that implementation of educational interventions may reduce 
health care-associated infections considerably but the before-and-after design of studies precluded drawing 
firm conclusions. Safdar and Abad37 recommended cluster randomised trials using validated educational 
interventions and costing methods should be developed to determine the independent effect of education 
on reducing healthcare-associated infections and the cost-savings that may be realised with this approach.
Cherry and colleagues49 aimed to determine individual features of educational interventions that impact 
on competence in aseptic insertion technique and maintenance of CVCs by health-care workers. Their 
review was not limited to catheter-BSI or critical care and it is unclear whether they applied publication 
language restrictions. Of 47 primary studies included, 28 were also included in our evidence map. Their 
main conclusions were that educational interventions appear to have the most profound and prolonged 
effect when used in conjunction with audit, feedback, and availability of new clinical supplies consistent 
with the content of the education provided, and if baseline compliance to best practice is low. Cherry 
and colleagues49 did not include informal learning and they did not explicitly report data to support their 
conclusions concerning audit and feedback.
Our searches did not find any more recent relevant systematic reviews than those by Safdar and Abad37 
and Cherry and colleagues.49 These reviews are now relatively old, with searches conducted up to 
November 2006 and August 2008, respectively. Our current evidence synthesis is more rigorous than these 
preceding systematic reviews in that we were not limited to English-language publications and we formally 
assessed study quality using risk of bias criteria. In contrast, Cherry and colleagues49 used a composite 
quality score expressed as a percentage which is difficult to interpret. The quality score focused on the 
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quality of education rather than other aspects of methodological quality and some studies that were 
also included in our systematic review50,108 received a maximum quality score (100%) from Cherry and 
colleagues49 despite having methodological limitations (see Chapter 4).
Discussion of the economic evaluation
Our systematic review of cost-effectiveness studies identified only three economic evaluations of 
educational interventions to prevent CRBSIs. One of the studies did not include the cost associated with 
the care bundle in the analysis; another study used a trial-based cohort analysis to derive estimates of the 
costs and benefits associated with a simulation-based education intervention in a hospital in the USA, 
whereas the third study did not consider long-term health benefits beyond the hospital stay. It was not 
possible to conclude from any study what the likely cost-effectiveness of the intervention would be in a UK 
setting. Literature searches updated in March 2012 did not identify any further relevant studies.
The model developed in this study allows us to estimate the cost-effectiveness of a CVC care bundle versus 
current clinical practice to prevent catheter-BSI. The CVC care bundle was found to be more effective 
and cheaper than current practice, i.e. a dominant strategy. The model results were robust to changes in 
the model parameters. The model results were most sensitive to the catheter-BSI incidence rate and the 
additional length of critical care stay associated with catheter-BSI. The PSA showed that the probability 
that the CVC care bundle dominated current practice was 0.85.
For the purposes of the model, we assumed that CABSI and CRBSI were synonymous and were collectively 
referred to as catheter-BSI. Although in theory CABSI overestimates the true incidence of CRBSI, our 
review of clinical effectiveness and another systematic review21 found that the definitions are used 
interchangeably and inconsistently in primary research studies.
Experience from a clinical member of the review team (TC) working in English health-care trusts suggested 
that implementation of evidence-based practices would vary between hospitals, and may even vary 
between critical care units within the same hospital. There is uncertainty about the uptake of evidence-
based practices before Matching Michigan was introduced, although many English health-care trusts 
would likely have followed ‘epic2’ guidelines39 and the Department of Health ‘High Impact Intervention’28 
for best practice in prevention of catheter-BSI. It is possible that current clinical practice in some critical 
care units already incorporated some elements of the CVC care bundle. This variation was not reported in 
primary studies and cannot be directly quantified. However, there is likely to have been similar variability 
in implementing evidence-based practices among the critical care units in the CLAB ICU study by Burrell 
and colleagues83 that we have chosen for providing an estimate of the clinical effectiveness of the CVC 
care bundle.
Much of the primary evidence relating to educational interventions for preventing catheter-BSI is from 
studies conducted in the USA, whilst the study used for the clinical effectiveness estimate for the economic 
model was conducted in Australia. Critical care in the USA is believed to be significantly different 
from practice in the UK with regard to bed number, staffing, resource and case mix.192 The UK has the 
lowest number of critical care beds per capita in the developed world whereas the USA has the highest. 
Differences also exist for general health care and critical care expenditure.192,193 Australian critical care is 
believed to lie somewhere between these two outlier nations.
Despite being populated with some data from outside the UK, there are two aspects of the model that 
provide reassurance that the model outputs are relevant to critical care units in English NHS trusts. First, 
the clinical effectiveness estimate from the Australian CLAB ICU study is similar to clinical effectiveness 
estimates from other primary studies conducted in different countries, suggesting that clinical effectiveness 
may not be strongly dependent on the geographical variations in critical care infrastructure and case mix 
noted above. Second, as the model outputs are robust to sensitivity analyses it seems likely that variation 
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that would result from geographical differences in critical care delivery approaches will already have 
been captured.
As the model was restricted to adult critical care, it is unclear whether the current results are generalisable 
to paediatric critical care or especially to neonatal critical care which has different risk factors for and 
prognosis of catheter-BSI. In principle, the model structure is likely to also be applicable to neonatal and 
paediatric populations and could be rerun using parameter estimates from studies conducted specifically 
on these populations. A question relevant to the primary evidence is whether effective educational 
interventions for preventing catheter-BSI in paediatric and neonatal populations are any different to 
those used in adult populations. Results of updated clinical effectiveness literature searches (described 
above) suggest that an increasing proportion of the primary research is being conducted in paediatric and 
neonatal critical care units and that at least 16 studies in paediatric and 15 studies in neonatal critical care 
units have been published that could be assessed.
In the NHS, although national patient safety initiatives are intended to be implemented throughout 
England, variations in infrastructure and resource availability (e.g. staffing) mean that in practice local 
interventions are often implemented in a small scale way, frequently without good baseline data collection. 
Many of the different educational interventions reported in Chapter 4 may therefore reflect actual practice. 
The model results indicate that a range of educational intervention types for preventing catheter-BSI could 
be cost-saving, meaning that the NHS could consider implementing smaller-scale interventions that appear 
effective, as listed in Boxes 3 and 5 in Chapter 4.
At present there is no information available on how the individual components of a care bundle contribute 
to the overall cost-effectiveness of the bundle. An assumption is made that all components are necessary 
for clinical effectiveness and, hence, cost-effectiveness, and care bundles are intended to be implemented 
on an all-or-nothing basis.33
Strengths, limitations and uncertainties of this report
Systematic review of clinical effectiveness
One of the strengths of this review is its adherence to rigorous systematic review methods. We conducted 
exhaustive searches that were not limited to English-language publications, applied explicit inclusion 
criteria to the search results, critically appraised the included studies, and used transparent methods 
to synthesise study findings. A further strength is our inclusion of an initial descriptive mapping stage 
followed by a systematic review of a subset of studies. This process facilitated the involvement of clinical 
experts in the design of the review. The review team included clinical experts in infection prevention, 
critical care and medical education and was supported by an AG that included clinical experts directly 
involved in implementing NHS policies for the prevention of catheter-BSI.
Despite its strengths the review had limitations. It was preferable for the subset of the studies in the 
systematic review to be homogeneous in terms of the intervention characteristics to ensure that their 
aggregation statistically would be meaningful and appropriate (i.e. comparing like with like) but, in 
accordance with the systematic review eligibility criteria developed in consultation with clinical experts, 
a wide variety of intervention types was included. Although this diversity of interventional approaches 
does appear relevant to NHS practice, it was not appropriate to pool outcomes for different interventions 
in a quantitative meta-analysis and so we instead conducted a narrative synthesis. The systematic review 
was restricted to studies that defined catheter-BSI so that we could investigate any impact of differing 
infection definitions on study outcomes. However, upon scrutiny of the studies we found that definitions 
of CABSI and CRBSI were applied inconsistently and generally did not agree with the definitions used in 
NHS practice. Therefore, we could not explore the potential influence of different infection definitions on 
effectiveness outcomes.
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There are some uncertainties in our systematic review of clinical effectiveness. All studies that appeared 
to demonstrate clinical effectiveness of their educational interventions were single-cohort studies without 
concurrent control groups. The extent to which secular trends might have played a part in determining the 
observed changes in catheter-BSI incidence densities is unclear. The systematic review focused on adult 
critical care specialties that represent the majority of critical care specialties in the NHS, but it is not known 
whether similar findings would have been obtained for studies in paediatric and neonatal critical care units 
(it was not feasible to conduct a systematic review on all specialties in this project owing to the review 
team resources that would be required). Other uncertainties concerned poor reporting in the primary 
study publications: intervention details, especially the concentration of education and resources needed to 
implement education were often unclear or not reported, and nearly all of the studies were judged to be 
at unclear risk of bias owing to inadequate reporting of key methodological information.
Although it would have been preferable to have included the Matching Michigan programme in our 
evidence map and systematic review of clinical effectiveness (subject to meeting the inclusion criteria), 
this was not feasible as results from Matching Michigan were not available at the time of our analyses. 
However, where possible we have used interim information from Matching Michigan to inform our 
economic evaluation.
Economic evaluation
Our economic evaluation is the only published example of an assessment of the cost-effectiveness of 
educational interventions for prevention of catheter-BSI in the UK. The model specifically addresses 
clinical practices in critical care units in NHS trusts in England but the results are probably generalisable 
to the wider UK. The economic evaluation was informed by systematic reviews of effectiveness and 
cost-effectiveness, and systematic searches for input parameter data. The model was developed 
following a structured and objective process in accordance with standard NICE practice, and the model 
structure and data inputs are clearly presented in this report to facilitate replication and testing of our 
model assumptions.
Despite these strengths, the economic evaluation has some limitations. Owing to lack of data, we had to 
assume that mortality rates during the hospital stay following critical care discharge, and after hospital 
discharge, do not differ between patients who have catheter-BSI in the critical care unit and those who 
do not. We also had to assume that CABSI and CRBSI are synonymous, as the systematic review of clinical 
effectiveness had indicated that these definitions were not meaningfully separable in the primary research 
literature. The model does not consider the HRQoL of patients in critical care units because the time spent 
in critical care is very small compared with the lifetime horizon, and therefore any QALY gains during this 
period are insignificant. In addition, non-fatal adverse events associated with catheter-BSI were included 
within the model as a cost but not as a utility decrement. The economic evaluation does not include 
non-tangible benefits or disbenefits associated with the intervention, such as changes to staff morale and 
public confidence in the health-care system.
There are uncertainties around the cost of the CVC care bundle intervention. The implementation of the 
intervention is likely to vary widely in practice between critical care units. Different critical care units are 
also likely to vary in the extent to which they would have already implemented components of the CVC 
care bundle at baseline. Some model input parameters could not be sourced from the UK and clinical 
effectiveness estimates were obtained from a relevant Australian study. Where possible we conducted 
sensitivity analyses to illustrate the influence of these uncertainties on the cost-effectiveness estimates 
produced by the model.
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Chapter 8 Conclusions
The evaluation of educational interventions for preventing catheter-BSI is an active area of primary research, but there are concerns about the reliability of the evidence, which comes predominantly from 
uncontrolled before-and-after studies and may not convincingly distinguish intervention effectiveness from 
background secular trends. Very limited primary research has been conducted in the UK and at the time 
this report was prepared none had been published from England.
Our economic evaluation suggests that an educational intervention based on a CVC care bundle 
implemented in critical care units in England would be more effective and less costly than current 
clinical practice, even after allowing for heterogeneity of baseline clinical practices and heterogeneity of 
implementation. The model results are robust to variations in cost of the CVC care bundle and clinical 
effectiveness, indicating that a variety of other educational interventions could potentially be cost-saving 
if implemented at local or regional scales. More robust primary studies of clinical effectiveness are needed, 
however, to clarify cause and effect to ensure that model input parameters for clinical effectiveness truly 
reflect intervention impacts rather than secular trends.
There is general agreement about the types of evidence-based practices that should be employed for 
preventing catheter-BSI, as reflected in the UK ‘epic2’ guidelines (and also the US IHI guidelines). These 
guidelines emphasise the need for education to support the evidence-based clinical practices for infection 
prevention but cannot make recommendations about which educational practices are appropriate as the 
primary research studies are of insufficient quality to be informative. Primary study investigators should be 
informed of the limitations of uncontrolled cohort studies and encouraged to use more robust methods 
that can identify causality. These could include RCTs and ITS designs.
The same core sets of clinical practices for infection prevention in relation to CVC insertion and ongoing 
care are currently being addressed by a wide variety of different educational strategies. The educational 
approaches do not draw upon pedagogic, theoretical or conceptual frameworks and, consequently, do 
not provide generalisable lessons to inform the ‘epic2’ (or IHI) guidelines. Harmonisation of education, 
using validated approaches (that could link to national curricula) would improve the relevance of primary 
research for informing national guidelines, and improve the comparability and analysis of the primary 
research studies. It seems appropriate that the evaluation of whether and how to standardise educational 
approaches could be considered by a relevant evidence-based-practice guideline development group.
Despite the existence of several checklists and statements relevant to the reporting of educational 
interventions for infection prevention (e.g. STROBE, TREND, ORION), the standard of reporting primary 
studies appears very poor. Consideration should be given to why these statements/checklists may not have 
been effective at improving reporting standards, and whether the compliance of study investigators with 
the reporting standards could be improved.
Recommendations for practice
NHS organisations should carefully consider whether existing practice for preventing catheter-BSI may be 
improved by implementing educational interventions in critical care units either at local or regional scales. 
Although it is not possible to be specific about which type of intervention may be most appropriate, 
economic evaluation suggests that a variety of approaches could be cost-effective or cost-saving. As 
potential cost savings could be achieved, implementation of educational interventions may be compatible 
with organisational cost reduction plans.
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Consideration should be given to the need to adopt standard definitions of CABSI and CRBSI, and apply 
and report these consistently. Definitions used by the NHS during the Matching Michigan programme (and 
presented in Table 1 of this report) may be appropriate.
When clinical practice is delivered within a research setting, for example if interventions are intended 
to be implemented into practice while their effectiveness is monitored, consideration should be given 
to ensuring that the research design is appropriate for cause–effect relationships to be determined (as 
discussed in this report). To assist future economic evaluations, the resources required to implement and 
sustain an intervention should be clearly reported.
Coordinated collection of surveillance data on catheter-BSI, mortality and LOS in critical care units would 
be helpful to inform future economic evaluations, particularly to assist in establishing the extent to which 
infection with catheter-BSI influences these outcomes.
Recommendations for research
To ensure that future primary studies of the effectiveness of educational interventions for prevention 
of catheter-BSI provide useful evidence to inform national guidelines, researchers should give careful 
consideration to the choice of study design. Uncontrolled single-cohort study designs are unlikely to 
provide information of sufficient quality to inform national guidelines, unless a detailed ITS analysis can be 
undertaken to exclude any influences of secular trends on study outcomes.
It is important that the study design is appropriate for the research question and can identify causality. 
Where feasible, the preferred research design may be a RCT.
When developing educational interventions for prevention of catheter-BSI, consideration should be 
given to the MRC guidance on the development and evaluation of complex interventions. To ensure 
generalisability, educational interventions should be supported by educational and behavioural theory, and 
educationalists should be involved in their design. Outcome evaluations should be accompanied by process 
evaluations and have an integral cost-effectiveness evaluation.
Development of educational interventions for preventing catheter-BSI (and other infections) is likely to 
benefit from being co-ordinated at a national level, to ensure that valid and reliable approaches are 
employed that yield findings which are generalisable and inform national guidelines.
Research commissioners, journal editors and other relevant research stakeholders should encourage 
researchers to clearly report research studies of educational interventions to provide greater confidence 
about the validity and generalisability of the results and to fully identify the risks of bias and confounding. 
Consideration should be given to whether current reporting guidelines (e.g. the STROBE, TREND and 
ORION checklists/statements) are being adequately followed, and whether steps could be taken to improve 
authors’ compliance with recommended reporting standards.
Updates to this review may help to clarify the extent of the growing evidence base and to ensure that the 
quality controls recommended above, if implemented, are effective. Given that there is current research 
interest in the effectiveness of educational interventions for preventing catheter-BSI in paediatric and 
neonatal populations, a more detailed review of the evidence for these populations would be appropriate.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
93
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Acknowledgements
We thank the AG for their input throughout the course of the project and for commenting on a draft of this report.
Members of the AG were:
Julian Bion, Professor and Dean, Faculty of Intensive Care Medicine, University of Birmingham; clinical lead 
for Matching Michigan in England.
Andrew Jackson, Consultant Nurse IV Therapy & Care; Infection Prevention Society (IPS) representative.
Annette Richardson, Nurse Consultant Critical Care, The Newcastle upon Tyne Hospitals NHS Foundation 
Trust; British Association of Critical Care Nurses (BACCN) National Board.
Trudie Roberts, Professor and Director, Leeds Institute of Medical Education; Association for the Study of 
Medical Education (ASME) representative.
Katie Scales, Consultant Nurse in Critical care; Member of the Steering Committee of the RCN IV forum; 
National Infusion and Vascular Access Society (NIVAS) representative.
Barry Williams, Chair of CritPal (Critical Care Patient Liaison Committee of the Intensive Care Society); 
member of Critical Care Stakeholders’ Forum and Intercollegiate Board for Training in Intensive 
Care Medicine.
Duncan Wyncoll, Consultant Intensivist, St Thomas Hospital, London, Intensive Care Society (ICS) 
representative.
We also thank the following people:
Jackie Bryant, at Southampton Health Technology Assessments Centre (SHTAC), for internal editing of a 
draft version of this report.
Olatunde Aremu, formerly at SHTAC, for contributing to writing the protocol, screening studies for 
inclusion in the descriptive map, applying mapping keywords and assisting with the translation of  
non-English-language research publications.
Diana Mendes and Jo Picot, at SHTAC, for assisting with the translation of non-English-language 
research publications.
Hanne Bruhn and Yvonne Hopf, at the Centre for Primary Care, University of Aberdeen, for assisting with 
the translation of non-English-language research publications.
Angela Vincent, at SHTAC, for assistance with project administration.
ACkNOwLEDGEMENTS
94
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Contribution of authors
Geoff K Frampton (Research Fellow, SHTAC) was the Principal Investigator and chaired the project 
meetings and AG. He scoped the research question, prepared the draft protocol and contributed to 
the writing of the protocol; screening studies for inclusion in the descriptive map; piloting and applying 
mapping keywords; extracting data from studies included in the systematic review of clinical effectiveness; 
assessing the quality of the included studies; conducting the analysis of the descriptive map; conducting 
the synthesis of outcome data in the systematic review of effectiveness; and writing the final report.
Petra Harris (Research Fellow, SHTAC) contributed to discussions at project meetings; writing of the 
protocol; screening studies for inclusion in the descriptive map; piloting and applying mapping keywords; 
extracting data from studies included in the systematic review of clinical effectiveness; assessing the 
quality of the included studies; conducting the analysis of the descriptive map; conducting the synthesis of 
outcome data in the systematic review of effectiveness; and writing the final report.
Keith Cooper (Senior Research Fellow, Health Economics, SHTAC) contributed to discussions at project 
meetings; piloting and applying mapping keywords; screening studies for inclusion in the systematic review 
of cost-effectiveness; extracting data from studies included in the systematic review of cost-effectiveness; 
assessing the quality of the included studies; developing the economic model and conducting the  
cost-effectiveness analysis; and writing the final report.
Tracey Cooper (Director of Infection Prevention & Control, South London Healthcare NHS Trust) 
contributed to discussions at project meetings; writing of the protocol; piloting and applying mapping 
keywords; and writing the final report.
Jennifer Cleland (Professor of Medical Education, University of Aberdeen) contributed to discussions 
at project meetings; writing of the protocol; piloting and applying mapping keywords; and writing the 
final report.
Jeremy Jones (Principal Research Fellow, Health Economics, SHTAC) contributed to discussions at project 
meetings; piloting and applying mapping keywords; screening studies for inclusion in the systematic review 
of cost-effectiveness; extracting data from studies included in the systematic review of cost-effectiveness; 
assessing the quality of the included studies; developing the economic model and conducting the  
cost-effectiveness analysis; and writing the final report.
Jonathan Shepherd (Principal Research Fellow, SHTAC) contributed to discussions at project meetings; 
writing of the protocol; piloting and applying mapping keywords; and writing the final report.
Andrew Clegg (Professor of Health Services Research & Director of SHTAC) contributed to discussions 
at project meetings; writing of the protocol; piloting and applying mapping keywords; and writing the 
final report.
Nicholas Graves (Professor of Health Economics, Queensland University of Technology) contributed to 
discussions at project meetings; piloting and applying mapping keywords; commenting on and reviewing a 
draft version of the economic model; and writing the final report.
Karen Welch (Information Specialist, SHTAC) conducted the literature searches for the systematic reviews 
of clinical effectiveness and cost-effectiveness, and commented on a draft version of the final report.
Brian H Cuthbertson (Professor of Critical Care, Sunnybrook Health Sciences) contributed to the writing 
of the protocol; piloting and applying mapping keywords; and writing the final report.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
95
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
References
1. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a 
prospective and observational study of 2,595 catheters. Crit Care 2005;9:R631–5.
2. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different 
intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin Proc 
2006;81:1159–71. http://dx.doi.org/10.4065/81.9.1159
3. Hospital Infection Society. The Third Prevalence Survey of Healthcare Associated Infections in Acute 
Hospitals in England 2006. London: Department of Health; 2007.
4. Penne K. Using evidence in central catheter care. Semin Oncol Nurs 2002;18:66–70. http://dx.doi.
org/10.1053/sonu.2002.30047
5. Timsit J-F, Bruneel F, Cheval C, Mamzer M-F, Garrouste-Org, Wolff M, et al. Use of tunneled femoral 
catheters to prevent catheter-related infection: a randomized, controlled trial. Ann Intern Med 
1999;130:729–35. http://dx.doi.org/10.7326/0003-4819-130-9-199905040-00004
6. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for  
the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:e162–93.  
http://dx.doi.org/10.1093/cid/cir257
7. Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on 
prevention based on educational programs. Clin Microbiol Infect 2002;8:295–309. http://dx.doi.
org/10.1046/j.1469-0691.2002.00467.x
8. Osma S, Kahveci SF, Kaya FN, Akalin H, Ozakin C, Yilmaz E, et al. Efficacy of antiseptic-impregnated 
catheters on catheter colonization and catheter-related bloodstream infections in patients in an 
intensive care unit. J Hosp Infect 2006;62:156–62. http://dx.doi.org/10.1016/j.jhin.2005.06.030
9. Pearson ML, Hierholzer WJ, Jr., Garner JS, Mayhall CG, Adams A, Craven DE, et al. Guideline  
for prevention of intravascular device-related infections. Am J Infect Control 1996;24:262–93. 
http://dx.doi.org/10.1086/647338
10. van der Kooi TI, de Boer AS, Mannien J, Wille JC, Beaumont MT, Mooi BW, et al. Incidence and risk 
factors of device-associated infections and associated mortality at the intensive care in the Dutch 
surveillance system. Intensive Care Med 2007;33:271–8.
11. Johnston B, Conly J. What do central venous catheter-associated bloodstream infections have to do 
with bundles? Can J Infect Dis Med Microbiol 2005;16:215–18.
12. Health Protection Agency (HPA). English National Point Prevalence Survey on Healthcare-associated 
Infections and Antimicrobial Use, 2011: preliminary data. 1–139. London: HPA; 2012.
13. Shapey IM, Foster MA, Whitehouse T, Jumaa P, Bion JF. Central venous catheter-related bloodstream 
infections: improving post-insertion catheter care. J Hosp Infect 2009;71:117–22. http://dx.doi.
org/10.1016/j.jhin.2008.09.016
14. Aslakson RA, Romig M, Galvagno SM, Colantuoni E, Cosgrove SE, Perl TM, et al. Effect of 
accounting for multiple concurrent catheters on central line-associated bloodstream infection rates: 
practical data supporting a theoretical concern. Infect Control Hosp Epidemiol 2011;32:121–4. 
http://dx.doi.org/10.1086/657941
15. Plimmer SE, Miles A, Harding R. Implementation of a multidisciplinary frameworkfor prevention of 
central venous catheter blood stream infections in a rural district general ICU. Intensive Care Med 
2011;37(Suppl. 1):S139.
rEfErENCES
96
NIHR Journals Library www.journalslibrary.nihr.ac.uk
16. Kulkarni S, Nair P, Sule A. Trends in the central line related infections in winter months in a tertiary 
neurosurgical intensive care unit in the north west of England in the last 2 years in comparison with 
the national statistics and with the ongoing Matching Michigan trial: a systematic statistical review 
and analysis. Intensive Care Med 2011:S18.
17. Abrusci T, Bion J. Validating the diagnosis of central venous catheter bloodstream infections  
(CVC-BSIs) in ICUs in England. Intensive Care Med 2011:S13.
18. Health Protection Scotland. Intensive Care Unit Associated Infection National Surveillance 
Programme. Glasgow: Health Protection Scotland; 2011.
19. European Centre for Disease Prevention and Control. Annual Epidemiological Report on 
Communicable Diseases in Europe. Stockholm: European Centre for Disease Prevention and 
Control; 2009.
20. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood 
stream infections – United States, 2001, 2008, and 2009. MMWR – Morb Mort Weekly Rep 
2011;60:243–8.
21. Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L. Defining bloodstream 
infections related to central venous catheters in patients with cancer: a systematic review.  
Clin Infect Dis 2011;53:697–710. http://dx.doi.org/10.1093/cid/cir523
22. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical Practice Guidelines 
for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update 
by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45. http://dx.doi.
org/10.1086/599376
23. Plowman R, Graves N, Griffin M, Roberts JA, Swan AV, Cookson B, et al. The Socio-economic 
Burden of Hospital Acquired Infection. London: School of Hygiene and Tropical Medicine, Public 
Health Laboratory Service; 1999.
24. Armenian SH, Singh J, Arrieta AC. Risk factors for mortality resulting from bloodstream infections 
in a pediatric intensive care unit. Pediatr Infect Dis J 2005;24:309–14. http://dx.doi.org/10.1097/01.
inf.0000157086.97503.bd
25. Fletcher S. Catheter-related bloodstream infection. Contin Educ Anaesth Crit Care Pain 2005;5:49–51. 
http://dx.doi.org/10.1093/bjaceaccp/mki011
26. Wenzel RP, Edmond MB. Team-based prevention of catheter-related infections. N Engl J Med 
2006;355:2781–3. http://dx.doi.org/10.1056/NEJMe068230
27. Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs  
of catheter-related bloodstream infections in intensive care units of four European countries:  
literature- and registry-based estimates. J Hosp Infect 2009;72:97–103. http://dx.doi.org/10.1016/ 
j.jhin.2008.12.012
28. Department of Health. High Impact Intervention No. 1 Central Venous Catheter Care Bundle.  
URL: www.gosh.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=80528 (accessed May 2012).
29. Atherton SL, Tjoelker RC. Evidence based fact sheet: an effective method for implementing change. 
Am J Infect Control 2006;34:E51. http://dx.doi.org/10.1016/j.ajic.2006.05.107
30. Aboelela SW, Stone PW, Larson EL. Effectiveness of bundled behavioural interventions to control 
healthcare-associated infections: a systematic review of the literature. J Hosp Infect 2007;66:101–8. 
http://dx.doi.org/10.1016/j.jhin.2006.10.019
31. Rogers S, Brennan S. Continuous quality improvement: effects on professional practice and patient 
outcomes. Cochrane Database Syst Rev 2001;4:CD003319. http://dx.doi.org/10.1002/14651858.
CD003319
www.gosh.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=80528
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
97
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
32. Conn VS, Rantz MJ, Wipke-Tevis DD, Maas ML. Designing effective nursing interventions.  
Res Nurs Health 2001;24:433–42. http://dx.doi.org/10.1002/nur.1043
33. Marwick C, Davey P. Care bundles: The holy grail of infectious risk management in hospital? 
Curr Opin Infect Dis 2009;22:364–9. http://dx.doi.org/10.1097/QCO.0b013e32832e0736
34. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to 
decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–32. 
http://dx.doi.org/10.1056/NEJMoa061115
35. Griesbach D, Taylor A. Educational Interventions to Prevent Hepatitis C: A Review of the Literature 
and Expert Opinion. NHS Health Scotland; 2009.
36. Reed D, Price EG, Windish DM, Wright SM, Gozu A, Hsu EB, et al. Challenges in systematic 
reviews of educational intervention studies. Ann Intern Med 2005;142:1080–9. http://dx.doi.
org/10.7326/0003-4819-142-12_Part_2-200506211-00008
37. Safdar N, Abad C. Educational interventions for prevention of healthcare-associated 
infection: a systematic review. Crit Care Med 2008;36:933–40. http://dx.doi.org/10.1097/
CCM.0B013E318165FAF3
38. Richardson A. Minimising central venous catheter-associated bloodstream infections – ‘Matching 
Michigan’ in England. Nurs Crit Care 2009;14:105–6.
39. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al. epic2: National  
evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in 
England. J Hosp Infect 2007;65(Suppl. 1):1–64. http://dx.doi.org/10.1016/S0195-6701(07)60002-4
40. Department of Health. Clean, Safe Care: Reducing Infections and Saving Lives. URL: http://
antibiotic-action.com/wp-content/uploads/2011/07/DH-Clean-safe-care-v2007.pdf  
(accessed May 2012).
41. Department of Health. High Quality Care for All. Department of Health; 2008. URL: www.dh.gov.
uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_085825
42. National Patient Safety Agency. Minimising central venous catheter associated bloodstream 
infections: Matching Michigan. URL: www.npsa.nhs.uk/EasySiteWeb/getresource.
axd?AssetID=60249 (accessed May 2012).
43. Adams-Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. 
Curr Opin Pediatr 2002;14:157–64. http://dx.doi.org/10.1097/00008480-200204000-00003
44. Chittick P, Sherertz RJ. Recognition and prevention of nosocomial vascular device and related 
bloodstream infections in the intensive care unit. Crit Care Med 2010;38(Suppl. 8):363–72.  
http://dx.doi.org/10.1097/CCM.0b013e3181e6cdca
45. Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the 
intensive care unit. Crit Care 2010;14:212. http://dx.doi.org/10.1186/cc8853
46. Semelsberger CF. Educational interventions to reduce the rate of central catheter-related 
bloodstream infections in the NICU: a review of the research literature. Neonatal Netw 
2009;28:391–5. http://dx.doi.org/10.1891/0730-0832.28.6.391
47. Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies 
published between 2002 and 2005. J Hosp Infect 2006;64:326–35. http://dx.doi.org/10.1016/ 
j.jhin.2006.07.005
48. Ramritu P, Halton K, Cook D, Whitby M, Graves N. Catheter-related bloodstream infections in 
intensive care units: a systematic review with meta-analysis. J Adv Nurs 2008;62:3–21.  
http://dx.doi.org/10.1111/j.1365-2648.2007.04564.x
rEfErENCES
98
NIHR Journals Library www.journalslibrary.nihr.ac.uk
49. Cherry MG, Brown JM, Neal T, Shaw NB. What features of educational interventions lead to 
competence in aseptic insertion and maintenance of CV catheters in acute care? BEME Guide 
No. 15. Med Teach 2010;32:198–218. http://dx.doi.org/10.3109/01421591003596600
50. Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, et al. Effect of an 
education program on decreasing catheter-related bloodstream infections in the surgical intensive 
care unit. Crit Care Med 2002;30:59–64. http://dx.doi.org/10.1097/00003246-200201000-00009
51. Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, et al. The effect of an education 
program on the incidence of central venous catheter-associated bloodstream infection in a medical 
ICU. Chest 2004;126:1612–18. http://dx.doi.org/10.1378/chest.126.5.1612
52. Shepherd J, Kavanagh J, Picot J, Cooper K, Harden A, Barnett-Page E, et al. The effectiveness and 
cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections 
in young people aged 13–19: a systematic review and economic evaluation. Health Technol Assess 
2010;14(7).
53. Shepherd J, Harden A, Rees R, Brunton G, Garcia J, Oliver S, et al. Young people and healthy eating: 
a systematic review of research on barriers and facilitators. Health Educ Res 2006;21:239–57.  
http://dx.doi.org/10.1093/her/cyh060
54. Rees R, Kavanagh J, Harden A, Shepherd J, Brunton G, Oliver S, et al. Young people and physical 
activity: a systematic review matching their views to effective interventions. Health Educ Res 
2006;21:806–25. http://dx.doi.org/10.1093/her/cyl120
55. Des Jarlais DC, Lyles C, Crepaz N, The TREND Group. Improving the reporting quality of 
nonrandomised evaluations of behavioural and public health interventions: the TREND statement. 
Am J Public Health 2004;94:361–6.
56. Hammick M, Dornan T, Steinert Y. Conducting a best evidence systematic review. Part 1. 
From idea to data coding. BEME Guide No 13. Med Teach 2010;32:3–15. http://dx.doi.
org/10.3109/01421590903414245
57. Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION Statement: 
guidelines for transparent reporting of Outbreak Reports and Intervention studies of Nosocomial 
infection. J Antimicrob Chemother 2007;59:833–40. http://dx.doi.org/10.1093/jac/dkm055
58. Higgins JPT, Altman DG, Gøetzsche P, Jüni P, Moher D, Oxman AD, et al. The Cochrane 
Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.  
http://dx.doi.org/10.1136/bmj.d5928
59. Reeves CB, Deeks JJ, Higgins JPT, Wells GA. Including non-randomised studies. In Higgins JPT,  
Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 
(updated September 2009). The Cochrane Collaboration; 2008. pp. 13.1–13.4.
60. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo BD, Cummings GG. Assessment of study quality for 
systematic reviews: a comparison of the Cochrane Collaboration risk of bias tool and the Effective 
Public Health Practice Project quality assessment tool: methodological research. J Eval Clin Pract 
2010;18:12–18. http://dx.doi.org/10.1111/j.1365-2753.2010.01516.x
61. Rodgers M, Sowden A, Petticrew M, Arai L, Roberts H, Britten N, et al. Testing methodological 
guidance on the conduct of narrative synthesis in systematic reviews. Evaluation 2009;15:47–71. 
http://dx.doi.org/10.1177/1356389008097871
62. Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd edn. Oxford: Blackwell Science; 2003.
63. Agra Varela Y, Sierra E, Drake M, Terol E. The Zero Bacteremia Project. Reduction of bacteremia 
caused by central venous catheters at ICUs in Spain. Rev Enferm 2009;32:15–18.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
99
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
64. Anguera Saperas L, Aragonés Mestre M, March JM, Rius Ferrus LI, Uruén Pueyo S, Diaz Santos E,  
et al. New strategy of actuation in central venous catheter and its influence in infection. 
Enferm Intensiva 2004;15:11–16.
65. Esteve F, Pujol M, Ariza J, Gudiol F, Verdaguer R, Cisnal M, et al. Impact of a prevention program for 
catheter-related bloodstream infection in the intensive care unit of a tertiary hospital. Enferm Infecc 
Microbiol Clin 2009;27:561–5.
66. Lisboa T, Rello J. Prevention of nosocomial infections: strategies to improve the safety of the 
patients in the Intensive Care Unit. Med Intensiva 2008;32:248–52.
67. Palomar M, Rodriguez P, Nieto M, Sancho S. Prevention of nosocomial infection in critical patients. 
Med Intensiva 2010;34:523–33.
68. Palomar Martinez M, Lerma FA, Badia MAR, Gil CL, Pueyo MJL, Tobajas CD, et al. Prevention of 
bacteriema related with ICU catheters by multifactorial intervention: a report of the pilot study. 
Med Intensiva 2010;34:581–9.
69. Urrea Ayala M, Rozas QL. Catheter-associated bloodstream infections: Implementation of a new 
consensus protocol. An Pediatr 2009;71:20–4.
70. Leboucher B, Leblanc M, Berlie I, Savagner C, Lemarie C, Le Bouedec S. Effectiveness of an 
informative report on the prevention of nosocomial bloodstream infections in a neonatal intensive 
care unit. Arch Pediatrie 2006;13:436–41.
71. Riel-Roberge G. Central catheterization. Reduction of bacteremia. Sensitivity of intensive care 
nursing personnel. Perspect Infirm 2010;7:52.
72. Lolom I, Deblangy C, Capelle A, Guerinot W, Bouvert E, Barry B, et al. Effect of a long-term quality 
improvement program on the risk of infection related to peripheral venous catheters. Presse Med 
2009;38:34–42.
73. Schindler B. Prevention of catheter-related infections in the intensive care unit. 
Krankenhauspharmazie 2007;28:448.
74. Agvald-Ohman C, Hanberger H, Struwe J, Walther SM. The “push” and “pull” method to 
reduce nosocomial infections at ICU. A pilot project with an active follow up. Lakartidningen 
2010;107:28–31.
75. Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Use of simulation-based education to 
reduce catheter-related bloodstream infections. Arch Intern Med 2009;169:1420–3. http://dx.doi.
org/10.1001/archinternmed.2009.215
76. Cohen ER, Feinglass J, Barsuk JH, Barnard C, O’Donnell A, McGaghie WC, et al. Cost savings from 
reduced catheter-related bloodstream infection after simulation-based education for residents 
in a medical intensive care unit. Simul Healthc 2010;5:98–102. http://dx.doi.org/10.1097/
SIH.0b013e3181bc8304
77. Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Parley JE, et al. Eliminating  
catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–20. 
http://dx.doi.org/10.1097/01.CCM.0000142399.70913.2F
78. Bhutta A, Gilliam C, Honeycutt M, Schexnayder S, Green J, Moss M, et al. Reduction of 
bloodstream infections associated with catheters in paediatric intensive care unit: stepwise 
approach. BMJ 2007;334:362–5. http://dx.doi.org/10.1136/bmj.39064.457025.DE
79. Berriel-Cass D, Adkins FW, Jones P, Fakih MG. Eliminating nosocomial infections at Ascension 
Health. Jt Comm J Qual Pt Saf 2006;32:612–20.
rEfErENCES
100
NIHR Journals Library www.journalslibrary.nihr.ac.uk
80. Bishop-Kurylo D. The clinical experience of continuous quality improvement in the neonatal  
intensive care unit. J Perinat Neonat Nurs 1998;12:51–7. http://dx.doi.org/10.1097/ 
00005237-199806000-00008
81. Bizzarro MJ, Sabo B, Noonan M, Bonfiglio M-P, Northrup V, Diefenbach K. A quality improvement 
initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. 
Infect Control Hosp Epidemiol 2010;31:241–8. http://dx.doi.org/10.1086/650448
82. Bonello RS, Fletcher CE, Becker WK, Clutter KL, Arjes SL, Cook JJ, et al. An intensive care unit 
quality improvement collaborative in nine Department of Veterans Affairs hospitals: reducing 
ventilator-associated pneumonia and catheter-related bloodstream infection rates. Jt Comm J Qual 
Pt Saf 2008;34:639–45.
83. Burrell AR, McLaws ML, Murgo M, Calabria E, Pantle AC, Herkes R. Aseptic insertion of central 
venous lines to reduce bacteraemia. Med J Aus 2011;194:583–7.
84. Buttes P, Lattus J, Stout C, Thomas LA. Drive down infection rates. Nurs Crit Care 2006;1:41–5. 
http://dx.doi.org/10.1097/01244666-200605000-00008
85. Centers for Disease Control and Prevention (CDC). Reduction in central line-associated bloodstream 
infections among patients in intensive care units: Pennsylvania, April 2001-March 2005. Morb Mort 
Weekly Rep 2005;54:1013–16.
86. Chua C, Wisniewski T, Ramos A, Schlepp M, Fildes JJ, Kuhls DA. Multidisciplinary trauma intensive 
care unit checklist: impact on infection rates. J Trauma Nurs 2010;17:163–6. http://dx.doi.
org/10.1097/JTN.0b013e3181fb38a6
87. Coopersmith CM, Zack JE, Ward MR, Sona CS, Schallom ME, Everett SJ, et al. the impact of bedside 
behavior on catheter-related bacteremia in the intensive care unit. Arch Surg 2004;139:131–6. 
http://dx.doi.org/10.1001/archsurg.139.2.131
88. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic 
intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac 
intensive care unit. Pediatrics 2008;121:915–23. http://dx.doi.org/10.1542/peds.2007-1577
89. Curchoe RM, Powers J, El-Daher N. Weekly transparent dressing changes linked to increased 
bacteremia rates. Infect Control Hosp Epidemiol 2002;23:730–2. http://dx.doi.org/10.1086/502002
90. Curry S, Honeycutt M, Goins G, Gilliam C. Catheter-associated bloodstream infections in the NICU: 
getting to zero. Neonatal Netw 2009;28:151–5. http://dx.doi.org/10.1891/0730-0832.28.3.151
91. DePalo VA, McNicoll L, Cornell M, Rocha JM, Adams L, Pronovost PJ. The Rhode Island ICU 
collaborative: a model for reducing central line-associated bloodstream infection and ventilator-
associated pneumonia statewide. Qual Saf Health Care 2010;19:555–61. http://dx.doi.org/10.1136/
qshc.2009.038265
92. Duane TM, Brown H, Borchers CT, Wolfe LG, Malhotra AK, Aboutanos MB, et al. A central venous 
line protocol decreases bloodstream infections and length of stay in a trauma intensive care unit 
population. Am Surg 2009;75:1166–70.
93. DuBose JJ, Inaba K, Shiflett A, Trankiem C, Teixeira PGR, Salim A, et al. Measurable outcomes 
of quality improvement in the trauma intensive care unit: The impact of a daily quality rounding 
checklist. J Trauma 2008;64:22–7. http://dx.doi.org/10.1097/TA.0b013e318161b0c8
94. Eggimann P, Harbarth S, Constantin M-N, Touveneau S, Chevrolet J-C, Pittet D. Impact of a 
prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive 
care. Lancet 2000;355:1864–8. http://dx.doi.org/10.1016/S0140-6736(00)02291-1
95. Eggimann P, Hugonnet S, Sax H, Harbarth S, Chevrolet J-C, Pittet D. Long-term reduction  
of vascular access-associated bloodstream infection. Ann Intern Med 2005;142:875–6.  
http://dx.doi.org/10.7326/0003-4819-142-10-200505170-00025
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
101
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
96. Frankel HL, Crede WB, Topal JE, Roumanis SA, Devlin MW, Foley AB. Use of corporate six sigma 
performance-improvement strategies to reduce incidence of catheter-related bloodstream  
infections in a surgical ICU. J Am Coll Surg 2005;201:349–58. http://dx.doi.org/10.1016/ 
j.jamcollsurg.2005.04.027
97. Galpern D, Guerrero A, Tu A, Fahoum B, Wise L. Effectiveness of a central line bundle campaign 
on line-associated infections in the intensive care unit. Surgery 2008;144:492–5. http://dx.doi.
org/10.1016/j.surg.2008.06.004
98. Guerin K, Wagner J, Rains K, Bessesen M. Reduction in central line-associated bloodstream 
infections by implementation of a postinsertion care bundle. Am J Infect Control 2010;38:430–3. 
http://dx.doi.org/10.1016/j.ajic.2010.03.007
99. Harnage S. Innovative bundle wipes out catheter-related bloodstream infections. Nursing 
2008;38:17–18. http://dx.doi.org/10.1097/01.NURSE.0000337217.01808.5a
100. Harnage SA. Achieving zero catheter related blood stream infections: 15 months success in a 
community based medical center. JAVA 2007;12:218–24. http://dx.doi.org/10.2309/java.12-4-8
101. Harrigan S, Hurst D, Lee C, Christie V, Wolfe RB, Morrical D, et al. Developing and implementing 
quality initiatives in the ICU: strategies and outcomes. Crit Care Nurs Clin N Am 2006;18:469–79. 
http://dx.doi.org/10.1016/j.ccell.2006.09.004
102. Hatler CW, Mast D, Corderella J, Mitchell G, Howard K, Aragon J, et al. Using evidence and process  
improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. 
Am J Crit Care 2006;15:549–54.
103. Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on 
the incidence of central venous catheter-associated bloodstream infections and mortality in 
intensive care units in Mexico. Crit Care Med 2005;33:2022–7. http://dx.doi.org/10.1097/01.
CCM.0000178190.89663.E5
104. Jain M, Miller L, Belt D, King D, Berwick DM. Decline in ICU adverse events, nosocomial infections 
and cost through a quality improvement initiative focusing on teamwork and culture change. 
Qual Saf Health Care 2006;15:235–9. http://dx.doi.org/10.1136/qshc.2005.016576
105. Joy-Joseph L, Colin JM, Rosenstein CR, Chinye-Onyejuruwa F. An evidence-based approach for 
managing catheter-associated bloodstream infection in a level II neonatal intensive care unit. 
J Nurs Care Qual 2010;25:100–4. http://dx.doi.org/10.1097/NCQ.0b013e3181d151b8
106. Koll B. Preventing central-line associated bloodstream infections at Beth Israel Medical Center. 
In Nolan KM, Schall MW, editors. Spreading Improvement Across Your Health Care Organization. 
Oakbrook Terrace, IL: Joint Commission Resources; 2007. pp. 41–53.
107. Koll BS, Straub TA, Jalon HS, Block R, Heller KS, Ruiz RE. The CLABs collaborative: a regionwide 
effort to improve the quality of care in hospitals. Jt Comm J Qual Pt Saf 2008;34:713–23.
108. Lobo RD, Levin AS, Brasileiro Gomes LM, Cursino R, Park M, Figueiredo VB, et al. Impact of an 
educational program and policy changes on decreasing catheter-associated bloodstream infections 
in a medical intensive care unit in Brazil. Am J Infect Control 2005;33:83–7. http://dx.doi.
org/10.1016/j.ajic.2004.05.003
109. Lobo RD, Levin AS, Oliveira MS, Gomes LMB, Gobara S, Park M, et al. Evaluation of interventions to 
reduce catheter-associated bloodstream infection: Continuous tailored education versus one basic 
lecture. Am J Infect Control 2010;38:440–8. http://dx.doi.org/10.1016/j.ajic.2009.09.013
110. Longmate AG, Ellis KS, Boyle L, Maher S, Cairns CJS, Lloyd SM, et al. Elimination of central-venous-
catheter-related bloodstream infectons from the intensive care unit. BMJ Qual Saf 2011;20:174–80.
rEfErENCES
102
NIHR Journals Library www.journalslibrary.nihr.ac.uk
111. Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ. Central venous catheter-related 
bacteraemia in critically ill neonates: Risk factors and impact of a prevention programme. J Hosp 
Infect 1998;40:211–24. http://dx.doi.org/10.1016/S0195-6701(98)90139-6
112. Marra AR, Cal RGR, Durao MS, Correa L, Guastelli LR, Moura J, et al. Impact of a program to 
prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control 
2010;38:434–9. http://dx.doi.org/10.1016/j.ajic.2009.11.012
113. McKee C, Berkowitz I, Cosgrove SE, Bradley K, Beers C, Perl TM, et al. Reduction of catheter-
associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit 
Care Med 2008;9:40–6. http://dx.doi.org/10.1097/01.PCC.0000299821.46193.A3
114. Miller RS, Norris PR, Jenkins JM, Talbot III TR, Starmer JM, Hutchison SA, et al. Systems initiatives 
reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. 
J Trauma 2010;68:23–31. http://dx.doi.org/10.1097/TA.0b013e3181c82678
115. Miller MR, Griswold M, Harris II JM, Yenokyan G, Charles HW, Moss M, et al. Decreasing PICU 
catheter-associated bloodstream infections: NACHRI’s quality transformation efforts. Pediatrics 
2010;125:206–13. http://dx.doi.org/10.1542/peds.2009-1382
116. Miller-Hoover S. Pediatric central line: bundle implementation and outcomes. J Infusion Nurs 
2011;34:36–48.
117. Misset B, Timsit J-F, Dumay M-F, Garrouste M, Chalfine A, Flouriot I, et al. A continuous  
quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med 
2004;30:395–400. http://dx.doi.org/10.1007/s00134-003-2096-1
118. Moreira M, Freitas MR, Martias ST, Castelo A, Medeires EAS. Efficacy of a program of prevention 
and control for methicillin-resistant Staphylococcus aureus infections in an intensive-care unit. 
Braz J Infect Dis 2007;11:57–62. http://dx.doi.org/10.1590/S1413-86702007000100015
119. Northway T, Mawdsley C. The Canadian ICU Collaborative: sustaining the gains: a lesson in 
humility. Dynamics 2009;20:23–7.
120. Orsi GB, Raponi M, Franchi C, Rocco M, Mancini C, Venditti M. Surveillance and infection 
control in an intensive care unit. Infect Control Hosp Epidemiol 2005;26:321–5. http://dx.doi.
org/10.1086/502547
121. Peredo R, Sabatier C, Villagra A, Gonzalez J, Hernandez C, Perez F, et al. Reduction in catheter-
related bloodstream infections in critically ill patients through a multiple system intervention. 
Eur J Clin Microbiol Infect Dis 2010;29:1173–7. http://dx.doi.org/10.1007/s10096-010-0971-6
122. Perez Parra A, Menarguez MC, Granda MJP, Tomey MJ, Padilla B, Bouza E. A Simple Educational 
Intervention to Decrease Incidence of Central Line-Associated Bloodstream Infection (CLABSI) 
in Intensive Care Units with Low Baseline Incidence of CLABSI. Infect Control Hosp Epidemiol 
2010;31:964–7. http://dx.doi.org/10.1086/655841
123. Pronovost PJ, Goeschel CA, Colantuoni E, Watson S, Lubomski LH, Berenholtz SM, et al. Sustaining 
reductions in catheter-related bloodstream infections in Michigan intensive care units: observational 
study. BMJ 2010;340:c309. http://dx.doi.org/10.1136/bmj.c309
124. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: The 
Keystone Intensive Care Unit Project. Am J Infect Control 2008;36:S171, e1–5. http://dx.doi.
org/10.1016/j.ajic.2008.10.008
125. Racco M, Horn K. Central catheter infections: use of a multidisciplinary team to find simple 
solutions. Crit Care Nurs 2007;27:80, 78–9.
126. Render ML, Brungs S, Kotagal U, Nicholson M, Burns P, Ellis D, et al. Evidence-based practice to 
reduce central line infections. Jt Comm J Qual Pt Saf 2006;32:253–60.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
103
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
127. Rey C, Alvarez F, De-La-Rua V, Concha A, Medina A, Díaz J-J, et al. Intervention to reduce catheter-
related bloodstream infections in a pediatric intensive care unit. Intensive Care Med 2011;37:678–85. 
http://dx.doi.org/10.1007/s00134-010-2116-x
128. Rogers E, Alderdice F, McCall E, Jenkins J, Craig S. Reducing nosocomial infections in neonatal 
intensive care. J Matern Fetal Neonatal Med 2010;23:1039–46. http://dx.doi.org/10.3109/ 
14767050903387029
129. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using 
education and performance feedback on rates of intravascular device-associated bloodstream 
infections in intensive care units in Argentina. Am J Infect Control 2003;31:405–9. http://dx.doi.
org/10.1067/mic.2003.52
130. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene 
in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33:392–7. 
http://dx.doi.org/10.1016/j.ajic.2004.08.009
131. Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B. A multimodal approach to central venous 
catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control 
2010;38:424–9. http://dx.doi.org/10.1016/j.ajic.2009.07.014
132. Santana SL, Furtado GHC, Wey SB, Medeiros EAS. Impact of an education program on the 
incidence of central line-associated bloodstream infection in 2 medical-surgical intensive care units 
in Brazil. Infect Control Hosp Epidemiol 2008;29:1171–3. http://dx.doi.org/10.1086/591862
133. Schulman J, Stricof R, Stevens TP, Horgan M, Gase K, Holzman IR, et al. Statewide NICU  
central-line-associated bloodstream infection rates decline after bundles and checklists. 
Pediatrics 2011;127:436–44. http://dx.doi.org/10.1542/peds.2010-2873
134. Shannon RP, Frndak D, Grunden N, Lloyd JC, Herbert C, Patel B, et al. Using real-time problem 
solving to eliminate central line infections. Jt Comm J Qual Pt Saf 2006;32:479–87.
135. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, et al. Education of physicians-
in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000;132:641–8. 
http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00007
136. Speroff T, Ely EW, Greevy R, Weinger MB, Talbot TR, Wall RJ, et al. Quality improvement projects 
targeting health care-associated infections: comparing virtual collaborative and toolkit approaches. 
J Hosp Med 2011;6:271–8. http://dx.doi.org/10.1002/jhm.873
137. Venkatram S, Rachmale S, Kanna B. Study of device use adjusted rates in health care-associated 
infections after implementation of ‘bundles’ in a closed-model medical intensive care unit. 
J Crit Care 2010;25:174, e11–18. http://dx.doi.org/10.1016/j.jcrc.2009.06.016
138. Wall RJ, Ely EW, Elasy TA, Dittus RS, Foss J, Wilkerson KS, et al. Using real time process 
measurements to reduce catheter related bloodstream infections in the intensive care unit. 
Qual Saf Health Care 2005;14:295–302. http://dx.doi.org/10.1136/qshc.2004.013516
139. Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational intervention to prevent 
catheter-associated bloodstream infections in a nonteaching, community medical center.  
Crit Care Med 2003;31:1959–63. http://dx.doi.org/10.1097/01.CCM.0000069513.15417.1C
140. Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, et al. A multicenter 
intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 
2006;27:662–9. http://dx.doi.org/10.1086/506184
141. Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, et al. A statewide quality 
improvement collaborative to reduce neonatal central line-associated blood stream infections. 
J Perinatol 2010;30:170–81. http://dx.doi.org/10.1038/jp.2009.172
rEfErENCES
104
NIHR Journals Library www.journalslibrary.nihr.ac.uk
142. Yoo S, Ha M, Choi D, Pai H. Effectiveness of surveillance of central catheter-related bloodstream 
infection in an ICU in Korea. Infect Control Hosp Epidemiol 2001;22:433–6. http://dx.doi.
org/10.1086/501930
143. Zack J. Zeroing in on zero tolerance for central line-associated bacteremia. Am J Infect Control 
2008;36:S176, e1–2. http://dx.doi.org/10.1016/j.ajic.2008.10.014
144. Zingg W, Imhof A, Maggiorini M, Stocker R, Keller E, Ruef C. Impact of a prevention strategy 
targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream 
infections. Crit Care Med 2009;37:2167–73. http://dx.doi.org/10.1097/CCM.0b013e3181a02d8f
145. Khouli H, Jahnes K, Shapiro J, Rose K, Mathew J, Gohil A, et al. Performance of medical residents  
in sterile techniques during central vein catheterization: randomized trial of efficacy of  
simulation-based training. Chest 2011;139:80–7. http://dx.doi.org/10.1378/chest.10-0979
146. Clinical Excellence Commission (CEC). Central Line Associated Bacteraemia in NSW Intensive Care 
Units (CLAB ICU) Final Report. Sydney, Australia: Clinical Excellence Commission; 2010.
147. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 
1988. Am J Infect Control 1988;16:128–40. http://dx.doi.org/10.1016/0196-6553(88)90053-3
148. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? 
Stat Med 2002;21:1559–73. http://dx.doi.org/10.1002/sim.1187
149. Dixon-Woods M, Bosk CL, Aveling EL, Goeschel CA, Pronovost PJ. Explaining Michigan: developing 
an ex post theory of a quality improvement program. Millbank Q 2011;89:167–205. http://dx.doi.
org/10.1111/j.1468-0009.2011.00625.x
150. Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R. Review of guidelines for good 
practice in decision-analytic modelling in health technology assessment. Health Technol Assess 
2004;8(36). http://dx.doi.org/10.2165/00019053-200624040-00006
151. Halton KA, Cook D, Paterson DL, Safdar N, Graves N. Cost-effectiveness of a central venous 
catheter care bundle. PLoS ONE 2010;5:1–11. http://dx.doi.org/10.1371/journal.pone.0012815
152. Bond WF, King AE. Modeling for the decision process to implement an educational intervention: 
an example of a central venous catheter insertion course. J Patient Saf 2011;7:85–91. http://dx.doi.
org/10.1097/PTS.0b013e31821b3ab6
153. Drummond MF, O’Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of 
Health Care Programmes. 3rd edn. Oxford: Oxford University Press; 2005.
154. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. 
2008. URL: www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf (accessed  
May 2010).
155. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial 
catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 2009;13:R35. 
http://dx.doi.org/10.1186/cc7744
156. McLaws ML, Berry G. Nonuniform risk of bloodstream infection with increasing central venous 
catheter-days. Infect Control Hosp Epidemiol 2005;26:715–19. http://dx.doi.org/10.1086/502608
157. Hawthorne G, Osborne R. Population norms and meaningful differences for the Assessment of 
Quality of Life (AQoL) measure. Aus N Z J Public Health 2005;29:136–42. http://dx.doi.org/10.1111/
j.1467-842X.2005.tb00063.x
158. Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, et al. A systematic review 
comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. 
Am J Infect Control 2008;36:104–17. http://dx.doi.org/10.1016/j.ajic.2007.02.012
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
105
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
159. Cuthbertson BH, Scott J, Strachan M, Kilonzo M, Vale L. Quality of life before and after intensive 
care. Anaesthesia 2005;60:332–9. http://dx.doi.org/10.1111/j.1365-2044.2004.04109.x
160. Rechner IJ, Lipman J. The costs of caring for patients in a tertiary referral Australian Intensive Care 
Unit. Anaesth Intensive Care 2005;33:477–82.
161. Graves N, Birrell FA, Whitby M. Modeling the economic losses from pressure ulcers among 
hospitalized patients in Australia. Wound Repair Regen 2005;13:462–7. http://dx.doi.
org/10.1111/j.1067-1927.2005.00066.x
162. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford: 
Oxford University Press; 2006.
163. Richardson A, Bion J. Matching Michigan in England. BACCN Conference 2010, Southport, 
UK 2010.
164. Intensive Care National Audit & Research Centre (ICNARC). CMP Case Mix and Outcome Summary 
Statistics. URL: www.icnarc.org (accessed May 2012).
165. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, et al. Clinical outcomes of 
health-care-associated infections and antimicrobial resistance in patients admitted to European 
intensive-care units: a cohort study. Lancet Infect Dis 2011;11:30–8. http://dx.doi.org/10.1016/
S1473-3099(10)70258-9
166. Irish Critical Care Trials Group (ICCTG), Intensive Care Society of Ireland (ICSI), Health Protection 
Surveillance Centre (HPSC), Health Service Executive Critical Care Program (HSE-CCP). Catheter-
related Infection (CRI) in Irish Intensive Care Units – A pilot surveillance study. URL: www.hpsc.ie/
hpsc/ (accessed May 2012).
167. Department of Health. NHS Reference Costs 2010/11. URL: www.dh.gov.uk/en/
Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_095859 (accessed 
May 2012).
168. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of 
catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. 
Crit Care Med 2006;34:2084–9. http://dx.doi.org/10.1097/01.CCM.0000227648.15804.2D
169. Ward S, Lloyd JM, Pandor A, Holmes M, Ara R, Ryan A, et al. A systematic review and economic 
evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11(14).
170. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-
dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 
2010;14:381–6.
171. De Angelis G, Murthy A, Beyersmann J, Harbarth S. Estimating the impact of healthcare-associated 
infections on length of stay and costs. Clin Microbiol Infect 2010;16:1729–35. http://dx.doi.
org/10.1111/j.1469-0691.2010.03332.x
172. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Modeling the effect of time-dependent 
exposure on intensive care unit mortality. Intensive Care Med 2009;35:826–32. http://dx.doi.
org/10.1007/s00134-009-1423-6
173. Barnett AG, Graves N, Rosenthal VD, Salomao R, Rangel-Frausto MS. Excess length of stay due to 
central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico. 
Infect Control Hosp Epidemiol 2010;31:1106–14. http://dx.doi.org/10.1086/656593
174. European Centre for Disease Control. Hospital in Europe Link for Infection Control Through 
Surveillnace (HELICS): Surveillance of Nosocomial Infections in Intensive Care Units Protocol 6.1. 
URL: http://helics univ-lyon1 fr/home htm (accessed May 2012).
rEfErENCES
106
NIHR Journals Library www.journalslibrary.nihr.ac.uk
175. Curtis L. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research 
Unit; 2011.
176. Department of Health. NHS Reference Costs 2009–10. 2011. URL: www.dh.gov.uk/ (accessed 
May 2012).
177. Office of National Statistics. Death Registrations by Single Year of Age, United Kingdom 2010. 
2011. URL: www.ons.gov.uk (accessed May 2012).
178. Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY, et al. Determinants of long-term 
survival after intensive care. Crit Care Med 2012;36:1523–30.
179. GRADE Working Group. Grading quality of evidence and strength of recommendations. 
BMJ 2004;328:1490.
180. Cook DA. Randomized controlled trials and meta-analysis in medical education: what role do they 
play? Med Teach 2012;34:468–73. http://dx.doi.org/10.3109/0142159X.2012.671978
181. Scales DC, Dainty K, Hales B, Pinto R, Fowler RA, Adhikari NK, et al. A multifaceted intervention 
for quality improvement in a network of intensive care units: a cluster randomized trial. 
JAMA 2011;305:363–72. http://dx.doi.org/10.1001/jama.2010.2000
182. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. 
Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and 
elaboration. PLOS Med 2012;4:e297.
183. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating 
complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.  
http://dx.doi.org/10.1136/bmj.a1655
184. Cohen DJ, Crabtree BF, Etz RS, Balasubramanian BA, Donahue KE, Leviton LC, et al. Fidelity versus 
flexibility. Translating evidence-based research into practice. Am J Prev Med 2008;35:S381–9.
185. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of 
infection surveillance and control programs in preventing nosocomial infections in US hospitals. 
Am J Epidemiol 1985;121:182–205.
186. National Nosocomial Infections Surveillance (NNIS). System Report, Data Summary from October 
1986–April 1998, Issued June 1998. Am J Infect Control 1998;26:522–33.
187. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated 
infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 
2008;36:309–32. http://dx.doi.org/10.1016/j.ajic.2008.03.002
188. McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there 
yet? Crit Care Med 2012;40:388–93. http://dx.doi.org/10.1097/CCM.0b013e318232e4f3
189. Render ML, Hasselbeck R, Freyberg RW, Hofer TP, Sales AE, Almenoff PL, et al. Reduction of central 
line infections in Veterans Administration intensive care units: an observational cohort using a 
central infrastructure to support learning and improvement. BMJ Qual Saf 2011;20:725–32.  
http://dx.doi.org/10.1136/bmjqs.2010.048462
190. Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use 
of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 
2011;39:640–6. http://dx.doi.org/10.1016/j.ajic.2010.11.005
191. Seddon ME, Hocking CJ, Mead P, Simpson C. Aiming for zero: decreasing central line associated 
bacteraemia in the intensive care unit. NZ Med J 2011;124:9–21.
192. Wunsch H, Angus DC, Harrison DA, Collange O, Fowler R, Hoste EA, et al. Variation in critical  
care services across North America and Western Europe. Crit Care Med 2008;36:2787–93.  
http://dx.doi.org/10.1097/CCM.0b013e318186aec8
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
107
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
193. Adhikari NKJ, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden  
of critical illness in adults. Lancet 2010;376:1339–46. http://dx.doi.org/10.1016/S0140- 
6736(10)60446-1
194. Drennan K, Hicks P, Hart GK. Intensive Care Resources and Activity: Australia and New Zealand 
2007/2008. 2010. Victoria, Australia: Australian and New Zealand Intensive Care Society (ANZICS); 
2010. pp. 1–166.
195. Drennan K, Hicks P, Hart GK. Intensive Care Safety and Quality Survey: Australia and New Zealand 
2007/2008. Victoria, Australia: Australian and New Zealand Intensive Care Society (ANZICS); 2010. 
pp. 1–50.
196. O’Grady, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the 
prevention of intravascular catheter-related infections. Morb Mortal Wkly Rep 2002;51(RR 10):1–26.
197. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital infection 
control practices advisory committee. Infect Control Hosp Epidemiol 1996;17:438–73 http://dx.doi.
org/10.1086/647338
198. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) 
Manual. Patient Safety Component Protocol. Atlanta, GA; CDC; 2008.
199. Centers for Disease Control and Prevention. CDC definitions for nosocomial infections. Am J Infect 
Control 1989;17:42–3.
200. Render M, Nicholson M. Collaborative cuts ICU infection rate in half. Hosp Peer Rev 2006;31:33–4.
201. Elder NC, Brungs SM, Nagy M, Kudel I, Render ML. Intensive care unit nurses’ perceptions of safety 
after a highly specific safety intervention. Qual Saf Health Care 2008;17:25–30. http://dx.doi.
org/10.1136/qshc.2006.021949
202. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 
1992;15:197–208. http://dx.doi.org/10.1093/clinids/15.2.197
203. Talbot TR, Tejedor SC, Greevy RA, Burgess H, Williams MV, Deshpande JK, et al. Survey of 
infection control programs in a large national healthcare system. Infect Control Hosp Epidemiol 
2007;28:1401–3. http://dx.doi.org/10.1086/523867
204. Berg DE, Hershow RC, Ramirez CA, Weinstein RA. Control of nosocomial infections in an 
intensive care unit in Guatemala City. Clin Infect Dis 1995;21:588–93. http://dx.doi.org/10.1093/
clinids/21.3.588
205. Bezzio S, Scolfaro C, Broglia R, Calabrese R, Mignone F, Abruzzese PA, et al. prospective incidence 
study of bloodstream infection in infants and children with central venous catheters after cardiac 
surgery in Italy. Infect Control Hosp Epidemiol 2009;30:698–701. http://dx.doi.org/10.1086/598242
206. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection 
in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999;20:618–20. http://dx.doi.
org/10.1086/501682
207. Chien LY, MacNab Y, Aziz K, Newman C, McMillan DD, Lee SK, et al. Central venous catheter 
related nosocomial bloodstream infections in the neonatal intensive care unit. Pediatr Res 
2001;49:A234.
208. Clancy CM. Reducing central line-related blood stream infections. AORN Journal 2009;89:1123–5. 
http://dx.doi.org/10.1016/j.aorn.2009.05.009
209. Collignon PJ, Sorrell TC, Uther JB. Prevention of sepsis associated with the insertion of intravenous 
cannulae. The experience in a coronary care unit. Med J Aus 1985;142:346–8.
210. Cooley K, Grady S. Minimizing catheter-related bloodstream infections: one unit’s approach. 
Adv Neonatal Care 2009;9:209–26.
rEfErENCES
108
NIHR Journals Library www.journalslibrary.nihr.ac.uk
211. DuBose J, Teixeira PGR, Inaba K, Lam L, Talving P, Putty B, et al. Measurable outcomes of quality 
improvement using a daily quality rounds checklist: One-year analysis in a trauma intensive care 
unit with sustained ventilator-associated pneumonia reduction. J Trauma – Injury Infect Crit Care 
2010;69:855–60. http://dx.doi.org/10.1097/TA.0b013e3181c4526f
212. Eggimann P, Pittet D. Education as the primary tool for prevention. In O’Grady NP, Pittet D, editors. 
Catheter-Related Infections in the Critically Ill. Dordrecht: Kluwer Academic Publishers; 2004. 
pp. 127–37.
213. Gnass SA, Barbosa L, Bilicich D, Angeloro P, Treiyer W, Grenovero S, Basualdo J. Prevention of 
central venous catheter-related bloodstream infections using non-technologic strategies. Infect 
Control Hosp Epidemiol 2004;25:657–77.
214. Goeschel CA, Holzmueller CG, Cosgrove SE, Ristaino P, Pronovost PJ. Infection prevention checklist 
to improve culture and reduce central line-associated bloodstream infections. Joint Commission J 
Qual Patient Saf 2010;36:571–5.
215. Goeschel CA. Nursing leadership at the crossroads: evidence-based practice ‘Matching Michigan-
minimizing catheter related blood stream infections’. Nurs Crit Care 2011;16:36–43. http://dx.doi.
org/10.1111/j.1478-5153.2010.00400.x
216. Gurskis V, Asembergiene J, Kevalas R, Miciuleviciene J, Pavilonis A, Valinteliene R, et al. Reduction of 
nosocomial infections and mortality attributable to nosocomial infections in pediatric intensive care 
units in Lithuania. Medicina-Lithuania 2009;45:203–13.
217. Harnage SA. Frontline fame: A peripherally inserted central line catheter (PICC) team ends CRBSIs. 
RN 2008;71:34–6.
218. Jeffries HE, Mason W, Brewer M, Oakes KL, Munoz EI, Gornick W, et al. Prevention of central 
venous catheter-associated bloodstream infections in pediatric intensive care units: a performance 
improvement collaborative. Infect Control Hosp Epidemiol 2009;30:645–51. http://dx.doi.
org/10.1086/598341
219. Joshi M, Kazandjian V, Martin P, Minogue W, Christian D, Silverman N, et al. A comprehensive 
grassroots model for statewide safety improvement. Jt Comm J Qual Patient Saf 2005;31:671–7.
220. Kilbride HW, Powers R, Wirtschafter DD, Sheehan MB, Charsha DS, LaCorte M, et al. Evaluation 
and development of potentially better practices to prevent neonatal nosocomial bacteremia. 
Pediatrics 2003;111:e504–18.
221. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB. Implementation of evidence-based 
potentially better practices to decrease nosocomial infections. Pediatrics 2003;111:e519–33.
222. Lindsey H, Chu J, Price C. Informing practice: An intervention reduces catheter-related bloodstream 
infections. Am J Nurs 2007;107:72CC.
223. Meier PA, Fredrickson M, Catney M, Nettleman MD. Impact of a dedicated intravenous therapy 
team on nosocomial bloodstream infection rates. Am J Infect Control 1998;26:388–92.  
http://dx.doi.org/10.1016/S0196-6553(98)70033-1
224. Moureau N. Legally speaking – the impact of competency, training, and quality assessment. JAVA: 
J Assoc Vasc Access 2005;10:106–7. http://dx.doi.org/10.2309/java.10-3-4
225. Moureau NL. Reducing the cost of catheter-related bloodstream infections. Nursing 2009;39:14–15. 
http://dx.doi.org/10.1097/01.NURSE.0000357259.58840.eb
226. Nelson SL, Schouten JM, Valentine LO, Hicks GM. Reducing vascular access complications: 
An evidence-based approach. J Vasc Access 2005;6:167–70.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
109
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
227. Northway T, Mawdsley C. The Canadian ICU Collaborative: on being a nurse champion. Influencing 
support and change. Dynamics (Pembroke, Ont.) 2007;18:25–7.
228. O’Grady NP. Novel strategies of preventing catheter-related infections in the ICU. In O’Grady NP, 
Pittet D, editors. Catheter-Related Infections in the Critically Ill. New York, NY: Springer Verlag; 
2004. pp. 159–72.
229. Papadimos TJ, Hensely SJ, Duggan JM, Hofmann JP, Khuder SA, Borst MJ, et al. Intensivist 
supervision of resident-placed central venous catheters decreases the incidence of catheter-
related blood stream infections. Patient Saf Surg [Electronic Resource] 2008;2:11. http://dx.doi.
org/10.1186/1754-9493-2-11
230. Plouffe JA. Spacelabs Innovative Project Award winner-–2007. Solar system of safety. Dynamics 
(Pembroke, Ont.) 2010;21:20–1.
231. Pronovost P, Goeschel C. Improving ICU care: it takes a team. Healthc Exec 2005;20:14–20.
232. Rizzo M. Striving to eliminate catheter-related bloodstream infections: A literature review of 
evidence-based strategies. Semin Anesth Periop Med Pain 2005;24:214–25. http://dx.doi.
org/10.1053/j.sane.2005.10.001
233. Rodriguez-Paz JM, Pronovost P. Prevention of catheter-related bloodstream infections. Adv Surg 
2008;42:229–48. http://dx.doi.org/10.1016/j.yasu.2008.03.012
234. Rosenthal VD. Device-associated nosocomial infections in limited-resources countries: findings 
of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control 
2008;36:S171.e7–12. http://dx.doi.org/10.1016/j.ajic.2008.10.009
235. Rosenthal VD, Maki DG, Rodrigues C, Varez-Moreno C, Leblebicioglu H, Sobreyra-Oropeza M, et al. 
Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central  
line-associated bloodstream infection rates in the intensive care units of 15 developing countries. 
Infect Control Hosp Epidemiol 2010;31:1264–72. http://dx.doi.org/10.1086/657140
236. Schelonka RL, Scruggs S, Nichols K, Dimmitt RA, Carlo WA. Sustained reductions in neonatal 
nosocomial infection rates following a comprehensive infection control intervention. J Perinatol 
2006;26:176–9. http://dx.doi.org/10.1038/sj.jp.7211411
237. Schuerer DJE, Zack JE, Thomas J, Borecki IB, Sona CS, Schallom ME, et al. Effect of chlorhexidine/
silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low 
blood stream infection rate after implementation of an educational program: A before–after trial. 
Surg Infect 2007;8:445–54. http://dx.doi.org/10.1089/sur.2006.073
238. Schulman J, Stricof RL, Stevens TP, Holzman IR, Shields EP, Angert RM, et al. Development of a 
statewide collaborative to decrease NICU central line-associated bloodstream infections. J Perinatol 
2009;29:591–9. http://dx.doi.org/10.1038/jp.2009.18
239. Seguin P, Laviolle B, Isslame S, Coue A, Malledant Y. Effectiveness of simple daily sensitization of 
physicians to the duration of central venous and urinary tract catheterization. Intensive Care Med 
2010;36:1202–6. http://dx.doi.org/10.1007/s00134-010-1829-1
240. Sherertz RJ. Education as an intervention for reducing vascular catheter infections. In O’Grady NP, 
Pittet D, editors. Catheter-Related Infections in the Critically Ill. New York, NY: Springer Verlag; 
2004. pp. 139–45.
241. Sherman RA, Flynn NM, Bradford M, Ryder MA, Cohen SH. Multilumen catheter sepsis and 
an educational program to combat it. Am J Infect Control 1988;16:31A–34A. http://dx.doi.
org/10.1016/0196-6553(88)90037-5
242. Smith A. The effect of a nursing staff education program on compliance with central line care policy 
in the cardiac intensive care unit. Pediatr Nurs 2006;32:95.
rEfErENCES
110
NIHR Journals Library www.journalslibrary.nihr.ac.uk
243. Smith M. A care bundle for management of central venous catheters. Paediatr Nurs 2007;19:39–44. 
http://dx.doi.org/10.7748/paed2007.05.19.4.39.c7792
244. Stewart DB. Eradicating catheter-associated bloodstream: infections in the PICU. Crit Care Nurse 
2008;28:71–2.
245. Tsuchida T, Makimoto K, Toki M, Sakai K, Onaka E, Otani Y. The effectiveness of a nurse-initiated 
intervention to reduce catheter-associated bloodstream infections in an urban acute hospital: 
An intervention study with before and after comparison. Int J Nurs Stud 2007;44:1324–33.  
http://dx.doi.org/10.1016/j.ijnurstu.2006.07.008
246. Vandijck DM, Labeau SO, Brusselaers N, De Wandel D, Vogelaers DP, Blot SI. Impact of a prevention 
strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream 
infections. Crit Care Med 2009;37:2998–9. http://dx.doi.org/10.1097/CCM.0b013e3181b77da9
247. Verdier R, Parer S, Jean-Pierre H, Dujols P, Picot M-C. Impact of an infection control program 
in an intensive care unit in France. Infect Control Hosp Epidemiol 2006;27:60–6. http://dx.doi.
org/10.1086/499150
248. Warye K, Granato J. Target: zero hospital-acquired infections. Healthc Financ Manage 
2009;63:86–91.
249. Watson SR, George C, Martin M, Bogan B, Goeschel C, Pronovost PJ. Preventing central  
line-associated bloodstream infections and improving safety culture: a statewide experience. 
Jt Comm J Qual Patient Saf 2009;35:593–7.
250. Weber DJ, Brown VM, Sickbert-Bennett EE, Rutala WA. Sustained and prolonged reduction in 
central line-associated bloodstream infections as a result of multiple interventions. Infect Control 
Hosp Epidemiol 2010;31:875–7. http://dx.doi.org/10.1086/655438
251. Yilmaz G, Caylan R, Aydin K, Topbas M, Koksal I. Effect of education on the rate of and the 
understanding of risk factors for intravascular catheter-related infections. Infect Control Hosp 
Epidemiol 2007;28:689–94. http://dx.doi.org/10.1086/517976
252. Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to prevent central venous 
catheter-associated bloodstream infections: A systems-based intervention. Am J Infect Control 
2006;34:503–6. http://dx.doi.org/10.1016/j.ajic.2006.03.011
253. Zack JE. Designing a getting-to-zero programme that works for you: a focus on process 
improvement. Infection Control Today October 15 2009.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
111
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Appendix 1 Protocol for Technology Assessment 
Report 9/01/25
COMMISSIONED BY THE NIHR HTA PROGRAMME MARCH 2011
1. Title of the project
A systematic review and economic evaluation of the effectiveness and generality of educational 
interventions for preventing CRBSIs in critical care
2. Protocol version: 2
This version of the protocol was amended on 14th April 2011. The inclusion criteria for participants in 
Table 1 were slightly modified and the updated criteria were applied to all titles and abstracts.
3. Plain English summary
Catheters are very important for the treatment of patients in critical care but provide a route of entry 
for bacteria and other micro-organisms into the bloodstream, and are frequently associated with serious 
infections. These infections increase patients’ discomfort, length of stay in hospital, the cost of their 
treatment and risk of death.
Education is important for ensuring that hospital staff understand how to maintain hygiene and follow 
practices that reduce the risk of infections. Education may be part of a ‘care bundle’, alongside other 
activities designed to reduce infections. Types of education are very diverse, ranging from simple leaflets 
or posters to seminars and group discussions and complex strategies designed to encourage staff to 
follow more hygienic procedures. Although some of these education strategies can prevent infections 
and potentially save lives, the effectiveness of most has not been evaluated in detail, especially whether 
infection prevention can be maintained in the longer term, and whether education carried out in one 
critical care setting is applicable to other settings.
This project (an evidence synthesis) will rigorously and systematically assess the evidence to determine 
which types of educational intervention can help prevent infections in critical care patients who have 
a vascular catheter, whether they can maintain long-term prevention of infections, and whether they 
are cost-effective. To address the difficulty of evaluating complex educational strategies, the project will 
employ an evidence mapping technique that can help to visualise the different parts of complex strategies 
and enable them to be assessed and compared. A decrease in the frequency of CRBSIs will be the key 
measure of the effectiveness of education. Where available, information will also be collected on the 
extent to which education strategies are followed and implemented by nurses and doctors.
This project will help the NHS to implement educational procedures for reducing infections that are the 
most effective and the best value for money. The project is particularly relevant to a strategy that was 
implemented during 2009–2011 in critical care units in some NHS trusts in England. The strategy, known 
as ‘Matching Michigan’, was originally developed in the USA and has not previously been evaluated to 
see if it has similar findings in the UK. The project will link to the Matching Michigan team in England to 
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ensure that the assessment of cost-effectiveness is directly relevant to NHS trusts in England. The findings 
of this project could assist future planning of infection prevention strategies related to Matching Michigan.
4. Decision problem
The aim of this health technology assessment project is to assess the clinical effectiveness and  
cost-effectiveness of different educational schemes for preventing catheter-related bloodstream 
infections (CRBSI) in patients in critical care. Initial scoping searches for this project suggest that research 
on educational interventions for preventing CRBSI appears to be mostly from studies that may not 
have optimal study designs and may not be representative of critical care settings and practices in the 
UK. Uncertainty remains about the extent of the evidence and effectiveness of interventions. There is 
therefore a need to systematically synthesise all relevant evidence about these educational interventions 
to clarify their effectiveness, strengths and limitations, and their relevance to the NHS. Results of this 
evidence synthesis will help to inform future research and policy for implementing educational infection 
prevention schemes.
5. Background
5.1 Catheter-related bloodstream infections (CRBSI) in critical care
Intravascular catheter placement is an important cause of bloodstream infections (BSI)1,2, and is the 
commonest source of hospital-acquired bacteraemia in hospitals in England3. CRBSIs (CRBSI) are a 
particular problem in critical care due to the high frequency of intravascular catheter placement and 
increased susceptibility to infections among critical care patients. CRBSI are associated with morbidity and, 
especially in paediatric critical care, also mortality4. Estimates of the additional length of stay per CRBSI 
episode in UK critical care units have ranged from 1.9 days5 to 11 days6. Owing to a lag in the publication 
of infection rates, there is uncertainty as to whether these published data are representative of current 
rates of CRBSI in UK critical care units.1
(1 Recent unpublished data from UK critical care units suggest that CRBSI rates may in some cases be much 
lower than those reported in the published literature (Dr D. Wyncoll, personal communication). In the 
current project, as indicated in section 8.2, the most relevant data to UK critical care units will be used to 
evaluate cost-effectiveness of educational interventions.)
CRBSI result from inadequate hygiene and suboptimal catheter management procedures. These include 
among others inadequate hand hygiene of hospital staff, inadequate skin hygiene at the site of patients’ 
catheter insertion, suboptimal location of catheters, and unnecessary placement of catheters. CRBSI are 
believed to be largely preventable following work in the UK that has successfully reduced the number of 
cases of MRSA BSI. It has been proposed that the majority of CRBSI could be prevented using  
evidence-based educational interventions to ensure that doctors and nurses are committed to a culture of 
safety and follow best practice to achieve this7,8.
5.1.1 Definitions of CRBSI
Various definitions and terms are used, and sometimes confused, in the literature to describe a 
bloodstream infection that has developed as a consequence of an indwelling intravascular catheter. To 
define CRBSI (sometimes also referred to as CRBI), both a percutaneously drawn blood culture, and a 
catheter tip culture (or blood drawn through the catheter itself) should quantitatively or semiquantitatively 
confirm the same organism up to 48 hours after removal of the catheter, together with clinical 
manifestations of systemic infection (e.g., fever, chills, hypotension)9,10.
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Catheter-associated BSI (CABSI), sometimes also referred to as CABI or central line associated bacteraemia 
(CLAB), are defined as all BSI in patients with central venous catheters (CVC) after excluding other sites 
of infection by medical review9,10. CLAB means a bloodstream infection with no other apparent focus of 
infection where a central line (i.e. CVC) has been in situ within 48 hours of the event.
According to these strict definitions, CABSI overestimates the true incidence of CRBSI. However, these 
definitions are not always rigidly adhered to.
These various definitions make direct comparison of rates of infection difficult and at times misleading, 
and care will be taken when reviewing studies that report rates of infection based upon the different 
definitions. The Matching Michigan project provides clear quantitative criteria for defining CABSI, CRBSI, 
and catheter-suspected BSI; these may assist classification of infections in the current work.
5.1.2 Diagnosis of CRBSI
Diagnosis of CRBSI is made in various ways, depending upon both local clinical practice and, for infection 
surveillance purposes, the definition of infection in use. Diagnostic criteria for surveillance purposes are 
rigorously applied and take account of multiple factors including:
 z The number of blood culture specimens performed, and whether these cultures are  
percutaneously-drawn, or drawn via the CVC
 z Whether the CVC has been removed, and if so whether culture of the line tip demonstrates significant 
quantities of the same micro-organism as is detected in percutaneously drawn blood
 z Identification of a known pathogen in a single blood culture, or a common skin organism identified in 
two or more sets of blood cultures
Presentation of identified signs of systemic infection in a patient, linked to one or more positive 
blood cultures.
Use of different definitions of infections can dramatically alter the reported infection rate unless they 
are aligned with clinical practice. For example, if clinical practice is not to send a CVC line tip to the 
laboratory for culture, or to draw only a single set of percutaneous cultures, then any definition requiring 
catheter-tip culture or more than one set of cultures will never be met, potentially giving an artificially low 
infection rate. However, provided that an infection definition is applied consistently over time, then the 
impact of interventions aimed at improving practice and reducing infection rates should still be reliably 
demonstrated. Care will be taken when reviewing studies to ensure that infection definitions have been 
applied consistently.
5.1.3 Impact of CRBSI on patients and health services
CRBSI increases patients’ discomfort and length of stay in hospital6 and their risk of health complications 
and death4. Complications include acute respiratory distress syndrome, disseminated intravascular 
coagulation, acute renal failure, and shock7. However, data on mortality, quality of life and long-term 
prognosis specifically related to CRBSI are not available for the UK. Recent estimates of the mortality rates 
of patients with CRBSI in critical care units in France, Germany and Italy ranged from 11% to 17.1%5. 
The most recent (2009) estimate of the financial impact for the NHS suggests that annual costs related to 
CRBSI in intensive care units are £19.1 to £36.2 million5.
5.2 Educational interventions for preventing CRBSI
5.2.1 Definition of educational interventions
In general, educational interventions involve the communication of information to a specific target group 
for one or more of the following purposes: to raise awareness; to enhance or improve knowledge; or 
to change behaviour11. Educational interventions for preventing CRBSI ideally should include behaviour 
modification components underpinned by relevant theory12. For the purposes of this project our working 
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definition of an educational intervention is any intervention that aims to prevent CRBSI and: (a) includes 
at least an element of factual information provision related to that aim; (b) is described by the authors 
as educational; or (c) is described by the authors as behavioural. Project scoping searches indicated that 
behaviour-modifying interventions to prevent CRBSI are often called ‘educational’ rather than ’behavioural’ 
interventions, and behaviour modification components of interventions are not always mentioned in the 
titles and abstracts of studies. We define educational interventions broadly in this project to ensure that 
relevant behavioural interventions are not missed at the study selection step.
5.2.2 Types of intervention
Educational interventions for preventing CRBSI have been trialled in critical care settings in many countries 
and vary considerably in their content and complexity. They range from the provision of simple fact sheets 
and posters13 to complex interventions comprising multiple behavioural components14. Interventions 
differ in the number and duration of education components, whether they are didactic or interactive, 
and whether surveillance and performance feedback are also present. Interventions that contain several 
different elements which together aim to achieve a particular outcome are referred to as ‘multi-faceted’, 
‘multi-component’, or ‘bundled’ interventions15. Multi-faceted educational interventions that have been 
developed for preventing CRBSI include the Michigan project in the USA16 and the NHS Central Venous 
Catheter Care Bundle17. These include, among others, specific components for ensuring staff hand 
hygiene, patient skin hygiene, appropriate choice of catheter type and insertion site, and appropriate 
ongoing catheter care.
5.2.3 Current usage in the NHS
To address the prevention of CRBSI, the NHS has recently developed ‘Saving Lives’ tools18 which include 
the ‘High-Impact’ care bundles for central venous catheters and peripheral intravenous cannula17. These 
bundles are based on ‘EPIC-2’ guidelines19, which stress the importance of education of hospital staff for 
successful implementation of infection control programmes. However, in the EPIC-2 guidelines there is a 
lack of evidence on the types of educational interventions that are most appropriate and effective, and 
the guidelines do not make any recommendations that specifically relate to critical care settings. EPIC-2 
guidelines are also inconsistent with US guidelines9 in interpreting the quality of evidence. Following 
a recommendation in the Darzi Report20, during 2009–2011 the UK National Patient Safety Agency 
implemented an initiative known as ‘Matching Michigan’8,21 to reduce CRBSI, based on a care bundle that 
has successfully reduced CRBSI in over 100 intensive care units (ICU) in the Michigan study in the USA16. 
However, the original study in the USA was not randomised and did not assess the importance of the 
education strategy in the effectiveness of the overall care bundle16. Guidance is needed from the wider 
literature on how to implement educational strategies to optimise the clinical effectiveness and  
cost-effectiveness of this and other related bundled interventions, but the evidence to support such 
guidance has not been critically synthesised.
6. Planned investigation
6.1 Existing research
6.1.1 Clinical effectiveness of educational interventions
Studies have suggested that the introduction of interventions involving staff education alone or in 
combination with performance feedback can reduce the frequency of CRBSI in ICU by 40% to 89%16,22–29. 
Various multi-faceted interventions involving staff education alongside other strategies have also been 
shown to reduce the frequency of CRBSI in ICU30–32. However, most of the evidence has not been critically 
appraised and appears to be mainly from non-randomised studies of relatively short duration. These may 
give an over optimistic picture of infection control, as they do not consider longer-term attenuation of the 
effectiveness of interventions. Some multi-component bundled interventions involving staff education in 
critical care may provide sustained (3-year) reductions in infections33, whereas other bundled interventions 
appear to have had no effect34. Although prevention of infections in some critical care units may be 
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enhanced using staff interventions with education reinforcement, surveillance, performance feedback 
and process control23, the cost-effectiveness and wider generalisability of these is unclear. Strategies that 
combine both education and behaviour change stimuli would be expected to have greater impact, by 
providing a paradigm in which education includes components to target change in the knowledge, beliefs 
and skills which influence practice35,36. However, health agencies also have to consider how to avoid 
overwhelming staff with new initiatives and deal with competing demands for safer care with higher 
throughput9, particularly as increased staff workload negatively affects the care of critically ill patients37. 
The most complex interventions might not therefore necessarily be the most clinically and cost-effective38.
6.1.2 Cost-effectiveness of educational interventions
Based on the estimated annual costs of CRBSI to the NHS above5, the potential cost reduction to the 
NHS that could be made by preventing CRBSI would clearly be substantial. The costs of implementing 
educational interventions to achieve this however are rather unclear. The Michigan intervention16 could 
prevent up to 15 deaths and save around $2 million annually in one intensive care unit (ICU) based on 
rates of CRBSI in the USA39 (which might not be representative of current rates of CRBSI in the UK –  
section 6.1), but there are many uncertainties about how to transfer this type of intervention to UK 
practice. For example, it is unclear whether interventions tested in ICU in specific localities are generalisable 
to different geographic regions and healthcare systems, and whether education reinforcement works in 
situations of high staff turnover and staff shortage as often occur in the UK. The purported simplicity and 
cost of some interventions is also questionable, for example the Michigan intervention was described as 
simple and inexpensive but appears to require the delivery of at least 16 lectures by trained staff39, the 
overall cost of which has not been explored.
6.1.3 Evidence scoping
Scoping searches for this proposal (which are likely to underestimate the true extent of the evidence) 
identified more than 20 prospective cohort studies of potentially relevant educational interventions 
(some of which are cited above) but no randomised controlled trials (RCTs). Eight potentially relevant 
narrative reviews were identified in scoping, but no systematic reviews have directly assessed the clinical 
effectiveness of educational strategies for preventing CRBSI in critical care. The most relevant systematic 
reviews in related areas have investigated: the effectiveness of bundled behavioural interventions to control 
healthcare associated infections (not limited to education, CRBSI or critical care)14; the effectiveness of 
interventions for preventing CRBSI in critical care (not limited to education or behavioural interventions)40; 
and educational interventions for preventing healthcare associated infections (not limited to educational or 
behavioural interventions, CRBSI, or critical care)41.
None of these systematic reviews included economic analyses. Most of the available information on the 
economic impact of CRBSI in critical care is from work conducted in the USA22,42. A recent brief narrative 
review of epidemiological studies, referred to above5, provides an insight into the economic burden of 
CRBSI in critical care in European countries including the UK but, due to a shortage of information on 
costs, its findings are based on numerous assumptions and uncertainties.
The scoping search highlights the need for an evidence synthesis assessing both the clinical and  
cost-effectiveness of educational interventions for preventing CRBSI in critical care, to assist decision 
making in the NHS.
6.2 Research objectives
The aim of this project is to conduct an evidence synthesis of the clinical and cost-effectiveness of 
educational interventions aimed at hospital staff in critical care (doctors and nurses) for preventing CRBSI. 
An economic model will be devised by adapting an existing cost-effectiveness model or constructing a 
new one using the best available evidence to determine cost-effectiveness in a UK critical care setting. 
The project aims also to provide recommendations that will be sufficiently specific to be of use to those 
implementing infection-prevention strategies in the NHS and for further research.
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The main objectives will be as follows:
1. To systematically review: (a) the clinical effectiveness; and (b) the cost-effectiveness of educational 
interventions for the prevention of CRBSI.
2. To use an evidence mapping approach to describe the scope of the clinical effectiveness evidence 
base in terms of the different types of educational interventions, critical care settings, study 
designs and their theoretical basis, types and duration of education reinforcement, and outcomes 
reported including evidence of sustainability of effect. The evidence map would: (a) provide an 
overview, classification and characterisation of relevant educational interventions to enable complex 
interventions to be visualised and, where appropriate, compared; (b) provide a classification and report 
of other key study attributes, for example illustrating how CRBSI and CABSI are defined and applied in 
the studies; and (c) use recognised criteria to screen studies in terms of their relevance to the NHS.
3. To apply the evidence mapping exercise results to prioritise a subset of studies of highest relevance for 
detailed appraisal in the systematic review of clinical effectiveness.
4. To develop a decision-analytic model to determine and compare cost-effectiveness of relevant groups 
of interventions and settings identified through evidence mapping, either by adapting an existing 
economic model or constructing a model for the UK de novo.
5. To identify future research needs and make specific recommendations about the implementation of 
educational interventions for preventing CRBSI that are relevant to service users in the NHS.
7. Research methods
The project will involve a systematic review of the clinical effectiveness (section 8.1) and a systematic 
review and economic evaluation of the cost-effectiveness (section 8.2) of educational interventions for 
preventing CRBSI in critical care (Figure 1). The purpose of the cost-effectiveness systematic review will 
be twofold: to assess whether an appropriate economic evaluation has been undertaken and, if not, to 
provide evidence to develop and populate a de novo economic evaluation.
7.1 Systematic review of clinical effectiveness
7.1.1 Literature search
Literature will be identified from several sources including:
1. General health and biomedical databases including BIOSIS, the British Nursing Index, CINAHL, 
EMBASE, MEDLINE, the Science Citation Index, and the Social Sciences Citation Index (also others if 
considered relevant);
2. Specialist electronic databases (e.g. The Cochrane Library; Database of Abstracts and Reviews 
of Effectiveness);
3. Unpublished literature and conference proceedings;
4. Contact with individuals with expertise in the field;
5. Checking of reference lists;
6. Research in progress databases (e.g. the UK Clinical Research Network website, Current Controlled 
Trials, and Clinical trials.gov);
7. Relevant websites identified by the project team and Advisory Group.
All databases will be searched from their inception to the current date. Hand searching will focus on 
key journals and meeting abstracts published in the past two years, with the key journals identified in 
consultation with experts and from analyses of search results. Based on the scoping searches, we do not 
envisage that many non-English-language studies will be found (studies conducted in other countries were 
usually reported in English). We will include relevant non-English language as well as English-language 
studies in the project, irrespective of their geographical location. The search strategy will be developed and 
applied by an experienced information specialist to ensure that as many relevant foreign-language studies 
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as possible are identified. Where required, translation will be done by native speakers of the language 
within the project team’s research institutions. If an excessive number of foreign-language studies requires 
translation, we will contact the HTA programme to advise of the situation, in case provision of additional 
resources is considered appropriate.
A comprehensive database of relevant published and unpublished articles will be constructed using 
Reference Manager bibliographic software.
FIGURE 1 Overview of the project approach.
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7.1.2 Inclusion criteria and search strategy
Inclusion criteria for the systematic review of clinical effectiveness will be based on the PICOD scheme 
(Population, Intervention, Outcome, Comparator, Design) and are shown in Table 1. Inclusion criteria for 
the systematic review of cost-effectiveness are reported below (section 8.2). Note that although the target 
for educational interventions is critical care staff (doctors and nurses), it is the patients that are the relevant 
population for inclusion in evidence synthesis. This is because the relevant primary outcomes (CRBSI) are 
reported for patients.
Care will be taken to ensure that the search strategy can adequately capture educational interventions, 
given that these may be very diverse, inconsistently or poorly reported, or that education may make up a 
relatively small component of multi-faceted interventions. The search strategy will also be developed to 
capture the different possible variants, acronyms, synonyms and definitions of CRBSIs (including CRBSI, 
CABSI), taking into consideration that these might not have been used consistently and correctly in the 
literature. A search strategy for studies of cost-effectiveness will also be developed, following standard 
procedures (section 8.2).
Understanding how and why interventions work is an integral part of the appraisal of complex 
interventions43. Process evaluations and secondary outcomes (e.g. knowledge, behaviour, attitudes or 
compliance of staff) may help to explain intervention mechanisms. Process evaluations and secondary 
outcomes will be included provided that relevant primary (infection) outcomes are also reported (Table 1). 
If reported in sufficient detail, process evaluations will be assessed following a systematic approach, to 
be agreed by the project team (e.g. an approach employed in a recent synthesis of evidence on sexually 
transmitted infections44 may be suitable).
The study designs which will be included are not limited to controlled trials (Table 1). This is because in  
a scoping exercise much of the evidence found was from cohort studies. For the systematic review of  
TABLE 1 Inclusion criteria for the systematic review of clinical effectiveness
Participants (P) Patients in any critical care units who receive vascular catheters of any type whilst in critical care 
(including tunnelled and non-tunnelled catheters, subcutaneous catheter ports, peripherally inserted 
central catheters and cannula) for any medical purposes. 
Intervention (I) Any educational interventions for preventing CRBSI in critical care as defined in section 6.2.1. Studies 
that do not explicitly state an aim to prevent infections, but which report educational interventions that 
could prevent CRBSI in critical care, will be included if they meet the other inclusion criteria and report 
relevant outcomes. 
Comparator (C) Relevant comparators are: usual care (no active intervention) or any educational intervention that differs 
from the primary intervention in one or more educational components. 
Outcomes (O) Primary outcomes will be used for study selection decisions.
Primary outcomes: (1) The frequency of CRBSIs, expressed as infection rates per device-days (usually 
expressed as BSI per 1000 catheter-days), per hospital days, as a proportion of the study population,  
or relative to a comparator. Any related infection definitions will be accepted for inclusion screening  
(e.g. CRBSI, CABSI) as the accuracy and appropriateness of these will be scrutinised at the evidence 
mapping step. (2) Mortality due to CRBSI.
Secondary outcomes: These will be assessed if relevant primary outcomes are reported, and may include: 
knowledge; attitudes; behaviour; and compliance of critical care staff.
Process evaluations: These will be assessed if relevant primary outcomes are reported.
Design (D) Interventional studies only. Randomised controlled trials, non-randomised or quasi-randomised 
controlled clinical trials, prospective cohort studies, retrospective cohort studies, controlled before-and-
after studies, and interrupted time series studies will be included if they evaluate a relevant intervention. 
Case–control studies, case series, cross-sectional studies, and descriptive studies will be excluded. Where 
there is evidence from different types of study design for a specific intervention, only those studies with 
the most rigorous designs will be included and data extracted.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
119
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
cost-effectiveness, studies will only be included if they report the results of full economic evaluations  
[cost-effectiveness, cost–utility, cost–benefit or cost–consequence analyses].
7.1.3 Study selection
Studies will be selected for inclusion through a two-stage process using the pre-defined and explicit 
criteria outlined in Table 1. The full literature search results will be screened by two reviewers to 
identify all citations that may meet the inclusion criteria. Full manuscripts of all selected citations will be 
retrieved and assessed by two reviewers against the inclusion criteria. Studies published as abstracts or 
conference presentations will only be included if sufficient details are presented to allow an appraisal of 
the methodology and the assessment of results to be undertaken. To ensure that studies are screened 
consistently, an inclusion decision checklist will be developed and used for each manuscript assessed. 
Any disagreements over study inclusion will be resolved by consensus or if necessary by arbitration by a 
third reviewer.
7.1.4 Evidence mapping
All studies that meet the inclusion criteria will be entered into a mapping exercise in order to clarify the 
structure of educational interventions and identify those that are potentially of most relevance to the NHS.
The mapping exercise is summarised in Figure 2 and will follow principles developed by the Global 
Evidence Mapping Initiative45 to classify and summarise the evidence base as well as guidance from the 
Medical Research Council43 and the National Institute for Health and Clinical Excellence (NICE)46 on the 
reporting and evaluation of complex interventions. The key objectives of this step will be to: (a) provide 
an overview, classification and characterisation of relevant educational interventions to enable complex 
interventions to be visualised and, where appropriate, compared; (b) provide a classification and report of 
other key study attributes, for example illustrating how CRBSI and CABSI are defined and applied in the 
studies, and whether studies included process evaluations, information on potential facilitators or barriers 
to implementation, or other secondary outcomes; and (c) identify studies that are of most relevance to 
the NHS which should be prioritised for full evidence synthesis. The mapping exercise will be conducted as 
follows (Figure 2):
1. With assistance from the Project Advisory Group (section 10), the characteristics of studies to be 
included in the descriptive map will be determined and made into a list;
2. In a pilot exercise involving two researchers, keywords will be developed that reliably and reproducibly 
describe each of the study characteristics in the list;
3. Each included study will be mapped by one researcher and the agreed keywords relevant to describe 
the characteristics of each study will be entered into a Microsoft Excel or Access database such that 
study interventions and keywords can be cross-tabulated;
4. Keyword assignments and database entries for each study will be checked by a second researcher;
5. Entries in the database will be used to concisely summarise the structure and composition of the study 
interventions using numerical, graphical and/or narrative methods where appropriate.
Depending upon the overall quality and quantity of evidence available, the evidence mapping exercise 
could include a preliminary appraisal of methodological quality to help decide which studies are prioritised 
for detailed full evidence synthesis (e.g. based on study design and sample size). A thorough appraisal of 
methodological quality, using risk of bias criteria, will be applied later to those studies that are identified as 
being of most relevance to the NHS and which proceed for full data extraction (section 8.1.5).
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FIGURE 2 Overview of the evidence mapping procedure for studies of clinical effectiveness.
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The project team lists key characteristics of the studies relevant for assessing clinical effectiveness,
based on team specialist expertise in infection prevention (TC), critical care (BC), and healthcare
education (JC). The list is circulated to the Advisory Group for comment and possible refinement.
Example of some of the
key study characteristics
likely to be considered
KEYWORDS that describe relevant aspects of each of the key study characteristics are
developed. These are tested on a subset of studies to ensure reproducibility. Each study is then
screened systematically to determine which of the key characteristics it includes, and the
appropriate keywords are assigned to the study in a database to record this. The database of
keywords enables a matrix of various combinations and groups of study characteristics to be
displayed and analysed.
AN EVIDENCE MAP is presented as an overview of the study characteristics for all studies that
meet the systematic review inclusion criteria. Presentation involves using graphical, tabulated
and narrative summaries, including novel methods if appropriate to summarise complex
information.
FULL EVIDENCE SYNTHESIS  is performed on a set of
studies identified in the evidence map as being those of
highest relevance to UK critical care settings. The criteria for
identifying this set of studies are informed by the evidence
mapping results and developed by the project team in
consultation with the Advisory Group. To avoid selection bias,
decision-making is fully documented in the project report.
Results of evidence mapping
may provide a basis for
focused research
recommendations (e.g.
identification of specific
knowledge gaps or issues of
methodological quality).
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
121
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
7.1.5 Data extraction and quality assessment
The extraction of studies’ findings will be conducted by one reviewer and independently checked by a 
second reviewer using a pre-designed and piloted data extraction form to avoid any errors. The data 
extraction form will be based on the PICOD scheme to clearly record and report all relevant aspects of the 
populations (P), interventions (I), comparators (C) outcomes (O), as well as methodological aspects of the 
study designs (D). Any disagreements between reviewers will be resolved by consensus or if necessary by 
arbitration involving a third reviewer. This process will be applied to those studies identified in the mapping 
exercise (section 8.1.4) as being of highest relevance in the context of current practice in the NHS. The 
methodological quality of these included studies, including their internal and external validity, will be 
appraised using established criteria for studies of clinical effectiveness47 and recognised quality assessment 
approaches for studies of cost-effectiveness and economic models (section 8.2). Missing information will 
be obtained from investigators of the primary studies if possible, so as to maximise the information about 
the educational interventions that can be extracted from each study.
7.1.6 Data synthesis
Studies will be synthesised through a narrative review with tabulation of results of included studies. If 
feasible, the results from individual studies will be synthesised through meta-analysis using established 
methods47, with causes of heterogeneity of results examined.
7.2 Economic evaluation
The cost-effectiveness of educational interventions in preventing CRBSI in critical care will be assessed in 
two stages: a systematic review of cost-effectiveness and development of a decision-analytic economic 
model (Figure 1).
7.2.1 Systematic review of cost-effectiveness
Searches of general health and biomedical databases (as listed in section 8.1.1), specialist electronic 
databases (e.g. the NHS Economic Evaluation Database; The Cochrane Library), and unpublished literature 
and conference proceedings will be carried out to identify relevant studies. The systematic review will 
focus on economic evaluations of educational interventions to prevent CRBSI. To inform development of 
our economic evaluation we will also include any studies that report model-based economic evaluations 
of other (non-educational) interventions, if they were published since a 2007 review of the economics of 
preventing CRBSI48. Experts will be contacted to ask if they know of any relevant published or unpublished 
studies that we have not identified. Studies will be included in the systematic review if they are full 
economic evaluations (cost utility or cost-effectiveness studies) that report both measures of costs and 
consequences, and include outcomes expressed as CRBSI cases avoided, or life years or quality-adjusted 
life years gained. The methodological quality of included cost-effectiveness studies will be appraised using 
accepted criteria for appraising economic evaluations49,50. Studies will be synthesised through a narrative 
review that includes: a clear explanation of the assessment process; a detailed critical appraisal of study 
methods; tabulation of the results of the included studies; a summary indicating which data are used in 
the economic model; and an explanation of any knowledge gaps and assumptions.
7.2.2 Decision-analytic model
Evidence from both the systematic review of cost-effectiveness and the systematic review of clinical 
effectiveness (section 8.1) will be used to develop the economic model. Existing economic models 
of interventions to prevent CRBSI identified in the systematic review of economic evaluations will be 
assessed for their relevance and quality. If these are not suitable, a de novo decision-analytic model will be 
developed. Development of model structure will be informed by previously published models (such as that 
developed by one of the applicants51) and validated through discussion with clinical and methodological 
advisors. Accepted guidelines for good practice in decision-analytic modelling52 and the general principles 
outlined in the NICE ‘reference case’53 will be followed. Clinical effectiveness parameters in the model will 
be taken from the systematic review of clinical effectiveness. Additional targeted literature searches will be 
required to populate other parameters in the model, such as the baseline risk of CRBSI. Expert opinion will 
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be used where suitable data to populate the model cannot be identified from the literature. Where expert 
opinion has been used, this will be clearly identified in the report of the model.
The model will provide a cost-consequences analysis, reporting the costs of alternative educational 
interventions (broken down by key components, such as staff training, administration, consumables etc. 
where possible) and their consequences in terms of patient outcomes, principally any effect on the risk of 
CRBSI. The outcome of the model will be presented as the incremental cost per CRBSI avoided. We will 
consider the feasibility of developing also a cost-utility analysis model incorporating final outcomes (life 
expectancy or quality-adjusted life expectancy – i.e. QALYs). This will require estimating excess mortality 
attributable to CRBSI in patients admitted to ICU and the impact of such infections on patients’ quality of 
life. The model will adopt a UK NHS and Personal Social Services perspective.
The resources necessary for providing the educational interventions will be estimated from studies 
included in the systematic review of effectiveness (section 8.1), and from discussion with expert advisors. 
The costing will concentrate on costing studies that were conducted in health systems with similar 
institutional arrangements to the NHS, and those including educational interventions that are similar to 
those being introduced in the NHS (for example, ‘Matching Michigan’). Unit costs will be developed based 
on published evidence, official sources such as NHS Reference Costs54 and Unit Costs of Health and Social 
Care55, and from the Costing Unit at Southampton General Hospital. Costs will be inflated to current prices 
as necessary. If no published data on resource use are available, estimates will be based on information 
from expert advisors.
Uncertainty relating to key parameters will be explored using deterministic and, where appropriate, 
probabilistic sensitivity analyses. If it is feasible to develop a full cost-utility model, probabilistic sensitivity 
analyses will be conducted and the results expressed using cost-effectiveness acceptability curves (CEACs). 
The key variables to be explored will include: effectiveness of educational interventions, baseline risk of 
CRBSI, cost and duration of CRBSI, mortality attributable to CRBSI, and QALYs.
The model will be developed using standard software including Excel and TreeAge Pro to ensure 
transparency and would be flexible in terms of permitting different estimates to be used for key input 
parameters. Any structural assumptions underlying the model would be transparently reported. The model 
could therefore be updated in response to new information about critical care (intensive care) practices. 
We propose to consult the project’s Advisory Group, which will include clinicians working in critical care,  
to identify which of the possible changes in critical care practices are likely to be most relevant.  
This will ensure that appropriate, modifiable, input parameters and structural assumptions are included  
in the model.
8. Project timetable and milestones
The project will take 18 months, commencing 4th January 2011. Twelve milestones and three proposed 
research publications arising from the project are detailed in the full project proposal (see also Fig 1). 
Interim reports will be prepared and submitted at dates to be confirmed by the HTA programme. A final 
project report will be completed and disseminated by 30 June 2012.
9. Advisory Group
Julian Bion – Professor of Critical Care; clinical lead of Matching Michigan project
Andrew Jackson – Consultant Nurse IV Therapy & Care; Infection Prevention Society
Annette Richardson – Nurse Consultant Critical Care; British Association of Critical Care Nurses
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Trudie Roberts – Professor of Medical Education; Association for the Study of Medical Education
Katie Scales – Consultant Nurse Critical care; National Infusion and Vascular Access Society
Barry Williams – Critical Care Patient Liaison Committee (CritPal)
Duncan Wyncoll – Consultant Intensivist; Intensive Care Society
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Appendix 2 Search strategies
Clinical effectiveness search strategy
Database, date 
searched, host, 
years, keywords Search strategy Results
MEDLINE (Ovid)
1948–2010
Searched  
19 January 2011
  1. exp Critical Care/ (36,392)
  2. exp Intensive Care/ or exp Intensive Care Units/ (56,613)
  3. (“acute care” or “critical care” or “critically ill” or “critical illness”).tw. 
(39,816)
  4. (high dependency adj1 (care or unit*1)).tw. (334)
  5. “intensive care”.tw. (64,078)
  6. (intensive adj therapy adj unit*).tw. (470)
  7. (ITU or ICU or CCU or CICU or CITU).tw. (20,600)
  8. (“level 2 care” or “level 3 care”).tw. (10)
  9. Catheterization, Central Venous/ or Catheterization/ or 
Catheterization, Peripheral/ (43,836)
 10. Catheters, Indwelling/ (13,995)
 11. exp catheters/ (14,041)
 12. (catheter* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(24,337)
 13. (tunnel* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(567)
 14. (device* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(4016)
 15. (CVC or PICC or JICC or SICC or SBCC or PVC or IVI).tw. (5474)
 16. (“Porta-cath” or Portacath or Hickman* or Broviac or Venflon or 
Groshong).tw. (1046)
 17. (“implantable port” or “access port”).tw. (421)
 18. cannula*.tw. (28,306)
 19. exp Bacterial Infections/ (621,883)
 20. exp Bacteremia/ (16,592)
 21. septicemia/ (35,825)
 22. Sepsis/ (35,825)
 23. Asepsis/ (1371)
 24. cross infection/ (38,455)
 25. Infectious Disease Transmission, Professional-to-Patient/ (1298)
 26. Communicable Diseases/ (14,197)
 27. exp bacteria/ (898,770)
 28. fungemia/ (2236)
 29. exp Staphylococcal Infections/ (43,061)
 30. Staphylococcus aureus/ (37,167)
 31. Methicillin Resistance/ (8874)
 32. Staphylococcus/ or Staphylococcus epidermidis/ (25,893)
 33. exp Streptococcus/ or exp Streptococcal Infections/ (93,168)
 34. Pseudomonas aeruginosa/ (26761)
2383
Updated  
13 March 2012: 215
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Database, date 
searched, host, 
years, keywords Search strategy Results
MEDLINE 
(continued )
 35. Escherichia coli/ (199,341)
 36. exp Enterobacter/ (5257)
 37. exp Klebsiella/ or exp Klebsiella Infections/ (14,273)
 38. exp Corynebacterium/ or exp Corynebacterium Infections/ (11,752)
 39. exp Acinetobacter/ or exp Acinetobacter Infections/ (4555)
 40. exp Enterococcus/ (12,385)
 41. exp Candida/ (29,862)
 42. exp Blood-Borne Pathogens/ (2208)
 43. exp Enterobacteriaceae Infections/ (69,490)
 44. equipment contamination/ (7863)
 45. colony count microbial/ (24,932)
 46. exp Infection/bl [Blood] (11,976)
 47. bacter?emia.tw. (16,603)
 48. (infection* or acinetobacter* or asepsis or bacter?emia* or bacteria* 
or candida or coloni?ation or contaminat* or cfu or colony or colonies 
or corynebacterium or escherichia or enterococc* or enterobacter* 
or fungi or fungus or fungal or fung?emia or klebsiella or met?icillin 
or microorganism* or micro-organism* or microbial* or microbe* 
or microbiologic* or mycology or mycological or organism* or 
nosocomial* or pathogen* or sepsis or septic or septic?emia 
septicemia or staphylococc* or streptococc*).tw. (1,829,791)
 49. (blood?stream adj infection*).tw. (2725)
 50. (blood-stream adj infection*).tw. (321)
 51. (blood* adj3 infect*).tw. (12,628)
 52. (“healthcare associated” adj infection*).tw. (434)
 53. (HAI or HAIs or “HAI’s” or HCAI or HCAIs or “HCAI’s”).tw. (1965)
 54. (extraluminal adj infection*).tw. (2)
 55. (MRSA or MSSA).tw. (9036)
 56. (blood adj culture*).tw. (13,853)
 57. (positive adj2 culture*).tw. (18,147)
 58. (positive adj isolate*).tw. (1274)
 59. Infection Control/ (15,889)
 60. Catheter Related infections/ (550)
 61. Catheters/mi [Microbiology] (8)
 62. Catheters, Indwelling/mi [Microbiology] (916)
 63. (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or  
“AC-CRI “ or “AC-CRIs”).tw. (3189)
 64. (line adj3 (infection* or sepsis or bacter?emia)).tw. (871)
 65. (catheter* and blood* and infection*).tw. (3333)
 66. (catheter* and (sepsis or bacter?emia*)).tw. (4544)
 67. exp Education, Medical/ (111,037)
 68. exp Education, Nursing/ (63,596)
 69. education continuing/ (6798)
 70. Education, Department Hospital/ (203)
 71. Educational Measurement/ (22,708)
 72. Internal Medicine/ed [Education] (3666)
 73. Nursing Staff, Hospital/ed [Education] (7762)
 74. exp Health Education/ (116,581)
 75. Health Knowledge, Attitudes, Practice/ (51,711)
 76. Inservice training/ or Training Support/ or Instruction/ (19,943)
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Database, date 
searched, host, 
years, keywords Search strategy Results
MEDLINE 
(continued )
 77. Preceptorship/ (3313)
 78. Mentors/ (5422)
 79. Interdisciplinary communication/ (5646)
 80. Teaching Rounds/ or Hospitals, Teaching/ or Teaching Materials/ or 
Teaching/ (56,353)
 81. Personnel, Hospital/ed [Education] (2314)
 82. Emergency Medicine/ed [Education] (2971)
 83. exp Critical Care/ed [Education] (30)
 84. Curriculum/ (49,213)
 85. Program Evaluation/ (36,217)
 86. Program Development/ (17,654)
 87. Infection Control/mt, og, st [Methods, Organization & Administration, 
Standards] (8562)
 88. Equipment Contamination/pc, st [Prevention & Control, Standards] 
(2540)
 89. Safety Management/mt, og, st [Methods, Organization & 
Administration, Standards] (6730)
 90. Intensive Care Units/mt, st [Methods, Standards] (1456)
 91. Point-of-Care Systems/og, st [Organization & Administration, 
Standards] (797)
 92. Clinical Competence/st [Standards] (10,874)
 93. Total Quality Management/mt, og [Methods, Organization & 
Administration] (5517)
 94. (educat* or awareness or bundle* or collaborat* or campaign* or 
communicat*).tw. (520,606)
 95. (feedback or “feed back” or “feeding back” or course* or instruct* 
or inform* or impart* or knowledge or learn* or “e-learn” or 
“e-learning” or lecture*).tw. (1,375,734)
 96. (module* or modular or session* or study or studies or studying or 
studies).tw. (4,597,782)
 97. (“self study” or re-educat* or “self-educat*”).tw. (1322)
 98. (assess* or apprais* or competenc* or competent* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop*).tw. (4,262,387)
 99. (link* adj2 (staff or nurs*)).tw. (395)
100. (preceptor* or mentor*).tw. (7136)
101. (component* or “multi-component” or “multi-faceted” or  
“multi-modal” or initiative* or intervention*).tw. (883,237)
102. (session* or strategy or strategies or initiative or program* or 
package*).tw. (823,678)
103. “blended learning”.tw. (65)
104. “self-learn*”.tw. (372)
105. (shar* adj3 practice*).tw. (685)
106. (risk* adj3 (reduc* or management)).tw. (66,351)
107. (booklet* or workbook* or checklist* or library or libraries or literature 
or questionnaire* or sheet* or pamphlet* or poster* or pictorial* 
or verbal* or video* or audiovisual* or podcast or telemedicine or 
teleconferenc*).tw. (909,308)
108. (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”).tw. (1608)
109. (behavio?r* adj2 chang*).tw. (19,294)
110. (behavio?r adj2 alter*).tw. (3091)
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Database, date 
searched, host, 
years, keywords Search strategy Results
MEDLINE 
(continued )
111. (chang* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw. (747)
112. (alterat* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw. (31)
113. (management adj5 (contaminat* or hygien* or handwash* or hand 
wash* or disinfect* or sterilisation or sterilization)).tw. (787)
114. (precaution* adj5 (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization)).tw. (319)
115. (behavio?r* adj2 management).tw. (2099)
116. (risk* adj (manage* or assess*)).tw. (26,622)
117. governance.tw. (3690)
118. or/1-8 (129,513)
119. or/9-18 (95,966)
120. or/19-59 (2,461,905)
121. or/60-66 (11,112)
122. or/67-117 (8,445,986)
123. 118 and 119 and 120 and 122 (1919)
124. 118 and 121 and 122 (1643)
125. 123 or 124 (2418)
126. (editorial or letter or comment).pt. (1,024,427)
127. 125 not 126 (2383)
128. from 127 keep 1-1000 (1000)
129. from 127 keep 1001-2000 (1000)
130. from 127 keep 2001-2383 (383)
Ovid MEDLINE(R) 
In-Process & Other 
Non-Indexed 
Citations
Searched  
1 February 2011
Adapted from MEDLINE strategy 92
Updated  
13 March 2012: 71
EMBASE (Ovid)
Searched  
25 January 2011
  1. exp intensive care/ (324,789)
  2. exp intensive care unit/ (53,595)
  3. (“acute care” or “critical care” or “critically ill” or “critical illness”).tw. 
(52,785)
  4. (high dependency adj1 (care or unit*1)).tw. (469)
  5. (“intensive care” or “intensive medical care”).tw. (83,359)
  6. (intensive adj therapy adj unit*).tw. (556)
  7. (ITU or ICU or CCU or CICU or CITU or SCBU).tw. (31,316)
  8. (“level 2 care” or “level 3 care”).tw. (24)
  9. or/1-8 (407,797)
 10. exp catheterization/ (100,116)
 11. INTRAVENOUS CATHETER/ or ARTERY CATHETER/ or CATHETER/ 
or INDWELLING CATHETER/ or PERIPHERALLY INSERTED CENTRAL 
VENOUS CATHETER/ or CENTRAL VENOUS CATHETER/ or 
INTRAVASCULAR CATHETER/ (36,464)
 12. (catheter* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(28,927)
 13. (tunnel* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(727)
2944
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Database, date 
searched, host, 
years, keywords Search strategy Results
EMBASE (continued )  14. (device* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw. 
(5087)
 15. (CVC or PICC or JICC or SICC or SBCC or PVC or IVI).tw. (7571)
 16. (“Porta-cath” or Portacath or Hickman* or Broviac or Venflon or 
Groshong).tw. (1244)
 17. (“implantable port” or “access port”).tw. (514)
 18. cannula*.tw. (31,388)
 19. or/10-18 (176,786)
 20. catheter infection/ (6889)
 21. (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or  
“AC-CRI “ or “AC-CRIs”).tw. (4339)
 22. (line adj3 (infection* or sepsis or bacter?emia)).tw. (1112)
 23. (catheter* and blood* and infection*).tw. (4439)
 24. (catheter* and (sepsis or bacter?emia*)).tw. (5609)
 25. “catheter-related bloodstream infection*”.tw. (705)
 26. “catheter-associated bloodstream infection*”.tw. (131)
 27. or/20-26 (17,675)
 28. 9 and 27 (4542)
 29. exp INFECTION/ or GRAM POSITIVE INFECTION/ or STAPHYLOCOCCUS 
INFECTION/ or BACTERIAL INFECTION/ or GROUP A STREPTOCOCCAL 
INFECTION/ or ENTEROCOCCAL INFECTION/ or KLEBSIELLA 
INFECTION/ or HOSPITAL INFECTION/ or STREPTOCOCCUS 
INFECTION/ or GRAM NEGATIVE INFECTION/ or METHICILLIN 
RESISTANT STAPHYLOCOCCUS AUREUS INFECTION/ or GROUP 
B STREPTOCOCCAL INFECTION/ or DEVICE INFECTION/ or 
ENTEROBACTERIACEAE INFECTION/ or BLOODSTREAM INFECTION/ or 
CROSS INFECTION/ (2,002,322)
 30. FUNGAL CONTAMINATION/ or BACTERIUM CONTAMINATION/ or 
VIRAL CONTAMINATION/ or MICROBIAL CONTAMINATION/ (13,226)
 31. bacteremia/ or sepsis/ (86,693)
 32. (infection* or acinetobacter* or asepsis or bacter?emia* or bacteria* 
or candida or coloni?ation or contaminat* or cfu or colony or colonies 
or corynebacterium or escherichia or enterococc* or enterobacter* 
or fungi or fungus or fungal or fung?emia or klebsiella or met?icillin 
or microorganism* or micro-organism* or microbial* or microbe* 
or microbiologic* or mycology or mycological or organism* or 
nosocomial* or pathogen* or sepsis or septic or septic?emia or 
staphylococc* or streptococc*).tw. (2,124,000)
 33. (MRSA or MSSA).tw. (12,771)
 34. or/29-33 (3,293,446)
 35. CLINICAL EDUCATION/ or NURSING EDUCATION/ or CONTINUING 
EDUCATION/ or EDUCATION PROGRAM/ or RESEARCH BASED 
NURSING EDUCATION/ or CONTINUING EDUCATION PROVIDER/ or 
INTERDISCIPLINARY EDUCATION/ or EMERGENCY MEDICAL SERVICES 
EDUCATION/ or MEDICAL EDUCATION/ or HEALTH EDUCATION/ or 
EDUCATION/ or “OUTCOME OF EDUCATION”/ (482,831)
 36. IN SERVICE TRAINING/ or TRAINING/ or STAFF TRAINING/ (67,556)
 37. (educat* or awareness or bundle* or collaborat* or campaign* or 
communicat*).tw. (627,949)
 38. (feedback or “feed back” or “feeding back” or course* or instruct* 
or inform* or impart* or knowledge or learn* or “e-learn” or 
“e-learning” or lecture*).tw. (1,706,178)
 39. (module* or modular or session*).tw. (126,951)
 40. (“self study” or re-educat* or “self-educat*”).tw. (1752)
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EMBASE (continued )  41. (assess* or apprais* or competenc* or competent* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop*).tw. (5,171,099)
 42. (link* adj2 (staff or nurs*)).tw. (427)
 43. (preceptor* or mentor*).tw. (8258)
 44. (component* or “multi-component” or “multi-faceted” or  
“multi-modal” or initiative* or intervention*).tw. (1,069,468)
 45. (session* or strategy or strategies or initiative or program* or 
package*).tw. (1,023,638)
 46. “blended learning”.tw. (93)
 47. “self-learn*”.tw. (438)
 48. (shar* adj3 practice*).tw. (878)
 49. (risk* adj3 (reduc* or management)).tw. (86,429)
 50. (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”).tw. (2080)
 51. (booklet* or workbook* or checklist* or library or libraries or literature 
or questionnaire* or sheet* or pamphlet* or poster* or pictorial* 
or verbal* or video* or audiovisual* or podcast* or telemedicine or 
teleconferenc*).tw. (1,109,759)
 52. (behavio?r* adj2 chang*).tw. (23,225)
 53. (behavio?r adj2 alter*).tw. (3549)
 54. (chang* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw. (828)
 55. (alterat* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw. (36)
 56. (manag* adj5 (contaminat* or hygien* or handwash* or hand wash* 
or disinfect* or sterilisation or sterilization)).tw. (1241)
 57. (precaution* adj5 (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization)).tw. (424)
 58. (behavio?r* adj2 manag*).tw. (3687)
 59. (prevent* adj5 (measure* or control*)).tw. (54,004)
 60. (risk* adj (manage* or assess* or contain*)).tw. (35,159)
 61. infection control practitioner/ (61)
 62. (infection* and prevent*).tw. (87,720)
 63. RISK REDUCTION/ or BEHAVIORAL RISK FACTOR SURVEILLANCE 
SYSTEM/ or HIGH RISK BEHAVIOR/ or RISK ASSESSMENT/ or RISK 
MANAGEMENT/ (304,788)
 64. or/35-63 (8,009,274)
 65. 28 and 64 (3151)
 66. (bloodstream or blood-stream or “blood stream”).tw. (13,990)
 67. 9 and 19 and 34 and 64 and 66 (759)
 68. 65 or 67 (3182)
 69. bacteremia/ or bloodstream infection/ or sepsis/ (87,784)
 70. 9 and 19 and 64 and 69 (1376)
 71. 68 or 70 (3460)
 72. (comment or letter or editorial).pt. (1,078,117)
 73. 71 not 72 (3396)
 74. limit 73 to embase (2944)
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Database, date 
searched, host, 
years, keywords Search strategy Results
Web of Science
Time span = all years
Searched on  
1 February 2011
Databases:
Science Citation 
Index Expanded 
(SCI-E):  
1970–present
Social Sciences 
Citation Index 
(SSCI): 1970–present
Arts & Humanities 
Citation Index 
(A&HCI):  
1975–present
Conference 
Proceedings  
Citation Index -  
Science (CPCI-S): 
1990–present
Conference 
Proceedings Citation 
Index - Social Science 
& Humanities  
(CPCI-SSH):  
1990–present
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH
# 1 83,956 TS=(“intensive care” or “critical care” or “intensive therapy 
unit” or ITU or ICU or CCU or CICU or CITU)
# 2 24,167 TS=(catheter* SAME (venous or intravenous or arterial 
or vascular or intravascular or central or indwelling or peripheral or 
peripherally))
# 3 1511 TS=(tunnel* SAME (venous or intravenous or arterial or vascular 
or intravascular or central or indwelling or peripheral or peripherally))
# 4 7870 TS=(device* SAME (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally))
# 5 1193 TS=(“central line”)
# 6 19,168 TS=(CVC or PICC or JICC or SICC or SBCC or PVC or IVI)
# 7 1434 TS=(“Porta-cath” or Portacath or Hickman* or Broviac or Venflon 
or Groshong)
#8 22,666 TS=(“implantable port” or “access port” or cannula*)
# 9 5752 TS=(infection* SAME (“bloodstream” or “blood stream” or 
“blood-stream”))
# 10 > 100,000 TS=(sepsis or asepsis or septic* or bacteremia or bacteraemia)
# 11 1873 TS=(healthcare associated infection*)
# 12 5279 TS=(“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs 
or CABSI or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or 
“AC-CRI “ or “AC-CRIs”)
# 13 72,693 (#2 or #3 or #4 or #5 or #6 or #7 or #8)
# 14 > 100,000 (#9 or #10 or #11 or #12 or #13)
# 15 3003 (#1 and #13 and #14)
# 16 464 (#1 and #12)
# 17 3178 (#15 or #16)
# 18 >100,000 TS=(educat*)
# 19 137 (#17 and #18)
# 20 > 100,000 TS=(train* or teach* or program* or feedback or lean* or 
instruct*)
# 21 > 100,000 TS=(strateg* or component* or initiative*)
#22 > 100,000 TS=(booklet* or workbook* or checklist* or library or libraries 
or questionnaire* or pamphlet* or poster* or pictorial* or verbal* or video* 
or audiovisual* or podcast* or telemedicine or teleconferenc* or website*)
# 23 9557 TS=(“scrub the hub” or “Matching Michigan” or “Michigan 
project” or “Michigan Intervention” or “NHS Venous Catheter Care” or 
EPIC or “EPIC-2” or “saving lives”)
# 24 > 100,000 (#20 or #21 or #22 or #23)
# 25 807 (#17 and #24)
# 26 838 (#19 or #25)
838
Updated  
13 March 2012: 138
BIOSIS 1969–2011
Searched  
1 February 2011
Same strategy as Web of Science 449
Updated  
13 March 2012:
11 BIOSIS Previews
82 BIOSIS Citation 
Index
Total N = 93
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Database, date 
searched, host, 
years, keywords Search strategy Results
HMIC
Searched  
1 February 2011
As MEDLINE search – HMIC download filter would not work easily – only 
37 imported but remainder checked and were duplicates so 37 were 
downloaded
43 (37 downloaded)
DATABASE 
NO LONGER 
SUBSCRIBED TO SO 
NO UPDATE WAS 
FEASIBLE
The Cochrane 
Library
Searched  
2 January 2011
#1 Medical subject heading (MeSH) descriptor Intensive Care explode all 
trees (1050)
#2 MeSH descriptor Critical Care explode all trees (1704)
#3 MeSH descriptor Intensive Care Units explode all trees (2344)
#4 (“acute care” or “critical care” or “critically ill” or “critical illness”) 
(9593)
#5 “high dependency care” or “high dependency unit” (51)
#6 high next dependency next unit* (41)
#7 “intensive care” (11,969)
#8 (ITU or ICU or CCU or CICU or CITU) (2595)
#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8) (19,362)
#10 MeSH descriptor Catheterization, Central Venous explode all trees (667)
#11 central near catheter* (1867)
#12 central near cannul* (182)
#13 central near3 line (298)
#14 central near3 device (198)
#15 central near3 device (198)
#16 (catheter NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally)) (2518)
#17 (catheterization NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally)) (1494)
#18 (catheterisation NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally)) (1494)
#19 (tunnel near (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)) (262)
#20 (device near (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)) (1098)
#21 (CVC or PICC or JICC or SICC or SBCC or PVC or IVI or CVL or PCVC or 
CVAD or TCVC) (475)
#22 umbilical near catheter* (94)
#23 umbilical near cannul* (6)
#24 umbilical near3 line* (8)
#25 (Portacath or Hickman* or Broviac or Venflon or Groshong) (195)
#26 port next cath* (9)
#27 porta next cath* (2)
#28 (#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 
OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27) 
(5519)
#29 blood next stream next infection (50)
#30 bloodstream near infection* (273)
#31 blood stream near infection* (56)
#32 bacteria* near infection* (5699)
#33 MeSH descriptor Infection explode all trees (15,511)
#34 MeSH descriptor Communicable Diseases explode all trees (126)
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Database, date 
searched, host, 
years, keywords Search strategy Results
Cochrane databases 
(continued )
#35 MeSH descriptor Bacterial Infections and Mycoses explode all trees 
(24,790)
#36 MeSH descriptor Infectious Disease Transmission,  
Professional-to-Patient explode all trees (29)
#37 MeSH descriptor Bacteremia explode all trees (670)
#38 (sepsis or asepsis or septic* or bacteremia* or bacteraemia* or 
bacteria* or endotoxin*) (24,032)
#39 blood near poison* (177)
#40 culture near3 (blood or positive) (2428)
#41 “healthcare associated” next infection* (22)
#42 (HAI or HAIs or “HAI’s” or HCAI or HCAIs or “HCAI’s”) (471)
#43 (MRSA or MSSA) (259)
#44 infection*:ti,ab (28,643)
#45 (#29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 
OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44) (52,153)
#46 MeSH descriptor Catheter-Related Infections, this term only 49
#47 catheter* near3 infect* (719)
#48 catheter* near3 microb* (138)
#49 (catheter* and blood and infection*):ti,ab (208)
#50 (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or “AC-CRI“  
or “AC-CRIs”) (316)
#51 (#46 OR #47 OR #48 OR #49 OR #50) (1110)
#52 MeSH descriptor Education explode all trees (15,114)
#53 MeSH descriptor Inservice Training explode all trees (441)
#54 MeSH descriptor Training Support, this term only (14)
#55 (awareness or bundle* or collaborat* or campaign* or 
communicat*):ti,ab (9811)
#56 (feedback or “feed back” or “feeding back” or course* or instruct* or 
inform* or impart* or knowledge or learn* or “e-learn” or “e-learning” or 
lecture*) (111,227)
#57 (module* or modular or message* or session* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop* or outreach) (335,667)
#58 (booklet* or workbook* or checklist* or library or libraries or 
questionnaire* or sheet* or pamphlet* or poster* or pictorial* or verbal* 
or video* or audiovisual* or podcast or telemedicine or teleconferenc* or 
symposia or symposium) (61,099)
#59 change next management (35)
#60 ((change or changing) near (process or procedure)) (1161)
#61 early next warning next system* (23)
#62 (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or  
“EPIC-2” or “saving lives”) (124)
#63 educat* (30,296)
#64 (chang* near (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)) (85)
#65 (alter* near (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)) (53)
#66 (management near (contaminat* or hygien* or handwash* or hand 
wash* or disinfect* or sterilisation or sterilization)) (45)
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Database, date 
searched, host, 
years, keywords Search strategy Results
Cochrane databases 
(continued )
#67 (precaution* near (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization)) (13)
#68 prevent* near infect* (10,190)
#69 (quality near (strateg* or intervention* or management or initiative*)) 
(4354)
#70 (risk near (management or prevention or intervention*)) (8647)
#71 (precaution near infect*) (25)
#72 (#52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 
OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67 OR #68 OR #69 
OR #70 OR #71) (387,381)
#73 (#9 AND #28 AND #45 AND #72) (325)
#74 (#9 AND #51 AND 72) (48)
#75 (#73 OR #74) (340)
CINAHL 
EBSCOhost
Searched  
2 February 2011
S1 (MH “Intensive Care Units”) OR (MH “Intensive Care Units, Pediatric”) 
OR (MH “Intensive Care, Neonatal”) OR (MH “Neonatal Intensive Care 
Nursing”) OR (MH “Critical Care”) OR (MH “Critical Care Nursing”) OR (MH 
“Intensive Care Units, Neonatal”) (33,939)
S2 TX (ITU or ICU or CCU or CICU or CITU) (9272)
S3 S1 or S2 (38,088)
S4 (MH “Central Venous Catheters”) OR (MH “Catheters, Vascular”) OR 
(MH “Catheters+”) OR (MH “Catheters and Tubes”) OR (MH “Peripherally 
Inserted Central Catheters”) OR (MH “Catheterization”) OR (MH “Catheter 
Care”) OR “catheter*” (21,661)
S5 TX (CVC or PICC or JICC or SICC or SBCC or PVC or IVI or CVL or PCVC 
or CVAD or TCVC or Portacath or Hickman* or Broviac or Venflon or 
Groshong) (1654)
S6 TX (central n3 cannul* or central n3 line* or central n3 device (1166)
S7 TX (Portacath or “Port-A-Cath” or Hickman or Broviac or Venflon or 
Groshong) (540)
S8 S4 or S5 or S6 or S7 (22,929)
S9 (MH “Infection”) OR “infection” OR (MH “Bacterial Infections) (64,326)
S10 (MH “Bacteremia”) (2044)
S11 TX (bacteremia or bacteraemia or sepsis or asepsis or septic* or “blood 
poison*”) (11,692)
S12 (MH “Endotoxins”) OR “endotoxin” OR (MH “Endotoxemia”)  (840)
S13 (MH “Toxemia”) OR “toxemia” (51)
S14 TX bloodstream infection* (1127
S15 TX blood-stream infection* (98)
S16 (MH “Bacterial Colonization”) OR “colonization” (3085)
S17 S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 (73,507)
S18 (MH “Catheter-Related Infections”) (2447)
S19 TX (catheter related bloodstream infection*) (298)
S20 TX (CRBSI or CLABSI or CABSI or BSI or CRI)  (1812)
S21 S18 or S19 or S20 (4115)
S22 (MH “Education, Clinical”) OR (MH “Education, Competency-Based”) 
OR (MH “Education, Allied Health”) OR “education*”  (306,068)
S23 (MH “Hygiene/ED”) OR (MH “Handwashing/ED”) (250)
S24 TX (“scrub the hub” or “Matching Michigan” or “Michigan project”  
or “Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”) (650)
S25 (learn* or teach* or train* or feedback) (170,039)
209
Updated  
13 March 2012: 78
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Database, date 
searched, host, 
years, keywords Search strategy Results
CINAHL (continued ) S26 S22 or S23 or S24 or S25 (395,945)
S27 S3 and S8 and S17 and S26 (199)
S28 S3 and S21 and S26  (150)
S29 S27 or S28 (209)
CRD
Searched  
3 February 2011
# 1 ( “intensive care” OR “critical care” OR “critical illness” OR “critically 
ill” ) (2133)
# 2 MeSH Critical Care EXPLODE 1 2 (484)
# 3 MeSH Intensive Care EXPLODE 1 2 (313)
# 4 MeSH Intensive Care Units, Neonatal EXPLODE 1 (107)
# 5 MeSH Intensive Care Units, Pediatric EXPLODE 1 (157)
# 6 ( ITU OR ICU OR CCU OR CICU OR CITU ) (464)
# 7 #1 or #2 or #3 or #4 or #5 or #6 (2435)
# 8 MeSH Catheterization, Central Venous EXPLODE 1 (154)
# 9 MeSH Catheterization, Peripheral EXPLODE 1 (68)
# 10 MeSH Catheters, Indwelling EXPLODE 1 (123)
# 11 ( CVC OR PICC OR JICC OR SICC OR SBCC OR PVC OR IVI OR CVL OR 
PCVC OR CVAD OR TCVC ) (56)
# 12 ( catheter* OR cannul* ) (1084)
# 13 #8 or #9 or #10 or #11 or #12 (1162)
# 14 MeSH Bacterial Infections EXPLODE 1 (1999)
# 15 MeSH Bacteremia EXPLODE 1 2 3 (147)
# 16 MeSH Sepsis EXPLODE 1 2 (390)
# 17 MeSH Asepsis EXPLODE 1 (3)
# 18 MeSH Fungemia EXPLODE 1 2 3 (20)
# 19 ( infection* OR acinetobacter* OR asepsis OR bacter?emia* OR 
bacteria* OR candida OR coloni?ation OR contaminat* OR cfu OR colony 
OR colonies OR corynebacterium OR escherichia OR enterococc* OR 
enterobacter* OR fungi OR fungus OR fungal OR fung?emia OR klebsiella 
OR met?icillin OR microorganism* OR micro-organism* OR microbial* OR 
microbe* OR microbiologic* OR mycology OR mycological OR organism* 
OR nosocomial* OR pathogen* OR sepsis OR septic OR septic?emia AND 
septicemia OR staphylococc* OR streptococc* ) (6148)
# 20 ( HAI OR HAIs OR “HAI’s” OR HCAI OR HCAIs OR “HCAI’s” ) (15)
# 21 ( MRSA OR MSSA ) (85)
# 22 #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 (6993)
# 23 ( “CR-BSI” OR “CR-BSIs” OR CRBSI OR CRBSIs OR CABI OR CABIs OR 
CABSI OR CABSIs OR CLABSI OR CLABSIs OR CRI OR CRIs OR BSI OR BSIs 
OR “AC-CRI “ OR “AC-CRIs” ) (77)
# 24 catheter AND related AND infection* (170)
# 25 ( line AND ( infection* OR sepsis OR bacter?emia ) ) (292)
# 26 ( catheter* AND ( sepsis OR septic OR bacter?emia* ) ) (56)
# 27 #23 or #24 or #25 or #26 (518)
# 28 ( educat* OR train* OR teach* OR feedback OR bundle OR course* 
OR learn* OR lecture* OR workshop* ) (7927)
# 29 ( component* OR “multi-component” OR “multi-faceted” OR  
“multi-modal” OR initiative* OR intervention* OR program* OR strateg* ) 
(24,642)
# 30 ( booklet* OR checklist* OR library OR libraries OR literature OR 
questionnaire* OR sheet* OR pamphlet* OR poster* OR pictorial* OR 
verbal* OR video* OR audiovisual* OR podcast OR telemedicine OR 
teleconferenc* OR workbook ) (20,644)
Results cross 
checked manually 
against database – 
nothing new to add
Updated  
13 March 2012:
0 relevant to 
education
Taking education 
out of the  
equation 3
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searched, host, 
years, keywords Search strategy Results
CRD (continued ) # 31 ( “scrub the hub” OR “Matching Michigan” OR “Michigan project” 
OR “Michigan Intervention” OR “NHS Venous Catheter Care” OR EPIC OR 
“EPIC-2” OR “saving lives” ) (20)
# 32 #25 or #26 or #27 or #28 or #29 or #30 or #31 (33,207)
# 33 7 AND 13 AND 22 AND 32 (82)
# 34 7 AND 27 AND 32 (187)
# 35 #33 or #34 (237)
# 36 #2 OR #3 OR #4 OR #5 (620)
# 37 #13 AND #22 AND #32 AND #36 (17)
# 38 #27 AND #32 AND #36 (18)
# 39 #37 OR #38 (23)
40 ( “intensive care” OR “critical care” ) (2038)
# 41 27 AND 32 AND 40 (125)
# 42 catheter* AND educat* (42)
# 43 ( catheter* AND educat* AND intensive AND unit* ) (12)
# 44 ( catheter* AND educat* AND critical AND unit* ) (7)
# 45 #43 or #44 (17)
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Cost-effectiveness search strategy 
Database Search strategy Results
MEDLINE Ovid
Serached 22 
February 2011
  1. exp Critical Care/
  2. exp Intensive Care/ or exp Intensive Care Units/
  3. (“acute care” or “critical care” or “critically ill” or “critical illness”).tw.
  4. (high dependency adj1 (care or unit*1)).tw.
  5. “intensive care”.tw.
  6. (intensive adj therapy adj unit*).tw.
  7. (ITU or ICU or CCU or CICU or CITU).tw.
  8. (“level 2 care” or “level 3 care”).tw.
  9. Catheterization, Central Venous/ or Catheterization/ or 
Catheterization, Peripheral/
 10. Catheters, Indwelling/
 11. exp catheters/
 12. (catheter* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 13. (tunnel* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 14. (device* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 15. (CVC or PICC or JICC or SICC or SBCC or PVC or IVI).tw.
 16. (“Porta-cath” or Portacath or Hickman* or Broviac or Venflon or 
Groshong).tw.
 17. (“implantable port” or “access port”).tw.
 18. cannula*.tw.
 19. exp Bacterial Infections/
 20. exp Bacteremia/
 21. septicemia/
 22. Sepsis/
 23. Asepsis/
 24. cross infection/
 25. Infectious Disease Transmission, Professional-to-Patient/
 26. Communicable Diseases/
 27. exp bacteria/
 28. fungemia/
 29. exp Staphylococcal Infections/
 30. Staphylococcus aureus/
 31. Methicillin Resistance/
 32. Staphylococcus/ or Staphylococcus epidermidis/
 33. exp Streptococcus/ or exp Streptococcal Infections/
 34. Pseudomonas aeruginosa/
 35. Escherichia coli/
 36. exp Enterobacter/
 37. exp Klebsiella/ or exp Klebsiella Infections/
 38. exp Corynebacterium/ or exp Corynebacterium Infections/
 39. exp Acinetobacter/ or exp Acinetobacter Infections/
 40. exp Enterococcus/
 41. exp Candida/
266
Updated  
14 March 2012: 43
 42. exp Blood-Borne Pathogens/
 43. exp Enterobacteriaceae Infections/
 44. equipment contamination/
 45. colony count microbial/
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Database Search strategy Results
MEDLINE 
(continued )
 46. exp Infection/bl [Blood]
 47. bacter?emia.tw.
 48. (infection* or acinetobacter* or asepsis or bacter?emia* or bacteria* 
or candida or coloni?ation or contaminat* or cfu or colony or colonies 
or corynebacterium or escherichia or enterococc* or enterobacter* 
or fungi or fungus or fungal or fung?emia or klebsiella or met?icillin 
or microorganism* or micro-organism* or microbial* or microbe* 
or microbiologic* or mycology or mycological or organism* or 
nosocomial* or pathogen* or sepsis or septic or septic?emia 
septicemia or staphylococc* or streptococc*).tw.
 49. (blood?stream adj infection*).tw.
 50. (blood-stream adj infection*).tw.
 51. (blood* adj3 infect*).tw.
 52. (“healthcare associated” adj infection*).tw.
 53. (HAI or HAIs or “HAI’s” or HCAI or HCAIs or “HCAI’s”).tw.
 54. (extraluminal adj infection*).tw.
 55. (MRSA or MSSA).tw.
 56. (blood adj culture*).tw.
 57. (positive adj2 culture*).tw.
 58. (positive adj isolate*).tw.
 59. Infectioan Control/
 60. Catheter Related infections/
 61. Catheters/mi [Microbiology]
 62. Catheters, Indwelling/mi [Microbiology]
 63. (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or  
“AC-CRI “ or “AC-CRIs”).tw.
 64. (line adj3 (infection* or sepsis or bacter?emia)).tw.
 65. (catheter* and blood* and infection*).tw.
 66. (catheter* and (sepsis or bacter?emia*)).tw.
 67. exp Education, Medical/
 68. exp Education, Nursing/
 69. education continuing/
 70. Education, Department Hospital/
 71. Educational Measurement/
 72. Internal Medicine/ed [Education]
 73. Nursing Staff, Hospital/ed [Education]
 74. exp Health Education/
 75. Health Knowledge, Attitudes, Practice/
 76. Inservice training/ or Training Support/ or Instruction/
 77. Preceptorship/
 78. Mentors/
 79. Interdisciplinary communication/
 80. Teaching Rounds/ or Hospitals, Teaching/ or Teaching Materials/ or 
Teaching/
 81. Personnel, Hospital/ed [Education]
 82. Emergency Medicine/ed [Education]
 83. exp Critical Care/ed [Education]
 84. Curriculum/
 85. Program Evaluation/
 86. Program Development/
 87. Infection Control/mt, og, st [Methods, Organization & Administration, 
Standards]
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Database Search strategy Results
MEDLINE 
(continued )
 88. Equipment Contamination/pc, st [Prevention & Control, Standards]
 89. Safety Management/mt, og, st [Methods, Organization & 
Administration, Standards]
 90. Intensive Care Units/mt, st [Methods, Standards]
 91. Point-of-Care Systems/og, st [Organization & Administration, 
Standards]
 92. Clinical Competence/st [Standards]
 93. Total Quality Management/mt, og [Methods, Organization & 
Administration]
 94. (educat* or awareness or bundle* or collaborat* or campaign* or 
communicat*).tw.
 95. (feedback or “feed back” or “feeding back” or course* or instruct* 
or inform* or impart* or knowledge or learn* or “e-learn” or 
“e-learning” or lecture*).tw.
 96. (module* or modular or session* or study or studies or studying or 
studies).tw.
 97. (“self study” or re-educat* or “self-educat*”).tw.
 98. (assess* or apprais* or competenc* or competent* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop*).tw.
 99. (link* adj2 (staff or nurs*)).tw.
100. (preceptor* or mentor*).tw.
101. (component* or “multi-component” or “multi-faceted” or  
“multi-modal” or initiative* or intervention*).tw.
102. (session* or strategy or strategies or initiative or program* or 
package*).tw.
103. “blended learning”.tw.
104. “self-learn*”.tw.
105. (shar* adj3 practice*).tw.
106. (risk* adj3 (reduc* or management)).tw.
107. (booklet* or workbook* or checklist* or library or libraries or literature 
or questionnaire* or sheet* or pamphlet* or poster* or pictorial* 
or verbal* or video* or audiovisual* or podcast or telemedicine or 
teleconferenc*).tw.
108. (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”).tw.
109. (behavio?r* adj2 chang*).tw.
110. (behavio?r adj2 alter*).tw.
111. (chang* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw.
112. (alterat* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw.
113. (management adj5 (contaminat* or hygien* or handwash* or hand 
wash* or disinfect* or sterilisation or sterilization)).tw.
114. (precaution* adj5 (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization)).tw.
115. (behavio?r* adj2 management).tw.
116. (risk* adj (manage* or assess*)).tw.
117. governance.tw.
118. or/1-8
119. or/9-18
120. or/19-59
121. or/60-66
122. or/67-117
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MEDLINE 
(continued )
123. 118 and 119 and 120 and 122
124. 118 and 121 and 122
125. 123 or 124
126. (editorial or letter or comment).pt.
127. 125 not 126
128. exp economics/
129. exp economics hospital/
130. exp economics pharmaceutical/
131. exp economics nursing/
132. exp economics medical/
133. exp “Costs and Cost Analysis”/
134. Cost Benefit Analysis/
135. exp models economic/
136. exp fees/ and charges/
137. exp budgets/
138. (economic* or cost or costs or costly or costing or price or prices or 
pricing or pharmacoeconomic*).tw.
139. (value adj1 money).tw.
140. budget$.tw.
141. or/128-140
142. ((energy or oxygen) adj cost).tw.
143. (metabolic adj cost).tw.
144. ((energy or oxygen) adj expenditure).tw.
145. or/142-144
146. 141 not 145
147. (letter or editorial or comment or historical article).pt.
148. 146 not 147
149. 127 and 148
ADDED IN BEHAVIO?R AS FREE TEXT WORD – NOTHING NEW IDENTIFIED  
(1 March 2011)
150. 150 behavio?r*.tw. (536,358)
151. 151 118 and 119 and 120 and 148 and 150 (4)
152. 152 118 and 121 and 148 and 150 (4)
153. 153 151 or 152 (5)
154. 154 153 not 149 (0)
MEDLINE in 
Process & Other 
Non-Indexed 
Citations
Ovid
Searched 22 
February 2011
As per MEDLINE 9
Updated  
14 March 2012: 38
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Database Search strategy Results
EMBASE Ovid
Searched 22 
February 2011
  1. exp intensive care/
  2. exp intensive care unit/
  3. (“acute care” or “critical care” or “critically ill” or “critical illness”).tw.
  4. (high dependency adj1 (care or unit*1)).tw.
  5. (“intensive care” or “intensive medical care”).tw.
  6. (intensive adj therapy adj unit*).tw.
  7. (ITU or ICU or CCU or CICU or CITU or SCBU).tw.
  8. (“level 2 care” or “level 3 care”).tw.
  9. or/1-8
 10. exp catheterization/
 11. INTRAVENOUS CATHETER/ or ARTERY CATHETER/ or CATHETER/ 
or INDWELLING CATHETER/ or PERIPHERALLY INSERTED CENTRAL 
VENOUS CATHETER/ or CENTRAL VENOUS CATHETER/ or 
INTRAVASCULAR CATHETER/
 12. (catheter* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 13. (tunnel* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 14. (device* adj5 (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally)).tw.
 15. (CVC or PICC or JICC or SICC or SBCC or PVC or IVI).tw.
 16. (“Porta-cath” or Portacath or Hickman* or Broviac or Venflon or 
Groshong).tw.
 17. (“implantable port” or “access port”).tw.
 18. cannula*.tw.
 19. or/10-18
 20. catheter infection/
 21. (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or  
“AC-CRI “ or “AC-CRIs”).tw.
 22. (line adj3 (infection* or sepsis or bacter?emia)).tw.
 23. (catheter* and blood* and infection*).tw.
 24. (catheter* and (sepsis or bacter?emia*)).tw.
 25. “catheter-related bloodstream infection*”.tw.
 26. “catheter-associated bloodstream infection*”.tw.
 27. or/20-26
 28. 9 and 27
 29. exp INFECTION/ or GRAM POSITIVE INFECTION/ or STAPHYLOCOCCUS 
INFECTION/ or BACTERIAL INFECTION/ or GROUP A STREPTOCOCCAL 
INFECTION/ or ENTEROCOCCAL INFECTION/ or KLEBSIELLA 
INFECTION/ or HOSPITAL INFECTION/ or STREPTOCOCCUS 
INFECTION/ or GRAM NEGATIVE INFECTION/ or METHICILLIN 
RESISTANT STAPHYLOCOCCUS AUREUS INFECTION/ or GROUP 
B STREPTOCOCCAL INFECTION/ or DEVICE INFECTION/ or 
ENTEROBACTERIACEAE INFECTION/ or BLOODSTREAM INFECTION/ or 
CROSS INFECTION/
 30. FUNGAL CONTAMINATION/ or BACTERIUM CONTAMINATION/ or 
VIRAL CONTAMINATION/ or MICROBIAL CONTAMINATION/
 31. bacteremia/ or sepsis/
305
Updated  
20 March 2012: 116
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EMBASE (continued )  32. (infection* or acinetobacter* or asepsis or bacter?emia* or bacteria* 
or candida or coloni?ation or contaminat* or cfu or colony or colonies 
or corynebacterium or escherichia or enterococc* or enterobacter* 
or fungi or fungus or fungal or fung?emia or klebsiella or met?icillin 
or microorganism* or micro-organism* or microbial* or microbe* 
or microbiologic* or mycology or mycological or organism* or 
nosocomial* or pathogen* or sepsis or septic or septic?emia or 
staphylococc* or streptococc*).tw.
 33. (MRSA or MSSA).tw.
 34. or/29-33
 35. CLINICAL EDUCATION/ or NURSING EDUCATION/ or CONTINUING 
EDUCATION/ or EDUCATION PROGRAM/ or RESEARCH BASED 
NURSING EDUCATION/ or CONTINUING EDUCATION PROVIDER/ or 
INTERDISCIPLINARY EDUCATION/ or EMERGENCY MEDICAL SERVICES 
EDUCATION/ or MEDICAL EDUCATION/ or HEALTH EDUCATION/ or 
EDUCATION/ or “OUTCOME OF EDUCATION”/
 36. IN SERVICE TRAINING/ or TRAINING/ or STAFF TRAINING/
 37. (educat* or awareness or bundle* or collaborat* or campaign* or 
communicat*).tw.
 38. (feedback or “feed back” or “feeding back” or course* or instruct* 
or inform* or impart* or knowledge or learn* or “e-learn” or 
“e-learning” or lecture*).tw.
 39. (module* or modular or session*).tw.
 40. (“self study” or re-educat* or “self-educat*”).tw.
 41. (assess* or apprais* or competenc* or competent* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop*).tw.
 42. (link* adj2 (staff or nurs*)).tw.
 43. (preceptor* or mentor*).tw.
 44. (component* or “multi-component” or “multi-faceted” or  
“multi-modal” or initiative* or intervention*).tw.
 45. (session* or strategy or strategies or initiative or program* or 
package*).tw.
 46. “blended learning”.tw.
 47. “self-learn*”.tw.
 48. (shar* adj3 practice*).tw.
 49. (risk* adj3 (reduc* or management)).tw.
 50. (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”).tw.
 51. (booklet* or workbook* or checklist* or library or libraries or literature 
or questionnaire* or sheet* or pamphlet* or poster* or pictorial* 
or verbal* or video* or audiovisual* or podcast* or telemedicine or 
teleconferenc*).tw.
 52. (behavio?r* adj2 chang*).tw.
 53. (behavio?r adj2 alter*).tw.
 54. (chang* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw.
 55. (alterat* adj5 (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization)).tw.
 56. (manag* adj5 (contaminat* or hygien* or handwash* or hand wash* 
or disinfect* or sterilisation or sterilization)).tw.
 57. (precaution* adj5 (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization)).tw.
 58. (behavio?r* adj2 manag*).tw.
 59. (prevent* adj5 (measure* or control*)).tw.
 60. (risk* adj (manage* or assess* or contain*)).tw.
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Database Search strategy Results
EMBASE (continued )  61. infection control practitioner/
 62. (infection* and prevent*).tw.
 63. RISK REDUCTION/ or BEHAVIORAL RISK FACTOR SURVEILLANCE 
SYSTEM/ or HIGH RISK BEHAVIOR/ or RISK ASSESSMENT/ or RISK 
MANAGEMENT/
 64. or/35-63
 65. 28 and 64
 66. (bloodstream or blood-stream or “blood stream”).tw.
 67. 9 and 19 and 34 and 64 and 66
 68. 65 or 67
 69. bacteremia/ or bloodstream infection/ or sepsis/
 70. 9 and 19 and 64 and 69
 71. 68 or 70
 72. (comment or letter or editorial).pt.
 73. 71 not 72
 74. limit 73 to embase
 75. exp Health Economics/
 76. monte carlo method/
 77. markov.ti,ab.
 78. (financial or finance or finances or financed).ti,ab.
 79. cost/
 80. cost minimization analysis/
 81. cost of illness/
 82. cost utility analysis/
 83. budget/
 84. “resource use”.ti,ab.
 85. (decision adj1 (tree* or analys* or model*)).tw.
 86. (resource? adj1 allocat*).tw.
 87. exp economic evaluation/
 88. exp “health care cost”/
 89. exp pharmacoeconomics/
 90. (cost adj3 (util* or effective* or efficac* or benefit* or consequence* 
or analys* or minimi* or saving* or breakdown* or lowering or 
estimate* or variable* or allocation* or control* or illness* or 
instrument* or technolog*)).tw.
 91. (econom* or pharmacoeconomic* or “pharmaco economic*”).ti,ab.
 92. or/75-91
 93. 74 and 92
 94. (letter or editorial or note).pt.
 95. 93 not 94
CINAHL 
EBSCOhost
Searched 22 
February 2011
Following COST FILTER Added on to clinical search:
S30 (MH “Economics+”) (341,991)
S31 (MH “Financial Management+”) (26,259)
S32 (MH “Financial Support+”) (217674)
S33 (MH “Financing, Organized+”) (67782)
S34 (MH “Business+”) (50121)
S35 S31 or S32 or S33 or S34 (337744)
S36 S30 NOT S35 (35930)
S37 (MH “Health Resource Allocation”) (4520)
S38 (MH “Health Resource Utilization”) (6625)
41
Updated  
20 February 2012: 24
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CINAHL (continued ) S39 S37 or S38 (10,914)
S40 S36 or S39 (43,151)
S41 TI (cost or costs or economic* or pharmacoeconomic* or price* or 
pricing) OR AB (cost or costs or economic* or pharmacoeconomic* or 
price* or pricing*) (64,812)
S42 S40 or S41 (93,923)
S43 S29 and S42 (41)
Web of Science
Searched 23 March 
2011
Following COST FILTER added on to clinical search:
# 27 > 100,000 TI=(cost* or economic* or pharmacoeconomic*)
# 28 > 100,000 TS=(“cost effective*” or “cost benefit*” or “cost 
saving*” or “cost analys*” or “cost utili*” or “cost mimimi*” or “cost 
consequence*” or “cost comparison*” or “cost identificat*”)
# 29 15,887 TS=(“health economic*” or “healthcare cost*” or “health care 
cost*” or “economic evaluation*”)
# 30 32,009 TS=(economical)
# 31 > 100,000 (#27 or #28 or #29 or #30)
#32 45 (#26 and #31)
45
Updated  
21 March 2012: 12
BIOSIS
Searched 23 
February 2011
Same as Web of Science Strategy 6
Updated  
21 March 2012: 17
The Cochrane 
Library
Searched 23 
February 2011
#1 MeSH descriptor Intensive Care explode all trees
#2 MeSH descriptor Critical Care explode all trees
#3 MeSH descriptor Intensive Care Units explode all trees
#4 (“acute care” or “critical care” or “critically ill” or “critical illness”)
#5 “high dependency care” or “high dependency unit”
#6 high next dependency next unit*
#7 “intensive care”
#8 (ITU or ICU or CCU or CICU or CITU)
#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)
#10 MeSH descriptor Catheterization, Central Venous explode all trees
#11 central near catheter*
#12 central near cannul*
#13 central near3 line
#14 central near3 device
#15 central near3 device
#16 (catheter NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally))
#17 (catheterization NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally))
50 in total
11 CENTRAL
4 DARE
35 NHSEED
2 CDSR not 
downloaded not 
relevant)
Updated  
21 March 2012:
1 Cochrane HTA
4 Cochrane CDSR
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Database Search strategy Results
Cochrane databases 
(continued )
#18 (catheterisation NEAR (venous or intravenous or arterial or vascular or 
intravascular or indwelling or peripheral or peripherally))
#19 (tunnel near (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally))
#20 (device near (venous or intravenous or arterial or vascular or 
intravascular or central or indwelling or peripheral or peripherally))
#21 (CVC or PICC or JICC or SICC or SBCC or PVC or IVI or CVL or PCVC or 
CVAD or TCVC)
#22 umbilical near catheter*
#23 umbilical near cannul*
#24 umbilical near3 line*
#25  (Portacath or Hickman* or Broviac or Venflon or Groshong)
#26 port next cath*
#27 porta next cath*
#28 (#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 
OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR 
#27)
#29 blood next stream next infection
#30 bloodstream near infection*
#31 blood stream near infection*
#32 bacteria* near infection*
#33 MeSH descriptor Infection explode all trees
#34 MeSH descriptor Communicable Diseases explode all trees
#35 MeSH descriptor Bacterial Infections and Mycoses explode all trees
#36 MeSH descriptor Infectious Disease Transmission,  
Professional-to-Patient explode all trees
#37 MeSH descriptor Bacteremia explode all trees
#38 (sepsis or asepsis or septic* or bacteremia* or bacteraemia* or bacteria* or 
endotoxin*)
#39 blood near poison*
#40 culture near3 (blood or positive)
#41 “healthcare associated” next infection*
#42 (HAI or HAIs or “HAI’s” or HCAI or HCAIs or “HCAI’s”)
#43 (MRSA or MSSA)
#44 infection*:ti,ab
#45 (#29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 
OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44)
#46 MeSH descriptor Catheter-Related Infections, this term only
#47 catheter* near3 infect*
#48 catheter* near3 microb*
#49 (catheter* and blood and infection*):ti,ab
#50 (“CR-BSI” or “CR-BSIs” or CRBSI or CRBSIs or CABI or CABIs or CABSI 
or CABSIs or CLABSI or CLABSIs or CRI or CRIs or BSI or BSIs or  
“AC-CRI “ or “AC-CRIs”)
#51 (#46 OR #47 OR #48 OR #49 OR #50)
#52 MeSH descriptor Education explode all trees
#53 MeSH descriptor Inservice Training explode all trees
#54 MeSH descriptor Training Support, this term only
#55 (awareness or bundle* or collaborat* or campaign* or 
communicat*):ti,ab
#56 (feedback or “feed back” or “feeding back” or course* or instruct* 
or inform* or impart* or knowledge or learn* or “e-learn” or 
“e-learning” or lecture*)
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Database Search strategy Results
Cochrane databases 
(continued )
#57 (module* or modular or message* or session* or curriculum* or 
evaluat* or seminar* or test* or teach* or taught or train* or simulat* 
or refresh* or tool* or meeting* or presentation* or skill* or drill* or 
workshop* or outreach)
#58 (booklet* or workbook* or checklist* or library or libraries or 
questionnaire* or sheet* or pamphlet* or poster* or pictorial* or 
verbal* or video* or audiovisual* or podcast or telemedicine or 
teleconferenc* or symposia or symposium)
#59 change next management
#60 ((change or changing) near (process or procedure))
#61 early next warning next system*
#62 (“scrub the hub” or “Matching Michigan” or “Michigan project” or 
“Michigan Intervention” or “NHS Venous Catheter Care” or EPIC or 
“EPIC-2” or “saving lives”)
#63 educat*
#64 (chang* near (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization))
#65 (alter* near (hygien* or handwash* or hand wash* or disinfect* or 
sterilisation or sterilization))
#66 (management near (contaminat* or hygien* or handwash* or hand 
wash* or disinfect* or sterilisation or sterilization))
#67 (precaution* near (hygien* or handwash* or hand wash* or disinfect* 
or sterilisation or sterilization))
#68 prevent* near infect*
#69 (quality near (strateg* or intervention* or management or initiative*))
#70 (risk near (management or prevention or intervention*))
#71 (precaution near infect*)
#72 (#52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 
OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67 OR #68 OR 
#69 OR #70 OR #71)
#73 (#9 AND #28 AND #45 AND #72)
#74 (#9 AND #51 AND 72)
#75 (#73 OR #74)
#76 (“cost effective*” or “cost benefit*” or “cost saving*” or “cost 
analys*” or “cost utili*” or “cost mimimi*” or “cost consequence*” 
or “cost comparison*” or “cost identificat*”):ti,ab,kw
#77 (cost* or economic* or pharmacoeconomic*):ti
#78 (“health economic*” or “healthcare cost*” or “health care cost*” or 
“economic evaluation*”):ti,ab,kw
#79 (economical):ti,ab
#80 MeSH descriptor Costs and Cost Analysis explode all trees
#81 MeSH descriptor Cost-Benefit Analysis explode all trees
#82 MeSH descriptor Models, Economic, this term only
#83 MeSH descriptor Economics, Hospital explode all trees
#84 MeSH descriptor Economics, Medical explode all trees
#85 MeSH descriptor Economics, Nursing explode all trees
#86 MeSH descriptor Health Care Costs explode all trees
#87 (#76 OR #77 OR #78 OR #79 OR #80 OR #81 OR #82 OR #83 OR #84 
OR #85 OR #86)
#88 (#75 AND #87)
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Database Search strategy Results
CRD
Searched 23 
February 2011
# 1 ( “intensive care” OR “critical care” OR “critical illness” OR “critically 
ill” )
# 2 MeSH Critical Care EXPLODE 1 2
# 3 MeSH Intensive Care EXPLODE 1 2
# 4 MeSH Intensive Care Units, Neonatal EXPLODE 1
# 5 MeSH Intensive Care Units, Pediatric EXPLODE 1
# 6 ( ITU OR ICU OR CCU OR CICU OR CITU )
# 7 #1 or #2 or #3 or #4 or #5 or #6
# 8 MeSH Catheterization, Central Venous EXPLODE 1 154
# 9 MeSH Catheterization, Peripheral EXPLODE 1
# 10 MeSH Catheters, Indwelling EXPLODE 1
38
Updated  
21 March 2012: 36
# 11 ( CVC OR PICC OR JICC OR SICC OR SBCC OR PVC OR IVI OR CVL OR 
PCVC OR CVAD OR TCVC )
# 12 ( catheter* OR cannul* )
# 13 #8 or #9 or #10 or #11 or #12
# 14 MeSH Bacterial Infections EXPLODE 1
# 15 MeSH Bacteremia EXPLODE 1 2 3
# 16 MeSH Sepsis EXPLODE 1 2
# 17 MeSH Asepsis EXPLODE 1 3
# 18 MeSH Fungemia EXPLODE 1 2 3
# 19 ( infection* OR acinetobacter* OR asepsis OR bacter?emia* OR 
bacteria* OR candida OR coloni?ation OR contaminat* OR cfu OR colony 
OR colonies OR corynebacterium OR escherichia OR enterococc* OR 
enterobacter* OR fungi OR fungus OR fungal OR fung?emia OR klebsiella 
OR met?icillin OR microorganism* OR micro-organism* OR microbial* OR 
microbe* OR microbiologic* OR mycology OR mycological OR organism* 
OR nosocomial* OR pathogen* OR sepsis OR septic OR septic?emia AND 
septicemia OR staphylococc* OR streptococc* )
# 20 ( HAI OR HAIs OR “HAI’s” OR HCAI OR HCAIs OR “HCAI’s” )
# 21 ( MRSA OR MSSA )
# 22 #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21
# 23 ( “CR-BSI” OR “CR-BSIs” OR CRBSI OR CRBSIs OR CABI OR CABIs OR 
CABSI OR CABSIs OR CLABSI OR CLABSIs OR CRI OR CRIs OR BSI OR BSIs OR 
“AC-CRI “ OR “AC-CRIs” )
# 24 ( catheter AND related AND infection* )
# 25 ( line AND ( infection* OR sepsis OR bacter?emia ) )
# 26 ( catheter* AND ( sepsis OR septic OR bacter?emia* ) )
# 27 #23 or #24 or #25 or #26
# 28 ( educat* OR train* OR teach* OR feedback OR bundle OR course* 
OR learn* OR lecture* OR workshop* )
# 29 ( component* OR “multi-component” OR “multi-faceted” OR  
“multi-modal” OR initiative* OR intervention* OR program* OR strateg* )
# 30 ( booklet* OR checklist* OR library OR libraries OR literature OR 
questionnaire* OR sheet* OR pamphlet* OR poster* OR pictorial* OR 
verbal* OR video* OR audiovisual* OR podcast OR telemedicine OR 
teleconferenc* OR workbook )
# 31 ( “scrub the hub” OR “Matching Michigan” OR “Michigan project” 
OR “Michigan Intervention” OR “NHS Venous Catheter Care” OR EPIC OR 
“EPIC-2” OR “saving lives” )
# 32 #25 or #26 or #27 or #28 or #29 or #30 or #31
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Database Search strategy Results
CRD (continued ) # 33 7 AND 13 AND 22 AND 32
# 34 7 AND 27 AND 32
# 35 #33 or #34
# 36 #2 OR #3 OR #4 OR #5
# 37 #13 AND #22 AND #32
# 38 #27 AND #32 AND #36
# 39 #37 OR #38
# 40 #13 AND #22 AND #32 AND #36
# 41 #38 or #40
# 42 ( catheter* AND educat* AND intensive AND unit* )
# 43 ( catheter* AND educat* AND critical AND unit* )
# 44 #41 or #42 or #43
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Appendix 3 Study inclusion worksheet for titles 
and abstracts
Selection criteria worksheet to be used on titles and abstracts
Educational intervetntions for preventing catheter-related bloodstream 
infections in critical care
Lead author name and ref. ID number:
Population Patients in critical carea with vascular catheter(s)b Yes Unclear No
↓ ↓ →
Next question Next question EXCLUDE
Design Interventional study, primary research Yes Unclear No
↓ ↓ →
Next question Next question EXCLUDE
Intervention Educational interventionsc with an objective to reduce or 
prevent CRBSIs
Yes Unclear No
↓ ↓ →
Next question Next question EXCLUDE
Outcomes BSIs, or mortality associated with, related to, or suspected 
to result from catheter use.d 
Yes Unclear No
↓ ↓ →
Next question Next question EXCLUDE
Final decision INCLUDE UNCLEAR (discuss) EXCLUDE
a Any critical or intensive caree including high-dependency units. Excludes general wards and specialist (e.g. cardiac, 
neurological, surgical) non-critical units.
b Excludes studies that are solely on urinary or other non-vascular catheters. Patients with urinary or other non-vascular 
catheters may be included only if vascular catheterse are also present.
c For the purposes of this systematic review, an educational intervention is defined as any intervention that aims 
to prevent CRBSI and (a) includes at least an element of factual information provision related to that aim; (b) is 
described by the authors as educational; or (c) is described by the authors as behavioural. Includes checklists. Excludes 
interventions that do not target CRBSIs (e.g. interventions for hand hygiene alone). Excludes surveillance unless a 
relevant intervention is also reported. Excludes provision of factual information if it is unrelated to the intervention.
d Excludes BSIse that are not related to vascular catheter use. Excludes non-vascular infections (e.g. urinary tract, skin), 
unless relevant BSIs are also reported.
e There are many possible synonyms for critical care, vascular catheters, education, and BSIs – refer to the search 
strategy for a full list (see Appendix 2).
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Appendix 4 Keyword tool for evidence map 
study classification
1. Study identification
Reference ID: Reviewer:
Lead author:
Publication year:
Intervention implementation date(s):
Country (if USA, also the state):
Recording the state here (USA studies only) helps us to identify linked studies. Write ‘multistate’ if more than one, or ‘state 
not reported’ if appropriate
No. of critical care units:
No. of centres (specify if not hospitals):
‘Centres’ here refers to the hospitals in which critical care units are sited (not the departments within hospitals, or clusters 
of hospitals within administrative regions). Please write the type of unit here if not a hospital
If one centre only, name of centre:
This information helps us to identify linked studies (it will not be systematically collected for evidence mapping)
2. Critical care specialties
Cardiac If ‘Other’ is selected please write the type(s) of critical care 
here (this will be used to update the list)
Medical
Neonatal
Neurological
Paediatric
Surgical
Trauma
Mixed
Other
Unclear
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3. Vascular devices
Device type(s) reported Device type refers to what type of catheter it is (e.g. CVC, 
PICC)
Insertion site(s) reported Insertion site refers to the specific blood vessel in which the 
catheter is inserted
Lumen material reported Lumen material refers to what the catheter tubing is  
made of
Lumen coating reported Lumen coating refers to any chemical coating or 
impregnation of the catheter, e.g. catheters with 
antimicrobial or anticoagulant surfaces
Lumen no. and use reported The number of catheter lumens can affect risk of CRBSI 
(unused lumens can act as a conduit for microorganisms). 
Select this option only if the use of all reported lumens is 
explained
Device changes reported Changing catheters can increase risk of infections and other 
complications (e.g. pneumothorax). Select this option if any 
information about device changes (e.g. number, frequency, 
interval or reasons for changes) is reported
Device purpose(s) stated Device purpose refers to what the catheter(s) lumen(s) 
are used for (e.g. drug provision, nutrition provision, 
haemodynamic monitoring or haemodialysis)
None of the above reported This is a required response if none of the other options 
applies, to help ensure that you have systematically checked 
the paper and not inadvertently missed information
4. Device placement
Precritical care Patients arrive in critical care with vascular catheters  
already in situ
In critical care unit Vascular catheters are placed while patients are in the 
critical care unit. Select both options if catheters are placed 
both before and during critical care stay
Unclear
5. Concurrent invasive devices
Urinary catheter
Other non-vascular
None
Unclear
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6. Population information
Sample size: patients This refers to the number of patients for whom relevant 
outcome data are presented. It may or may not reflect the 
number of critical care beds
Sample size: critical  
care staff
This refers to the number of critical care staff who receive 
the relevant intervention(s) (not necessarily the same as the 
number of critical care staff)
Attrition: patients
Attrition: critical care staff
None of the above reported This is a required response if none of the other options 
applies, to help ensure that you have systematically checked 
the paper and not inadvertently missed information
7. Length of follow-up (months)
Insert a number, or state if follow-up timing is not reported or unclear
8. Type of intervention
 z A ‘bundle’ is defined as two or more interventions that are implemented together and aim to 
influence the same outcome(s).
 z An ‘initiative’ refers to two or more interventions delivered together or in a linked way such that the 
structure and process may appear rather complex and does not clearly fit the description of a bundle. 
Initiatives may include additional components in support of intervention implementation (e.g. provider 
collaboration strategies).
Education alone Select this option if the intervention is purely educational
Single intervention with 
education component(s) or 
support
Select this option if there is a single intervention that 
contains a mix of educational and non-educational 
components, or a single non-educational intervention 
supported by education provided separately (i.e. education 
that supports the intervention but is not part of it)
Bundle or initiative 
with discrete education 
component(s)
Select this option if a relevant bundle or initiative to prevent 
BSIs is reported and:
 z one or more of the bundle or initiative components 
involves education, or
 z the bundle or initiative components do not themselves 
involve education but education is provided separately to 
support part or all of the bundle or initiative
Bundle or initiative with 
unspecified/unclear 
education component(s)
Select this option if a relevant bundle or initiative to prevent 
BSIs is reported and education is provided to support the 
bundle or initiative, but it is unclear to which part(s) of the 
bundle or initiative the education relates
Unclear Select this option if none of the above options can be 
ascertained (e.g. owing to inadequate or  
ambiguous reporting)
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9. Aim of intervention
Specifically to prevent CRBSI
Other
10. Study design
Select one from ‘a’ to ‘j’; select ‘k’ if appropriate.
This classification is consistent with chapter 13 of the Cochrane Handbook.58
a.  Controlled trial (including 
RCT, quasi-RCT, non-
randomised)
A study with two or more parallel groups recruited 
simultaneously and matched for population characteristics, 
at least one of which receives a relevant intervention and at 
least one of which acts as a relevant comparator (e.g. no-
intervention control group). As we expect to find relatively 
few controlled trials, this option covers both randomised 
and non-randomised designs
b.  ITS (controlled or 
uncontrolled)
A study that uses observations at multiple time points 
before and after an intervention (the ‘interruption’). The 
design attempts to detect whether the intervention has 
had an effect significantly greater than any underlying 
trend over time. There is no clear consensus on how many 
measurements are required in order to classify the design 
as an ITS (as the number and spacing of measurements is 
determined by the hypothesis of individual studies). Only 
select this option if the study authors call the design an ITS
c.  Controlled cohort before-
and-after study (CchBA) – 
prospective
A study with two or more separately-recruited concurrent 
groups (cohorts), at least one of which receives a relevant 
intervention, and at least one of which acts as a relevant 
comparator (e.g. no-intervention control group). A 
‘prospective’ controlled cohort study recruits participants 
before any intervention and follows them into the future
d.  Controlled cohort before-
and-after study (CchBA) – 
retrospective
A study with two or more separately-recruited concurrent 
groups (cohorts), at least one of which receives a relevant 
intervention and at least one of which acts as a relevant 
comparator (e.g. no-intervention control group). A 
‘retrospective’ controlled cohort study identifies subjects 
from past records describing the interventions received and 
follows them from the time of those records
e.  Controlled cohort before-
and-after study (CchBA) – 
unclear
A controlled cohort before-and-after study for which it 
is unclear whether the study was done prospectively or 
retrospectively
f.  Cohort before-and-
after study (ChBA) – 
prospective
A study on a single group, which is monitored before and 
after a relevant intervention is implemented. A ‘prospective’ 
cohort study recruits participants before any intervention 
and follows them into the future
g.  Cohort before-and-
after study (ChBA) – 
retrospective
A study on a single group, which is monitored before 
and after a relevant intervention is implemented. A 
‘retrospective’ cohort study identifies subjects from past 
records describing the interventions received and follows 
them from the time of those records
h.  Cohort before-and-after 
study (ChBA) – unclear
A cohort before-and-after study for which it is unclear 
whether the study was done prospectively or retrospectively
i.  Historically controlled 
study
A study that compares a group of participants who received 
an intervention with a similar group from the past who  
did not
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j. Design unclear
k.  Incremental or phased 
implementation of 
intervention(s)
This option identifies studies in which parts of an 
intervention are implemented at different times, or different 
interventions are introduced in a staggered or sequential 
fashion. It can apply to different study designs. Please select 
the study design above
11. Concurrent interventions
Yes Concurrent interventions are interventions that overlap in 
time with the educational intervention of interest. Examples 
include simultaneous or overlapping implementation of 
interventions for CRBSI, VAP, pressure ulcers, sepsis, or 
glycaemic control. This option identifies studies in which 
confounding of interventions might be a problem
No
Unclear
12. Intervention appraisal
Evidence base specified We are seeking any justification given in the paper for 
why this intervention is being applied in this population 
and setting. A statement merely that the intervention is 
‘evidence-based’ would not be acceptable as a justification 
unless supported by relevant citations
Educational theory specified
Previous development and/
or testing reported
This refers only to previous primary research that has 
evaluated this intervention or its precursors. If only 
secondary research is available to justify the use of this 
intervention, select ‘Evidence base specified’ instead
Facilitators reported Facilitators are variables measured in the study that could 
contribute to the intervention working as (or better than) 
intended (i.e. at preventing CRBSI). Examples could include 
positive attitudes, good compliance, possession of relevant 
clinical skills, or high intervention implementation fidelity
Barriers reported Barriers are variables measured in the study that could 
contribute to the intervention not working as intended  
(i.e. not preventing CRBSI). Examples could include negative 
attitudes, poor compliance, lack of relevant clinical skills, 
high staff turnover, or low intervention  
implementation fidelity
Other process evaluation A process evaluation seeks to establish why an intervention 
works (or does not). By definition, analysis of facilitators 
and barriers is part of process evaluation. ‘Other process 
evaluation’ refers to any aspects of evaluating why the 
intervention works (or does not) that do not clearly fit under 
the headings of facilitators or barriers
None of the above reported This is a required response if none of the other options 
apply, to help ensure that you have systematically checked 
the paper and not inadvertently missed information
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13. Education messages (targets)
Antimicrobial use
Barrier precautions – full
Barrier precautions – specific 
(e.g. drapes, gloves, gown)
Catheter type selection  
(e.g. lumen number,  
chemical impregnation)
Catheter placement 
procedure (e.g. use of 
ultrasound or X-ray; 
avoidance of guidewires)
Catheter insertion site 
selection (e.g. avoidance of 
femoral site)
Catheter insertion  
site preparation  
(e.g. chlorhexidine)
Catheter ongoing 
management (e.g. flushing; 
hub care, including ‘scrub 
the hub’)
Catheter need review  
(e.g. daily inspection; 
removal of unnecessary 
catheters)
Checklist use [i.e. education 
on how to use checklist(s)]
Central line cart use
Documentation and 
auditing of processes
Dressing selection  
(e.g. antimicrobial bioptach)
Dressing care (hygiene, 
removal, replacement)
Hand hygiene
Infection prevention and/or 
control (including evidence-
based practice; guidelines)
Micro-organism 
epidemiology
Nurse empowerment (in 
critical care or  
infection prevention)
Team approach to  
catheter care
Other
Unclear
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14. Type(s) of education
Checklist with factual 
information
CD or DVD
Device training
Discussion group
Fact sheet
Goal sheet
In-service training
Lecture
Mentor led
Peer led
Poster
Practical demonstration
Residential course
Skills practice
Self-study module
Simulation based
Slide show
Supervision
Website
Workshop
Written material
Unclear component(s)
15. Education delivery
Providers specified The provider is the person or technology (e.g. computer) 
delivering the intervention (i.e. the communicator of the 
information provision or practical skills training)
Recipients specified The recipient is the staff member (or group) within the 
critical care unit to whom the educational intervention  
is directed
Neither of the  
above reported
This is a required response if none of the other options 
applies, to help ensure that you have systematically checked 
the paper and not inadvertently missed information
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16. Education contextual support
Performance feedback 
(including  
assessment/testing)
Performance feedback refers to the provision of feedback to 
the person or group receiving the educational intervention 
on how well they are progressing with the intended learning 
outcomes. This includes tests or assessments (e.g. of 
knowledge, behaviour or skills)
Infection surveillance 
feedback
Infection surveillance feedback is any process whereby 
real-time or recent information on CRBSI infection rates 
is provided in support of an educational intervention. The 
information may be made available to intervention providers 
and/or recipients
17. Duration of education
Fully reported Select this option if all educational components associated 
with the intervention(s) are reported sufficiently well 
that the total amount of time needed to implement the 
education can be ascertained (e.g. total number of hours 
required for lectures, tests and practical skills  
training sessions)
Partially reported Select this option if there are several educational 
components associated with the intervention(s) but the 
duration is only reported for some of them
Unclear Select this option if the duration is not reported for any 
educational components associated with the intervention(s), 
or is reported but unclear
18. Bloodstream infections outcomes reported
Catheter related (CRBSI) Select this option if catheter- or central line-related BSIs are 
reported, irrespective of how they are defined
Catheter associated (CABSI, 
CLAB, CLABSI)
Select this option if catheter- or central line-associated BSIs 
are reported, irrespective of how they are defined
Catheter suspected BSI Select this option if catheter- or central line-associated BSIs 
are reported, irrespective of how they are defined
Other or unclear Select this option if outcomes do not match any of the 
above categories
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19. Bloodstream infections outcome units
Rate/1000 device-days
Rate/no. of admissions
Rate/no. of patient-days
Relative risk reduction
Absolute risk reduction
Number needed to treat
Infections prevented
Percentage change  
infection rate
Incidence rate ratio
20. Secondary outcomes
Attitudes
Compliance
Knowledge
Skills
21. Other outcomes
Mortality Select this option if any type of mortality is reported  
(e.g. catheter related, BSI related, all cause)
Adverse events Select this option if adverse events due to catheter use  
and/or BSIs are reported
LOS Select this option if any LOS is reported (critical care or total 
hospital stay)
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Appendix 5 Data extraction forms for clinical 
effectiveness studies
BURRELL (2011)83
Methods
Study characteristics
Lead author, 
publication year(s) 
and reference ID(s)
Burrell (2011);83 CEC (2010)146
Summary of 
approach
A state-wide collaborative QI programme (CLAB ICU project) in Australia based on the principles 
of the Michigan Keystone ICU project, with top-down and bottom-up drivers of change 
Location Australia: New South Wales
Language English
Critical care specialty Not specified other than ICUs were primarily adult (2/37 units were paediatric)
No. of critical care 
units
37 ICUs (10 tertiary, 12 metropolitan, 13 rural, 2 paediatric)
No. of hospitals Not reported
Study design Variant of a cohort before-and-after study in which true pre-intervention data were not collected 
but instead the first 12 months of intervention were considered to be the baseline  
(‘run-in’ period)
Study time periods Pre-intervention: No data reported
Total duration of intervention: 18 months (July 2007 to December 2008)
 z ‘Run-in period’: July 2007 to June 2008: 12-month period from start of intervention 
implementation
 z ‘Analysis period’: July 2008 to December 2008: final 6-month period (assumed full 
implementation of intervention occurred by 12 months)
Follow-up: None (continuous QI programme)
Uptake of the project was staggered, with a small (unspecified) percentage of units late to start146
Funding source New South Wales Department of Health provided funding for the CEC to implement and 
support the project
Conflicts of interest Stated that none were identified 
CEC, Clinical Excellence Commission.
Population and setting
Critical care unit characteristics
Not reported. General information on the characteristics of most of the participating ICUs including 
staffing and bed number is available in cited surveys194,195 but the survey data cover the whole study 
period, not discriminating the ‘run-in’ and ‘analysis’ periods. From the surveys it appears that in 
addition to the two paediatric intensive care units (PICUs), adult units in New South Wales also included 
some paediatric patients.194 Adult ICUs in New South Wales also appear to have included some 
high-dependency beds.194
164
NIHR Journals Library www.journalslibrary.nihr.ac.uk
AppENDIx 5 – burrELL (2011)
Data are from the subset of checklists that reported insertion site (10,850 of 11,575 checklists; 93.7%).
Population and setting 
characteristics
Run-in period (months 
1–12) (24 critical care 
units in month 1)
Analysis period 
(months 13–18) (up to 
34 critical care units)
Difference between 
analysis and run-in 
periods 
Patient population characteristics Not reported Not reported Not reported
Device characteristics
Insertion site – jugular 1119 (33.0%) 2452 (32.9%) Overall effect of 
insertion site p = 0.998 
(ridit analysis)Insertion site – subclavian 999 (29.4%) 2082 (27.9%)
Insertion site – femoral 772 (22.8%) 1875 (25.1%)
 Insertion site – cubital fossa 400 (11.8%) 809 (10.8%)
 Insertion site – other/unknown 103 (3.0%) 239 (3.2%)
 Total available data for insertion site 
(93.7% of the checklists that  
were returned)
3393 (100%) 7457 (100%)
Insertion site antisepsis used Not reported. A project update in an ICCMU newsletter (February 2008) noted 
that for one-third of central lines in the project database the line coating was 
not specified
Dressing type and duration/frequency Not reported
ICCMU, Intensive Care Coordination and Monitoring Unit.
Intervention characteristics
Objective To achieve a measurable reduction of CLAB in New South Wales ICUs. Initially defined by health service 
agreements as a 20% reduction by January 2008 and a further 80% by January 2010146
Main focus of 
education 
Catheter insertion. Focusing on the preparation of the clinician (hand hygiene, barrier precautions 
and sterile technique) and patient [skin preparation, patient draping and catheter positioning during 
insertion (imaging)]. Referred to as a clinician bundle and a patient bundle, respectively
Trainers 
(providers)
CEC and ICCMU promoted the intervention to ICU clinicians. Project governance was provided by 
a steering committee, with stakeholder representation. The steering committee members and their 
contributions to meetings during 2007–9 are listed in the final project report.146 ICUs developed 
improvement teams with physician and nursing representation from existing staff
Training of 
trainers
Not reported
Learners 
(recipients) 
ICU staff (‘proceduralists’) who were permitted or being trained to insert CVLs (staff grades  
not specified)
Target 
behaviour 
change
Sterile catheter insertion procedure
Development 
and testing
A multidisciplinary expert group was convened to develop a guideline for CVL insertion based on 
existing guidelines. A checklist including the ‘patient bundle’ and the ‘clinician bundle’ was developed 
to support the compliance with the guideline and to collect data. The intervention was based in 
principle on the Michigan Keystone ICU project intervention. As a QI initiative, some aspects of 
development and testing ran concurrently with implementation
Educational or 
behavioural 
theory
Not reported
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Educational 
strategies 
and topics 
targeted
Principal focus on catheter insertion guidelines supported by an insertion checklist and awareness 
campaign. The guideline, checklist, training framework, posters, newsletters and data collection 
document are available at: www.cec.health.nsw.gov.au/programs/clab-icu#resources2 (accessed  
October 2012)
Evidence-based percutaneous catheter insertion guideline: Emphasised importance of hand 
hygiene, skin preparation and full barrier precautions (displayed prominently in some ICUs)
Checklist: Developed and revised based on feedback from learning sessions. To facilitate data 
collection and ensure compliance with the guideline. Observer empowered to stop procedure if a 
significant breach of aseptic technique by the proceduralist. Check items were: staff competency; hat, 
mask and protective eyewear, hand hygiene, sterile gloves and gown, skin preparation with alcoholic 
chlorhexidine; full patient draping with sterile sheets; maintenance of sterile technique throughout 
procedure; documentation of guidewire removal; securing and dressing catheter; confirmation of 
catheter vascular position; complications
Education and training workshops: Two large initial workshops in June 2007 (introduction and 
forging links) and November 2007 (feedback and sharing initial successes). Included open discussion of 
barriers to implementation and suggestions for improvement. Subsequently, smaller workshops were 
held to develop standard education and training approaches and an e-learning package. Some ICUs 
had weekly or biweekly multidisciplinary meetings to review CLABs (e.g. as reported in November 2008 
ICCMU newsletter)
Training framework (developed and improved during October 2007 to August 2008): Defining the 
minimum knowledge and practical skills required for CVC insertion, with catheter insertion competence 
assessed under supervision and documentation of feedback and learning needs in a logbook. Supported 
by a 1-page training support tool listing 56 competence/knowledge criteria
Posters of three types: (1) explained the definition of CLAB; (2) explained the process for confirming 
CLAB including need for multidisciplinary team consultation; (3) bullet point reminders of appropriate 
site selection; hand hygiene; aseptic technique; maximal barrier precautions; securing and dressing of 
catheter; and daily assessment of need for catheter
Data collection document: Provided an explanation of CLAB definitions; emphasised that collection 
and submission of CLAB data are a multidisciplinary activity involving intensive care, microbiology and 
infection control practitioners
Unstructured teleconferences: Monthly for first year then bimonthly, held by the project co-ordinator
Electronic updates: Articles in bimonthly newsletters of the ICCMU, Listserv circulars and ad hoc 
e-mails from the project team to participating sites
Infection 
surveillance 
feedback 
approach 
Checklists were submitted by ICUs to the CEC project co-ordinators who prepared and disseminated 
surveillance reports to ICUs as they were received. The project team conducted data integrity checks and 
followed up missing or improbable data, and confirmed the validity of reported CLABs with individual 
ICUs. Outliers were identified based on CLAB numbers or incidence rates, with identified ICUs subjected 
to additional analyses to provide insight into causes and to promote improvement
Performance 
feedback 
approach 
Monthly reports of compliance with the patient bundle and clinician bundle were provided to ICUs, 
starting in October 2007. Reports were also issued monthly to area health service clinical governance 
units and quarterly to New South Wales Health. Checklist submission was used as a proxy for 
participation. Validation and reliability of the reporting process not stated
Within the training framework undertaken by new or unqualified staff, proceduralists were supervised 
before performing independent CVL insertions. The supervisor recorded feedback and learning needs in 
a log book
Concentration 
of education 
Owing to the complex nature of the collaborative intervention, in which the methods adopted varied 
among the participating ICUs and were continuously implemented, the precise frequency and duration 
of all education activities cannot be established. However, sufficiently detailed information is given (if 
the online supporting documents are consulted) to allow numerous aspects of the programme to be 
repeated or adapted (including the guideline, checklist, posters and training framework). The frequency 
and type of meetings required is largely discernible from the information given
Non-
educational 
intervention 
components
Standard sterile equipment pack made available for use across all New South Wales adult ICUs; staff 
empowerment to halt procedure
Costs 
reported
Yes. Detailed costs of the intervention for 2008 are given in an appendix to the project report
CEC, Clinical Excellence Commission; CVL, central venous line; ICCMU, Intensive Care Coordination and 
Monitoring Unit.
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Outcome characteristics
Catheter-BSI 
definition
Reference cited: 
O’Grady et al.196
Based on New South Wales Department of Health 2005 and CDC surveillance definitions for CLAB 
(reference cited), except that only CLABs occurring in patients in the critical care unit or within 24 hours 
of transfer out were recorded
 z The cultured organism is not related to an infection at another site and
 z The presence of a recognised pathogen cultured from one or more blood cultures or
 z The presence of fever (> 38 °C), chills or rigors; or hypotension (episode), within 24 hours of a 
positive blood culture being collected and at least one of the following:
 | Isolation of the same potential contaminant from two or more blood cultures drawn on separate 
occasions within a 48-hour period (isolates identified by suitable microbiological techniques) or
 | Isolation of a potential contaminant from a single blood culture drawn from a patient with an 
intravascular line (within 48 hours of the episode) and appropriate antimicrobial therapy against 
the isolate is commenced
Outcomes 
reported
Not referred to as primary or secondary, but stated that the main outcomes were compliance with 
aseptic CVL insertion and rates of CLAB
CLAB incidence: per 1000 central line-days; % change
No. of catheters used
Catheter dwell time
Compliance with clinician bundle
Compliance with patient bundle
Adverse events (retained and broken guidewires) (data not extracted by reviewers)
CVL, central venous line.
Results data
Primary outcomes
Data are from the subset of checklists that reported central venous line (CVL) type (10,890 of 11,575 
checklists; 94.1%). Date of discharge from ICU was used as a proxy for date of CVL removal if a CVL was 
still present at discharge. Simultaneous CVLs in the same patient were counted as a single device.
Outcome
Baseline (run-in period) 
(months 1–12) (24 critical 
care units in month 1)
Intervention (analysis 
period) (months 13–18) 
(up to 34 critical care 
units)
Difference between 
baseline (run-in) and 
intervention (analysis) 
periods 
Device utilisation
CVLs used
 Centrally inserted 2432 5289 Statistical comparison not 
reported
 Peripherally inserted 475 992
 Dialysis 397 865
 Other and unspecified 43 82
 Total 3347 7228
Total (range) line duration, days*
Centrally inserted 13,174 (1–58) 29,331 (1–104) Statistical comparison not 
reported
Peripherally inserted 1352 (1–37) 3365 (1–242)
Dialysis 2215 (1–130) 4434 (1–52)
Other and unspecified 210 (1–25) 290 (1–21)
Total 16,951 (1–130) 37,420 (1–248)
*Includes only inserted CVLs for which data on CVL type and line-days were available
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Outcome
Baseline (run-in period) 
(months 1–12) (24 critical 
care units in month 1)
Intervention (analysis 
period) (months 13–18) 
(up to 34 critical care 
units)
Difference between 
baseline (run-in) and 
intervention (analysis) 
periods 
Median (IQR) in situ period, days
Centrally inserted 8 (8) 8 (8) Statistical comparison not 
reported
Peripherally inserted 6 (10) 8 (15)
Dialysis 9 (9) 8 (8)
Other and unspecified 8 (10) 6 (10)
Total 8 (8) 8 (8)
Device-days (not reported; 
e-mailed by author)
First quarter 9308 Second quarter 7684
Third quarter 9634
Fourth quarter 9725
Fifth quarter 9589
Sixth quarter 8773
No. of devices/patient Not reported Not reported Not reported
CLAB incidence rate Not reported Not reported Not reported
CLAB incidence  
per 1000 catheter-days:  
(a) reported; (b) e-mailed 
by the author
(a) First quarter 3.0 (95% CI 
2.0 to 4.3)a
(a) Sixth quarter 1.2 (95% 
CI 0.6 to 2.2)a
(a) 60% reduction; 
p = 0.0006; χ2 of 
slope = 11.71
(b) First quarter 3.0 (b) Second quarter 2.6
(b) Third quarter 1.3
(b) Fourth quarter 1.9
(b) Fifth quarter 1.0
(b) Sixth quarter 1.3
CLAB incidence per 1000 
patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Estimated only, not 
measured
a Further incidence rate data reported by quarter in a graph but not extracted by reviewers.
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Secondary outcomes
Outcome
Baseline (run-in period) 
(months 1–12) (24 critical 
care units in month 1)
Intervention (analysis 
period) (months 13–18) 
(up to 34 critical care 
units)
Difference between 
baseline (run-in) and 
intervention (analysis) 
periods 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance with clinician 
bundle
74% (reported for a quarter 
but unclear which one)
81% (for last quarter of 
project)
7% improvement; 
p < 0.0001; χ2 of 
slope = 118.83
Compliance with patient 
bundle
81% (reported for a quarter 
but unclear which one)
92% (for last quarter of 
project)
11% improvement; 
p < 0.001; χ2 of 
slope = 108.34
Compliance with both 
bundles
Not reported Not reported 1.4 times more likely in 
analysis period; p = 0.0001; 
χ2 of slope = 14.325
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation
Internal evaluation revealed:83
 z Reduced risk of CLAB if insertion was conducted by physicians compliant in both bundles: RR = 0.5 (95% CI 0.4 to 0.8); 
p = 0.004
 z Increased risk of CLAB if insertion was conducted by physicians not compliant with the clinician bundle: RR = 1.62 
(95% CI 1.1 to 2.4); p = 0.018
 z Reduced risk of CLAB associated with centrally inserted CVLs: RR = 0.5 (95% CI 0.3 to 0.9); p = 0.01
 z Increased risk of CLAB if patient had a centrally inserted CVL and insertion was conducted by physicians not compliant 
with the clinician bundle: RR = 1.99 (95% CI 1.2 to 3.2); p = 0.004
 z Increased (but not statistically significant) risk of CLAB if patient had a peripherally inserted CVL and insertion was 
conducted by physicians not compliant with the clinician bundle: RR = 5.08 (95% CI 1.03 to 25); p = 0.059
 z No significant difference in risk whether physicians complied with the clinician bundle but not the patient bundle, or 
complied with both bundles (p = 0.891)
 z No significant risk change associated with using peripherally inserted CVLs (p = 0.07) or other CVL types (p = 1.0)
 z 94.0% of cases of non-compliance with the clinician bundle were due to failure to wear a hat, mask and eyewear
Attendance at teleconferences by expert group and month was recorded and reported146
The following potential or actual barriers to implementation were reported, but not quantified:146
 z Some clinicians considered the incidence of CLAB in New South Wales to be low and doubted the value of the project, 
as Australian practice was considered to be equal to, or better than, the methods informing the project
 z Some clinicians doubted the evidence even with supportive CDC guidelines. Methodology was based on a single 
successful collaborative (Pronovost and colleagues34,123,124) without a detailed analysis of all available evidence. This 
allowed criticism of methodology to be an excuse for non-compliance
 z Hat wearing was a contentious element of the physician bundle – clinicians cited lack of evidence for their use and four 
ICUs elected to omit their use as standard practice for CVL insertion
 z Inadequate staffing rates in some ICUs impacted on data capture rates. Some units resisted a requirement for staff to 
follow up on CVLs and submit checklists. Some checklists were self-completed by proceduralists as assistance was not 
always available
 z Difficulty was encountered in ensuring that infection surveillance definitions were applied and adhered to
 z Difficulties were encountered regarding data collection and associated information technology such that the project 
team resorted to hard copy receipt of checklists in October 2007 and manual data entry in August 2008. The lack of a 
continuous and sustainable data collection system involving cross-specialty collaboration was seen as a serious risk to 
sustainability of the CLAB ICU principles
 z Reliable baseline data did not exist prior to the project, owing to variable reporting mechanisms. Some units were 
hesitant to accept previously reported rates
 z Frequently CLAB was reported without discussion with senior ICU staff, despite dissemination of posters and concise 
definition notes
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Critical appraisal
Potential for bias
Group 
selection
Were there systematic differences between the baseline and intervention groups? NOT REPORTED
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates or 
subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT REPORTED. No state-wide changes in related health policy or practice concurrent 
with the intervention were mentioned by the authors but it was not explicitly stated that such 
changes did not occur. However, although most ICUs formed improvement teams, there was variable 
engagement of key personnel
Was the effect of educational practice separable from effects of non-educational practice? NO. 
Although the intervention was primarily based on educational approaches, other non-education 
components were included, notably a standard sterile equipment pack made for use across all New 
South Wales adult ICUs
Were the intervention component(s) implemented as planned?
PARTIALLY. Reported all-or-nothing compliance with patient and clinician bundles improved from 
baseline and reached 81% and 92%, respectively. However, difficulties were encountered regarding 
data collection and associated information technology such that the project team resorted to hard copy 
receipt of checklists in October 2007 and manual data entry in August 2008
Missing data Were there systematic differences between the baseline and intervention groups in attrition or 
exclusions (includes withdrawal due to mortality; missing outcome data)? UNCLEAR. Device utilisation 
data differed between the two study periods but it is unclear whether this reflects real differences in 
device utilisation and/or differences in checklist returns
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. This intervention 
encouraged standardisation of how outcomes were defined, detected and reported so it is difficult to 
identify possible bias in outcome measurement
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
Self-reporting bias: some checklists were filled in by the proceduralist, as assistance was not always 
available. Authors stated that as this was a QI initiative and not a study, these factors could not be 
controlled. Data on CVL type and line-days not available for all CVLs – unclear whether this is a possible 
source of bias as reasons for data non-availability not given
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? YES
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Stated that data entry was manual, with an infection 
nurse checking data on each form. Collected data were received and collated by the CEC
If YES or PARTIALLY, was the data collection process shown to be valid? PARTIALLY. Authors state that 
missing and invalid data were followed up and validity of reported CLAB were confirmed with individual 
ICUs. However, a quality test to review data capture was not completed by all sites and at least one 
tertiary unit had low data capture
If YES or PARTIALLY, was the data collection process shown to be reliable? NO. Many ICUs did not 
have microbiological support and reported CLAB with discussion with senior ICU staff. Improved 
understanding of surveillance definitions vs. clinical definitions led to some CLABs cases to  
be reclassified
Statistical tests described? PARTIALLY. Not all outcome analyses (e.g. ridit) were reported in the  
methods section
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? PARTIALLY. Some aspects of catheter insertion procedure were 
complied with more extensively than others. Changing sterile hat-wearing behaviour seemed to be a 
particular obstacle
CEC, Clinical Excellence Commission.
Additional comments
 z The project involved collaboration between the New South Wales Department of Health, the NSW 
Clinical Excellence Commission (CEC), ICCMU and individual ICUs.
 z Following the project, an independent external project evaluation was conducted by the Centre for 
Clinical Governance Research University of New South Wales. This led to seven key recommendations 
for the operation of similar collaborative projects.
 z The data reported above are from the primary research publication,83 final project report146 and 
extensive online material associated with the project: a catheter insertion guideline, checklist, training 
framework, posters, data collection document, and newsletters, available at: www.cec.health.nsw.gov.
au/programs/clab-icu#resources2 (accessed October 2012).
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COOPERSMITH (2002)50
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Coopersmith (2002)50
Summary of approach Single unit, education initiative to decrease the primary BSI rate, based on a self-study 
module aimed primarily at full-time ICU nursing staff (to provide continuity given the rotation 
of residents and fellows in the ICU)
Location USA, Missouri
Language English
Critical care specialty Surgical/burn/trauma Intensive Care Unit (ICU)
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Barnes-Jewish Hospital, St Louis, MO, USA
Study design Single cohort before-and-after study 
Study time periods Baseline: January 1998 to June 1999 (18 months)
Intervention: July to December 1999 (6 months)
Follow-up: none (only intervention monitored)
Funding source Stated that work was supported in part by funding from the Centers for Disease Control and 
Prevention Cooperative Agreement, the BJC Hospital Epidemiology and Infection Control 
Consortium and the National Institutes of Health
Conflicts of interest Not reported
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Population and setting
Critical care unit characteristics
University-affiliated teaching hospital with 18 ICU beds, with an average of 1400 patients admitted per year
Mean LOS: 3.8 days
Nurse to patient ratio 2 : 1, but with very high acuity levels may be 1 : 1 (at the discretion of the charge nurse)
Clinical practice: nursing staff have primary responsibility for catheter maintenance and function as bedside assistants 
when physicians place CVCs. CVCs placed throughout the length of the study were inserted by residents from the 
departments of surgery (PGY-1, PGY-2), anaesthesiology (PGY-2, PGY-3) and emergency medicine (PGY-2) as part of their 
4- to 6-week rotation through the ICU. CVC placement was supervised by surgery, anaesthesiology or pulmonary critical 
care fellows
Use of antibiotics and antiseptics: Not reported
Stated that nursing and technician staffing patterns were similar throughout the length of the study
Patient population characteristics 
(not stated whether mean or median) Baseline Intervention 
Difference between baseline and 
intervention
Patient census per month 121.6 115.6 Statistical significance of acuity score not 
mentioned; stated all other p-values were not 
statistically significantBed occupancy, % 85.8 83.7
Ventilated patients per month 68.3 66.3
Length of mechanical ventilation, days 2.5 2.8 
Patient acuity score (average of 
36-indicator Medicus system)
2.9 2.9
Male, % 59.8 55.3
Weight, kg 78.0 80.2
CVCs placed per month 40.2 40.4
Device characteristics Devices reported as CVC; PICCs were excluded from analysis. Chlorhexidine 
and silver sulfadiazine-impregnated catheters were inserted when patients 
were clinically judged to need four CVC lumens for access purposes (around 
1–2%). Quadruple-lumen, antibiotic-impregnated catheters were used pre 
and post interventions but accessibility was ‘specifically limited’ after the 
implementation of the education
Insertion site antisepsis used Not reported
Dressing type and duration/
frequency 
Not reported 
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Intervention characteristics
Objective To determine whether an education initiative aimed at improving CVC insertion and care in a 
surgical/burn/trauma ICU can decrease the rate of primary BSIs
Main focus of 
education 
Detailed module covering CVC insertion and maintenance, and prevention of primary BSI; aimed 
primarily at nurses 
Trainers (providers) Not applicable for self-study module; providers of in-service and lectures not reported
Training of trainers Not reported
Learners 
(recipients) 
All registered nurses in the ICU [the self-study module and tests were mandatory – but note that 
compliance (reported below) was not 100%]. All new nurses hired after 1/7/1999 were required to 
complete the study module and post test but no critical care fellow hired after this date took part 
in the programme; no residents placing CVCs participated in the full education module
Target behaviour 
change
Multiple hygienic practices associated with catheter insertion and maintenance
Development and 
testing
Comparison of hospital policy with CDC recommendations on insertion and care of CVCs 
by a multidisciplinary task force (a physician and infection control practitioners) consisting of 
representatives from nine hospitals in the Barnes-Jewish-Christian Health System (13 acute-care 
hospitals located in the St Louis area). Nurses in the ICU completed a 17-question survey about 
their own CVC care practice and a 13-question observation survey on physician practice that they 
witnessed during CVC insertion. Based on the information obtained, the task force designed an 
education module to improve practices related to CVC insertion and care. No pilot testing of the 
module was reported
Educational or 
behavioural theory
Not reported
Educational 
strategies and 
topics targeted
Ten-page self-study module: topics included epidemiology and scope of the problem, risk 
factors, aetiology, definition and methods to decrease risk. Risk factors specifically addressed 
included length of both hospitalisation and catheterisation, colonisation of insertion site and hub,  
and anatomical location of CVC placement. Specific risk reduction strategies addressed included 
hand washing and aseptic technique; methods for detecting potential clinical signs and symptoms 
of local infection; technique for sending catheter tip culture; routine catheter site care; replacing 
administration sets and fluids; cleaning and changing injection ports and Luer-lock caps; how 
to handle parenteral fluids and multidose vials; and procedure for drawing blood cultures. 
Guidelines covered in the module: included changing injection caps and intravenous tubing for 
fluids and medications every 72 hours (or immediately if blood accumulated around the cap or its 
integrity was compromised); replacing transparent line dressings every 7 days or gauze dressings 
(used solely if bleeding or oozing at the insertion site) every 48 hours; and immediate replacement 
of dressings that were soiled or no longer occlusive
Staff-wide in-service training: implied that staff listened to this; content not reported
Six fact sheets and one poster from the study module were displayed in the ICU
Lectures: Given to a subset of attending physicians, fellows and a single group of residents 
rotating through the ICU (content, providers, duration and frequency not reported)
Infection 
surveillance 
feedback approach 
Conducted during both baseline and intervention periods: Monthly updates on the ICU’s infection 
rate and comparisons to NNIS data were presented at staff meetings
Performance 
feedback approach 
Mandatory 20-question examination on knowledge of catheter-related bacteraemia before and 
after the self-study module and in-service training. Details of the examination topics were provided 
in a table (data not extracted by reviewers). Nurses who scored < 80% in the post-test were 
required to repeat the module
Concentration of 
education 
Total time for two tests, reading the self-study module and listening to the in-service was around 
1 hour (variations between staff mentioned but no further details reported). Staff scoring below 
80% had to repeat the self-study module (time taken unclear). Apart for monthly BSI rate updates 
in the ICU, paper states that no formal programme aimed at reinforcing the material in the 
education module was required
Non-educational 
intervention 
components 
Quadruple-lumen, antibiotic-impregnated catheters were used pre and post interventions, but 
accessibility was ‘specifically limited’ after the implementation of the education
Costs reported No. Only a crude estimate of cost saving reported
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Outcome characteristics
Catheter-BSI 
definition
Reference cited: 
Pearson197
Infections were classified as primary or secondary based upon CDC NNIS definitions (reference cited)
Primary BSI (bacteraemia) was defined as (1) recognised pathogen isolated from blood culture not 
related to infection at another site or (2) fever of > 38.5 °C, chills or hypotension, and either of 
the following: (a) common skin contaminant isolated from two blood cultures drawn on separate 
occasions, within 24 hours, unrelated to infection at another site, or (b) common skin contaminant 
isolated from a blood culture from a patient with an intravascular device and the physician institutes 
appropriate antimicrobial therapy
Secondary bacteraemia was defined as BSI, which develops as a result of a documented infection with 
the same microorganism at another body site
Outcomes 
reported 
Not stated whether primary or secondary:
BSIs per 1000 catheter-days; % decrease of BSIs; primary BSIs in 6-month intervals pre and post 
intervention; total number of catheter-days; number of isolates and % decrease of total isolates; 
bacteraemia; acuity; compliance; average % correct on pre-intervention test; improvement in test 
scores; average increase in pre to post-test scores; identical average scores pre and post-test, average 
decrease scores from pre to post-test
Monthly rate per 1000 CVC-days of BSIs from January 1998 to December 2000 displayed in graph 
format (not data extracted)
Results data
Primary outcomes 
Outcome
Baseline 2188 
patients; 18 months
Intervention 2095 
patients; 6 months
Difference between 
baseline and intervention 
(statistics not reported 
unless stated)
Device duration Not reported Not reported
Total device utilisation, days 6874 7044
No. of devices/patient Not reported Not reported
Total no. of primary BSI 74 26
BSI incidence per 1000 catheter-days 10.8 3.7 66% decrease; p < 0.0001
BSI incidence per 1000 patient-days Not reported Not reported
LOS, days 3.7 4.0
Mortality Not reported Not reported
Outcomes data for 6-month periods
Reporting perioda
Infections per 1000 CVC-days (no. of primary BSI)
Baseline Intervention
January to June 1998 11.6 (25) (for 2150 CVC-days)
July to December 1998 11.9 (28) (for 2355 CVC-days)
January to June 1999 8.9 (21) (for 2369 CVC-days)
July to December 1999 5.1 (12) (for 2358 CVC-days)
January to June 2000 2.4 (6) (for 2455 CVC-days)
July to December 2000 3.6 (8) (for 2231 CVC-days)
a Monthly infection incidence per 1000 catheter-days also reported in a graph (not extracted by reviewers).
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Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Overall 52/66 staff (78.8%) completed the entire education module, comprising 49/56  
full-time nurses (87.5%); 1/6 attending physicians (17%); and 2/4 critical care fellows (50%);
5 (9%) nurses read the study module and took only the post test
2 (3.5%) nurses read the study module but did not take any tests
Knowledge, test scores Baseline Intervention Difference between 
baseline and intervention 
Average score,  
% correct ± SD
78.3% ± 12.9% 89.9% ± 8.3% p < 0.0001 (95% CI 7.97 to 
15.30)
No. (%) with higher score 
on post test
36 (69.2%) Not reported
Average test score increase, 
% ± SD
74.0% ± 11.7% to 91.7% ± 6.9% p < 0.0001 (95% CI 13.8 
to 21.5)
No. (%) with identical 
baseline and post-
intervention scores (average 
score 87% correct)
12 (23.1%) Not applicable
No. (%) with decrease on  
% correct post intervention
4 (7.7%) Change in average correct 
score from 92.5% to 85%
Average score for five nurses 
who took module and post 
test only
86% Not reported
Skills Not a study outcome
Process evaluation Compliance assessed (data above). No other process evaluation reported
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? 
UNCLEAR. Patient age was not reported
If YES, were the differences between the groups adjusted for in statistical analyses  
(e.g. as covariates or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the 
overall intervention? YES. Authors stated that decreases in catheter-related fungaemia 
from 9 to 0 cases may be a reflection of changes in antibiotic prescribing patterns. The 
accessibility of quadruple-lumen antibiotic-coated catheters changed during the study; 
it was ‘specifically limited’ after the implementation of the education, with the authors 
stating they could not rule this out as a confounding influence
Was the effect of educational practice separable from effects of non-educational practice? 
YES (educational intervention), assuming that the potential confounders noted above 
would be of negligible importance
Were the intervention component(s) implemented as planned? PARTIALLY. Education was 
mandatory but compliance was not 100%
Missing data Were there systematic differences between the baseline and intervention groups in  
attrition or exclusions (includes withdrawal due to mortality; missing outcome data)?  
NOT REPORTED
Outcome measurement Were there systematic differences between the baseline and intervention groups in how 
outcomes were determined (including differences in how outcomes were defined)? YES. 
The authors stated: Because one definition of infection was ‘common skin contaminant 
isolated from blood culture from patient with intravascular device and physician institutes 
appropriate antimicrobial therapy,’ treatment of catheter colonisation could have accounted 
for a large number of documented infections in the pre-intervention time period. Although 
the meaning is unclear, it implies a procedural difference occurred between the baseline 
and intervention periods
Was any blinding of personnel and/or outcome assessors reported (including assessors of 
blood cultures)? ICU staff not blinded, no further details reported
Other possible sources 
of bias
Authors stated that treatment of catheter colonisation could have accounted for a large 
number of documented infections in the pre-intervention period
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Other critical appraisal criteria
Methods Intervention described in sufficient detail to be replicated? NO. The content of the  
self-study module and tests was reasonably well described but did not precisely list the test 
questions asked. The in-service training and lectures were not described at all. The reported 
completion time of one hour on average for two 20-question tests, a 10-page self-study 
module and unspecified in-service training suggests that only superficial coverage of the 
content could have been achieved
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT APPLICABLE
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? NOT REPORTED. The authors stated that improvement 
in test scores led to a change in behavioural pattern but this was based on an assumption, 
not on measured changes in bedside practice
Additional comments
 z Monthly infection incidence data per 1000 catheter-days were reported in figure 1 of the primary 
study (full data not extracted by reviewers). These data indicate high month-to-month variability in 
incidence rates. During July, August and September 1998 baseline incidence rates were, respectively, 
about 5, 24 and 12 per 1000 catheter-days (data estimated from graph). During July and August 
1999, incidence rates (around 9 per 1000 catheter-days) exceeded some of the monthly incidence 
rates in the baseline period.
 z No information on what proportion of patients in either time period were completely monitored with 
regard to BSIs.
 z Unclear whether BSI monitoring was based on blood culture monitoring in response to clinical signs or 
whether there was routine monitoring of factors, such as catheter tip removal.
 z Unclear how long after the education module the post test was, and unclear how long the knowledge 
gained persisted.
 z The target nurses were not involved in the development of the intervention that was aimed primarily 
at them.
 z Rationale of intervention was that educating nurses may have had a knock-on effect on practitioners 
who inserted CVCs but this was not tested.
 z Very limited, almost no, information on the use of antibiotics and antiseptics.
 z Unclear whether staff were advised of the existence of the study.
 z During development of the intervention the views of physicians who insert CVCs were not included.
 z Coopersmith (2004)87 provides additional follow-up data and suggests that compliance with  
evidence-based practices was poor following the initial intervention.
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COOPERSMITH (2004)87
Methods
Study characteristics
Lead author, publication 
year(s) and reference ID(s)
Coopersmith (2004)87
Summary of approach Single unit behavioural intervention to improve compliance with all facets of best practice 
of CVC insertions and maintenance (followed, but independent of, a previous intervention 
reported by Coopersmith (2002)50)
Location USA, Missouri
Language English
Critical care specialty SICU
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Barnes-Jewish Hospital, St Louis
Study design Single cohort before-and-after study 
Study time periods Baseline: July 1999 to June 2001 (24 months)*
Pre-intervention audit: November 2000 to January 2001
Intervention: July 2001 to September 2002 (15 months)
Post-intervention audit: November 2001 to February 2002
Follow-up: None (continuous intervention implementation)
[*Previous education intervention implemented July 1999 and monitored up to December 
1999; reported by Coopersmith (2002)50]
Funding source Funding received from the Centers for Disease Control and Prevention Cooperative 
Agreement, the BJC Hospital Epidemiology and Infection Control Consortium and the 
National Institutes of Health
Conflicts of interest Not reported
SICU, surgical intensive care unit.
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Population and setting 
Critical care unit characteristics
Eighteen beds (staffed by 69 nurses during previous educational programme implementation), with around 1400 patients 
admitted per year. Extended to 24 beds by the end of the study (exact time of change not reported), with 12 attending 
physicians (final number of nursing staff not reported)
Average LOS: 4.3 days
Clinical practice based on an educational programme aimed at preventing CRBSIs: reported by Coopersmith et al.50  
(Note that there was relatively poor compliance with this – details below)
During the whole study period, CVC maintenance and site care were performed by registered nurses only. The CVCs were 
placed by residents from the departments of surgery (PGY-1, PGY-2), anaesthesiology (PGY-2, PGY-3) and emergency 
medicine (PGY-2) as part of their 4- to 6-week rotation through the ICU and a full-time nurse practitioner. CVC placement 
was supervised by surgery, anaesthesiology or pulmonary/critical care fellows or by ICU attending staff. CVCs were not 
routinely changed over guidewires at any time during the study
Baseline Intervention
Patient population 
characteristics
Male, % 49.4 56.9
Mean age, years 54.5 57.4
Contact isolation, % 25.2 25.0
Device characteristics (% of CVCs) (171 CVCs in 99 patients) (138 CVCs in 72 patients)
Insertion site Subclavian 53 53
Internal jugular 41 41
Femoral 6 6
Location of catheter 
insertion
SICU 73 84
Operating room 21 10
Emergency department 1 2
Other (hospital ward, 
outside hospital)
5 4
Insertion site antisepsis used: (171 CVCs in 99 patients) (138 CVCs in 72 patients)
 Antibiotic ointment (% of CVCs) 3 4
Dressing type (% of CVCs): (171 CVCs in 99 patients) (138 CVCs in 72 patients)
 Transparent 93 98
 Gauze 3 1
 Both 4 1
SICU, surgical intensive care unit.
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Intervention characteristics
Objective To improve compliance with evidence-based guidelines for CVC insertion and maintenance
Main focus of 
education 
Specified behaviours associated with CVC insertion and maintenance (hand hygiene; barrier 
precautions; antibiotic ointment and dressing use; dating dressings; avoiding stopcocks)
Trainers 
(providers)
One or two named study authors gave lectures and hands-on demonstrations
Training of 
trainers
Not reported
Learners 
(recipients) 
Nurses received lectures and hands-on demonstrations as part of their annual skills sessions. The entire 
resident staff of surgery and emergency medicine departments received lectures. Monthly lectures were 
given to all residents rotating through the ICU
Target 
behaviour 
change
Compliance with best practice for CVC maintenance for nursing staff and CVC insertion for physicians 
including preferred insertion site and no stopcocks, hand hygiene, maximal sterile barrier, type of 
catheter site dressing, and avoidance of antibiotic ointment
Development 
and testing
Audit tool: Development of flow charts of evidence-based best practice, detailing maintenance and 
insertion of CVC by a multidisciplinary team of physicians (an infection control specialist, nurses, a 
pharmacist and a QI specialist). Team used literature-based determination of risk factors involved in 
catheter infections to develop an audit tool and behaviours on the audit sheet were marked as ‘yes’ or 
‘no’ (e.g. did the person inserting the CVC use appropriate hand hygiene before insertion?)
Behavioural intervention: Stated only that this was based on the results of the bedside audits
Educational or 
behavioural 
theory
Not reported
Educational 
strategies 
and topics 
targeted
Referred to as a behavioural intervention; stressed compliance with all facets of best practice of CVC 
insertions and maintenance
Pictures: Placed at end of every patient’s bed, throughout the ICU, and in the manual each resident 
received when they rotated through the ICU. These demonstrated each step of CVC insertion (aimed at 
physicians) and maintenance (aimed at nursing staff)
Lectures: Topics not reported
Hands-on demonstrations: Topics not reported
Infection 
surveillance 
feedback 
approach
During both the baseline and intervention periods: BSI rates and comparison with national rates using 
NNIS data were presented on a monthly basis at multidisciplinary staff meetings
Performance 
feedback 
approach 
Not included in intervention. Audits of compliance informed the development of the intervention but 
audit results were not reported to have been directly fed back to the ICU teams
Concentration 
of education 
Lectures and hands-on demonstrations were given to nurses as part of their annual skills sessions. 
Lectures of unspecified frequency were given to the entire resident staff in the departments of surgery 
and emergency medicine and monthly lectures were given to all residents rotating through the ICU. 
Frequency and duration of sessions not reported. Reinforcement of sessions (e.g. whether annual 
repetition) not reported
Non-
educational 
intervention 
components 
None – intervention purely educational
Costs 
reported
Not reported
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Outcome characteristics
Catheter-BSI 
definition
Reference 
cited: 
Pearson197
BSIs were classified as primary or secondary on the basis of NNIS definitions (reference cited). CRBSI 
defined as:
a microorganism isolated from a blood culture not related to distant infection, or:
1. a fever > 38.5 °C, chills, or hypotension, and either:
2. a common skin contaminant (typically a coagulase-negative Staphylococcus species) isolated from 
two blood cultures drawn at separate times within 24 hours unrelated to distant infection or isolated 
from a blood culture in a patient with a CVC and treated by the attending ICU physician with a 
full course of antibiotics. BSIs with documented distant infection with the same pathogen were 
characterised as secondary bacteraemias
Outcomes 
reported 
Primary outcome: Compliance with practices known to decrease CRBSI (appropriate hand hygiene, 
sterile gown, mask, sterile gloves, large sterile drape, absence of antibiotic ointment, catheter sutured in, 
transparent dressing appropriately placed)
Secondary outcome: CRBSI rate for all ICU patients
Results data
Primary outcomes
Outcome
Baseline (24 months), 
2716 patients, 
9353 catheter-days
Intervention (15 months), 
1773 patients, 
6152 catheter-days 
Difference between 
baseline and intervention 
Device 
duration 
(days), %
< 7 days 62.9 57.8
7–10 days 29.4 35.9
> 10 days 7.7 6.3
Days in 
place, 
mean
6.0 6.3
Total device utilisation,  
CVC-days 
9353 (n = 2716) 6152 (n = 1773)
No. of devices/patient Not reported Not reported
CRBSI incidence rate 32 17
Incidence per 1000  
catheter-days 
3.4 2.8 p = 0.40
Incidence per 1000  
patient-days
Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
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Additional primary outcomes data
Device duration  
(% of CVCs) – data from 
randomly selected subsets 
of patients
Baseline (3 months),  
99 patients, 171 CVCs
Intervention (4 months), 
72 patients, 138 CVCs
Difference between 
baseline and intervention 
(not reported unless 
indicated)
< 7 days
7–10 days
> 10 days
Mean duration, days
62.9%
29.4%
7.7%
6.0
57.8%
35.9%
6.3%
6.3
Statistics not reported
Secondary outcomes 
Compliance with target 
behaviour (number (%) 
of CVCs) – data from 
randomly selected 
subsets of CVCs
Baseline (3 months),  
six CVCs, six patients
Intervention (4 months) 
10 CVCs, 10 patients
Difference between 
baseline and intervention 
Appropriate hand hygiene 1 (17%) 3 (30%) Statistics not reported
Sterile gown 6 (100%) 10 (100%)
Mask 6 (100%) 10 (100%)
Sterile gloves 6 (100%) 10 (100%)
Large sterile drape 3 (50%) 8 (80%)
Absence of antibiotic 
ointment
6 (100%) 10 (100%)
Catheter sutured in 5 (83%) 10 (100%)
Transparent dressing 
appropriately placed
6 (100%) 10 (100%)
Compliance with target 
behaviour associated 
with CVC insertion  
(% of CVCs) – data 
from randomly selected 
subsets of patients
Baseline (3 months),  
99 patients, 171 CVCs
Intervention (4 months), 
72 patients, 138 CVCs
Difference between 
baseline and intervention 
Properly dating the CVC 
dressing
11% 21% p < 0.001
Stopcock use (avoidance of) 70% 24% p < 0.001
Appropriate hand hygiene 
use
17% 30% p > 0.99
Maximal sterile barrier 
precautions
50% 80% p = 0.29
Reaction to education Not a study outcome 
Attitudes Not a study outcome 
Knowledge Not a study outcome 
Skills Not a study outcome 
Process evaluation No other process evaluation apart from the random audits, which suggested lack of 
compliance with target behaviours may have been a barrier (data above)
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Critical appraisal
Potential for bias 
Selection bias Were there systematic differences between the baseline and intervention groups? UNCLEAR. Authors 
stated that patient demographics were similar throughout the course of the study but limited data were 
reported, with no indication of patients’ health status. Random subsets of patients and CVC insertions 
were used for reporting outcomes in the baseline and intervention groups but no information was 
provided on how random selection was achieved
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates or 
subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the estimate for the overall intervention? 
YES. There were six additional ICU beds in the intervention period (33% increase) but staff numbers 
and staff to patient ratios were not reported. The number CVCs inserted in the ICU increased by 9%, 
whereas those inserted in the operating room decreased by 11%
Was the effect of educational practice separable from effects of non-educational practice? YES. The 
intervention comprised purely educational components. However, the reduction in infection rates was 
not statistically significant
Were the intervention component(s) implemented as planned? UNCLEAR. Stated in methods section 
that lectures and hands-on demonstrations were given to nurses as part of their annual skills sessions 
by two of the authors and also to all staff in departments of emergency medicine and surgery, and 
monthly lectures were given to all residents rotating through the ICU. However, no details of attendance 
for lectures or hands-on demonstrations were reported
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. For CRBSI data it appears that all patients in the ICU were monitored. However, for 
behavioural outcomes subgroups of patients and CVCs were randomly selected but no details were 
provided on how random selection was carried out
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes were 
determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NOT REPORTED
Other possible 
sources of bias
Were any other sources of bias present? YES. The authors reported a potential investigator bias, as the 
audit tool was administered by members of the team that designed the intervention and audit tool. 
Authors stated that knowledge of observations alone could alter staff behaviours. Intervention took 
place 24 months after a previous educational programme targeting CRBSIs
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. Pictures of the CVC insertion process 
were mentioned but no details of the content of lectures and hands-on demonstrations were reported 
so the mechanisms for eliciting the target behaviour changes are unclear
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED. The authors stated only that the audit tool was 
administered by members of the team who designed the intervention and the audit tool
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT APPLICABLE 
Statistical tests described? YES
Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? PARTIALLY. Compliance with all target behaviours increased 
following implementation of the intervention but for hand hygiene and dating of dressings the 
improvements were small, and post-intervention compliance was only 30% and 21%, respectively
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Additional comments
 z Authors commented that the diffuseness of the behavioural intervention message may have reduced 
the impact on CRBSI rates.
 z Monthly infection incidence data reported in a graph – illustrates high temporal variability in BSI 
incidence, with incidence rates in some months post intervention implementation being higher than 
some baseline rates.
 z Unclear whether staff were advised of the existence of the study.
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DUBOSE (2008)93
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
DuBose (2008)93
Summary of approach Single-unit daily quality rounds checklist to increase compliance with prophylactic measures 
for prevention of VAP, deep venous thrombosis or pulmonary embolism, central line infection 
and other ICU complications
Location USA: California
Language English
Critical care specialty Trauma
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Division of Trauma Surgery and Surgical Critical Care, University of Southern California,  
Los Angeles
Study design Single cohort before-and-after study
Study time periods Baseline: 1 month (date not reported)
Intervention: 3 months (date not reported)
Follow-up: None (monitoring only during intervention)
Funding source Not reported
Conflicts of interest Not reported
Population and setting
Critical care unit characteristics 
(stated only that unit was a  
high-volume level I trauma centre)
Baseline 
(1 month)
Intervention 
month 1
Intervention 
month 2
Intervention 
month 3
Patient 
population 
characteristics
ICU patient-days 
surveyed
244 185 188 193
Mean age, years 41.1 41.0 41.6 40.3
Gender, % male 73.0 76.8 67.0 78.9
Mean injury 
severity score
17.3 20.9 15.0 16.1
Device characteristics CVCs routinely used were antimicrobial-coated (ARROWgard Blue PLUS  
Multi-lumen, antimicrobial surface-coated using chlorhexidine, chlorhexidine 
acetate, and silver sulfadiazine) and placed directly through an introducer 
(ARROW percutaneous sheath introducer kit 8.5 Fr). All routine catheters were 
placed with full barrier precautions, and catheters placed in emergency situations 
where the use of full barrier precautions was not documented were removed 
within 24 hours
Insertion site antisepsis used Not reported
Dressing type and duration/frequency Not reported
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Intervention characteristics
Objective To increase compliance with measures that aim to reduce ICU complications and identify areas for 
improvement in quality of care
Main focus of 
education 
General: to reduce ICU complications. Prevention of CRBSI was a relatively minor part  
(2/16 checklist items were relevant)
Trainers (providers) Not explicitly stated; appears to have involved the multidisciplinary team noted below under 
development and testing and/or the trauma and surgical critical care QI committee. Stated surgical 
critical care fellows acted as ‘champions’ of daily prophylaxis
Training of trainers Not reported
Learners 
(recipients) 
Checklists were completed by ICU fellows and their team of residents and medical students on the 
daily rounding basis
Target behaviour 
change
General: Sixteen different activities for reducing complications in the ICU
Development and 
testing
A multidisciplinary team of care providers that included intensivists, trauma surgeons, nursing staff 
and a biostatistician conducted a comprehensive review of best-practices data to identify items to 
be included in the checklist
Educational or 
behavioural theory
Not reported
Educational 
strategies and 
topics targeted
Daily quality rounds checklist. Listed 16 evidence-based measures for preventing ICU 
complications. Of these, two were relevant to prevention of central line infections: checking the 
central line day and checking the continued need for invasive devices
Monthly review of deficiencies by a multidisciplinary team of intensivists, trauma surgeons, 
nursing staff and a biostatistician resulted in the highlighting of those measures most clearly requiring 
more focused effort. Improvements were then designed and implemented following discussion
Training on new protocol strategies and improvement of existing approaches (no details given)
Infection 
surveillance 
feedback 
Not included
Performance 
feedback 
Unclear. Some feedback of process was mentioned for insulin management; results appear to 
have been fed back monthly to the trauma and surgical critical care QI committee – unclear 
whether and how disseminated to ICU staff. Paper checklists were completed by an ICU fellow and 
manually entered into an Excel database
Concentration of 
education 
The initial time required for completion of the checklist and institution of corrective changes 
averaged approximately 1 hour per day. With familiarity, after the first few weeks of use, the time 
decreased to 20–30 minutes per day. This equated to approximately two additional minutes  
per patient
Non-educational 
intervention 
components
None. However, the majority of checklist topics were not directly relevant to catheter BSIs
Costs reported No, but authors stated that the cost was quite minimal: the completion of the checklist 
represented little additional burden on the ICU fellow and did not significantly alter  
nursing workloads
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Outcome characteristics
Catheter-BSI 
definition 
Central-line related infection:
Positive blood cultures with a recognised pathogen without evidence of alternative septic source 
must be documented, and the catheter must have been in place for > 48 hours
Outcomes reported Not stated whether primary or secondary:
 z CLABSI rate
 z CVC duration
 z VAP ratea
 z Self-extubation ratea
 z Mechanical ventilation durationa
 z Compliance with VAP bundle (head of bed angle, sedation holiday, peptic ulcer disease 
prophylaxis, deep-vein thrombosis prophylaxis)a
a Data not extracted by reviewers.
Results data
Primary outcomes
Outcome
Baseline (3 months;  
dates not reported)
Intervention (3 months; 
dates not reported)
Difference between 
baseline and intervention 
CVC 
duration
% lines 
> 24 hours
89.4 88.4 (86.2 = result for first 
month of intervention)
Statistical test of difference 
not reported
% lines 
> 48 hours
74.1 68.4 (64.1 = result for first 
month of intervention)
% lines 
> 72 hours
62.4 52.8 (49.1 = result for first 
month of intervention) 
Total device utilisation Not reported Not reported Not reported
No. of devices/patient Not reported Not reported Not reported
Mean monthly central 
line-associated BSI 
[central line-related 
infection] incidence rate 
per 1000 device-daysa
8.9b
11.3b
5.8 Statistical test of difference 
not reported
Incidence per 1000  
patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Two descriptions (device-related and device-associated infections) were given for the same outcome.
b Two different values were reported for the same outcome (the value of 11.3 appeared both in the abstract and 
results; the value of 8.9 in the results only).
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Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Compliance with daily CVC site evaluation according to a previously established quality 
assurance pathway exceeded 95% [not stated which time period(s) this referred to]
Compliance was reported in more detail for VAP prevention (data not extracted  
by reviewers)
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not a study outcome
Critical appraisal
Potential for bias
Group selection Were there systematic differences between the baseline and intervention groups? UNCLEAR. Reported 
that demographic characteristics ‘remained constant’ between groups but limited data given  
(the maximum difference in mean age between the baseline and intervention periods was 1.3 years; 
the maximum difference in injury severity score was 4.8; and the maximum difference in the 
proportion male was 11.9%)
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT APPLICABLE
Was the effect of educational practice separable from effects of non-educational practice? YES. Only a 
checklist (i.e. educational) was used (although only 2 of the 16 checklist items concerned catheter BSIs)
Were the intervention component(s) implemented as planned?
NOT REPORTED. Compliance with the checklist was not reported
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. The number of checklists completed and entered into the database was not reported
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? NO. States that a standard 
definition of infections was used throughout the study and all potential nosocomial infections, central 
line-related infections and VAP were diagnosed by the hospital epidemiology service
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? YES. The checklist was used by an ICU fellow not directly involved in patient care for 
1 month during the baseline period to establish pre-intervention compliance. During this period only, 
nursing and clinical staff were blinded to the use of the checklist
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on the 
information presented
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? YES. The intervention consisted principally 
of a checklist that could be reproduced or adapted
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED. Stated only that compliance of the nursing staff in 
the completion of specified measures was ensured by the monitoring of a unit nurse manager through 
a previously established quality assurance pathway (details not reported)
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? NO
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? UNCLEAR. Some aspects of practice for reducing complications 
in the ICU were complied with more extensively than others. Primarily reported compliance data 
for a VAP intervention (data not extracted by reviewers). Compliance with daily CVC site evaluation 
(assessed according to a previously established quality assurance pathway) was reported to have only 
exceeded 95%, but it is not clear by how much compliance had increased or to which time period(s) 
of the study this refers
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EGGIMANN (2000–5)94,95
Methods
Study characteristics
Lead author, 
publication year(s) 
and reference(s)
Eggimann (2000);94 Eggimann (2005)95
Summary of approach Single unit educational intervention consisting primarily of short slide shows and bedside 
education 
Location Switzerland
Language English
Critical care specialty Medical
No. of critical care 
units
1
No. of hospitals 1
Hospital name (unless 
multicentre); city
University of Geneva Hospital; Geneva
Study design Single cohort before-and-after study
Study time periods Baseline: October 1995 to February 1997 (16 months)
Intervention: March 1997 to October 1997 (8 months)94
Intervention continuation: March 1997 to 2002 (month unspecified) (total duration 
approximately 6 years)95
Follow-up: None (continuous monitoring of intervention)
Funding source Lead author was supported in part by a grant from G and L Hirsch, Geneva, Switzerland 
during the preparation of the paper. Co-author (Harbarth) was supported by a grant from the 
Max-Kade Foundation, New York, USA during the preparation of the paper. The intervention 
continuation was supported in part by a grant from the Swiss National Science Foundation
Conflicts of interest Stated in the intervention continuation report95 that no potential financial conflicts of interest 
were disclosed 
Population and setting
Critical care unit 
characteristics
18 beds in a MICU at a 1500-bed primary care and tertiary care centre
Average of 1400 patients per year admitted to the ICU
Mean LOS 4 days (further data in Results section)
All vascular lines were inserted by advanced internal medicine residents or fellows in the MICU; there 
was no change in the physicians’ profile between the study periods
Device insertion and management were based on institutional written guidelines promulgated by the 
nursing department
Material preparation: Based on physicians’ individual preferences
Patient positioning: According to nursing habits acquired elsewhere
Skin preparation: Hair shaving
Barrier precautions: Sterile gloves, small fenestrated sheets, paper mask
Insertion technique: Various techniques; no specific training
Device replacement: Every 24 hours for all administration sets and devices.
Device removal: Peripheral line after 3–5 days; no specific recommendation for central lines
Hand hygiene: With surgical soap in sink before and after each patient care, or hand disinfection
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Patient population 
characteristics: all adult 
patients admitted to 
the MICU for more than 
48 hours
Baseline: October  
1995 to February 1997  
(16 months), 
2104 patients
Intervention: April 
to November 1997 
(8 months), 1050 patients
Difference between 
baseline and 
intervention: total 
patient-days for baseline 
and intervention = 13,200
No. of patients
Unstable angina 554 (26%) 296 (28%) Difference in number of 
patients not statistically 
significantMyocardial infarction 406 (19%) 218 (21%)
Cardiac monitoring 222 (11%) 116 (11%)
Cardiac arrest 48 (2.3%) 32 (3.0%)
Hypertensive crisis 76 (3.6%) 25 (2.3%)
Acute heart failure 55 (2.6%) 41 (3.9%)
Acute respiratory 
insufficiency
122 (5.8%) 74 (7.1%)
Asthma 54 (2.6%) 19 (1.8%)
COPD 54 (2.6%) 15 (1.4%)
ARDS 20 (1.0%) 9 (0.9%)
Neurological – intoxication 106 (5.0%) 55 (5.2%)
Neurological – miscellaneous 105 (5.0%) 42 (4.0%)
Infections 98 (4.7%) 32 (3.0%)
Other disorders 184 (8.7%) 76 (7.2%)
Total patients 2104 1050
Age, years, mean (SD)
Unstable angina 66 (12) 66 (12) Differences in age not 
statistically significant except 
*p < 0.05Myocardial infarction 63 (13) 67 (13)*
Cardiac monitoring 68 (14) 67 (13)
Cardiac arrest 68 (14) 65 (15)
Hypertensive crisis 57 (21) 58 (17)
Acute heart failure 70 (10) 73 (8)
Acute respiratory 
insufficiency
63 (14) 67 (13)
Asthma 45 (18) 36 (14)
COPD 66 (13) 66 (10) 49 (14)
ARDS 42 (17) 42 (20)
Neurological – intoxication 38 (16) 56 (19)
Neurological – miscellaneous 58 (17) 57 (16)
Infections 54 (18) 57 (17)
Other disorders 56 (18) 63 (16)*
Total patients 62 (16) 66 (12)
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Patient population 
characteristics: all adult 
patients admitted to 
the MICU for more than 
48 hours
Baseline: October  
1995 to February 1997  
(16 months), 
2104 patients
Intervention: April 
to November 1997 
(8 months), 1050 patients
Difference between 
baseline and 
intervention: total 
patient-days for baseline 
and intervention = 13,200
No. mechanically ventilated
Unstable angina 5 (0.9%) 3 (0.9%) Differences in number 
mechanically ventilated not 
statistically significant except 
*p < 0.05
Myocardial infarction 54 (13%) 15 (7.0%)*
Cardiac monitoring 7 (3.2%) 1 (0.8%)
Cardiac arrest 43 (90%) 30 (94%)
Hypertensive crisis 9 (12%) 3 (12%)
Acute heart failure 26 (47%) 16 (39%)
Acute respiratory 
insufficiency
59 (48%) 28 (38%)
Asthma 12 (22%) 4 (21%)
COPD 9 (17%) 2 (13%)
ARDS 2 (100%) 9 (100%)
Neurological – intoxication 35 (33%) 17 (31%)
Neurological – miscellaneous 68 (65%) 25 (60%)
Infections 59 (60%) 20 (63%)
Other disorders 33 (18%) 24 (32%)*
Total patients 439 (21%) 194 (19%)
Nursing workload: mean 
(SD; range) monthly 
Research in Nursing  
system scores:
188 (66; 152–210) 191 (61; 178–207)
Device characteristics A total of 3154 patients in the study (baseline and intervention combined) had at least one 
intravenous device inserted, 966 (31%) were exposed to arterial lines and 1121 (35%) to 
CVCs, with similar proportions in the baseline and intervention periods
Insertion site antisepsis used Povidone–iodine or chlorhexidine gluconate
Dressing type and duration/
frequency 
Several types according to individual non-standardised criteria. Transparent occlusive 
dressings or preprepared devices for peripheral lines. Dressing replacement every 24 hours
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Intervention characteristics
Objective To decrease rates of vascular-access infections using a multimodal, multidisciplinary 
prevention strategy and to assess the impact of the strategy on the incidence of  
ICU-acquired infections
Main focus of education Prevention of ICU acquired infections, including those associated vascular catheter insertion, 
maintenance and use
Trainers (providers) Five named study authors carried out the educational intervention
Training of trainers Not reported directly but the identity of the trainers was reported so their expertise could be 
checked (three authors wrote and five authors reviewed the guidelines)
Learners (recipients) All ICU staff received the slide shows and practical demonstrations: 21 fellows or residents, 
82 nurses and 15 nursing assistants
Target behaviour change Behaviours associated with the insertion, maintenance and use of vascular catheters 
Development and testing Not reported
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
30-minute slide shows complemented by individual bedside teaching.*
Topics covered were:
 z Material preparation: in advance to avoid any interruption during insertion
 z Patient positioning: followed recommendations to permit optimum access to the 
insertion site; presence of nurse to assist physician mandatory
 z Skin preparation: hair cutting instead of shaving; use of chlorhexidine gluconate
 z Maximal barrier precautions: sterile gloves, gown, cap, mask, and large sheet used for all 
but peripheral lines
 z Insertion site selection: subclavian or wrist vein as standard
 z Device replacement: every 72 hours for administration sets and devices; 24 hours for 
lipid emulsion
 z Device removal: as clinically indicated for central lines, not routinely, with prompt 
removal of any device not intended for use recommended; peripheral lines after 
72 hours systematically
 z Hand hygiene: hand disinfection strongly emphasised before and after any care; hand 
washing for soiled hands to be followed by hand disinfection
 z Dressings: dry gauze covered by a non-occlusive adhesive band. Replaced every 72 hours 
except for the first dressing after catheter insertion
(*Practical demonstration mentioned but no details reported)
Infection surveillance 
feedback approach 
Not included in intervention
Performance feedback 
approach 
Not included in intervention
Concentration of 
education 
Education comprised 30-minute slide show sessions and unspecified bedside teaching 
sessions given to all staff. Frequency of slide shows unclear; not stated whether sessions 
were repeated annually or at other intervals for staff who had already been trained
Non-educational 
intervention components
None
Costs reported No
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Outcome characteristics
Catheter-BSI 
definition 
The infection was regarded as ICU acquired if it occurred within 48 hours of discharge from the ICU. 
Primary BSIs were defined as bacteraemia (or fungaemia) for which there was no documented distal 
source, and included infections resulting from insertion of an intravenous or arterial line. The infection 
was categorised either as microbiologically documented or as clinical sepsis. CRBSI were those for which 
the same organism had been isolated from a quantitative culture of the distal catheter segment, and from 
the blood of a patient with clinical symptoms and no other apparent source of infection. In the absence 
of catheter culture, defervescence after removal of an implicated catheter from a patient with a BSI was 
regarded as indirect evidence of infection. Catheter exit site infection, catheter colonisation and clinical 
sepsis were also defined
Infections were defined according to Garner et al.147
Outcomes 
reported
Not stated whether primary or secondary:
 z BSI incidence (defined as microbiologically documented bacteraemia)
 z LOS
 z Mortality
 z Catheter exit site infections*
 z Bloodstream infections related to clinical sepsis (i.e. other than microbiologically documented)*
 z Respiratory infections*
 z Urinary tract infections*
 z Skin or mucous membrane infections*
 z Miscellaneous infections*
 z Total ICU-acquired infections*
(*Data not extracted by reviewers)
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Results data
Primary outcomes
Outcome
Baseline: October 
1995 to February 1997 
(16 months),  
2104 patients
Intervention: April 
to November 1997 
(8 months), 1050 patients 
(longer-term data also 
reported94)
Difference between 
baseline and 
intervention: relative 
risk (95% CI)
Device duration, days, median 8 7
Exposure to CVCs, days, median 4 4
Total device utilisation Not reported Not reported
No. of devices/patient Not reported Not reported
BSI per 
1000 
CVC-days, 
mean 
(95% CI)
(a) Initial data from 
Eggimann (2000)94
(b) Longer-term  
data from Eggimann 
(2005)95
(a) 6.6
(b) 6.3 (4.0 to 9.4)
(a) 2.3
(b) Annual rates:
1997: 2.9 (0.8 to 7.3)
1998: Not reported
1999: 2.4 (1.0 to 4.7)
2000: 2.7 (0.9 to 6.3)
2001: 1.7 (0.5 to 3.9)
2002: 3.4 (1.7 to 6.1)
(a) Not reported
(b) Average rate reduction 
over the study period 
56% (range 46% to 
63%); no statistical tests 
of differences reported
[Note: Data for calculating CIs 
of risk ratios (presented in the 
main report) were not reported 
by Eggimann et al.95 but were 
obtained by contacting the study 
authors (see Appendix 7)]
BSI incidence per 1000  
patient-days
Not reported Not reported
LOS, days, mean (SD)
Unstable angina 2.6 (2.7) 2.7 (1.3) Differences not 
statistically significant
Myocardial infarction 3.8 (3.6) 3.6 (2.5)
Cardiac monitoring 2.1 (1.7) 2.3 (1.6)
Cardiac arrest 6.0 (5.6) 6.0 (4.8)
Hypertensive crisis 6.1 (14.0) 2.8 (1.2)
Acute heart failure 5.4 (5.3) 5.2 (4.4)
Acute respiratory insufficiency 9.0 (8.2) 8.2 (8.5)
Asthma 3.9 (3.3) 3.5 (2.0)
COPD 7.6 (6.0) 6.1 (2.9)
ARDS 13.6 (12.0) 13.8 (9.7)
Neurological – intoxication 3.5 (7.1) 2.6 (1.4)
Neurological – miscellaneous 5.8 (8.2) 5.0 (3.6)
Infections 5.3 (4.4) 8.3 (8.6)
Other disorders 4.0 (6.4) 3.8 (3.4)
Total patients 4.1 (5.8) 3.9 (4.2)
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Outcome
Baseline: October 
1995 to February 1997 
(16 months),  
2104 patients
Intervention: April 
to November 
1997 (8 months), 
1050 patients
Difference between 
baseline and 
intervention: relative 
risk (95% CI)
Mortality (no. of ICU deaths)
Unstable angina 2 (0.4%) 1 (0.3%) Differences not 
statistically significant 
except *p < 0.05Myocardial infarction 31 (7.6%) 9 (4.1%)
Cardiac monitoring 4 (1.8%) 0
Cardiac arrest 15 (31%) 19 (59%)*
Hypertensive crisis 7 (9.2%) 3 (12%)
Acute heart failure 2 (3.6%) 2 (4.9%)
Acute respiratory insufficiency 19 (16%) 10 (14%)
Asthma 0 0
COPD 3 (5.6%) 0
ARDS 13 (65%) 5 (56%)
Neurological – intoxication 2 (1.9%) 0
Neurological – miscellaneous 16 (15%) 6 (14%)
Infections 33 (34%) 11 (34%)
Other disorders 12 (6.5%) 7 (9.2%)
Total patients 159 (7.6%) 71 (6.8%)
Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not a study outcome
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NO. The groups 
were similar with respect to number of patients per month, age, number mechanically ventilated, LOS, 
infection risk factors and mortality
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NO. The authors stated that there were no changes in the physicians’ profile or in 
nursing workload. A hospital-wide campaign to improve compliance with hand hygiene practices 
was introduced before the start of the baseline period. Monitoring infection incidence in a SICU at 
the same hospital revealed no changes over time in infection incidence rates, suggesting that those 
observed in the study ICU did not result from external factors
Was the effect of educational practice separable from effects of non-educational practice? YES.  
The intervention was purely educational
Were the intervention component(s) implemented as planned? NOT REPORTED
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
NO. The number of patients in the baseline and intervention periods did not differ noticeably 
(quantitative data reported). Infection surveillance involved all patients (dedicated chart for each 
patient). Mortality rates were slightly but not statistically significantly lower in the intervention period. 
Data on the number of devices per patient were not separable by baseline and intervention period
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. The annual 
incidence rates reported by Eggiman (2005)95 do not specify which months were used in the 
measurement ranges: it is unclear whether the 1997 data were adjusted to account for 1997 
comprising only 9 months of intervention (since the first 3 months were part of the baseline period)
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on the 
information presented
SICU, surgical intensive care unit.
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. The educational 
characteristics of the bedside education sessions were not reported. The extent of 
education reinforcement needed (how often staff were re-educated) to achieve the 
reported changes in infection rates was not reported. The main components of the slide 
show were reported but a copy of the slide show was not provided
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Surveillance of nosocomial infections was 
conducted by two named infection control nurses who visited the ICU daily and completed 
a dedicated surveillance chart for each patient. Surveillance was continued until 5 days after 
discharge to detect incubating infections attributable to ICU stay. All surveillance records 
were prospectively reviewed and validated by two named infection control physicians
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? YES. 
Surveillance methods were pretested and standardised in several pilot phases. Interobserver 
variability was assessed during three separate periods when the two observers worked 
simultaneously. Inter-rater reliability was high for all infections (κ = 0.89; range 0.78–1.0)
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? UNCLEAR. Information on compliance or other aspects 
of process was not reported
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GALPERN (2008)97
Methods
Study characteristics
Lead author, publication 
year(s) and reference ID(s)
Galpern (2008)97
Summary of approach Single unit central line bundle implementation (proposed by Greater New York Hospital 
Association) to decrease CLABSIs
Location (country, state/
region)
USA, New York
Language English
Critical care specialty Mentions SICU, but in discussion of question and answer section states that it included a 
MICU and a CCU
No. of critical care units 3 (medical–surgical, mixed across three locations; and cardiac) (not reported in the 
publication – information provided by the author) 
No. of hospitals 1
Hospital name (unless 
multicentre); city
Methodist Hospital, Brooklyn, New York
Study design Single cohort before-and-after study 
Study time periods Baseline: February to June 2005 (5 months)
Intervention: July 2005 to February 2006 (19 months)
Infection surveillance: 1 February 2005 to 31 April 2007 (26 months)
Follow-up: Unclear (not explicitly stated whether results are for intervention period only 
(0 months follow up) or for full infection monitoring period (14 months’ follow-up)
Funding source None reported
Conflicts of interest None reported
CCU, cardiac critical care unit; SICU, surgical intensive care unit.
Population and setting 
Critical care unit 
characteristics
Ranged from 26 to 30 ICU beds
The ICUs were in a 628-bed community teaching hospital
Stated that there were no changes in materials during the time of the study (catheter kits, 
drapes, gowns, gloves and caps were all kept the same)
Patient population 
characteristics
Not reported
Device characteristics CVCs; avoidance of femoral site; device duration reported. Ultrasonography was used 
intermittently in the placement of the central lines. Central lines were placed by critical care 
physicians without assistance, unless requested
Insertion site 
antisepsis used
Chlorhexidine (ChloraPrep)
Dressing type and 
duration/frequency 
Not reported, but no antibiotic patches were used owing to lack of level 1 evidence
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Intervention characteristics 
Objective To determine whether using central line bundles would decrease the incidence of CLABSI
Main focus of 
education 
Catheter insertion
Trainers (providers) Team to implement bundle: head of SICU as team leader, ICU nurse managers and two 
infection-control nurses
Training of trainers Not reported
Learners (recipients) All ICU staff (physicians and nurses)
Target behaviour 
change
Nurse to assist with central line insertion, compliance with hand washing, use of full-barrier 
precautions, appropriate skin preparation, checking and restocking of central cart, avoidance of 
femoral lines, and early removal of central lines
Development and 
testing
None reported, but mentions that the bundle protocol was based on the latest evidence-based 
techniques
Educational or 
behavioural theory
Not reported
Educational 
strategies and topics 
targeted
Education of resident physicians and nurses on BSI control practices. Included:
Discussion of: proper hand washing, use of full barrier precautions during central line insertion, 
appropriate skin preparation with chlorhexidine (ChloraPrep), avoiding the femoral site if 
possible, and early removal of all central lines (justification for continued line use noted on a 
chart)
Checklist completed by nurses to ensure compliance with the evidence-based guidelines
Infection surveillance 
feedback approach 
The data (number of critical-care beds used, number of catheters placed, number of days 
catheters left in place, and number of line-associated infections) were collected by a trained, 
hospital-based infection-control practitioner. The data were reported to the directors of the 
surgical and MICUs, which allowed for real-time feedback to the staff on how the intervention 
was proceeding. Validation and reliability of process was not reported
Process audit 
feedback approach 
Monthly feedback (number of critical care beds used, number of catheters placed, number of 
days catheters left in place, and number of line-associated infections) to directors of SICU, CCU 
and MICU, allowing for real-time staff feedback on intervention process
Performance 
feedback approach 
Not included in intervention
Concentration of 
education 
Not reported
Non-educational 
intervention 
components
Catheter cart provided
Personnel change: A policy was instituted that required nurses to assist in central line insertion
Costs reported Cost reported as being limited to central line cart cost (reported as around US$500 in the 
discussion of question and answer section) 
CCU, cardiac critical care unit; SICU, surgical intensive care unit.
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Outcome characteristics
Catheter-BSI 
definition 
NNIS criteria: presence of a recognised pathogen cultured from one or more blood cultures and 
the organism cultured from the blood not to be related to infection at another site plus presence 
of a temperature greater > 38 °C, chills or hypotension, along with signs and symptoms of an 
infection not related to another site and presence of a common skin contaminant cultured from 
two or more blood samples on separate occasions, or common skin contaminant cultured from 
at least one blood sample in a patient with an intravascular catheter, or a positive antigen test on 
diagnostic phlebotomy
Outcomes reported Not stated whether primary or secondary:
Central line-associated BSI per 1000 catheter-days
No. of central lines
No. of central line days
Development of a line infection
Results data
Primary outcomes
Outcome Baseline (5 months) Intervention (19 months)
Difference between 
baseline and intervention
Device duration (days), 
average
8.5 ± 1.3 6.8 ± 0.97 p = 0.17
Total device utilisation Not reported Not reported (Total for both baseline and 
intervention: 1395 CVCs; 
9938 central line-days)
No. of devices/patient Not reported Not reported
CABSI incidence rate Not reported Not reported
Incidence per 1000  
catheter-days – averagea
5.0 ± 4.3 0.90 ± 1.3 p < 0.001
Incidence per 1000  
patient-days
Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
a Data for calculating risk ratios with CIs (presented in the main report) were not reported in the primary publication 
but were obtained by contacting the author.
Secondary outcomes
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Stated only that ongoing monitoring kept ICU teams committed to the new protocols  
(no details given)
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups?  
NOT REPORTED
If YES, were the differences between the groups adjusted for in statistical analyses  
(e.g. as covariates or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the 
overall intervention? NO. Authors stated that there were no changes in materials and that 
catheter kits, drapes, gowns, gloves and caps were all kept the same during the study period). 
However, no information was provided on staffing, infrastructure or policy changes, except for a 
specific staff role change that occurred within the intervention bundle (policy required nurses to 
assist critical care physicians, who previously did all insertions)
Was the effect of educational practice separable from effects of non-educational practice? NO. 
Education was part of a bundle: catheter carts were provided and staff changes also occurred
Were the intervention component(s) implemented as planned? NOT REPORTED
Missing data Were there systematic differences between study groups in attrition or exclusions (includes 
withdrawal due to mortality; missing outcome data)? NOT REPORTED
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how 
outcomes were determined (including differences in how outcomes were defined)?  
NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
Were any other sources of bias present? NO. No other sources of bias were reported by the 
authors or identified by the reviewers based on the information presented. Authors state that 
bias of under-reporting infections was controlled by having each patient checked by a qualified 
trained infection-control nurse on a daily basis
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. The duration and number of 
educational sessions required was not reported, although an overview of the content was given. 
The checklist was briefly described but was not presented so could not be duplicated or adapted
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Stated only that data were collected on a monthly 
basis, which included the number of critical care beds in use at the time, the number of 
catheters placed, the number of days the catheters were left in place expressed as catheter-days, 
and the number of line-associated infections. The data were then entered into a spreadsheet 
and descriptive analysis was performed
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? NO
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? NOT REPORTED
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GUERIN (2010)98
Methods
Study characteristics
Lead author, publication 
year(s) and reference ID(s)
Guerin (2010)98
Summary of approach Local addition of a CVC post-insertion care bundle to an existing nationwide CVC insertion 
bundle as the latter did not prevent CLABSI, despite high compliance
Location (country, state/
region)
USA, Colorado
Language English
Critical care specialty MICU and SICU
No. of critical care units 2
No. of hospitals 1
Hospital name (unless 
multicentre); city
Department of Veterans Affairs Medical Center, Denver
Study design Single cohort before-and-after study (two ICUs treated as a single group) 
Study time periods Baseline: 1 October 2006 to 30 September 2008 (24 months)
Intervention: 1 October 2008 to 30 September 2009 (12 months)
Follow-up: None (only intervention monitored)
[Note: A nationwide CVC insertion bundle was implemented in April 2006 (i.e. during the 
baseline period)]
Funding source None reported
Conflicts of interest Stated none
SICU, surgical intensive care unit.
204
NIHR Journals Library www.journalslibrary.nihr.ac.uk
AppENDIx 5 – GuErIN (2010)
Population and setting 
Critical care unit 
characteristics
MICU = 10 beds; SICU = 13 beds
Physician staff members were postgraduate residents
1 : 2 nurse to patient ratio
University-affiliated acute care teaching hospital
From April 2006 onwards: Nationwide CVC insertion bundle: hand hygiene: sterile gloves 
and gown for all in the room prior to procedure; cap and mask for physician inserting 
the catheter; use of a 2% chlorhexidine gluconate in 70% ethanol scrub for the insertion 
site; head-to-toe sterile drape of the patient during insertion; time out before performing 
the procedure; avoidance of the femoral insertion site. Intravenous tubing for parenteral 
nutrition solutions changed daily, tubing for other intravenous solutions changed every 
72 hours
Baseline period (October 2006 onwards): standard infection control practices as per 
facility’s infection control manual and annual online review training for all nursing staff 
(required pass rate 80%). Implementation of insertion bundle
Training in proper application of the chlorhexidine gluconate-impregnated sponge provided 
by the manufacturer’s representative educator
Staff empowerment: Nurses monitored compliance of insertion bundle and were 
empowered to stop procedures breaching sterile technique. Four trained nurses inserted 
polyurethane peripheral CVCs (PICCs)
Patient population 
characteristics
Not reported
Device characteristics 96% PICCs (Bard, Murray Hill, NJ, USA) coated in chlorhexidine gluconate and silver 
sulfadiazine. In patients allergic to coatings, uncoated PICCs (4%) were used – silicone 
Groshong catheters (Bard). No other concurrent invasive devices were used
Insertion sites: subclavian, internal jugular and femoral
Insertion site antisepsis 
used
Chlorhexidine gluconate-impregnated sponge
Dressing type and 
duration/frequency 
Transparent dressing applied weekly or more frequently if wet or soiled, with a new 
chlorhexidine gluconate-impregnated sponge applied at each dressing change
SICU, surgical intensive care unit.
Intervention characteristics 
Objective Prevention of post-insertion CLABSI
Main focus of education Post-insertion care
Trainers (providers) Line care bundle was implemented by an intravenous champion in each unit (no details 
reported). Providers of hands-on training not reported
Training of trainers Not reported
Learners (recipients) All nursing staff
Target behaviour change Hand hygiene, insertion and maintenance of PICCs
Development and testing Stated that the line care bundle was developed by the nursing staff, and that the 
interventions were developed by frontline nursing staff. A 6-month pilot phase enabled 
staff to gain experience with device-day monitoring and data collection
Educational or 
behavioural theory
Not reported
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Educational strategies 
and topics targeted
Hands-on training and competency evaluation: for all nursing staff based on accessing and 
caring for all intravenous catheters. Insertion site competence covered wearing a mask and 
sterile gloves for a central line dressing change, scrubbing the site with 2% chlorhexidine 
gluconate in alcohol for 30 seconds and applying the chlorhexidine gluconate-impregnated 
sponge properly. Hub care competence included scrubbing the catheter hub for 15 seconds 
with an alcohol pad at each access and replacing the hub every 72 hours
Infection surveillance 
feedback approach
Infection surveillance reported but not feedback – except to infection prevention and 
control (not ICU staff)
Performance feedback 
approach
Competence evaluation following the hands-on training in which each nurse was required 
to demonstrate competence in catheter insertion site and hub care
Concentration of 
education
Four-hour hands-on mandatory training for all nursing staff followed by a competency 
evaluation (duration not specified). Not stated whether reinforced or re-assessed annually
Other intervention 
components beyond 
education
1. An intravenous team provided insertion and site care of PICCs, and monitored site care 
and dwell time of all intravenous catheters throughout the hospital
2. A line care bundle, developed by the nursing staff and implemented by each unit’s 
intravenous champion: daily inspection of the insertion site; documenting ongoing need 
for a catheter; proper chlorhexidine gluconate-impregnated sponge application at the 
insertion site; hand hygiene prior to handling intravenous system; alcohol scrub to the 
infusion hub for 15 seconds prior to use
3. A nationwide CVC insertion bundle introduced before the baseline period that 
continued during the intervention period
Device insertion 
procedure
Continued baseline infection control practices (see pre-intervention baseline control 
characteristics, clinical practice protocols)
Costs reported Not reported
Outcome characteristics
Catheter-BSI definition
Reference cited: Centers 
for Disease Control and 
Prevention198
Criterion 1: Patient has a recognised pathogen cultured from one or more blood cultures 
and the organism cultured from blood is not related to an infection at another site
Criterion 2: Patient has at least one of fever (> 38 °C), chills, or hypotension; positive 
laboratory results are not related to an infection at another site; and common skin 
contaminant [i.e. diphtheroids (Corynebacterium spp.), Bacillus (not B. anthracis) spp., 
Propionibacterium spp., coagulase-negative staphylococci (including S. epidermidis), 
viridans-group streptococci, Aerococcus spp., Micrococcus spp.] is cultured from two or 
more blood cultures drawn on separate occasions
Outcomes reported Not stated whether primary or secondary:
 z Catheter-days
 z Catheter dwell time
 z Catheter utilisation proportion
 z CLABSI incidence rates
 z Compliance with insertion bundle (but compliance with line care bundle, which is the 
main focus of interest, not reported)
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Results data
Primary outcomes 
Outcome Baseline Intervention
Difference between baseline and 
intervention: relative risk (RR)  
(95% CI); p-value. Except where 
indicated, statistical comparisons 
were not reported
Catheter dwell timea (no. of days 
between catheter insertion and 
onset of CLABSI), days 
Mean = 14.5
Median = 12
Range = 0–47b
IQR = 6–24
Mean = 15
Median = 7
Range = 7–33
IQR not reported
Total device utilisation,  
catheter-days 
4415 2825
Total no. of patient-days 11,434 5937
Catheter utilisation proportion:  
no. of catheter-days divided by  
no. of patient-days 
0.39 0.48 p < 0.0001
No. of devices/patient Not reported Not reported
No. of CLABSI 25 3
CLABSI incidence per 1000  
catheter-days
5.7 1.1 RR = 0.19 (0.06 to 0.63); p = 0.004 
Adjusted RRc = 0.23 (0.07 –0.77); 
p = 0.017
Incidence per 1000 patient-days Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
a If a patient already had a vascular catheter at admission, the admission date was used for the date of insertion.
b Included two patients with an unexplained dwell time of zero days.
c Adjusted RR assumes constant utilisation proportion in baseline and intervention periods.
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Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance: CVC insertion bundle Pre-intervention period: 94% During intervention period: 93%
Knowledge Not a study outcome
Skills Not reported
Process evaluation Brief narrative comment only. The authors stated that their study of local 
compliance with recommended post-insertion care techniques revealed 
opportunities for improvement that could possibly lead to reductions in CLABSI. 
However, the only quantitative compliance data reported were for the CVC 
insertion bundle, not the post-insertion care bundle
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention 
groups? NOT REPORTED
Were any systematic differences between the groups adjusted for in statistical 
analyses (e.g. as covariates or subgroups, or stratification by propensity scores)? 
NOT REPORTED 
Intervention administration Were any confounding variables identified that could influence the effect 
estimate for the overall intervention? NOT REPORTED
Was the effect of educational practice separable from effects of non-educational 
practice? NO, part of a bundle
Were the intervention component(s) implemented as planned? UNCLEAR. The 
hands-on training and competency evaluation were compulsory. Teaching was 
given to all ICU nurses and other staff, but implementation of teaching was 
not reported. Stated that compliance with the CVC insertion bundle was 94% 
during the pre-intervention period and 93% during the intervention period
Missing data Were there systematic differences between the baseline and intervention groups 
in attrition or exclusions (includes withdrawal due to mortality; missing outcome 
data)? NOT REPORTED 
Outcome measurement Were there systematic differences between the study groups in how outcomes 
were determined (including differences in how outcomes were defined)?  
NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including 
assessors of blood cultures)? NOT REPORTED
Other possible sources of bias Were any other sources of bias present? NO. No other sources of bias were 
reported by the authors or identified by the reviewers based on the  
information presented 
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. No documentation of the 
bundle protocol or training sessions was provided. The principles and components of the line 
care bundle are reasonably clear but it would be difficult to replicate the hands-on training 
session owing to lack of information on the practical skills components (i.e. which of the line 
care topics had ‘hands-on’ activities)
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Surveillance was conducted by four certified 
infection preventionists. They reviewed the medical record of every patient who had a 
positive blood culture, using a standard data collection form. Each case was then reviewed 
by the hospital epidemiologist to ensure that it met the case definition. Device-day data 
collected by ICU nursing staff were compared with data collected daily by the intravenous 
catheter management team to confirm the accuracy of data collection
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED, but 
stated that it was piloted
If YES or PARTIALLY, was the data collection process shown to be reliable? UNCLEAR. Stated 
that device-day data collected by ICU nursing staff were compared with data collected daily 
by the intravenous catheter management team to confirm the accuracy of data collection, 
but no data were reported
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? NOT REPORTED. No information on compliance with the 
post-insertion care bundle was reported
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HIGUERA (2005)103
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Higuera (2005)103
Summary of approach Single hospital infection control programme comprising 1-hour classes and feedback of 
compliance with catheter care and hand hygiene, conducted in two ICUs. Focused on  
CVC-associated BSI but also covered VAP and UTIs
Part of an international multicentre project of nosocomial infection surveillance and control 
called the International Infection Control Consortium (49 ICUs of 39 hospitals in 28 cities of 
12 countries)
Location Mexico
Language English
Critical care specialties Medical SICU, neuroSICU
No. of critical care units 2
No. of hospitals 1
Hospital name (unless 
multicentre); city
General Hospital, Mexico City
Study design Before-and-after study in two ICUs that were treated mainly as a single cohort; limited 
outcomes data reported for the ICUs separately
Study time periods Baseline: June to August 2002 (3 months)
Intervention: September 2002 to May 2003 (9 months)
Follow-up: none (continuous monitoring of intervention)
Funding source Supported by a grant from Baxter Health Care International
Conflicts of interest Not reported
SICU, surgical intensive care unit.
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Population and setting
All adult patients admitted to the study ICUs who had a CVC in place for at least 24 hours; patients had 
undergone neurosurgical, general and orthopaedic surgery or had severe medical illness. Full barrier 
precautions were used occasionally as resources permitted.
Critical care unit characteristics: 
two level 3 ICUs in a 1000-bed 
public university hospital with  
six ICUs
Baseline: June 
to August 2003 
(3 months)
Intervention: 
September 2002 
to May 2003 
(9 months)
Difference between baseline and 
intervention: relative risk (RR)  
(95% CI); p-value
Mean patients per month 44.0 37.5 Statistics not reported except:
Bed occupancy RR = 0.84 (0.69 to 
1.02); p = 0.08
Nurse to patient ratio RR = 1.00  
(0.91 to 1.00);a p = 1.00
No. of beds per ICU 12 12
Total available ICU bed-days 2160 6480
Actual bed occupancy, % 45.9 40.1
Nurses per ICU per work shift 6 6
Total available nurse days 540 1620
Nurse to patient ratio 0.54 0.61
Patient characteristics
Total no. of patients 132 338
In medical-surgical ICUb 52 170
In neuroSICUb 80 168
Males, n (%) 60 (45.5) 163 (48.2) p = 0.588
Mean ± SD age, years 44.32 ± 18.3 45.91 ± 17.88 p = 0.422
Diabetes, n (%) 26 (19.7) 72 (21.3) p = 0.700
Cancer, n (%) 1 (0.8) 7 (2.1) p = 0.322
Hypertension,c n (%) 22 (16.7) 75 (22.2) p = 0.183
Cardiac failure, n (%) 3 (2.3) 16 (4.7) p = 0.223
Chronic obstructive pulmonary disease, 
n (%)
3 (2.3) 16 (4.7) p = 0.223
Smoker, n (%) 17 (12.9) 55 (16.3) p = 0.358
Alcoholism, n (%) 24 (18.2) 65 (19.2) p = 0.794
Renal impairment, n (%) 3 (2.3) 19 (5.6) p = 0.722
a Confidence interval is from table 3 of the primary publication; reported in the text as (0.91 to 1.10).
b Data are from table 2 of the primary publication; numbers reported in the text of the publication are different and do 
not sum to the total number of patients reported (Phase 1, 173; Phase 2, 297).
c Systolic blood pressure of > 140 mmHg.
Device characteristics A semirigid plastic open infusion system was used instead of a collapsible flexible 
closed infusion system
Insertion site antisepsis used Povidone–iodine
Dressing type and duration/frequency If a dressing was used at all, it would be a gauze dressing; no transparent 
dressings were used
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Intervention characteristics
Objective To ascertain the effect of an infection control programme including process control on ICU 
rates of intravascular device-associated bloodstream infection (BSI)
Main focus of education Insertion site dressing, intravenous administration set dating, and hand hygiene
Trainers (providers) An infection control nurse presented the educational classes
Training of trainers The project co-ordinator trained the data collectors at each ICU before the start of the study
Learners (recipients) Health-care workers in the ICU (nurses, ancillary staff and physicians)
Target behaviour change Insertion site dressing selection and placement, and hand hygiene before patient contact
Development and 
testing
Not reported
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
One-hour classes on epidemiology of nosocomial infections, hand hygiene, disinfection, 
prevention of intravascular device-associated BSIs, prevention of VAP, and prevention of UTIs
Infection control guidelines: as published by the CDC. Not reported whether these were 
disseminated separately or included within the educational classes
Infection surveillance 
feedback approach 
Not included in the intervention (active surveillance for infections took place during both the 
baseline and intervention periods but feedback to ICU staff was not reported)
Performance feedback 
approach 
Compliance with hand hygiene and catheter care were assessed using a standardised 
form. Placement of gauze on intravascular device insertion sites, marking the date on 
the intravascular administration set, condition of the gauze dressing, and hand hygiene 
with alcohol hand rub or povidone–iodine soap before patient contact were assessed on 
a standard form by local researchers who observed health-care worker behaviours in the 
ICUs 5 days a week. The gauze dressing was inspected, and the presence or absence of 
blood, moisture, and gross soilage, and the appearance of the insertion site were noted. 
Feedback was provided monthly by a chart with columns representing each month showing 
rates of compliance with hand hygiene, gauze on CVC insertion sites, dates on intravenous 
administration sets, and maintenance of gauze dressings on catheter sites. The charts were 
posted on the walls of the ICU in a visible place in front of the health-care workers (nurses, 
ancillary staff and physicians). Validity and reliability of the data collection approach not 
reported
Concentration of 
education 
Classes lasted 1 hour. Number of classes not reported. Classes were given to all the work 
shifts, with extra classes for new nurses (only few) and new medical residents. Not reported 
whether staff were re-educated annually
Non-educational 
intervention components
Alcohol hand rub or hand washing with povidone–iodine soap was started during the 
intervention period; previously regular non-antiseptic soap had been used
Costs reported No
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Outcome characteristics
Catheter-
BSI 
definition 
Reference 
cited: 
Garner 
et al.147
Criterion 1: Laboratory-confirmed BSI: The patient had a recognised pathogen cultured from one or more 
percutaneous blood specimens after 48 hours of vascular catheterisation, and the pathogen isolated from 
the blood was not related to an infection at another site; for common skin commensals (e.g. diphtheroids, 
Bacillus spp., Propionibacterium spp., coagulase-negative staphylococci or micrococci), the organism was 
cultured from two or more blood specimens obtained on separate occasions
Criterion 2: The patient had fever (temperature > 38 °C), hypotension, (systolic blood pressure < 90 mmHg), 
and/or oliguria (< 20 ml/hour) with no other recognised cause but blood specimens were not obtained for 
culture or organisms were not recovered from blood cultures; however, there was not apparent infection at 
another site, and the physician instituted treatment for sepsis
Decisions to remove catheters and obtain blood specimens for culture were made independently by the 
patient’s attending physicians. CVCs were removed aseptically and the last 5 cm of the catheter tip was 
cultured using a semiquantitative method. All cultures were inoculated within 8 hours of catheter removal. 
For blood cultures, two blood samples (5–10 ml) were obtained from two separate veins within an interval of 
15–20 minutes, inoculated in a 50-ml bottle, and sent to the microbiological laboratory
Outcomes 
reported 
Primary:
Rate of intravascular device-associated BSI
Secondary:
Hand hygiene
Catheter care compliance: dressing use and placement; dating of the catheter administration set
Hand hygiene compliance
Mortality rate 
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Results data
Primary outcomes 
Outcome
Baseline: June 
to August 2002 
(3 months)
Intervention: 
September 2002 
to May 2003 
(9 months)
Difference between 
baseline and 
intervention: 
relative risk (RR) 
(95% CI); p-value
Device duration Not reported Not reported Not reported
Device utilisation, CVC-days 605 2824 Not reported
No. of devices/patient Not reported Not reported Not reported
No. of CVC-associated BSI 28 55 Not reported
CVC-associated  
BSI incidence/ 
1000 CVC-days
Total 46.3 19.5 RR = 0.42 (0.27 to 
0.66); p = 0.0001
Medical-surgical ICU 57.4 22.1 RR = 0.38 (0.22 to 
0.68); p = 0.000
Neurosurgical ICU 32.8 17.1 RR = 0.52 (0.24 to 
1.11); p = 0.08
CVC-associated BSI incidence/ 
1000 patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Total deaths 64/132 111/338 RR = 0.68 (0.50 to 
0.91);a p = 0.01
Unadjusted mortality 
per 100 discharges
48.5% 32.8%
a From table 4 of the primary publication (three different values of the same CI were reported in the abstract  
(0.50–0.31), text (0.50–0.79) and table 4 (0.50–0.91) – the values in table 4 are consistent with the calculation 
method of Kirkwood and Sterne61 referred to in the main report).
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Additional data on central venous catheter-associated BSI incidence/1000 
central venous catheter-daysa
Month Medical-surgical ICU Neurosurgical ICU
June 2003 35.7 13.1
July 2003 67.7 36.6
August 2003 43.2 31.3
September 2003 40.8 16.9
October 2003 15.5 24.2
November 2003 16.5 19
December 2003 15.9  6
January 2004 46.2 16.4
February 2004 14.9 18.2
March 2004 15.3  9.4
April 2004 18.3 32.3
May 2004 21.9 13.9
a Data are from figures 1 and 2 in the primary publication and appear to be for an additional 12-month period beyond 
the specified study duration; unclear whether these data represent follow-up or ongoing monitoring of a continuing 
intervention or an error (no explanation of figure 2 given in the primary publication).
Secondary outcomes 
Outcome
Baseline: June to August 
2002 (3 months)
Intervention: September 
2002 to May 2003 
(9 months)
Difference between 
baseline and 
intervention: relative risk 
(RR) (95% CI); p-value 
Compliance
Proper catheter care
No. of observations 1413 2912
Gauze presence on  
insertion site
86.69% 99.24% RR = 1.14 (1.07 to 1.22); 
p = 0.0000
Proper gauze placement at 
insertion site
84.21% 97.87% RR = 1.16 (1.09 to 1.24); 
p = 0.0000
Dating of intravenous 
administration set
40.69% 93.85% RR = 2.34 (2.14 to 2.56); 
p = 0.0000
Hand hygiene before patient contact
No. of observations 584 584
Hand hygiene practised 62% 62% RR = 1.37 (1.21 to 1.51); 
p = 0.0000
Reaction to education Not a study outcome
Attitudes Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not reported other than compliance with catheter care and hand hygiene was assessed and 
reported back to ICU staff (as summarised above)
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NO. Patients were 
similar with regard to sex, age, major disease, smoking and alcoholism. Available beds and  
nurse to patient ratios were also similar in the baseline and intervention periods. Bed occupancy and 
mean number of patients per month were slightly lower (more favourable) in the intervention period 
but the differences were not statistically significant
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. The authors stated that a programme to improve hand hygiene was already in 
place in the neurosurgical ICU but the implementation date was not reported
Was the effect of educational practice separable from effects of non-educational practice? YES. The 
intervention was primarily educational (including information provision for compliance). Alcohol  
hand rub or hand washing with povidone iodine soap was started during the intervention period  
but although not an educational activity in itself this was a target of the education; no information 
was reported to suggest that use of the soap was due to non-educational factors (such as changes  
in availability)
Were the intervention component(s) implemented as planned? UNCLEAR. Compliance with the 
educational classes themselves (e.g. whether participation was mandatory for all ICU staff) was not 
reported and it is unclear whether dissemination of the CDC infection control guidelines was included 
in the classes or separate (and if the latter, how implementation was achieved). However, compliance 
with all target behaviours statistically significantly improved (did not reach 100%)
Missing data Were there systematic differences between the baseline and intervention groups in attrition or 
exclusions (includes withdrawal due to mortality; missing outcome data)? UNCLEAR. The authors 
report two different sets of data on the number of patients recruited. Tables 1–4 each agree that the 
number was 132 in the baseline period and 338 in the intervention period. The text states that the 
numbers for baseline and intervention periods were, respectively, 173 and 297 (but overall total of 
470 patients is the same). Mortality rate was significantly lower in the intervention period; it is unclear 
whether this was a consequence of the intervention (not discussed by the authors)
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. The definition 
of infections used appears to be that used within the International Infection Control Consortium; no 
changes in definition or microbiological culture technique during the study were reported. However, 
no information about staff diagnosing infections was given
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
The authors stated that study centre data collection sheets were checked for potential errors and 
missing items by the project co-ordinator to confirm each diagnosis of intravascular device-associated 
BSI, but no checking of compliance data was reported
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. The process feedback 
approach is reported well enough to be repeated in principle. However, the educational 
classes are reported superficially and the number of classes required to achieve the observed 
intervention effect is not clear. The dissemination approach for CDC guidelines is also not 
clear (whether standalone or included in classes)
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. A medical doctor at each ICU collected infection 
data prospectively from patient charts. Compliance data were collected by unspecified local 
researchers who observed health-care worker behaviours in the ICUs 5 days a week. Not 
reported how the data were stored after collection
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED. 
However, the authors stated that checks for errors and missing data were conducted for 
infection surveillance (see above)
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? YES. Compliance with the target behaviours (insertion 
site dressing selection and use; hand hygiene before patient contact) was increased by the 
intervention (compliance was high but did not reach 100%)
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LOBO (2005)108
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Lobo et al. (2005)108
Summary of approach Single unit educational programme targeted to specific points observed during CVC care 
practices on decreasing CVC-blood stream infections (BSI) in a MICU
Location Brazil
Language English
Critical care specialty MICU
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Hospital das Clinicas of University of São Paulo
Study design Cohort before-and-after study 
Study time periods Baseline: January 2001 to April 2002 (Phase 1: described as 1-year pre-intervention period 
and 3 months observation; described as 16 months in Results section)
Intervention: May 2002 to December 2002 (Phase 2: 8 months, including an observation 
period)
Follow-up: CVC-BSI were also evaluated during the following year after the educational 
intervention (Phase 3)
(Note: monthly surveillance feedback and prevention guide that was given to all medical 
residents were continued during follow-up)
Funding source None reported
Conflicts of interest Not reported
Population and setting
Critical care unit characteristics: The nursing staff was responsible for the CVC dressing and line care; the medical 
residents were responsible for CVC insertion and replacement; and CVC manipulation was done by both. ICU staff: five 
physicians, 36 medical residents, 23 assistant nurses and 10 nurses
Patient population 
characteristics
All adult patients admitted to the ICU with a CVC for > 24 hours
Device characteristics Device reported as CVC, no other details reported
Insertion site antisepsis 
used
Alcohol (chlorhexidine was not available at the hospital)
Dressing type and 
duration/frequency 
Not reported
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Intervention characteristics
Objective Determine the impact of an educational programme targeted to specific points observed 
during CVC care practices on decreasing CVC-BSI in a MICU
Main focus of education Hand washing, skin preparation of CVC insertion, pathogenesis of CVC infection and 
standardisation of CVC manipulation
Trainers (providers) Not reported (the infection control committee made the posters and set up the hand 
washing campaign)
Training of trainers Not reported
Learners (recipients) The entire unit staff was involved in monthly classes and discussion of infection rates
Target behaviour change Hand hygiene, sterile catheter insertion procedure and CVC maintenance 
Development and 
testing
The educational programme was developed by a multidisciplinary task force to highlight 
correct practices for CVC insertion, manipulation, and care. The multidisciplinary task force 
included three infection control nurses, one physician, and the entire staff of the unit. The 
educational programme was based on observations by the infection control staff of CVC 
care practices in the ICU
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
The programme consisted 
of a pre-test and 
monthly classes, posters, 
discussions with staff, and 
a new observation period 
(Phase 2). The programme 
was applied for the same 
people during the study 
period
Pre-test: included 10 questions concerning hand washing, information about when the 
health-care professional should wash their hands (before and after contact with the 
patient, before and after CVC insertion, manipulation and dressing) and how (with alcohol 
povidone–iodine or chlorhexidine), and that the use of glove does not exclude hand 
washing. The pre-test also covered CVC insertion (skin preparation, CVC site, technique, 
and the use of maximum barriers), CVC dressing (type, replacement and skin preparation), 
CVC manipulation (disinfection), hub and line care (replacement) and CVC replacement
Observation Phase 1: 3 months
Observation checklist: included hand washing, CVC insertion (skin preparation, site, technique, 
and use of maximum barriers), CVC dressing (hand washing; type, frequency of replacement, 
skin care), and CVC manipulation (hand washing, hub disinfecting and line care)
Intervention:
Classes/discussion: monthly classes and discussion with staff on infection rates
Hand washing campaign: use of chlorhexidine and posters with hand washing classes 
(hand-washing product remained the same pre and post intervention and was not  
alcohol based)
Colourful stamps: with tips to remind the unit staff of the importance of hand washing 
and CVC care were placed on the CVC insertion site or on the CVC lines
Posters: concerning hand hygiene and pathogenesis of CVC infection
CVC-BSI prevention guide: the catheter care policy included hand washing with 
chlorhexidine before and after any patient care and recommendations concerning CVC 
insertion (skin preparation with povidone–iodine and skin antisepsis with 70% alcohol 
povidone–iodine and use of maximum barriers; sterile gown and gloves, large sheets, cap and 
surgical mask, dressing (skin care with alcohol povidone–iodine and dry gauze, replacement 
every 24 hours and when wet), manipulation (hub disinfection with 70% alcohol), line 
care (replacement every 72 hours for administration sets, every 24 hours for lipid emulsion, 
and immediately removed after use for blood products), and CVC replacement (no routine 
replacement except when clinically indicated, e.g. if unexplained fever)
Observation Phase 2: checklist (not explicitly stated, but presumed to be the same as  
pre-intervention) on hand washing, CVC insertion (skin preparation, site, technique and  
use of maximum barriers), CVC dressing (hand washing; type, frequency of replacement,  
skin care) and CVC manipulation (hand washing, hub disinfecting and line care)
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Infection surveillance 
feedback approach
Monthly feedback on the CVC-BSI rate during the first year after the end of the intervention 
was given to the unit and the CVC-BSI prevention guide was given to all medical residents. 
Unclear if feedback was practiced prior to intervention. Validation and reliability of the 
reporting process not stated
Performance feedback 
approach 
Not reported
Concentration of 
education 
Stated monthly classes, no other details reported
Non-educational 
intervention components 
None (intervention purely educational)
Costs reported Not reported (stated campaign was done with own resources)
Outcome characteristics
Catheter-BSI 
definition
Reference 
cited: Garner 
et al.147
All patients with CVC for > 24 hours admitted to ICU were included in study. Laboratory-confirmed 
CVC-BSI was defined according to the Centers for Disease Control and Prevention (CDC). The infection 
was regarded as ICU acquired if it occurred during ICU stay or within 48 hours of discharge from the 
MICU. CVC-BSI representing primary bloodstream infection was defined by one of the following clinical 
signs or symptoms with no other recognised cause: recognised pathogen isolated from blood culture 
not related to infection at another site; common skin contaminant isolated, such as coagulase-negative 
Staphylococcus from two or more blood cultures drawn on separate occasions, within 24 hours, 
unrelated to infection at another site; and patients had at least one of the following signs or symptoms – 
fever of > 37.8 °C, chills or hypotension
Outcomes 
reported
Primary outcome: rate of CVC-BSI
Secondary outcomes: compliance with the CVC-BSI prevention guide
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Results data
Primary outcomes
Baseline 
(16 months), 
n = 316
Intervention 
(8 months), n = 190
Follow-up 
(12 months), 
n = 266
Difference 
between baseline, 
intervention and 
follow-up periods 
Outcome
n = no. of patients
CVC-days Not reported Not reported Not reported Not reported
Total device 
utilisation, days
2450 1481 1701 Not reported
No. of devices/
patient
Not reported Not reported Not reported Not reported
CLAB incidence rate 48 16 22 Not reported
CLAB incidence per 
1000 catheter-days
20 11 12 Baseline to post 
intervention: 40% 
reduction (no p-value 
reported)a
CLAB incidence per 
1000 patient-days
Not reported Not reported Not reported Not reported
LOS Not reported Not reported Not reported Not reported
Mortality Not reported Not reported Not reported Not reported
a Stated that the rate of CVC-BSI remained almost the same, 22 in 1701 catheter-days (12 per 1000 catheter-days), 
during the following year after the educational intervention (p = 0.07).
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Secondary outcomes
Outcome Baseline (16 months) Intervention (8 months)
Difference in compliance 
between baseline and 
intervention [relative risk (RR) 
(95% CI); p-value]a
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance, n (%)
CVC insertion (medical 
residents)
n = 22 n = 22
Hand washing before 
(chlorhexidine)
22 (100) 22 (100)
Maximal barrier (gloves, 
gown, mask)
20 (91) 22 (100) 0.91 (0.80 to 1.04a); p = 0.147
Skin antisepsis/alcohol-
based povidone–iodine
2 (10) 22 (100) 11.0 (2.93 to 41.2a); p < 0.001
CVC manipulation (nurses 
and medical residents)
n = 42 n = 46
Hand washing before 
(chlorhexidine)
2 (5) 28 (55) 12.78 (3.24 to 50.42); p < 0.001
Glove use 17 (40) 45 (98)b 2.36 (1.64 to 3.40a); p < 0.001
Line protection 29 (69)b 45 (98)b 1.38 (1.13 to 1.69a); p < 0.001
Hub disinfection 14 (34) 43 (90) 2.74 (1.78 to 4.22a); p < 0.001
Hand washing after 
(chlorhexidine)
16 (38) 20 (43) 1.14 (0.69 to 1.90a); p = 0.6079
CVC dressing (nurses) n = 31 n = 31
Hand washing before 
(chlorhexidine)
14 (45) 21 (68) 1.50 (0.95 to 2.37); p = 0.072
Glove use 30 (97) 30 (97) 1.00 (0.91 to 1.10); p = 1.00
Alcohol povidone–iodine 
antisepsis
1 (3) 31 (100) 31.00 (4.51 to 213.18); p ≤ 0.001
Hand washing after 
(chlorhexidine)
8 (26) 18 (58)b 2.25 (1.15 to 4.39); p = 0.010
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not reported other than compliance (above)
a Reported CIs differ from those that would be calculated using the method of Kirkwood and Sterne.62
b Percentage corrected by reviewers.
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Critical appraisal
Potential for bias 
Group 
selection
Were there systematic differences between the baseline and intervention groups? NOT REPORTED
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates or 
subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT REPORTED. However, authors stated that criteria to consider a common skin 
contaminant as a cause of CVC-BSI were rigid and that the pre- and post-intervention programme was 
applied to the same people during the study period
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention
Were the intervention component(s) implemented as planned? UNCLEAR. Stated in methods section 
that the entire unit staff was involved in the monthly classes and discussion of infection rates, but 
implementation was not reported in the results. All staff took part in a pre-test but post-testing was not 
reported. Authors stated they noticed a profound involvement of the unit staff during the educational 
period but did not give details
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. The combined number of nurses and medical residents differed from pre- (n = 42) to post-
intervention (n = 46) for observations on CVC manipulation data. However, the number of medical 
residents was the same both pre- and post-intervention for observations on CVC insertion, as was the 
number of nurses’ observations on CVC dressing
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes were 
determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? UNCLEAR. Blinding of assessors reported. Stated that the observation was blinded to 
following the CVC dressing, manipulation, and care. However, also stated that at times the infection 
staff was contacted to follow the CVC insertion (mainly during the night)
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on the 
information presented
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. Details about the structure, content and 
time resources required were not reported
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Surveillance of nosocomial infections was conducted by 2 
infection control nurses, who visited the medical unit daily
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? PARTLY. Compliance with hand hygiene did not improve 
significantly but other behaviours did. Compliance statistically significantly increased in four out of five 
target behaviour components for CVC manipulation, in one of three target behaviour components for 
CVC insertion, and one out of four target behaviour components for CVC dressing. Compliance with 
all target behaviour components increased only for CVC manipulation, but was inconsistent for CVC 
insertion and CVC dressing
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Additional comments
 z Device-days not defined (i.e. unclear whether accounts for multiple simultaneous CVCs in a patient).
 z Not reported whether participants were aware they were in a study.
 z Pre-test and the pre-intervention observation period showed that compliance with the guideline was 
low, with major problems concerning skin preparation during CVC insertion, disinfection of CVC 
during manipulation, and non-use of an alcohol-based product during the CVC dressing. Knowledge 
of CVC insertion procedures and line care were reasonable, but low compliance with disinfection of 
the CVC hub during manipulation and use of an alcohol-based product during preparation of the CVC 
dressing because only saline solution was used (data not extracted).
 z Authors stated that the distribution of pathogens was different comparing the pre- and post-
intervention period. S. aureus was the most common pathogen in phase 1 and decreased significantly 
during the study period (p = 0.02).
 z Also stated that the adhesion to the overall catheter care policy improved significantly in the  
post-intervention period (p = 0.01).
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LOBO (2010)109
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Lobo et al. (2010)109
Summary of approach Single centre evaluation of the impact of two models of educational intervention (tailored 
continuous intervention vs. a single lecture) on the rate of CVC-associated bloodstream 
infections (CVC-BSI) in 2 MICUs
Location Brazil
Language English
Critical care specialty MICU
No. of critical care units 2
No. of hospitals 1
Hospital name (unless 
multicentre); city
Hospital das Clinicas, São Paulo, Brazil
Study design Cohort before-and-after study comprising two separate cohorts with different interventions
Study time periods Baseline (surveillance): January 2005 to December 2005 (12 months)
Pre-intervention (knowledge assessment and observation of CVC care): January 2006 to 
September 2006 (9 months)
Intervention (differed in the two ICUs): October 2006 to June 2007 (9 months)
Follow-up: None (tailored continuous educational programme) but stated that continued 
educational intervention resulted in no CVC-BSIs in 2008
Funding source Main author received a grant from CAPES. (Not defined by the authors; assumed to refer 
to the CAPES Foundation – a Brazilian government agency awarding scholarship grants to 
graduate students at universities and research centres)
Conflicts of interest None stated
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Population and setting
Critical care unit 
characteristics
1000-bed tertiary care teaching hospital attached to the University of São Paulo. 
Medical residents rotated each 40 days
ICU A ICU B (control)
Beds 5 8
Physician–bed ratio 1 : 5 1 : 8
Medical resident–bed ratio 1 : 1 7 : 8
Registered nurse–bed ratio 1 : 5 3 : 8
Assistant nurse–bed ratio 2 : 5 4 : 8
Sinks–bed ratio 1 : 3 1 : 3
Alcohol-based gel 
dispensers–bed ratio
1 : 2 1 : 2
Patient population 
characteristics
ICU A
Pre-intervention: 
n = 141
Intervention: 
n = 41
Difference between pre-intervention 
and intervention
Patient-days 1699 1341 Not reported
CVC days 940 843 Not reported
Age, years: median 
(range)
51 (8–87) 50 (13–86) p = 0.832
Age, years: mean (SD) 54 (± 21) 53 (± 20)
Male: n, (%) 87 (62) 18 (43) p = 0.042
Underlying diseases, n p = 0.890
Cancer 12 2
Cardiovascular disease 6 7
Surgical condition 8 5
Diabetes mellitus 0 0
Haematological disease 0 0
Infectious disease 22 5
Neurological disease 0 0
Other diseases 46 12
Pneumonia 23 5
Renal failure 11 0
Respiratory failure 13 5
Septic shock 0 0
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Patient population 
characteristics
ICU B 
Pre-intervention, n = 378 Intervention, n = 262
Difference between 
pre-intervention and 
intervention 
Patient-days 3704 2523 Not reported
CVC-days 2175 1694 Not reported
Age, years median (range) 53 (11–97) 50 (14–93) p = 0.045
Age, years mean (± SD) 55 (± 20) 51 (± 19)
Male, n (%) 6 (10) 6 (14) p = 0.815
Underlying diseases, n p = 0.386
Cancer 22 14
Cardiovascular disease 50 26
Surgical condition 20 13
Diabetes mellitus 18 20
Haematological disease 16 4
Infectious disease 36 27
Neurological disease 47 37
Other diseases 69 40
Pneumonia 34 23
Renal failure 14 9
Respiratory failure 36 30
Septic shock 16 19
Device characteristics Device only described as CVC, no further details reported
Insertion site antisepsis used Standardised chlorhexidine gluconate 0.5% alcoholic – remained 
unchanged during the study
Dressing type and duration/frequency Not reported
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Intervention characteristics
Objective Evaluate the impact of two models of educational intervention on the rate of CVC-BSI 
Main focus of 
education 
Hand washing, CVC care and maintenance
Trainers (providers) Not reported
Training of trainers Not reported
Learners (recipients) All staff and medical residents in both ICUs
Target behaviour 
change
Adherence to CVC practices
Development and 
testing
The programme in ICU A was based on problems found during an observation phase
Educational or 
behavioural theory
Not reported
Educational 
strategies and 
topics targeted
Questionnaire pre-intervention period (ICU A and B): 11-questions questionnaire designed 
to evaluate health-care workers’ knowledge of the Nosocomial Infection Control Committee’s 
recommendations regarding CVC care (adapted from CDC guidelines; reference cited) was 
applied in both ICUs. The questionnaire covered the following issues:
 z Hand hygiene (when, how and with which product: chlorhexidine gluconate soap or  
alcohol-based gel) and the notion that the use of gloves does not preclude the need for hand 
hygiene
 z Hand hygiene with alcohol-based gel as an alternative to hand washing
 z CVC insertion (i.e. preferred CVC site, skin preparation, technique, and the use of maximal 
barrier precautions)
 z CVC dressing (i.e. types, changes and skin antisepsis)
 z CVC handling (e.g. hub disinfection)
 z CVC replacement sets (e.g. line care)
Second observation period (checklist): started 1 month after the start of the intervention 
period in ICU A and 1 month after the lecture in ICU B
ICU A:
Questionnaire (same as at pre-intervention): administered on a monthly basis as an educational 
strategy to medical residents
Monthly lectures: CVC care for all new medical residents
Lectures to small groups: simple messages, focusing on problems identified in the  
observation phase
Lectures on hand hygiene practices: intervention lectures included hand hygiene before and  
after any CVC care; use of alcohol-based gel or hand hygiene with soap for soiled hands;  
replacement of intravenous tubing (including add-on devices) no more frequently than at  
72-hour intervals; replacement of tubing used to administer blood, blood products or lipid 
emulsions within 24 hours of initiating infusion; replacement of the extension tubing used 
for intermittent infusions at every catheter change; use of alcoholic chlorhexidine gluconate 
0.5% solution for skin antisepsis during catheter dressing; replacement of gauze dressing every 
24 hours or when damp, loose or visibly soiled; replacement of transparent dressings every 7 days 
or when damp, loose or visibly soiled; protection of the catheter with impermeable material 
during showering; disinfection of hub and line with 70% alcohol; and protection of line and sets 
during catheter handling
Posters: displayed in the unit with stimulating messages in visible places and containing a  
step-by-step description of hand hygiene
Colourful labels with tips: reminder to the health-care worker of the importance of CVC care
ICU B:
Lecture: one lecture on CVC care given to all staff and medical residents who rotated in the unit 
during this period (immediately after the pre-intervention period)
Observation checklist: included CVC insertion (hand hygiene, skin antisepsis, and use of 
maximal barrier precautions); CVC dressing (hand hygiene, glove use, skin antisepsis); CVC 
handling (hand hygiene, glove use, hub disinfection)
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Infection 
surveillance 
feedback approach 
Surveillance was done by three infection control nurses who visited the ICUs daily. Intervention 
period: monthly updates of CVC-BSI rates posted in multiple locations in ICU A only. Validation 
and reliability of the reporting process not stated
Performance 
feedback approach
Intervention period: Feedback to the entire staff of ICU A regarding problems noted during the 
observation phase. No further details reported. Validation and reliability of the reporting process 
not stated
Concentration of 
education 
Monthly lectures and monthly questionnaire in ICU A; single lecture in ICU B. Lengths of lectures 
not reported
Non-educational 
intervention 
components
None (intervention purely educational)
Costs reported Not reported
Outcome characteristics
Catheter-BSI 
definition
Reference cited: 
Garner et al.147
Diagnosis of infection was based on CDC criteria. CVC-BSI was defined as primary BSI in the 
presence of a CVC. Only laboratory-documented infections were included. Each patient was 
followed up until 48 hours after discharge from the ICU
Outcomes reported Not stated whether primary or secondary:
 z CLAB incidence per 1000 catheter-days
 z Patient-days
 z Device utilisation and utilisation rate
 z Adherence to hand hygiene, maximal barrier precautions, hub disinfection, skin antisepsis 
during CVC insertion, handling and dressing
Results data
Primary outcomes
Outcome
ICU A Difference between 
baseline,  
pre-intervention 
and intervention
Baseline 
(12 months)
Pre-intervention 
(9 months)
Intervention 
(9 months)
Device duration Not reported Not reported Not reported Not reported
CVC-days Not reported 940 843 Not reported
Device utilisation ratea 0.72 0.55 Not reported
Month 1: 0.53 Not reported
Month 2: 0.65 Not reported
Month 3: 0.75 Not reported
Month 4: 0.64 Not reported
Month 5: 0.62 Not reported
Month 6: 0.59 Not reported
Month 7: 0.7 Not reported
Month 8: Not reported Not reported
Month 9: Not reported Not reported 
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Outcome
ICU A Difference between 
baseline,  
pre-intervention 
and intervention
Baseline 
(12 months)
Pre-intervention 
(9 months)
Intervention 
(9 months)
Patient-days 1699 1341 Not reported Not reported
No. of devices/patient Not reported Not reported Not reported Not reported
CLAB incidence per 
1000 catheter-days
Not reported 12 10.6 p = 0.03  
(pre-intervention  
vs. intervention)  
(chi-squared test  
for trend)
Month 1: 0 Not reported
Month 2: 10.3 Not reported
Month 3: 8.8 Not reported
Month 4: 0 Not reported
Month 5: 0 Not reported
Month 6: 8.8 Not reported
Month 7: 0 Not reported
Month 8: 0 Not reported
Month 9: 0 Not reported
CLAB incidence per 
1000 patient-days
Not reported Not reported Not reported Not reported
LOS, days: median 
(range), mean (SD)
Not reported 7 (1–32), 5 (7) 9 (1–57), 4 (11) p = 0.386
Mortality Not reported Not reported Not reported Not reported
Primary outcomes
ICU B Difference between 
baseline,  
pre-intervention 
and intervention
Baseline 
(12 months)
Pre-intervention 
(9 months)
Intervention 
(9 months)
Device duration Not reported Not reported Not reported Not reported
CVC-days Not reported 2175 1694 Not reported
Device utilisation ratea 0.61 0.59 Month 1: 0.67b Not reported
Month 2: 0.68 Not reported
Month 3: 0.74 Not reported
Month 4: 0.7 Not reported
Month 5: 0.69 Not reported
Month 6: 0.7 Not reported
Month 7: 0.69 Not reported
Month 8: 0.63 Not reported
Month 9: 0.64 Not reported
Patient-days 3704 2523 Not reported Not reported
No. of devices/patient Not reported Not reported Not reported Not reported
CLAB incidence rate Not reported Not reported Not reported Not reported
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Outcome
ICU B Difference between 
baseline,  
pre-intervention 
and intervention
Baseline 
(12 months)
Pre-intervention 
(9 months)
Intervention 
(9 months)
CLAB incidence per 
1000 catheter-days
Not reported 16.2 Overall: 12.9 Not reported by 
month
p = 0.41  
(pre-intervention  
vs. intervention)  
(chi-squared test  
for trend)
Month 1: 0
Month 2: 0
Month 3: 7.41
Month 4: 11.43
Month 5: 0
Month 6: 5.59
Month 7: 4.24
Month 8: 3.44
Month 9: 13.7
CLAB incidence per 
1000 patient-days
Not reported Not reported Not reported Not reported
LOS, days: median 
(range), mean (SD)
Not reported 10 (1–99), 6 (10) 11 (1–112), 6 (14) p = 0.402
Mortality Not reported Not reported Not reported Not reported
a  Device utilisation rate, number of central line-days/number of patient-days.
b  Obscured in graph and estimated by reviewer.
Secondary outcomes
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance (ICU A)  
(n = no. of observations)
Pre-intervention 
(9 months), n (%)
Intervention (9 months), 
n (%)
Difference in compliance 
between baseline and 
intervention: relative risk 
(RR) (95% CI); p-value)
CVC insertion n = 12 n = 12
 Hand hygiene before 
procedure
12 (100) 12 (100)
 Maximal barrier 
precautions
12 (100) 12 (100)
 Skin antisepsis 11 (100) 12 (100)
 Hand hygiene after 
procedure
7 (58) 10 (83) 1.43 (0.83 to 2.45); 
p = 0.370
CVC handling n = 63 n = 63
 Hand hygiene before 
procedure
22 (35) 51 (81) 2.32 (1.62 to 3.32); 
p < 0.001
 Washing with 
chlorhexidine soap
18 (29) 26 (41) Not reported
 Alcohol-based gel 4 (6) 25 (40) Not reported
 Use of gloves 63 (100) 63 (100)
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 Disinfection of hub 43 (68) 61 (97) 1.42 (1.19 to 1.69); 
p < 0.001
 Hand hygiene after 
procedure
12 (19) 53 (84) 4.42 (2.63 to 7.43), 
p < 0.001
 Washing with 
chlorhexidine soap
6 (9) 27 (43) Not reported
 Alcohol-based gel 6 (9) 26 (41) Not reported
CVC dressing n = 50 n = 50
 Hand hygiene before 
procedure
14 (28) 49 (98) 3.50 (2.24 to 5.47); 
p < 0.001
 Washing with 
chlorhexidine soap
12 (24) 8 (16) Not reported
 Alcohol-based gel 2 (4) 41 (82) Not reported
 Use of gloves 50 (100) 50 (100)
 Skin antisepsis 27 (54) 50 (100) 1.85 (1.43 to 2.39); 
p < 0.001
 Hand hygiene after 
procedure
17 (34) 48 (96) 2.82 (1.91 to 4.17); 
p < 0.001
 Washing with 
chlorhexidine soap
10 (20) 22 (44) Not reported
Alcohol-based gel 7 (14) 26 (52) Not reported
Compliance (ICU B)  
(n = no. of observations)
Pre-intervention, n (%) 
(9 months)
Intervention, n (%) 
(9 months)
Difference in compliance 
between pre-intervention 
and intervention: relative 
risk (RR) (95% CI); p-value
CVC insertion n = 12 n = 12
 Hand hygiene before 
procedure
12 (100) 12 (100)
 Maximal barrier 
precautions
12 (100) 12 (100)
 Skin antisepsis 12 (100) 12 (100)
 Hand hygiene after 
procedure
8 (67) 8 (67)
CVC handling n = 34 n = 34
 Hand hygiene before 
procedure
5 (15) 16 (48) 3.20 (1.33 to 7.72); 
p = 0.008
 Washing with 
chlorhexidine soap
3 (9) 15 (45) Not reported
 Alcohol-based gel 2 (6) 1 (3) Not reported
 Use of gloves 34 (100) 34 (100)
 Disinfection of hub 15 (44)a 27 (82) 1.80 (1.20 to 2.70; 
p < 0.004
 Hand hygiene after 
procedure
3 (9) 18 (54) 6.00 (1.95 to 18.44), 
p < 0.001
 Washing with 
chlorhexidine soap
3 (9) 13 (39) Not reported
 Alcohol-based gel 0 5 (15) Not reported
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CVC dressing n = 33 n = 33
 Hand hygiene before 
procedure
2 (6) 25 (76) 12.50 (3.22 to 48.56); 
p < 0.001
 Washing with 
chlorhexidine soap
2 (6) 23(70) Not reported
 Alcohol-based gel 0 2 (6) Not reported
 Use of gloves 33 (100) 33 (100)
 Skin antisepsis 9 (27) 32 (97) 3.56 (2.03 to 6.23); 
p < 0.001
 Hand hygiene after 
procedure
9 (27) 21 (64) 2.33 (1.26 to 4.31); 
p < 0.006
 Washing with 
chlorhexidine soap
9 (27) 18 (55) Not reported
 Alcohol-based gel 0 3 (9) Not reported
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation See above compliance with CVC practices
a Percentage corrected by reviewer.
Critical appraisal
Potential for bias 
Group 
selection
Were there systematic differences between the baseline and intervention groups? YES. There was no 
statistical comparison between ICU A and ICU B. Reported data that showed minor differences between 
the study periods in age, gender, LOS and frequency of underlying diseases. However, in both ICUs the 
number of patient-days and CVC-days were consistently lower in the intervention period than in the 
pre-intervention period
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates or 
subgroups or stratification by propensity scores)? NOT REPORTED 
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? YES. Authors report that both ICUs were located within the same building, that the 
chief nurse of ICU A was transferred to ICU B during the study, and that nurses and physicians of all 
hospital units attended regular general meetings during which the success in ICU A was reported. This 
could have affected health-care workers’ behaviour and had an impact on other units as well, possibly 
contributing to the initial decreased CVC-BSI rate in ICU B
Was the effect of educational practice separable from effects of non-educational practice? YES 
(education alone)
Were the intervention component(s) implemented as planned? NOT REPORTED. Stated that all staff in 
both ICUs responded to the questionnaire. However, the percentage of staff observed is unclear and 
there were a higher number of observations for CVC handling and dressing in ICU A, which had much 
lower patient numbers than ICU B during the intervention period (n = 41 vs. n = 262, respectively) 
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. Patient numbers differed considerably between ICUs, as well as between baseline  
and intervention
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Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes were 
determined (including differences in how outcomes were defined)? UNCLEAR. Authors implied (not explicitly 
stated) that the definition of infections and the approach for assessing outcomes would have been the same 
in both study periods. However, no information was given on the staff diagnosing infections
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
Stated that the high compliance with the CVC insertion recommendations observed in the study was 
likely related to a previous intervention performed in the hospital; however, these recommendations 
were not stressed in the present educational intervention. CVC-BSI rates already improved in the  
pre-intervention period prior to the start of the intervention in both ICUs
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. Good description of the content 
of the intervention, but no breakdown of the content of each lecture or information about lecture 
duration
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Three infection control nurses visited the ICUs daily and 
each patient was followed until 48 hours after discharge from ICU. However, does not state whether 
manual or electronic record management was used
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? PARTIALLY. Adherence to CVC practice was not 100% in all areas
Additional comments
 z Not reported whether the participants knew that they were being observed.
 z Device-days not defined (i.e. unclear whether captures multiple simultaneous CVCs/patients).
 z Authors were contacted for CVC utilisation rate definition (defined as: number of central line-days/
number of patient-days).
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LONGMATE (2011)110
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Longmate (2011)110
Summary of approach Single ICU, 4-year QI intervention based on gradual and iterative implementation of bundles, 
including infection surveillance feedback and performance feedback
Location Scotland
Language English
Critical care specialty MICU and SICU
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Stirling Royal Infirmary, Stirling
Study design Single-cohort before-and-after study with phased implementation of interventions
Study time periods Baseline 1 September 2005 to 31 December 2006: Infection surveillance and interventions 
aimed at improving hand hygiene practices
January 2007: CRBSI bundles and education implemented
March 2007 to August 2009: interventions to reduce VAP
March 2008: Scottish Patient Safety Programme launched in the ICU [stated this was for the 
last 16 months of the study (online Appendix 6) or last 18 months (primary publication)]
November to December 2008: centralisation of CVC insertion pack
March 2009: Three-nurse team assembled to support CVC bundles
August 2009: End of monitoring
Follow-up: None (continuous monitoring of QI programme)
Funding source Stated that Health Protection Scotland provided funding for a nurse salary for the second 
year of the project
Conflicts of interest Two authors had completed or were taking a SPSP Fellowship; one author was Nursing Lead 
for the Critical Care work stream of the SPSP at Stirling Royal Infirmary
SICU, surgical intensive care unit; SPSP, Scottish Patient Safety Programme.
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Population and setting
Critical care unit characteristics
Nine-bed ICU in a general hospital. Full aseptic technique was not consistently performed at catheter insertion. For 
established CVCs there was variation in hand hygiene practices, and techniques for commencing injections and infusions. 
No daily prompt and no consistent approach was used for CVC removal (common practice was routine replacement after 
7 days, sometimes over guidewire)
CVC defined as any i.v. catheter ending at or near the heart. Every patient admitted for more than 48 hours who during at 
least part of their admission had a CVC was assessed daily until discharge for CRBSI occurrence
Baseline (year 1) 
(September 2005 to 
August 2006)a
Intervention 
(January 2007 to  
31 August 2009)b
Difference between 
baseline and 
intervention 
Patient population characteristics (all ICU patients)
No. of patients admitted 439 Not tested statistically
 September 2007 to August 2008 (year 3) 465
 September 2008 to August 2009 (year 4) 358
Patients ventilated, % 69 Not tested statistically
 September 2007 to August 2008 (year 3) 74
 September 2008 to August 2009 (year 4) 73
Mean (SD) APACHE II score 19.8 (8.4)
 September 2007 to August 2008 (year 3) 21.0 (7.3) Year 3 vs. 1: p = 0.89
 September 2008 to August 2009 (year 4) 18.7 (8.7) Year 4 vs. 1: p = 0.38
Median LOS, days 2.2
 September 2007 to August 2008 (year 3) 2.5 Year 3 vs. 1: p = 0.18
 September 2008 to August 2009 (year 4) 2.3 Year 4 vs. 1: p = 0.72
ICU mortality rate, % 20
 September 2007 to August 2008 (year 3) 22 Year 3 vs. 1: p = 0.48
 September 2008 to August 2009 (year 4) 22.6 Year 4 vs. 1: p = 0.38
Male gender, n (%) for subgroup with CVC and 
ICU stay > 2 days
143/255 (56.1) Not tested statistically
 September 2007 to August 2008 (year 3) 127/235 (54.0)
 September 2008 to August 2009 (year 4) 125/225 (55.5)
Device characteristics
Total no. of CVCs 414
September 2007 to August 2008 (year 3) 317 Year 3 vs. 1: p < 0.01
September 2008 to August 2009 (year 4) 249 Year 4 vs. 1: p < 0.01
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Baseline (year 1) 
(September 2005 to 
August 2006)a
Intervention 
(January 2007 to  
31 August 2009)b
Difference between 
baseline and 
intervention 
Insertion site, n (%)
Internal jugular 332 (80.2)
 September 2007 to August 2008 (year 3) 283 (89.3) Year 3 vs. 1: p < 0.01
 September 2008 to August 2009 (year 4) 227 (91.1) Year 4 vs. 1: p < 0.01
Subclavian 63 (15.2)
 September 2007 to August 2008 (year 3) 24 (7.6) Year 3 vs. 1: p < 0.01
 September 2008 to August 2009 (year 4) 15 (6.02) Year 4 vs. 1: p < 0.01
Femoral 19 (4.6)
 September 2007 to August 2008 (year 3) 10 (3.1) Year 3 vs. 1: p > 0.33
 September 2008 to August 2009 (year 4) 7 (2.81) Year 4 vs. 1: p < 0.01
Insertion site antisepsis used Default catheters were non-impregnated, four- or five-lumen CVCs. 
Chlorhexidine antisepsis was not consistently performed at catheter 
insertion (online appendix 6)
Dressing type and duration/frequency IV 3000 semipermeable transparent dressing (Smith and Nephew) 
(online appendix 6)
a Baseline period included interventions for hand hygiene.
b Multiple interventions were introduced: CVC bundles from January 2007; VAP intervention from March 2007; Scottish 
Patient Safety Programme from March 2008.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 14
237
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Intervention characteristics
Objective To reduce CRBSI in a UK ICU setting
Main focus of education Catheter insertion and maintenance
Trainers (providers) Group comprising three consultant clinicians, an infection surveillance nurse and two ICU 
charge nurses whose stated aim was to reduce CRBSI in the ICU. Two consultants had 
responsibility for training doctors in anaesthesia and intensive care
Training of trainers Not reported
Learners (recipients) ICU nurses and trainee doctors
Target behaviour change Multiple behaviours associated with catheter insertion and maintenance practices
Development and testing Not reported other than some changes were made as a result of discussions
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted (part 
from online appendix 6)
Self-adhesive insertion checklist: affixed to patients’ notes. Highlighted aseptic 
technique, maximal barrier precautions, chlorhexidine skin antisepsis, preferred insertion 
site, and whether staff had completed CVC education package
Self-guided education programme including slide show: Information on the insertion 
and maintenance bundles, and on pathogenesis, recognition and consequences of 
CRBSI. Completed by nurses and trainee doctors, followed by a brief test involving simple 
questions, with a record kept of which staff completed the test. Slide show and test 
mandatory for nurses from late 2008
Regular updates, presentations and tutorials: no details given
Supervision: trainee doctors had to perform three supervised CVC insertions before  
working alone
Quarterly compulsory group education (9–18 per group): Part of ongoing nurse 
development programmes: covered rates of infections and preventative behaviours 
(insertion and maintenance bundles)
Transient information provision: discussion and visual displays
Lasting information provision: statistical process control charts displayed in the ICU 
(variables not stated, other than infection incidence)
Promotion of staff engagement: Initial daytime presence of an infection surveillance and 
QI nurse to prompt staff to follow bundles; checklist stickers made widely available in the 
ICU. Interventions publicised through presentations at hospital department meetings and a 
regional ICU meeting; open discussion and debate about the evidence base and bundles, 
with some changes made where necessary. Regular meetings with local infection control 
team and representatives of Health Protection Scotland
Infection surveillance 
feedback approach 
Infection incidence per 1000 device-days and 1000 patient-days was displayed on statistical 
process control charts. Data were checked against ICU admission records and Ward Watcher 
database to ensure every patient was captured. Although data in the study were reported 
monthly and quarterly, it is unclear how often the charts in the ICU were updated. Validity 
and reliability of data collection not reported
Performance feedback 
approach (from online 
Appendix 6)
Hand washing behaviours were audited prior to handling CVCs and results were reported to 
staff. Details, validity, and reliability of method not stated
Concentration of 
education 
Other than daily checklists and quarterly group sessions, frequency and duration 
educational approaches not reported
Non-educational 
intervention components
(online Appendix 6)
Self-contained CVC insertion pack (introduced November 2008)
Other interventions:
 z Interventions to reduce VAP/MRSA (March 2007–August 2009)
 z Scottish Patient Safety Programme (introduced March 2008)
 z Nurse team to support bundles (introduced March 2009)
Costs reported Not reported
238
NIHR Journals Library www.journalslibrary.nihr.ac.uk
AppENDIx 5 – LONGMATE (2011)
Outcome characteristics
Catheter-BSI definition
(from online appendix 2)
Reference cited: Hospital 
In Europe Link for Infection 
Control through Surveillance 
(HELICS);174 supported by flow 
chart to help classify infection 
as BSI-A or BSI-B: online 
appendix 3); supported by 
flow chart to help diagnose  
catheter-related infection as 
CRI 1, CRI 2 or CRI 3: online 
appendix 4); definitions 
reported for CRI 1 and CRI 2 
(local or general CVC-related 
infection without a positive 
blood culture – data not 
extracted)
HELICS catheter-related infection (CRI 3) definition (equivalent to CRBSI)
 z CVC-related BSI occurring 48 hours before or after catheter removal and positive 
culture with the same micro-organism of either quantitative CVC culture ≥ 103 CFU/ml 
or semiquantitative CVC culture > 15 CFU or quantitative blood culture ratio CVC blood 
sample/peripheral blood sample > 5, or differential delay of positivity of blood cultures 
or CVC blood sample culture positive ≤ 2 hours before peripheral blood culture (blood 
samples drawn at the same time) or positive culture with the same micro-organism 
from pus from insertion site
HELICS BSI classification
BSI-A: 1 positive blood culture for a recognised pathogen
or
Patient has at least one of the following signs or symptoms: fever (> 38 °C), chills, or 
hypotension and two positive blood cultures for a common skin contaminant (from two 
separate blood cultures drawn within 48 hours) (skin contaminants = coagulase-negative 
staphylococci, Micrococcus spp., Propionibacterium acnes, Bacillus spp., Corynebacterium 
spp.)
BSI-B: Patient has at least one of the following signs or symptoms: fever (> 38 °C), chills, 
or hypotension
and either
One positive blood culture with a skin contaminant in patient with an intravascular line in 
place and in whom the physician instituted appropriate antimicrobial therapy
or
Positive blood antigen test (e.g. Haemophilus influenzae, Streptococcus pneumoniae, 
Neisseria meningitidis or group B Streptococcus)
CVCs removed had their tips routinely sent for Maki roll testing (method reported in 
online appendix 5)
Outcomes reported Not stated whether primary or secondary:
 z All or none insertion bundle reliability
 z CRBSI annual incidence
 z CRBSI monthly and quarterly incidence (in statistical process control chart)
CFU, colony-forming units.
Results data
Primary outcomes 
Outcome
Baseline (year 1) 
(September 2005 to 
August 2006)a
Intervention 
(January 2007 to 
31 August 2009)b
Difference between 
baseline and 
intervention 
n = no. of patients who had a CVC during 
at least part of ICU stay and ICU stay of 
> 2 days
Mean (SD) CVC duration, days 4.94 (4.11)
 September 2007 to August 2008 (year 3) 6.11 (3.6) Year 3 vs. 1: 
p < 0.001
 September 2008 to August 2009 (year 4) 9.6 (8.46) Year 4 vs. 1: 
p < 0.001
Total device utilisation,  
catheter-days – HELICS definitionc
2660 (n = 255) Not reported
 September 2006 – August 2007 (year 2) 2613 (n = 257)
 September 2007 to August 2008 (year 3) 2155 (n = 235)
 September 2008 to August 2009 (year 4) 2138 (n = 225)
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Outcome
Baseline (year 1) 
(September 2005 to 
August 2006)a
Intervention 
(January 2007 to 
31 August 2009)b
Difference between 
baseline and 
intervention 
n = no. of patients who had a CVC during 
at least part of ICU stay and ICU stay of 
> 2 days
Patient-days – HELICS definitiond 1918 (n = 255) Not reported
 September 2006 to August 2007 (year 2) 1990 (n = 257)
 September 2007 to August 2008 (year 3) 1800 (n = 235)
 September 2008 to August 2009 (year 4) 1562 (n = 225)
No. of devices/patient Not reported Not reported Not reported
CRBSI incidence 9 (n = 255) Not reported
 September 2006 to August 2007 (year 2) 7 (n = 257)
 September 2007 to August 2008 (year 3) 1 (n = 235)
 September 2008 to August 2009 (year 4) 0 (n = 225)
CRBSI incidence per 1000 catheter-days: 
HELICS definitionc
3.38 (n = 255) Incidence rate ratio 
(95% CI):
Year 3 vs. 1:
0.137 (0.003 to 
0.990); p = 0.0134
Year 4 vs. 1:
0 (0.0 to 0.63); 
p = 0.0025
 September 2006 to August 2007 (year 2) 2.68 (n = 257)
 September 2007 to August 2008 (year 3) 0.46 (n = 235)
 September 2008 to August 2009 (year 4) 0.00 (n = 225)
CRBSI incidence per 1000 patient-days: 
HELICS definitione
4.69 (n = 255) Not reported
 September 2006 to August 2007 (year 2) 3.52 (n = 257)
 September 2007 to August 2008 (year 3) 0.56 (n = 235)
 September 2008 to August 2009 (year 4) 0.00 (n = 225)
Median (Q1, Q3) LOS, days 9.7 (4, 20)
 September 2007 to August 2008 (year 3) 8.9 (4, 13) Year 3 vs. 1: p = 0.64
 September 2008 to August 2009 (year 4) 6.0 (3, 11) Year 4 vs. 1: p = 0.63
Mean (SD) LOS, days 5.4 (3.9)
 September 2007 to August 2008 (year 3) 5.3 (3.7) Year 3 vs. 1: p = 0.65
 September 2008 to August 2009 (year 4) 5.9 (3.7) Year 4 vs. 1: p = 0.13
Mortality, n (%) 54 (21.2)
 September 2007 to August 2008 (year 3) 49 (20.9)f Year 3 vs. 1: 
p = 0.328
 September 2008 to August 2009 (year 4) 36 (16) Year 4 vs. 1: 
p = 0.013
a Baseline period included interventions for hand hygiene.
b Multiple interventions were introduced: CVC bundles from January 2007; VAP intervention from March 2007; 
Scottish Patient Safety Programme from March 2008.
c HELICS definition takes into account the number of CVCs per patient – therefore different from the CDC/
NNIS definition.
d HELICS definition of patient-days is equivalent to NNIS/CDC definition of device-days.
e HELICS definition of incidence per 1000 patient-days is equivalent to CDC/NNIS definition of incidence per 1000 
device-days (as patients and devices are synonymous in the CDC/NNIS definition).
f Incorrect percentage reported (21.7); correct value provided by reviewer (20.9).
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Secondary outcomes
Reaction to 
education
Not a study outcome
Attitudes Not a study outcome
Compliance Compliance with CVC insertion bundle reported (chart only) from March 2008 onwards – the time of 
implementation of Scottish Patient Safety Programme (data not extracted) 
Knowledge Not a study outcome
Skills Not a study outcome
Process 
evaluation 
Barriers identified (online appendix 6) (no quantitative data reported):
1. Some staff had difficulty seeing the skin area prepared with chlorhexidine, so it was agreed that 
povidone–iodine could be used to colour the skin, followed by chlorhexidine
2. Two consultant clinicians doubted the need for full aseptic technique for insertion; resolved after 
evidence sharing
3. Initially unable to reach agreement on a system for collecting process measurements that had full 
support of both clinicians and data analysts (eventually agreed concurrent with implementation of 
Scottish Patient Safety Programme)
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? UNCLEAR. Gender 
mix, overall morbidity score, LOS and mortality were broadly similar for years 1, 3 and 4. However, no 
patient characteristics were reported for year 2. Age not reported
If YES, were the differences between the groups adjusted for in statistical analyses? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Organisational changes took place during the intervention but were not 
fully described. The Scottish Patient Safety Programme (a government-supported national initiative) 
was applied in the ICU during the last 16 months (according to appendix 6) or 18 months (according 
to main text) of the study, although this was stated as being part of the QI process. Authors stated 
that this had significant positive implications for leadership, administrative support, prioritisation and 
infrastructure but details were not reported
Was the effect of educational practice separable from effects of non-educational practice? NO. 
Multicomponent interventions not limited to education
Were the intervention component(s) implemented as planned? PARTIALLY. Compliance (‘reliability’) 
reported only for the insertion bundle: data showed compliance reached 100% in some but not all 
months from March 2008 onwards
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. Two data sets are reported for the number of patients with CVCs. The data appear to show 
that the number of patients who had a CVC was smaller than the ‘study group’ number who had a 
CVC for at least part of a > 2-day stay in ICU
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined? NOT REPORTED. The HELICS definition and classification of infections was used 
throughout the study but no information was given on the staff involved in diagnosing infections
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO. Stated that the data collection and interventions were non-blinded
Other possible 
sources of bias
Insertion bundle compliance (‘reliability’) was self-reported by clinicians 
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. A complex intervention 
comprising many components, not all of which were clearly reported
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Limited information provided. No information 
on validity and reliability given
If YES or PARTIALLY, was the data collection process shown to be valid? NO. Authors stated 
that they did not seek to further enhance validity of the process measurement
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED
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MISSET (2004)117
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Misset et al. (2004)117
Summary of approach Single unit continuous quality-improvement programme to reduce nosocomial infection (NI) 
rates (VAP, UTI and CVC related)
Location France
Language English
Critical care specialty Medical–surgical 
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Saint Joseph Hospital, Paris 
Study design Variation of single-cohort before-and-after study, with trend analysis instead of baseline data
Study time periods Baseline: none
Intervention: 1995–2000
Follow-up: none (continuous quality-improvement programme)
Funding source None reported
Conflicts of interest Not reported
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Population and setting
Critical care unit characteristics
10-bed ICU in a 450-bed tertiary care centre hospital
Infection control throughout the hospital was co-ordinated by an NI Control Committee and an Operative Infection  
Control Unit
New nurses received a 2-month training course, during which specific protocols regarding NI prevention were discussed
Nurse to patient ratio: 1 : 2
Nursing assistant to patient ratio: 1 : 10
Universal measures for preventing person-to-person transmission:
 z Hand-washing before and after each patient contact
 z Wearing gloves for handling secretions or contaminated objects
 z Wearing a gown when soiling was anticipated and/or
 z When the patient had multiple-drug-resistant bacteria and
 z Geographical isolation of all patients
CVCs and arterial catheters were not routinely placed and CVCs were removed when infections was suspected. CVCs 
inserted before ICU admission were routinely removed or replaced within 48 hours after ICU admission
Patient population characteristics 
during the 5-year study period 
(starting/baseline data not 
reported)a Total patients = 1764 (n = no. of patients)
Age (years), mean (± SD) 61 (± 18)
Length of ICU stay, mean days (± SD) 9.7 (± 16.1)
SAPS IIb score, mean (± SD) 37 (± 21)
Omega score per ICU stay,c mean 
(± SD)
138 (± 256)
In-ICU mortality, % 21
Surgical reasons for admission, n n = 529
 Scheduled postoperative 
surveillance, n
n = 104
 Postoperative complications, n n = 396
 Trauma, n n = 29
Medial reasons for admission, n n = 1235
 Infection as the main diagnosis, n
 z Lower respiratory tract, %
 z Urinary tract,%
 z Neuromeningeal, %
 z Endocarditis, %
 z Cellulitis, %
n = 553
73
12
6
6
3
 Non-infectious disease as the main 
diagnosis, n 
n = 682
Device characteristics during the 
5-year study period (starting/
baseline data not reported)
The site of CVC insertion was at the physician’s discretion. Use of single or 
multiple-lumen catheters as clinically required and use of haemodialysis catheters 
for fluids or parenteral nutrition only when there was no alternative. CVCs and 
arterial catheters were not routinely placed and CVCs were removed when 
infection was suspected. CVCs inserted before ICU admission were routinely 
removed or replaced within 48 hours after ICU admission
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Device characteristics during the 
5-year study period (starting/
baseline data not reported)a Total patients = 1764 (n = no. of patients)
CVC (≥ 1), n (%) 765 (43)
CVC used for dialysis, n 203
Arterial catheter (≥ 1), n (%) 261 (15)
Other devices:
Mechanical ventilation, n (%) 976 (55)
Mechanical ventilation > 48 hours,  
n (%)
682 (39)
Urinary tract catheter, n (%) 960 (55)
Invasive procedure utilisation rate 
over the 5-year study periodd
Procedure utilisation rate,  
all patients (%)
Duration of procedure use per 
patient, mean days (± SD)
Mechanical ventilation 0.74 13.0 (± 18.8)
Urinary tract catheter 0.73 13.1 (± 17.9)
CVC 0.61 13.8 (± 18.3)
 Per CVC 6.2 (± 4.4)
Arterial catheter 0.05 3.5 (± 3.2)
 Per arterial catheter 3.1 (± 2.3)
Insertion site antisepsis used Skin disinfection with 10% povidone–iodine solution
Dressing type and duration/frequency Replacement of catheter site dressings every 48 hours or at longer intervals when 
clinically indicated
a Length of ICU stay, SAPS II and Omega scores also reported per year over the 5-year period but data not extracted 
by reviewers.
b SAPS II score, Simplified Acute Physiology Score II – used to measure disease severity.
c Omega score used to measure treatment intensity during ICU stay.
d Utilisation rate = procedure days divided by patient-days.
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Intervention characteristics
Objective Maximise compliance of physicians and nurses with infection control practices and assess its 
long-term impact on the rates of VAP, UTI and vascular catheter-related infection in critically ill 
patients
Main focus of 
education 
Simultaneous education and training for vascular catheter, VAP and UTI infection prevention 
and catheter maintenance
Trainers (providers) Head nurse
Training of trainers Not reported
Learners (recipients) All staff (nurses and residents)
Target behaviour 
change
Compliance with infection control practices
Development and 
testing
Infection control practices were written by the ICU staff together with the Infection Control 
Unit and were derived from CDC recommendations
Educational or 
behavioural theory
Not reported 
Educational strategies 
and topics targeted
Guidelines or their modifications were explained and given to all the staff during a yearly 
unit meeting and to the new nurses and residents by the head nurse. They were continuously 
available in a specific written form located in the unit
Infection prevention and catheter maintenance, including daily examination of catheter sites, 
skin disinfection with 10% povidone–iodine, use of surgical drapes and of a gown for the 
operator, use of single- or multiple-lumen catheters as clinically required, use of haemodialysis 
catheters for fluids or parenteral nutrition only when there was no alternative, replacement of 
catheter site dressings every 48 hours or at longer intervals when clinically indicated. Measures 
for preventing person-to-person transmission included hand washing before and after each 
patient contact, wearing gloves for handling secretions or contaminated objects, and wearing 
a gown when soiling was anticipated and/or when the patient had multiple-drug resistant 
bacteria, and geographical isolation of all patients. The site of the CVC insertion was at the 
physician’s discretion. The programme was updated regularly according to infection and 
colonisation rates and reports in the literature (no further details reported)
Infection surveillance 
feedback approach 
All the patients referred to the ICU were included in the nosocomial infection surveillance 
programme. Microbiological specimens were collected when the attending physician suspected 
infection based on systemic signs (unexplained fever, chills, hypotension) and/or local signs 
(pus or pain at a vascular catheter insertion site), consisting of the catheter tip for vascular 
catheter colonisation (details for VAP/UTI procedure not data extracted). All CVCs and arterial 
catheters were cultured at removal, regardless of whether or not infection was suspected.  
ICU-acquired infection was defined as infection documented after at least 48 hours in the ICU
Monitoring of trends in vascular catheter colonisation and related bacteraemia rates: 
programme on microbial resistance containment (policy for containing antibiotic resistance 
included collection of microbiological specimens from suspected infection sites if at all  
possible and starting broad-spectrum antibiotic therapy early, then changing to  
narrow-spectrum therapy as soon as the organism was identified and its antimicrobial 
susceptibility profile established. Selective digestive decontamination was used in 15 patients 
(0.8%) as an adjunctive technique to control outbreaks of multiple-drug-resistant bacteria)
Descriptive statistics of nosocomial infection rates were communicated to the ICU staff every 
6 months (no further details reported). Validity and reliability of the assessment approach were 
not reported
Performance feedback 
approach 
Not included in the study
Concentration of 
education 
Not reported, other than yearly unit meetings
Non-educational 
intervention 
components 
Catheter tunnelling was required for internal jugular and femoral sites from 1996 and 1999, 
respectively; use of povidone–iodine
Costs reported Not reported
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Outcome characteristics
Catheter-BSI definition
Reference cited: Centers 
for Disease Control and 
Prevention199
All patients in ICU were included. All CVCs and arterial catheters were cultured at removal, 
regardless of whether infection was suspected. ICU-acquired infection was defined as infection 
documented after at least 48 hours in the ICU
Microbiological specimens were collected as recommended by the CDC. For CVCs and arterial 
catheters. Colonisation was assessed by quantitatively culturing CVC/arterial catheter tips. CVC 
and arterial catheter infection was considered when bacteraemia due to a micro-organism 
simultaneously colonising the catheter (at least two positive blood cultures in the case of 
Staphylococcus spp. other than S. aureus) was present. Thresholds above which cultures were 
considered positive were 103 CFU/ml for CVC or arterial catheter colonisation
Outcomes reported Not stated whether primary or secondary:
 z CVC colonisation
 z CVC bacteraemia per 1000 procedure-days
 z Patient device-days
 z Device utilisation
Surveillance data also reported for VAP and UTI, but data not extracted by reviewers
Results data
Primary outcomes
Outcome 1995–6 1996–7 1997–8 1998–9 1999–2000
Changes in incidence 
rates over the 5-year 
study period (chi-squared 
test for tendency)
Device duration Not reported Not reported
Total device 
utilisationa
CVC 0.65 0.76 0.56 0.58 0.57 5-year rate not significant 
(no p-value reported)
Arterial 
catheter
0.07 0.07 0.05 0.05 0.04
CVC-BSI/CVC patients 7/117 6/154 6/178 2/147 0/153 p = 0.001
CLAB incidence rate 7 6 6 2 0 Not reported
CVC-BSI incidence per 1000  
CVC-days
3.5 2.4 2.9 0.9 0.0 Not reported
Mean length of ICU stay per 
yeara
9.52 10.67 9.52 9.14 8.76 Not reported
Mortality Not reported other than 5-year rate Not reported
a Data extracted from graph using Engauge software.
Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance: Compliance with hand washing guidelines was only assessed in the first year of the project
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not a study outcome
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Critical appraisal
Potential for bias
Group selection Were there systematic differences between the baseline and intervention groups? NOT REPORTED. 
However, states that there were no significant changes in disease severity (SAPS II score), mean length 
of ICU stay, and treatment intensity (Omega score) (graph provided), regardless of invasive device 
utilisation rates (no p-value reported)
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT REPORTED. However, stated that there were no changes in the structure or staffing 
of the unit during the study
Was the effect of educational practice separable from effects of non-educational practice? NO
Were the intervention component(s) implemented as planned? NOT REPORTED. However, states 
that 6% of items in an audit were considered insufficiently respected and the results allowed the 
continuous reinforcement of the observance of procedures of hand washing and surfaces cleaning and 
implementing formation sessions about cross-transmission
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
NOT REPORTED 
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on the 
information presented
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. No details of education and  
training provided
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Nurses collected the specimens and documented the 
dates of insertion and removal of devices. The physicians collected all other data. Format of data 
collection (e.g. electronic, hard copy) and nature of archiving not reported
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? UNCLEAR. Compliance assessment was made by the Infection 
Control Unit only twice during the first year of study and hand washing compliance was assessed only 
during the first year, but compliance data were not reported
Additional comments
 z Assessment of the quality of hand washing and invasive devices management was made each time a 
patient was colonised with MRSA among the nurses and physicians in charge of the colonised patient 
(136 audits assessing 26 items). No further details reported.
 z Hand washing compliance was assessed during the first year of the study only, with a global score built 
from the quality of washing, rinsing, soap or antiseptic utilisation, drying and duration. The results were 
based on 46 samples of hands before and after washing from 12 nurses and 8 physicians/residents  
[first 6 months of study: mean score 88 (± 5%); second 6 months of study: mean score 93 (± 4%)].
 z CVC colonisation data reported (not extracted).
 z Data were compared between first 2.5 years and last 2.5 years but these periods appear arbitrary  
(no justification was provided in relation to the timing of intervention components).
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PALOMAR MARTINEZ (2010)68
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Palomar Martinez (2010)68
Summary of approach A multicentre regional-scale pilot study to test the feasibility of applying the Michigan 
approach for preventing CRBSI in Spanish critical care units. Catheter maintenance practice 
was included in addition to the five-catheter insertion bundle components used in the 
Michigan study
Location Spain (three separate regions: Castilla-León, Cataluña, Andalucía)
Language Spanish
Critical care specialty Not reported (list of participating hospitals included cardiac surgery and general ICUs but 
specialties not mentioned for most hospitals)
No. of critical care units 17 (nine intervention, eight control) in study period; varied in baseline period
No. of hospitals 16
Hospital name (unless 
multicentre); city
Hospital names are listed in the publication
Study design Non-randomised parallel group study with nine intervention and nine control ICUs, 
distributed evenly among three separate autonomous regions of Spain
Study time periods Baseline: 2004, 2005, 2006 (3 years, with separate historical data for each) (note: no baseline 
data immediately preceding the intervention, i.e. during January to September 2007)
Intervention: 1 October to 31 December 2007 (3 months)
Follow-up: None reported 
Funding source Spanish Ministry of Health and Social Policy
Conflicts of interest Not reported
Population and setting
Critical care unit 
characteristics
Not reported
Patient population 
characteristics
Not reported
Device characteristics Described only as CVCs; stated that the use of catheters impregnated with antiseptic or 
antibiotics was not monitored
Insertion site antisepsis 
used
Not reported
Dressing type and 
duration/frequency
Not reported
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Intervention characteristics
Objective To assess the applicability on a national level in Spain of the interventions proposed by 
Pronovost and colleagues in Michigan, USA, for the prevention of central vascular  
catheter-related bacteraemia in patients admitted to the ICU
Main focus of education Catheter insertion and maintenance
Trainers (providers) Not explicitly reported. Authors stated that a responsible physician and a nurse were 
identified (in each intervention ICU) to ensure compliance with the intervention
Training of trainers Not reported
Learners (recipients) ICU doctors and nurses
Target behaviour change Not stated explicitly but compliance was assessed for skin preparation with chlorhexidine, 
hand hygiene, preparation and maintenance of the sterile field, and the use of barrier 
precautions (gloves, masks, gowns)
Development and testing A pilot study – no prior development or testing reported other than that the study was 
based on the Michigan intervention in the USA
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
Meetings: Briefing meeting: Held in September, 2007, attended by two representatives 
(physician and nurse) from each participating ICU. At this meeting, materials to be used 
were distributed, including an electronic version of the programme/intervention. To assess 
compliance with the recommendations and the degree of acceptance of the project, a 
meeting was held at the end of the study period, in which each of the leaders explained 
their experiences and reported especially on the worst aspects of compliance
Daily goals sheet (no details provided)
Catheter insertion checklist (no details provided)
Safety rounds (no details provided)
Online 2-hour course: For all ICU staff, synthesising the key points of catheter-related 
infections, particularly clinical impact and prevention measures
Poster(s): Covered the five proposed procedures to reduce bloodstream infections 
(hand hygiene, maximum use of aseptic barriers during insertion, asepsis of the skin at 
the insertion site with chlorhexidine, avoiding the femoral access route and removing all 
unnecessary CVCs). Posted in all intervention ICUs in joint meetings between the medical 
and nursing staff
Teams: Trained in each hospital or working group to ensure the implementation of 
interventions and safety of hospitalised patients (no further details given)
Supporting document(s): Available in graphical format recalling the points of intervention 
(no details provided)
Infection surveillance 
feedback approach
Stated that to be eligible in the project the ICUs should have experience in nosocomial 
infection surveillance, although not itself part of the intervention
Performance feedback 
approach
Not explicitly stated as being part of the intervention; unclear whether performance 
feedback might have occurred in specific ICUs. A standardised questionnaire [the Spanish 
version of the Hospital Survey on Patient Safety of the Agency for Healthcare Research and 
Quality (AHRQ)] was used to assess the safety culture, but it was not stated whether the 
results were known by ICU staff
Concentration of 
education 
Unclear whether all the meetings that took place are described. The main training 
component appeared to be an online study module with 2-hour duration
Non-educational 
intervention components 
Chlorhexidine skin antisepsis used. Note that, although a catheter insertion cart was also 
planned, this was not actually implemented
Costs reported No
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Outcome characteristics
CVC-related 
bacteraemia 
infection 
definition
Infections meeting the following definitions were accepted as CVC-related bacteraemia:
CVC-related bacteraemia (after withdrawal of the CVC):
 z Isolation of the same micro-organism (gender and species and identical antibiogram) in blood extracted 
from a peripheral vein and quantitative culture or respectively from tip of the catheter in a patient 
with clinical sepsis and without another apparent focus of infection. In the case of coagulase-negative 
staphylococci it is necessary to isolate the same micro-organism (gender, species and antibiogram) in at 
least two blood cultures
CVC-related bacteraemia (without removal of the CVC):
 z Clinical picture of sepsis, no other apparent source of infection, in which the same organism is isolated 
in quantitative simultaneous blood cultures at a rate ≥ 5 : 1 in samples extracted through catheter 
compared with those obtained by venepuncture
Bacteraemia probably related to CVC, in absence of catheter culture:
 z Clinical picture of sepsis but no other apparent source of infection, with blood culture positive and 
symptoms disappearing within 48 hours of withdrawal of the venous line. In case of coagulase-
negative staphylococci isolation of the same organism is required (genus, species and sensitivity) in at 
least two blood cultures. This clinical situation is known as primary bacteraemia
Outcomes 
reported
Catheter-related bacteraemia incidence and incidence density per 1000 CVC-days
Secondary bacteraemia incidence and incidence density per 1000 patient-days
No. of CVC-days
No. of patient-days
Compliance with evidence-based practices (most data reported for only six ICUs that submitted data)
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Results data
Primary outcomes
Outcome
Intervention ICUs Control ICUs 
Difference between 
baseline and post 
interventionn = no. of ICUs
Device duration Not reported Not reported Not reported
Total device utilisation, 
CVC-days
 (a) Baseline: 2004 (a) 6434 (n = 5) (a) 2600 (n = 5) Statistical significance not 
reported
 (b) Baseline: 2005 (b) 7960 (n = 7) (b) 3260 (n = 6)
 (c) Baseline: 2006 (c) 9164 (n = 8) (c) 4644 (n = 8)
 (d)  Intervention (2007; 
3 months)
(d) 11,432 (n = 9) (d) 8453 (n = 8)
No. of devices/patient Not reported Not reported Not reported
CVC-related bacteraemia 
incidence
 (a) Baseline: 2004 (a) 39 (n = 5) (a) 32 (n = 5) Statistical significance not 
reported
 (b) Baseline: 2005 (b) 60 (n = 7) (b) 47 (n = 6)
 (c) Baseline: 2006 (c) 59 (n = 8) (c) 59 (n = 8)
 (d)  Intervention (2007; 
3 months)
(d) 44 (n = 9) (d) 28 (n = 8)
CVC-related bacteraemia 
incidence density per 
1000 catheter-days
All three regions*
 (a) Baseline: 2004 (a) 6.06 (n = 5) (a) 12.31 (n = 5) Differences among all four 
study dates:
Intervention: p < 0.0032
Control: p < 0.0001
 (b) Baseline: 2005 (b) 7.54 (n = 7) (b) 14.4 (n = 6)
 (c) Baseline: 2006 (c) 6.44 (n = 8) (c) 12.7 (n = 8)
 (d)  Intervention (2007; 
3 months)
(d) 3.85 (n = 9) (d) 3.31 (n = 8)
*Data were also reported separately for Castilla-León, Andalucía and Cataluña but the numbers of ICUs contributing data 
for these regions in each year were not specified (data not extracted by reviewers)
CVC-related bacteraemia 
incidence per 1000 
patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
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Secondary outcomes 
Reaction to 
education 
Not a study outcome
Attitudes Not a study outcome
Compliance No compliance data were reported for the baseline years. For the study period, compliance with insertion 
checklists was reported narratively to be around 90%. No hospitals created a catheter insertion cart  
(i.e. 0% compliance). Removal of unnecessary catheters was not quantified. Femoral insertions were 
18% of the total CVC insertions. Further data on compliance with the following practices were reported 
only for six ICUs that submitted data: skin preparation with chlorhexidine, hand hygiene, preparation and 
maintenance of the sterile field, and the use of barrier precautions (gloves, masks, gowns). Compliance 
was high in all six ICUs except for chlorhexidine use in one ICU (approximately 17%) owing to lack of 
availability. The above data are assumed to be for intervention ICUs, although this was not stated explicitly
Knowledge Not a study outcome
Skills Not a study outcome
Process 
evaluation 
Formal process evaluation was not reported, although the following potential barriers and other factors 
were mentioned narratively
Variable implementation:
 z A daily goals sheet was used ‘unevenly’ across the ICUs
 z Only one unit developed a registry of problems related to CVCs
 z In the ‘Clean Hands Campaign’ one hospital provided bedside alcohol hand wash
 z Variation in the choice of insertion site was ‘very high’ across the ICUs
 z Some of the units formed working groups identifying specific mistakes and improvement targets but 
others did not
Potential barriers:
 z Stated that the heads of each unit, doctor and nurse, did not have the extra time resource for 
implementation of the programme as opposed to what happened in Michigan; more than half of the 
staff surveyed considered there were not enough staff to cope with the care load
 z Initially, some practitioners expressed doubts about the effectiveness of chlorhexidine; it was difficult to 
obtain from some pharmacies
 z Only one-third of the respondents considered themselves informed of the problems occurring in their unit/
service; and < 40% said that in their work unit errors were discussed and corrective measures sought
 z Only 40% of respondents considered that there was good cooperation between units/services
 z In one ICU a presentation was delivered only to doctors, not nurses, and in this ICU CVC-bacteraemia 
rates rose; in two other ICUs there were delays in presentations for various reasons
 z Stated that the posters used were small in size and over time they failed to attract attention
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? YES. Stated that the 
improvement (in CVC-bacteraemia rates) was more pronounced in those units that had the highest 
starting rates, which generally occurred more in the control ICUs
If YES, were the differences between the groups adjusted for in statistical analyses? NO
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Limited detail reported. Stated that the use of antiseptic or antibiotic 
impregnated catheters was not monitored
Was the effect of educational practice separable from effects of non-educational practice? UNCLEAR. 
No information provided about other practices such as use of antibiotics or impregnated catheters
Were the intervention component(s) implemented as planned? NO. None of the hospitals implemented 
a catheter insertion cart. Chlorhexidine was difficult to obtain in one ICU
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
NOT REPORTED. No information given on the patient population
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. Standard infection 
definitions appear to have been used, although it was not stated explicitly that these were always 
applied in all ICUs in all project years
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
The authors acknowledged that participants in control interventions were able to attend the initial 
intervention briefing meetings and would have been aware of the published Michigan study so 
may have independently implemented some aspects of clinical practice that formed the basis of the 
intervention. This could lead to performance bias
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. The objectives and the  
evidence-based practices included in the intervention are clear but details of how they were 
implemented are lacking, so the general principles could be reproduced but not the specific 
approaches used
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT APPLICABLE
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? UNCLEAR. Formal behaviour change targets were not explicitly 
specified. Compliance with some evidence-based practices was high but the data appear to be only 
from intervention ICUs (no baseline or control ICU data appear to have been presented for compliance)
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PEREZ PARRA (2010)122
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Perez Parra (2010)122
Summary of approach Single hospital intervention based on short (15-minute) lecture on evidence-based 
approaches for catheter insertion and maintenance, with pre- and post-tests in three 
ICUs (no reinforcement of education)
Location Spain
Language English
Critical care specialty Medical, general post-surgery, cardiac post-surgery
No. of critical care units 3
No. of hospitals 1
Hospital name (unless 
multicentre); city
Hospital General Universitario Gregorio Maragñón, Madrid
Study design Cohort before-and-after study, with outcomes data for three ICUs grouped as a single 
cohort and also presented as three separate cohorts
Study time periods Baseline: February to October 2006 (9 months)
Intervention: November 2006 (15–20 minutes)
Follow-up: December 2006 to August 2007 (9 months)
Post-intervention test: May 2007 (6 months after intervention)
Funding source La Investigación Biomédica del Hospital General Universitario Gregorio Maragñón and 
Fondo de Investigación Sanitaria (funding to lead author)
Conflicts of interest Stated no conflicts of interest
Population and setting
Critical care unit 
characteristics
Three critical care units with a joint total of 60 beds in a tertiary university hospital. 
CVCs were routinely inserted by physicians and managed by nurses
Mean (95% CI) duration of work experience for the ICU staff:
 z Nurses 8.9 (7.8–10.1) years
 z Physicians: 8.1 (5.3–10.8) years
Patient population 
characteristics
Not reported
Device characteristics Described only as CVCs; stated that the type of CVC did not change during the study
Insertion site antisepsis used Not reported, but stated that there were no changes in antiseptics during the study
Dressing type and duration/
frequency 
Not reported, but stated there were no changes in supplies used in CVC insertion and 
care during the study
256
NIHR Journals Library www.journalslibrary.nihr.ac.uk
AppENDIx 5 – pErEz pArrA (2010)
Intervention characteristics
Objective To analyse the effect of a single evidence-based educational intervention on the incidence of 
CLABSI in ICUs with acceptable baseline incidences and to assess the knowledge standards 
for CLABSI prevention among health-care workers in a large teaching hospital
Main focus of education Catheter insertion and maintenance
Trainers (providers) Not stated explicitly but the study authors implied that they gave the lectures
Training of trainers Not reported
Learners (recipients) The same lecture was given to all ICU workers (physicians, residents, nurses and students) 
on all shifts
Target behaviour change Compliance with IDSA-CDC guidelines for preventing intravascular catheter-related 
infections (10-point list as below)
Development and testing Not reported
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
Short lecture (15 minutes): On the 10 main points of the IDSA-CDC guidelines for 
prevention of intravascular catheter-related infections:
 1. Use of a sterile sheet when preparing CVC insertion site
 2. Choice of subclavian vein as preferred insertion site
 3. Use of closed needleless catheter connection systems
 4. Chlorhexidine skin disinfection before CVC insertion
 5. CVC site dressing regimens
 6. Aseptic technique during CVC care and maintenance (hand washing and use of gloves)
 7. Optimal frequency of CVC dressing replacement
 8. Use of parenteral nutrition through a multilumen CVC
 9. Management of suspected CLABSI (avoiding guidewire exchange of CVC)
10. Replacement of administration sets, needleless systems and parenteral fluids
Infection surveillance 
feedback approach 
Not included in intervention
Performance feedback 
approach 
Multiple-choice questionnaire conducted a few minutes before and 6 months after the 
lecture. Covered the 10 points specified in the lecture (see above). Validity and reliability of 
questionnaire not reported
Concentration of 
education 
Each questionnaire test took 15–20 minutes to complete. Total time to complete a 
15-minute lecture and two tests would be 45–55 minutes. In total, 30 lectures were given 
to cover all shifts in the three ICUs. Six months between education and post-education test
Non-educational 
intervention components 
None (intervention purely educational)
Costs reported No
Outcome characteristics
Catheter-BSI definition
Reference cited:  
O’Grady NP et al.196
Followed definitions and recommendations of the IDSA-CDC guidelines (reference cited).  
A CVC-related bloodstream infection was considered to be ICU-related if it occurred at  
least 48 hours after admission to or up to 48 hours after discharge from the ICU.
Catheter tips were cultured using the roll plate method (references and equipment for 
catheter tip and blood cultures cited)
Outcomes reported Not stated whether primary or secondary:
CLABSI incidence
Device utilisation (catheter-days)
Knowledge
IDSA, Infectious Diseases Society of America.
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Results data
Primary outcomes
Outcome Baseline (9 months)
Post intervention 
(9 months)
Difference between 
baseline and post 
intervention
Device duration Not reported Not reported Not reported
Total device utilisation, 
catheter-days
 All three ICUs 10,661 11,582 Not reported
 General post-surgery ICU 3,403 4,064
 Cardiac post-surgery ICU 2,842 2,981
 MICU 4,416 4,537
No. of devices/patient Not reported Not reported Not reported
CLABSI incidence
 All three ICUs 45 34 Relative riska = 0.69 (95%CI 
0.44 to 1.08); p = 0.11
 General post-surgery ICU 18 14
 Cardiac post-surgery ICU 12 8
 MICU 15 12
CLABSI incidence per 
1000 catheter-days
 All three ICUs 4.22 2.94 30.3%;b p = 0.03
 General post-surgery ICU 5.3 3.4 35.8%; p = 0.05
 Cardiac post-surgery ICU 4.2 2.7 35.7%; p = 0.12
MICU 3.4 2.6 23.5%; p = 0.31
CLABSI incidence per 
1000 patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Based on Poisson regression for overall CLABSI incidence.
b Reported by authors as 30.9%.
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Additional monthly CLABSI data extracted from graph 
(figure 1)122 using Engauge software Baseline Post intervention
January 2006 2.5
February 2006 5.9
March 2006 4.8
April 2006 3.8
May 2006 4.4
June 2006 4.6
July 2006 4.2
August 2006 3.3
September 2006 4.4
October 2006 3.2
November 2006 3.0
December 2006 2.9
January 2007 3.5
February 2007 3.8
March 2007 0
April 2007 3.6
May 2007 1.7
June 2007 3.6
July 2007 4.2
August 2007 2.7
September 2007 3.1
October 2007 2.3
November 2007 0.9
December 2007 2.9
January 2008 5.7
February 2008 2.2
March 2008 1.8
April 2008 2.5
May 2008 0.9
June 2008 6.9
July 2008 2.5
August 2008 4.6
September 2008 5.6
October 2008 2.3
November 2008 3.8
December 2008 2.5
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Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Number receiving the pre-test and intervention:
Nurses: 125 (including 22 students)
Physicians: 30 (including 10 residents)
Total health-care workers: 155
No. completing the post-intervention test (% of those who received the intervention):
 z Nurses: 64 (51%)
 z Physicians: 10 (33%)
 z Total health-care workers: 74 (48%)
The proportion of the total ICU staff that participated in the intervention was not reported
Knowledge Mean (95% CI) percentage of correctly answered questions among all health-care workers 
who took the intervention:
Baseline: 59.7% (39.9% to 78.4%)
Post intervention: 73.4% (58.1% to 88.6%)
Difference: 13.7%; p = 0.01
Skills Not a study outcome
Process evaluation The authors noted that the test questions that received the greatest number of incorrect 
responses (< 50% correct responses) were those on the use of full sterile barriers during 
CVC insertion and on the choice of antiseptic for skin disinfection. Small drapes were 
incorrectly assumed sufficient for CLABSI prevention and the 2002 IDSA-CDC guidelines 
indicated (incorrectly) that tincture of iodine could still be used, although Chlorhexidine 
was the current recommendation
IDSA, Infectious Diseases Society of America.
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NOT 
REPORTED. Authors stated that there were no changes in hospital policy on prevention 
of CLABSI or in the availability of supplies used (type of CVC, connectors, antiseptics or 
other supplies used in CVC insertion and care) but no data reported; no information at all 
provided on the patient population
If YES, were the differences between the groups adjusted for in statistical analyses  
(e.g. as covariates or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the 
overall intervention? NO. The authors stated no other interventions potentially affecting 
the incidence of CLABSI were performed. However, they also stated that to control for the 
confounding effects of secular trends and external events that occurred during the study 
period a Poisson regression technique was used. The potential confounding variables in 
question were not reported
Was the effect of educational practice separable from effects of non-educational practice? 
YES (education alone)
Were the intervention component(s) implemented as planned? UNCLEAR. Not reported 
what proportion of the ICU staff participated in the intervention. Of those that 
participated, approximately half completed the post test
Missing data Were there systematic differences between the baseline and intervention groups in data 
availability? NOT REPORTED. No information given on the patient population
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Outcome measurement Were there systematic differences between the baseline and intervention groups in how 
outcomes were determined (including differences in how outcomes were defined)? NO. 
The authors stated that there were no changes in CLABSI diagnosis procedures in the 
microbiology laboratory and the staff members responsible for data collection did not 
change during the study period
Was any blinding of personnel and/or outcome assessors reported (including assessors of 
blood cultures)? NO
Other possible sources  
of bias
No other sources of bias were reported by the authors or identified by the reviewers based 
on the information presented
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? YES. A short 15-minute lecture 
and tests, for which the component 10 topics were specified in a table; the number of 
lectures required was also reported
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT 
APPLICABLE
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED
Additional comments
 z The proportion of the patients monitored for CLABSI was not reported.
 z Not reported whether the participants knew they were involved in a research study.
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PRONOVOST (2006–10)34,123,124
Methods
Study characteristics
Lead author, publication 
year(s) and reference ID(s)
Pronovost 2006,34 2008,124 2010123 (data are from Pronovost 200634 unless specified)
Summary of approach State-wide safety initiative regarding patients in ICUs known as the MHA Keystone Center 
for Patient safety and Quality Keystone ICU project; set predominantly in Michigan
Location USA, Michigan (plus five out-of-state hospitals)
Language English
Critical care specialty ICUs for adults: included medical, surgical, cardiac medical, cardiac surgical, neurological, 
surgical trauma and one paediatric unit
No. of critical care units 103 (originally 108: two merged, four reported no data) participated in monitoring up to 
18 months.34 Ninety participated in monitoring up to 36 months; of which 43 reported 
data continuously for 0–36 months123
No. of hospitals Sixty-seven participated in monitoring up to 18 months (34 hospitals in Michigan did not 
participate).34 Sixty-one participated in monitoring up to 36 months123
Hospital name (unless 
multicentre); city
Ninety-three hospital units listed in an appendix to the paper (unclear how these relate to 
the number of ICUs included in the different study periods)
Study design Cohort before-and-after study 
Study time periods Baseline: Not reported (varied by ICU)
aImplementation period: The first 3 months of intervention123
Intervention period: March 2004 to September 2005 (18 months) (starting time varied by 
ICU: 40/103 ICUs started intervention immediately, i.e. had no baseline period)
Sustainability period: 19 to 36 months after implementation (continuation of same 
intervention but with slightly different eligibility criteria: participation fee)123
Follow-up: None (continuous monitoring of ongoing intervention)
Note: Staggered implementation: Two cultural interventions, followed by two interventions 
targeting patients’ safety (in any order), were each implemented at 3-month intervals 
Funding source Funded predominantly by the AHRQ and the MHA, plus congressional funding to develop 
and maintain the NNIS and a staff of hospital-based infection control practitioners. 
Stated there was no influence of the sponsors on study design, conduct, interpretation or 
publication
Conflicts of interest Reported in detail
AHRQ, Agency for Healthcare Research and Quality; MHA, Michigan Health and Hospital Association.
a Implied this was from June to August 2004.34 It was also implied34 that four intervention components each took  
3 months to implement, in sequence (i.e. implementation would have taken 12 months overall – if so, this  
3-month-period would have only captured the initial stages of implementation).
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Population and setting in the baseline (control) group 
Critical care unit 
characteristics
1625 beds in total (103 ICUs); 15.8 beds/ICU on average; represented 85% of all ICU beds 
in Michigan
52% of the hospitals were teaching facilities
Patient population 
characteristics
Not reported
Device characteristics Central catheters (defined) including PICCs (no further details reported). Average duration 
of catheter use in individual patients was not monitored
Insertion site  
antisepsis used
13/93 hospitals (19%) included chlorhexidine in the central-line kits used in the ICUs
Dressing type and 
duration/frequency 
Not reported
Intervention characteristics
Objective Reduction of CRBSIs
Main focus of education Catheter insertion
Trainers (providers) Team leaders: At least one physician and one nurse designated per ICU, dedicating  
20% of their effort to project activities (at a minimum, a team consisted of senior 
executive, the ICU director and nurse manager, plus a designated physician and nurse  
team leader)
Training of trainers Instructed in the science of safety and in the interventions then disseminated this 
information among their colleagues. Training received through conference calls every 
other week, coaching by research staff and state-wide meetings twice a year. Team leaders 
were partnered with their local hospital-based infection-control practitioners to assist 
implementation of the intervention and to obtain data on CRBSI
Learners (recipients) ICU colleagues (no further details)
Target behaviour change Hand washing, use of full-barrier precautions during insertion of CVC, skin cleaning with 
chlorhexidine, avoidance of femoral site and removal of unnecessary catheters
Development and testing Based on evidence-based procedures recommended by the CDC and identified as having 
the greatest effect on the rate of CRBSI and the lowest barriers to implementation 
(reference cited). No other details of development/testing reported. Conceptual model for 
large-scale knowledge translation123
Educational or 
behavioural theory
Not reported. However, the authors refer to the ‘4E’ framework proposed by Heifetz for 
distinguishing technical and adaptive aspects of the intervention; technical aspects are 
education and evaluation; adaptive aspects are engagement and execution
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Educational strategies 
and topics targeted
Education was one of five interventions to reduce CRBSI by targeting awareness of 
evidence-based infection control practices (hand hygiene, chlorhexidine skin preparation, 
full-barrier precautions during CVC insertion, subclavian vein placement as the preferred 
site, and CVC maintenance). Stated that clinicians were educated about practices to 
control infection and harm resulting from CRBSI – cited Berenholtz et al.77 but no other 
details given. Strategies included:
Checklist: To monitor adherence to infection control practice/CVC maintenance. Details 
not reported. Staff were empowered to halt breaches of evidence-based practice
Discussion: about removal of catheters at daily rounds
One-page fact sheet: Available in an online appendix.34 Lists evidence sources for  
evidence-based practices (hand hygiene, skin preparation with chlorhexidine, maximal 
barrier precautions, and avoidance of the femoral site). Provided to participants to share 
with their staff
Daily goals sheet: to improve clinician-to-clinician communication within the ICU. 
No other details reported (classified by the authors as separate from the educational 
intervention)
PowerPoint presentation: Provided to participants to share with their staff. Content  
not reported
Also stated that participants were provided with articles – but no details of which ones and 
whether reading was voluntary or mandatory and how encouraged or enforced
Infection surveillance 
feedback approach 
Number and rates of CRBSI were provided to staff at monthly and quarterly meetings 
respectively. Infection rates were collected and reported according to the guidelines of the 
NNIS by trained hospital-based infection-control practitioners who were independent of 
the ICU staff implementing the intervention. Validity and reliability not reported. Stated 
that infection control staff at the hospitals adjudicated cultures before submitting data for 
the study but no details reported
Performance feedback 
approach 
Not reported
Concentration of 
education 
Not reported
Non-educational 
intervention components
Catheter insertion cart; chlorhexidine for skin antisepsis
Costs reported No. The authors stated that the intervention was implemented without the use of 
expensive technology or additional ICU staffing. Funding was from the AHRQ and 
MHA and staffing was provided by the participating hospitals. However, resources were 
insufficient to enable evaluation of compliance with the study intervention. After the 
first 18 months of intervention ICUs were required to pay a MHA fee for continued 
participation (amount not specified)124
MHA, Michigan Health and Hospital Association.
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Outcome characteristics
Catheter-BSI definition
Defined according to 
the National Nosocomial 
Infections Surveillance System
Presence of a recognised pathogen cultured from one or more blood cultures, and 
organism cultured from blood not related to infection at another site
or
Presence of one or more of the following: fever (temperature > 38 °C), chills, hypotension, 
and:
Signs and symptoms and positive results not related to infection at another site, and:
Presence of one or more of the following:
Common skin contaminant (e.g. diphtheroids, Bacillus spp., Propionibacterium spp., 
coagulase-negative staphylococci or micrococci) cultured from two or more blood 
samples drawn on separate occasions
Common skin contaminant cultured from at least one blood culture in a sample from a 
patient with an intravascular catheter
Positive antigen test on blood (e.g. Haemophilus influenzae, Streptococcus 
pneumoniae, Neisseria meningitidis or group B streptococcus)
Outcomes reported Not stated whether primary or secondary:
 z Quarterly rate of CRBSI per 1000 catheter-days, catheter-days per month and incidence 
rate ratios 
Results data
Primary outcomes
The 0- to 18-month data are from Pronovost et al.,34 and 19- to 36-month data are from Pronovost 
et al.,124 except where stated otherwise.
Outcome
Baseline 
Intervention:  
(a) implementation period;  
(b) months 0–18;  
(c) months 19–36; and  
(d) individual quarters
Difference between 
baseline and 
intervention n = no. of ICUs
Device duration (months) Not reported Not reported Not reported 
551 (220–1091) 
(n = 55)
(a): 57,033 (n = 96) Not reported
(b): 300,175 (n = 103)
(c): 300,310 (n = 90)
(d)
 0–3 (n = 95)  436 (246–771) [4779a]*
 4–6 (n = 95)  460 (228–743) [4757)
 7–9 (n = 96)  467 (252–725)
 10–12 (n = 95)  431 (249–743)55,70
 13–15 (n = 95)  404 (158–695)
 16–18 (n = 95)  367 (177–682)
 19–21 (n = 89)  399 (230–680)
 22–24 (n = 89)  450 (254–817)
 25–27 (n = 88)  481 (266–769)
 28–30 (n = 90)  479 (253–846)
 31–33 (n = 88)  495 (265–779)
 34–36 (n = 85)  456 (235–787)
*Total device-days, median (IQR) [monthly mean]; n = no. of ICUs
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Outcome
Baseline 
Intervention:  
(a) implementation period;  
(b) months 0–18;  
(c) months 19–36; and  
(d) individual quarters
Difference between 
baseline and 
intervention n = no. of ICUs
No. of devices/patient Not reported Not reported Not reported
2 (1–3) (a): 1 (0–2)* Not reported
(b), (c): not reported
(d)
0– 3 (n = 95) 0 (0–2)
4–6 (n = 95) 0 (0–1)
7–9 (n = 96) 0 (0–1)
10–12 (n = 95) 0 (0–1)
13–15 (n = 95) 0 (0–1)
16–18 (n = 95) 0 (0–1)
19–21 (n = 89) 0 (0–1)
22–24 (n = 89) 0 (0–1)
25–27 (n = 88) 0 (0–1)
28–30 (n = 90) 0 (0–1)
31–33 (n = 88) 0 (0–1)
34–36 (n = 85) 0 (0–1)
*No. of CRBSI, median (IQR)
CRBSI incidence per 1000 catheter-days 2.7 (0.6–4.8); 
7.7 ± 28.9 
(n = 55)
(a): 1.6 (0–4.4); 2.8 ± 4.0*
(b), (c): Not reported
(d)
0–3 (n = 96) 0 (0–3.0); 2.3 ± 4.0 p ≤ 0.002
4–6 (n = 96) 0 (0–2.7); 1.8 ± 3.2 p ≤ 0.002
7–9 (n = 95) 0 (0–2.1b); 1.4 ± 2.8 p ≤ 0.002
10–12 (n = 90) 0 (0–1.9b); 1.2 ± 1.9 p ≤ 0.002
13–15 (n = 85) 0 (0–1.6b); 1.5 ± 4.0 p ≤ 0.002
16–18 (n = 70) 0 (0–2.4); 1.3 ± 2.4 p ≤ 0.002
19–21 (n = 89) 0 (0–1.4); 1.8 ± 5.2 Not reported
22–24 (n = 89) 0 (0–1.6); 1.4 ± 3.5 Not reported
25–27 (n = 88) 0 (0–2.1); 1.6 ± 3.9 Not reported
28–30 (n = 90) 0 (0–1.6); 1.3 ± 3.7 Not reported
31–33 (n = 88) 0 (0–1.1); 0.9 ± 1.9 Not reported
34–36 (n = 85) 0 (0–1.2); 1.1 ± 2.7 Not reported
*Median (IQR); mean ± SD
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Outcome
Baseline 
Intervention:  
(a) implementation period;  
(b) months 0–18;  
(c) months 19–36; and  
(d) individual quarters
Difference between 
baseline and 
intervention n = no. of ICUs
CRBSI incidence per 1000 patient-days Not reported Not reported
1.00* (a): 0.81 (0.61 to 1.08)*
(b), (c): Not reported
(d)
0–3 months 0.62 (0.47 to 0.81b) p = 0.001
4–6 months 0.56 (0.38 to 0.84b) p = 0.005
7–9 months 0.47 (0.34 to 0.65b) p < 0.001
10–12 months 0.42 (0.28 to 0.63b) p < 0.001
13–15 months 0.37 (0.20 to 0.68b) p = 0.001
16–18 months 0.34 (0.23 to 0.50b) p < 0.001
19–21 (n = 89) 0.34 (0.23 to 0.50) Not reported
22–24 (n = 89) 0.33 (0.23 to 0.48) Not reported
25–27 (n = 88) 0.44 (0.34 to 0.57) Not reported
28–30 (n = 90) 0.40 (0.30 to 0.53) Not reported
31–33 (n = 88) 0.31 (0.21 to 0.45) Not reported
34–36 (n = 85) 0.34 (0.24 to 0.48) Not reported
*Incidence rate ratio (95% CI)c
Mean per quarter change in rate of 
CRBSI (95% CI)
All ICUs (n not 
reported):
0–18 months 12% (9% to 15%) Not reported
19–36 months –1% (–9% to 7%)
ICUs with continuous 
data (n = 43)
0–18 months 13% (9% to 16%)
19–36 months –1% (–4% to 5%)
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Stated this is for ICUs that implemented interventions in the first 3 months after baseline; however, the number of 
ICUs it relates to is unclear.
b Different data for the same outcome were reported by Pronovost34 and Pronovost;124 the data presented here are from 
Pronovost 34 as they correspond to the reported p-values.
c Adjusted for the hospital’s teaching status and number of beds.
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Secondary outcomes 
Reaction to 
education 
Not assessed as an outcome
Attitudes Not assessed as an outcome
Compliance Not assessed as an outcome
Knowledge Not assessed as an outcome
Skills Not assessed as an outcome
Process 
Evaluation 
Effectiveness of intervention was found to be modestly higher in small hospitals, with an incidence rate 
ratio of 0.97 (95% CI 0.96 to 0.99; p < 0.001) for each 100-bed decrease in the size of the hospital, 
but it is unclear if the study was powered for this type of analysis. The stocking of chlorhexidine was 
also monitored and, 6 weeks following a letter to hospital CEOs to provide it, 56/67 (84%) stocked 
chlorhexidine, 46/67 (69%) stocked the agent in the ICU and 43/67 (64%) stocked it in central-line 
carts (1/67; 19% at baseline)
CEO, Chief Executive Officer.
Critical appraisal
Potential for bias 
Group 
selection
Were there systematic differences between the baseline and intervention groups? NOT REPORTED. No 
information was presented on patient demographics or health status other than that patients were 
mostly adult
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? UNCLEAR. Analyses were conducted to account 
for nested clustering within the data; analyses also adjusted for hospitals’ teaching status and bed size. 
However, no population variables were included in the analyses. A sensitivity analysis of results was 
conducted, which included only ICUs with continuous data, including baseline data. During months 
19–36 after intervention implementation (the ‘sustainability period’), 13 hospitals dropped out because 
they chose not to pay the MHA fee for continued participation).124 These 13 hospitals were more likely 
to be a teaching hospital (93% vs. 65%), p = 0.04, but they did not vary in median number of hospital 
beds (383 vs. 338) or in CRBSI incidence rates during the first and final quarters of the preceding 
18-month intervention period123
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT REPORTED, but ICUs could implement two interventions in any order. Authors stated 
that according to their knowledge, no other infection-reducing practices were implemented during the 
study. They also stated that they did not evaluate the use of new technologies such as impregnated 
dressings or catheters and chlorhexidine baths, on rates of infection124
Was the effect of educational practice separable from effects of non-educational practice? NO. Change 
in supplies (central line cart and chlorhexidine). Also introduced new QI initiative unrelated to CRBSI,124 
including an intervention to reduce the incidence of VAP
Were the intervention component(s) implemented as planned? NOT REPORTED
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. Only 53 ICUs reported data continuously from baseline to 18 months124 and 43 reported 
data continuously to 36 months.124 Sensitivity analysis (up to 18 months) showed little change in the 
association between the intervention and outcomes when only ICUs for which complete data (including 
baseline data) were available were included. However, data availability from 19–36 months may be 
related to hospital teaching status (see above). Stated124 that missing data were very high and lowered 
to about 12% by sending letters to CEOs of the hospitals informing them of the per cent of missing 
data for their hospital; CEOs were requested to submit the required data or advised they would have to 
be dropped from the collaborative. Also stated123 that roughly 5% of data were lost when the 13 units 
left the collaboration, and roughly 5% of CRBSI were missing for the remaining units
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Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes were 
determined (including differences in how outcomes were defined)? UNCLEAR. Three ICUs changed the 
CRBSI definition used from their own to that of the NNIS but these were not included in a sensitivity 
analysis. Authors stated that medians were used to summarise the data as the data were non-normal.34 
However, means were also reported123,124 and in some cases were markedly different to median  
values – but no guidance on interpretation was given
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NOT REPORTED
Other possible 
sources of bias
Were any other sources of bias present? UNCLEAR. Despite conducting a sensitivity analysis, authors 
refer to the possibility of measurement bias, which can if present exaggerate results
CEO, Chief Executive Officer; MHA, Michigan Health and Hospital Association.
Other critical appraisal criteria
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. The principles of the intervention 
are described well enough to be replicated, but not the specific content. A copy of the fact sheet 
was provided in a supplementary appendix. However, this was a very small component of the overall 
intervention and its effectiveness in isolation is not known. An underlying principle of the intervention 
is that it should be adaptable according to local circumstances: an independent post hoc analysis149 
revealed that the intervention evolved beyond what was initially stated in the protocol
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Stated only that throughout the study, data on the 
number of CRBSIs and catheter-days were collected monthly from a trained, hospital-based  
infection-control practitioner. Potential underreporting of catheter-related bloodstream infections and 
the lack of baseline data from ICUs that immediately implemented the intervention when the project 
was launched could have created a measurement bias that exaggerated the results
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED (behavioural outcomes not reported)
Additional comments
 z A programme evaluation of the Michigan study by Dixon-Woods and colleagues149 highlighted the fact 
that the intervention evolved over time. Later innovations included a networking section at residential 
project workshops, as well as project tokens, all not part of the original protocol.
 z The authors stated that random assignment of the intervention and the time of implementation was 
not feasible because all of the ICU teams wanted to implement the intervention and to decide for 
themselves when to do so. Some ICUs immediately implemented the intervention without collecting 
any baseline data but were included in sensitivity analyses.
 z The authors stated that they did not monitor catheter duration to simplify data collection, and they did 
not collect data on who inserted the central catheters.
 z Not reported why 67 hospitals participated, whereas 34 hospitals in Michigan did not (stated that 
hospitals were not asked to provide reasons). Mean number of beds per participating ICU was 
1625/103 = 15.8; mean number of beds per non-participating ICU was 268/34 = 7.9. Suggests study 
specifically excluded smaller ICUs but reason not given. The authors included hospital bed numbers 
as a variable and found the intervention appeared to be more effective in smaller hospitals but this 
analysis appears not to consider the size of the ICUs so its interpretation is unclear.
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 z Statistical analyses accounted for clustering of infections/ICUs/hospitals but did not account for any 
population variables.
 z Stated that inclusion of clustering effects in the statistical analysis (CRBSIs within ICUs, ICUs within 
hospitals, and hospitals within geographical regions) did not change the results.
 z The authors noted that similar large decreases in infection rates were not observed outside Michigan 
during the study period; however, CRBSI data were not collected from the non-participating ICUs.
 z Not reported whether participating staff were aware that they were part of a study.
 z Stated125 that Rhode Island implemented a similar programme, with every hospital in the state 
participating and reported similar results as Michigan.
 z The AHRQ has awarded a grant to the Health Research and Educational Trust and Quality and Safety 
Research Group (QSRG) researchers at Johns Hopkins to replicate the Michigan study in 10 states and 
the QSRG has received ‘philanthropic support’ to implement the collaborative in another 20 states.124
 z A graph123 shows that in some cases the 3-monthly infection incidence per 1000 catheter-days in  
50 randomly selected ICUs equalled or exceeded that in the baseline and implementation phases, 
but the graph does not distinguish the individual ICU data within this subgroup of 50. Not reported 
whether the graph presents mean, median or total values.
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RENDER (2006)126,200
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Render (2006);126,200 Elder (2008)201
Summary of approach Regional collaborative based on work/learning/reporting cycles, including performance 
feedback and infection surveillance feedback
Location USA
Language English
Critical care specialty Not reported, but stated that intervention was in a MICU if more than one ICU was present 
at a given hospital
No. of critical care units 8
No. of hospitals 4
Hospital name (unless 
multicentre); city
Multicentre
Study design Single cohort before-and-after study (results from eight critical care units pooled). Hospitals 
were randomised to CRBSI prevention in critical care units or surgical site prevention in 
operating rooms – only results for four hospitals that were randomised to CRBSI prevention 
are reported
Study time periods Baseline: 2003 (months not specified)
Intervention: Not explicitly stated. intervention period appears to be January 2004 to 
December 2006 (data reported for 2004)
Follow-up: None (continuous monitoring of ongoing QI intervention during 2004)
Funding source 50% funded by the health-care systems to which the hospitals belonged. No other funding 
sources reported
Conflicts of interest Not reported
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Population and setting
Critical care unit 
characteristics
Eight units in four hospitals (two urban referral and two suburban; one affiliated with a 
national health-care organisation)
Total critical care unit beds = 104
Total central line days per year = 7714
Total patients in the four hospitals in first year = 686
No other information on critical care units reported
(Also included a control group: five hospitals with 13 ICUs, no data reported)
Patient population 
characteristics
Not reported; author contacted by reviewer and confirmed that patients were adult 
(author’s reply would indicate that the included children’s hospital is part of the control 
group)
Device characteristics Central lines, defined as any intravenous catheter whose distal end was in a central vein
During first year:
 z Total central line-days = 742
 z Urgent lines = 27%
 z Multilumen catheters = 60%
 z Placed in femoral vein = 25%
No other details reported
Insertion site antisepsis used Not stated explicitly; implied that betadine was used 
Dressing type and duration/
frequency 
Not reported
Intervention characteristics
Objective To implement evidence-based patient safety practices that reduce CRBSI (chlorhexidine 
and maximal sterile barriers) in a regional group of hospitals, and train hospital staff 
in methods to successfully create and sustain change. Four hospitals that started the 
project set a goal to reduce their CRBSI rates by 50%
Main focus of education Catheter insertion, focusing on use of maximal sterile barriers and skin antisepsis
Trainers (providers) Experts in organisational change (two named co-authors) facilitated practice change 
strategies. At project initiation each hospital’s CEO and other hospital leaders identified 
the project leader and team members. Project leaders, often the infection control 
professionals, led the team, which consisted of the nurse manager of the intervention 
unit, two or more staff nurses, a physician champion, and the supply manager. Teams 
implemented the evidence based practices using a collaborative approach. Stated that 
all team members were invited but the number participating varied from only the team 
leader (the infection control practitioner) to eight or more team members
Training of trainers Not reported. However, stated that the leadership role of the infection control 
practitioner proved important because he/she already knew and believed the literature, 
had previously collaborated outside the confines of their own hospital, and understood 
the data collection issues. Stated200 that the infection control practitioners who were the 
project leaders had previous experience working together
Learners (recipients) ICU nurses and physicians
Target behaviour change Not explicitly stated but focused on use of skin antisepsis and large drapes during 
catheter insertion
Development and testing Stated that the project was developed by a patient safety researcher (the lead author). 
No other information provided
Educational or behavioural 
theory
None reported
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Educational strategies and 
topics targeted
Joint 1.5-day kick-off session: National experts presented evidence for practices; 
experts in organisational change presented the methods for change and mentored 
teams’ implementation planning. Teams were requested to provide: a ‘SMART’ aim 
(specific, measurable, actionable, reliable, and time driven); a 90-day goal, with 
communication strategy, measurement, and tests of change; and a 3-day itemised 
action plan addressing recruitment of additional team members, the first test of  
change, and roles
Work/learning/reporting cycles: Organised by project leaders at each site. Involved at 
minimum one (initially very small) test of change each month
Monthly small group meetings (< 10 people) between project leaders and leadership: 
to present experience in a standard format (6 presentation slides) to share effective 
strategies, solve joint problems together, reinforce the change theory (not specified) and 
methodology, and develop consistent data collection strategies and definitions
Checklist (provided in paper): Completed by ICU nurses as the physician prepared 
the catheter insertion. Nurses recorded binary choices (yes/no) for hand washing; 
chlorhexidine use; bed-sized sterile drape; and use of cap, mask, sterile gown, and 
sterile gloves during insertion; and the catheter date and insertion site. Stated200 that 
personnel were encouraged to use the checklist to identify the earliest possible moment 
when the central line could be removed; however, line need review was not a specific 
item on the checklist
Written policies: approved by the clinical executive board to match the best practices 
to codify practice changes
Stated200 that preferred insertion site was head or neck, with femoral lines to be 
removed within 48 hours, and all clinical lines were prepped with chlorhexidine rather 
than betadine. However, the specific educational approaches used to convey these 
policies were not reported
Infection surveillance 
feedback approach 
Each patient record was reviewed by the infection control nurses and compliance and 
infection rates were reported to the ICU clinical collaborative committee and posted in 
the unit monthly.200 Validity and reliability of data collection and reporting methods not 
reported
Performance feedback 
approach 
Unit level: Team leaders entered information from checklists in a secure de-identified 
web-based database. Each project leader reported processes and outcomes to the unit 
staff, usually posting the monthly project meeting slides on a bulletin board throughout 
the unit. Results also reported through existing hospital committees’ structure  
(e.g. infection control and critical care committees) and to the wider hospital through  
its newsletter
Community level: Project leadership reported outcomes to Greater Cincinnati Health 
Council (GCHC) infection control and patient safety committees. Twice yearly, hospital 
CEOs were informed of results by project leadership. Validity and reliability of data 
collection and reporting methods not reported. Stated that to ascertain capture of all 
central lines, nurse managers each month sampled the lines in place in the ICU against 
the forms (not described)
Concentration of education Not reported, other than kick-off meeting had duration of 1.5 days, checklists were 
used daily, and feedback was monthly. Unclear whether newly recruited staff received 
the intervention. Stated in a commentary paper200 that data continued to be posted 
quarterly but unclear when the switch from monthly to quarterly reporting occurred
Non-educational 
intervention components 
In collaboration with two manufacturers, team leaders modified pre-packaged insertion 
trays, removing the betadine (in most units) and small drape and developed an accessory 
pack that bundled the large drape, sterile gown, cap and mask. The insertion tray, 
accessory pack and sterile gloves were kept on a central line cart
Costs reported Not reported; stated that the drapes and new kits added some cost to the procedure, 
which had to be justified to leadership200
CEO, Chief Executive Officer.
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Outcome characteristics
CLBSI infection 
definition
Reference cited: 
Raad and Bodey201
A hospital-acquired infection is one that occurs 48 hours after admission to the hospital and 
< 72 hours following discharge
A CRBSI is defined as a positive blood culture with clinical or microbiological evidence that strongly 
implicates the catheter as the source of infection (reference cited, left). It is distinguished from local 
infection (evidence of purulence at the site of insertion) and catheter colonisation (growth  
of greater than 15 CFUs of an organism from the tip or subcutaneous portion of the catheter  
using the semiquantitative roll-plate culture technique) (reference cited)
Outcomes 
reported
Not stated whether primary or secondary:
 z Pre- and post-line-days
 z CRBSI incidence density/1000 line-days
 z Adherence to chlorhexidine and large drape
CFU, colony-forming unit.
Results data
Primary outcomes
Outcome
Baseline (2003) Intervention (2004)
Difference between 
baseline and 
intervention For eight critical care units
Mean (± SD) line duration, days 7.0 (± 6.2) Not reported Not reported
Total device utilisation Not reported Not reported Not reported
No. of devices/patient (not reported; data 
e-mailed by the author) 
7593 (in three 
quarters of 2003)
7830 (in three 
quarters of 2004)
Not reported
CRBSI incidence rate (not reported; data 
e-mailed by the author)
11 (in three quarters 
of 2003)
5 (in three quarters of 
2004)
Not reported
CRBSI incidence per 
1000 line-daysa
(a)  reported (period 
unclear)
(a) 1.7 (a) 0.4 (a) p < 0.05
(b)  calculated from 
data e-mailed 
by the author 
(three-quarter 
period)
(b) 1.4 (b) 0.6
CRBSI incidence per 1000 patient-days Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Data for calculating risk ratios with CIs (presented in the main report) were not reported in the primary publication 
but were obtained by contacting the author.
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Secondary outcomes 
Reaction to 
education
Not a study outcome
Attitudes Not a study outcome
Compliance The data presented indicate that an improvement in compliance occurred both for chlorhexidine and 
large drape use, but it is not clear from the information provided how the data relate to the timing of 
intervention implementation. Stated that four of the health-care systems implemented chlorhexidine and 
maximal sterile barriers in the first year and timing of antibiotics in the operating room or consistent use of 
maximal sterile barriers during the second year200
Adherence to evidence-based practices was reported to have increased from 30% to 95% at the project 
midpoint (three quarters of 2004)
Project yeara Adherence to chlorhexidine, % Adherence to large drape, %
Month 1 42 0
Month 2 45 39
Month 3 49 47
Month 4 72 67
Month 5 86 82
Month 6 90 82
Month 7 72 95
Month 8 73 62
Month 9 73 87
Month 10 92 68
Month 11 94 83
Month 12 82 83
Knowledge Not a study outcome
Skills Not a study outcome
Process 
evaluation 
A table (table 2) of facilitators and barriers is provided, but it is unclear whether this is based on 
quantitative evidence. Authors reported that after 6 months, the project leader and project co-ordinator 
(named authors) reviewed their detailed notes from the monthly reporting meetings to independently 
identify themes contributing to or delaying project success. The list of barriers and facilitators was then 
validated by the project leaders. However, the validation process was not explained. Some aspects of the 
reported information are unclear – for example, building on a prior pilot was rated as a facilitator but no 
prior pilot was reported elsewhere in the publications
a Data extracted by reviewer from graph using Engauge software. ‘Project year’ is taken to mean 12 months and not  
12 years, but graph label is unclear.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 14
275
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? UNCLEAR. 
Population characteristics not reported
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? NOT REPORTED. Not mentioned whether any changes in staffing occurred or whether 
any interventions were introduced in parallel at any of the ICUs. Stated that all commercially available 
central line trays included a small drape and both chlorhexidine and betadine, allowing practitioners to 
easily avoid practice change (meaning unclear)
Was the effect of educational practice separable from effects of non-educational practice? NO. 
In addition to educational activities, the insertion site antisepsis was changed from betadine to 
chlorhexidine and catheter insertion kits were re-organised, which may have influenced infection 
incidence
Were the intervention component(s) implemented as planned? NOT REPORTED
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
NOT REPORTED 
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. Stated that 
hospitals were already collecting CRBSI data using the CDC definitions at the project’s inception. 
However, also stated that collection of line days was more accurate after intervention
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
Stated in a subsequent publication201 that the four participating hospitals were more willing than 
others to participate in the study – suggesting that the management at these ICUs may possess 
different qualities than non-participating ICUs
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. The general intervention approach 
is described and the key topics are reported but it is unclear which parts of the approach were used 
to support each topic. The checklist is reproducible but is a rudimentary list mainly of binary (yes/no) 
responses that would be difficult to implement effectively without additional instructions
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES. Line days were stratified by ICU
Results Educational significance or effect size assessed? NOT REPORTED 
Target behaviour change achieved? PARTIALLY. Improvements in adherence to chlorhexidine and large 
drapes were reported but remained below 100% for both
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Additional comments
 z Stated that infection rates were zero in three of four hospitals for four quarters.
 z Lead author was contacted to clarify whether the population included children. She confirmed that 
the population was entirely adult.
 z A line-day was not defined – it is unclear whether the data reflect all the vascular catheters used or the 
number of days on which patients had at least one vascular catheter.
 z Not reported whether participants were aware they were being studied.
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ROSENTHAL (2003)129
Methods
Study characteristics
Lead author, publication year(s) and reference(s) Rosenthal (2003)129
Summary of approach Infection control intervention in four ICUs, comprising 
education followed by performance feedback; the 
performance feedback focused on compliance with 
the management of catheter dressings and dating of 
intravenous tubing sets 
Location Argentina
Language English
Critical care specialty Cardiac, medical/surgical
No. of critical care units 4
No. of hospitals 2 
Hospital name (unless multicentre); city Bernal Medical Center and Colegiales Medical Center, 
Buenos Aires
Study design Single cohort before-and-after study, with data from four 
ICUs pooled into single cohort
Study time periods
Note that a hand washing programme (not described) was 
implemented concurrently during the same time periods 
as the education and performance feedback intervention 
at Bernal Medical Center (total duration 12 months) but 
implementation times varied or differed in all phases at 
Colegiales Medical Center (total duration 11 months)
Phase 1, baseline (infection surveillance)
Bernal Medical Center: April to May 1999 (2 months)
Colegiales Medical Center: September to November 2000 
(3 months)
Intervention:
Phase 2, education:a
Bernal Medical Center: June to July 1999 (2 months)
Colegiales Medical Center: December 2000 (1 month)
Phase 3, performance feedback
Bernal Medical Center: August 1999 to March 2001 
(8 months)
Colegiales Medical Center: January to July 2001 (7 months)
Follow-up: None (monitoring only during intervention 
implementation phases)
Funding source Supported in part by a grant from Baxter Healthcare
Conflicts of interest Not reported
a Data are from table 1; text also stated that education was 1 month at Bernal and 3 months at Colegiales  
(appears contradictory).
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Population and setting
Critical care unit 
characteristics
Four level III cardiac and MICUs/SICUs in two hospitals
Bernal Medical Center:
Private hospital, 150 beds
1 medical–surgical ICU (17 beds)
1 coronary ICU (15 beds)
Colegiales Medical Center:
Private hospital, 180 beds
1 medical–surgical ICU (10 beds)
1 coronary ICU (10 beds)
Each hospital had an infection control team that comprised a medical doctor (with formal 
education and medical background in internal medicine, infectious diseases, and hospital 
epidemiology) and an infection control nurse
Patient population 
characteristicsa
All admitted adult patients 
with a CVC in place for at 
least 24 hours (840 patients) 
were included
Baseline
(2 or 3 months)
(172 patients b)
Intervention
(8 or 10 months)
(668 patients b)
Difference between baseline 
and intervention 
Male sex, n (%) 84 (48.8) 358 (53.6) p = 0.265
Mean ± SD age, years 71.98 ± 13.45 71.91 ± 12.19 p = 0.944
Diabetes, n (%) 32 (18.6) 103 (15.4) p = 0.314
Cancer, n (%) 9 (4.8) 33 (4.9) p = 0.925
HIV, n (%) 1 (0.6) 0 (0) p = 0.205
Device characteristics Not reported Not reported Not reported
Insertion site antisepsis used Not reported Not reported Not reported
Dressing type and duration/
frequency 
Not reported Not reported Not reported
SICU, surgical intensive care unit.
a Patients had undergone open heart, neurosurgical or orthopaedic operation, or had severe medical illness.
b Not reported; number estimated by reviewers from the percentage data given.
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Intervention characteristics
Objective To ascertain the effect of an infection control programme, using education and 
performance feedback, on intravascular device-associated BSI 
Main focus of education Unclear – appears to be catheter care in general (guidelines cited but unclear whether 
education was based on part or all of the guidelines) – but management and care 
of dressings and dating of intravascular administration sets were the areas for which 
compliance was assessed
Trainers (providers) Not reported
Training of trainers The principal investigator (lead author) trained the data collectors at each centre before in 
initiation of the trial, but the training of education providers was not reported
Learners (recipients) Not specified other than health-care workers from the ICUs
Target behaviour change Not explicitly stated in education, but target behaviours for which compliance was assessed 
were: placement of gauze on intravascular device insertion sites; marking of the date on 
the intravascular administration set; and checking/ensuring appropriate condition of the 
gauze dressing
Development and testing Not reported
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
Health-care workers from the ICUs underwent education and training for CVC care based 
on infection control practices published by the CDC and Hospital Infection Control Practices 
Advisory Committee (reference cited). This occurred during 1 month (Bernal Medical 
Center) or 3 months (Colegiales Medical Center). However, table 1 shows the duration of 
this phase as two months for Bernal Medical Center and 1 month for Colegiales Medical 
Center
Infection surveillance 
feedback approach 
Not included in the intervention
Performance feedback 
approach 
A research nurse observed health-care worker behaviour in the ICUs twice a week, 
and assessed and entered the following into a standard form: placement of gauze on 
intravascular device insertion sites; marking of the date on the intravascular administration 
set; and condition of the gauze dressing. Performance feedback was provided at monthly 
infection control meetings using bar charts documenting rates of compliance with hand 
washing, gauze on CVC insertion sites, dates on intravascular administration sets, and 
maintaining the condition of catheter gauze dressings. Also, a formal report of compliance 
rates was provided to administrators in each ICU. Validity and reliability of the method not 
reported
Concentration of 
education 
Not reported – no information was given on the number and duration of sessions, other 
than that performance feedback occurred monthly
Non-educational 
intervention components 
A study to improve health-care worker compliance with hand washing was undertaken 
at each institution and overlapped in time with the current trial. However, no details were 
reported
Costs reported Not reported
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Outcome characteristics
Catheter-BSI definition
Reference cited:  
Garner et al.147
There were two criteria for ‘laboratory-confirmed BSI’:
1. A recognised pathogen cultured from one or more percutaneous blood cultures,  
after 48 hours of vascular catheterisation, and the pathogen cultured from the blood 
was not related to an infection at another site. With common skin commensals  
(e.g. diphtheroids, Bacillus spp., Propionibacterium spp., coagulase-negative 
staphylococci or micrococci), the organism was cultured from two or more blood 
cultures drawn on separate occasions; and
2. Patient had at least one of the following signs or symptoms that were not considered  
to be related to an infection at another site: fever (> 100.4 °F), chills or hypotension
Blood and catheter tip culture techniques were briefly described (references cited)
Outcomes reported Primary outcome:
The combined rate of intravascular device-related BSI in Phases 2 and 3 of the study 
(education and performance feedback) compared with the rate in Phase 1 (baseline 
infection surveillance)
Secondary outcomes:
Rate of intravascular device-related BSI in phase 2 vs. Phase 1
Rate of intravascular device-related BSI in phase 3 vs. Phase 2
Results data
Primary outcomes
Outcome
Phase 1 
(baseline) 
Phase 2 
(education)
Phase 3 
(performance 
feedback)
Phase 2 + Phase 3 
(overall intervention)
Difference 
(relative risk 
(RR) (95% CI); 
p-value)
Device duration Not reported Not reported Not reported Not reported Not reported
Total device utilisation, 
intravascular device-
days 
1219 586 4140 4726 Not reported
No. of devices/patient Not reported Not reported Not reported Not reported Not reported
Intravascular  
device-related BSI 
incidence rate
56 10 41 51 Not reported
Intravascular  
device-related BSI 
incidence per 1000 
catheter-days
45.94 17.06 9.90 11.10 Phase 2 vs. 1: 
RR = 0.37 (0.19 to 
0.73), p < 0.001
Phase 3 vs. 2: 
RR = 0.58 (0.29 to 
1.18), p = 0.11
Phase 2 + 3 vs. 1: 
RR = 0.25 (0.17 to 
0.36), p < 0.001
Intravascular  
device-related BSI 
incidence per 1000 
patient-days
Not reported Not reported Not reported Not reported Not reported
LOS Not reported Not reported Not reported Not reported Not reported
Mortality Not reported Not reported Not reported Not reported Not reported
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Secondary outcomes 
Compliance (n = no. 
of observations)
Baseline (Phase 1) 
(n = 347)
Education (Phase 2) 
(n = 169)
Performance 
feedback (Phase 3) 
(n = 5165)
Difference (relative 
risk (RR) (95% CI); 
p-value)
Presence of gauze  
on intravascular 
device site
53.02% (184/347) 56.21% (95/169) 96.53% (4986/5165) Phase 2 vs. Phase 1: 
RR = 1.06 (0.86 to 
1.30); p = 0.64
Phase 3 vs. Phase 2: 
RR = 1.72 (1.40 to 
2.10); p < 0.001
Date on intravascular 
administration set
0.57% (2/347) 0% (0/169) 74.00% (3839/5165) Phase 2 vs. Phase 1: 
p = 0.32
Phase 3 vs. Phase 2:
p < 0.001
Good gauze condition 48.70% (169/347) 43.19% (73/169) 89.56% (4626/5165) Phase 2 vs. Phase 1: 
RR = 0.89 (0.67 to 
1.17); p = 0.39
Phase 3 vs. Phase 2: 
RR = 2.07 (1.65 to 
2.62); p < 0.001
Outcome
Reaction to education Not a study outcome
Attitudes Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not included in the 
study
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? UNCLEAR. 
Patients were similar in the baseline and intervention periods for gender, age, and proportion with 
diabetes, cancer or HIV. However, no other aspects of patients’ health status were reported
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as 
covariates or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? YES. Stated that a similar study to improve health-care worker compliance with 
hand washing was undertaken at each institution resulting in overlap with the current trial. 
However, no information on the hand washing programme was reported
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention with effects of education per se and performance feedback separable
Were the intervention component(s) implemented as planned? NOT REPORTED. The educational 
approach was not described
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Missing data Were there systematic differences between the baseline and intervention groups in data 
availability? NOT REPORTED. The sample sizes for the different study periods were not explicitly 
stated
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how 
outcomes were determined (including differences in how outcomes were defined)? NOT 
REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood cultures)? 
NO
Other possible 
sources of bias
YES. Study centre data collection sheets were checked for potential errors and missing items by 
one person – the study co-ordinator – to confirm each diagnosis of intravascular device-associated 
BSI. The study co-ordinator might have a vested interest in a successful outcome
The authors mentioned that the parallel implementation of a hand washing programme probably 
had an impact on the results of this study. They stated that in particular, it is possible that the 
earlier implementation of a hand washing programme at both institutions enhanced the impact 
of the educational phase of this study, potentially reducing the overall impact of performance 
feedback. However, this potential effect is speculative
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. The educational approach was not 
reported.
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. An infection control nurse at each study centre 
extracted data prospectively from charts. Study centre data collection sheets were checked 
for potential errors and missing items by the study co-ordinator to confirm each diagnosis of 
intravascular device-associated BSI
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? UNCLEAR. The target behaviours addressed by the education 
were not reported. Compliance with three reported behaviours ranged from 0% to 56.21% after 
education alone and from 74.00 to 96.53% after both education and performance feedback
Additional comments
 z The authors commented that most health-care institutions in Latin America lack the resources to 
prevent intravascular device-related BSI and many hospitals lack basic infection control programmes.  
In this context the high baseline incidence is notable.
 z It was not reported whether the participants were aware they were being studied.
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ROSENTHAL (2005)130
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Rosenthal (2005)130
Summary of approach Education and performance feedback intervention to improve hand hygiene practices in 
two ICUs
Location Argentina
Language English
Critical care specialty Coronary, medical surgical
No. of critical care units 2
No. of hospitals 1
Hospital name (unless 
multicentre); city
Colegiales Medical Center, Buenos Aires
Study design Single cohort before-and-after study, which pooled data from two ICUs
Study time periods Baseline (Phase 1): September to December 2000 (4 months)
Intervention (Phase 2): January 2001 to May 2002 (17 months)
Follow-up: None. The specified follow-up period from January 2001 to May 2002 
included the implementation of education in January 2001 and implementation of 
performance feedback in May 2001 (although education sessions appear to have been 
1 week long, performance feedback appears to have been continuous during the 
monitoring period – but precise details of timing were not reported)
Funding source Stated no external funding was provided; the human resources for the intervention were 
those of the infection control programme
Conflicts of interest Not reported
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Population and setting
Critical care unit 
characteristics
Private hospital, 180 beds:
1 medical–surgical ICU (12 beds)
1 coronary ICU (12 beds)
Infection control team composed of a medical doctor (with formal education and 
medical background in internal medicine, infectious diseases and hospital epidemiology), 
an infection control nurse, and personnel support
Stated that soap and antibiotic use were not changed
No other information reported
Patient population 
characteristics
Not reported
Device characteristics Mentioned only that devices were centrally inserted and peripherally inserted CVCs
Insertion site antisepsis 
used
Not reported other than that soap and antibiotic use were not changed 
Dressing type and duration/
frequency 
Not reported
Intervention characteristics
Objective To enhance compliance with hand hygiene by implementing education, training and 
performance feedback
Main focus of education Hand hygiene
Trainers (providers) Education providers were not reported. One nurse was trained to detect hand washing 
compliance and record it on a form designed for the study. A trained infection control 
nurse identified nosocomial infections. Senior hospital management provided full 
administrative support for the study
Training of trainers Not reported
Learners (recipients) Health-care workers in the ICU (nurses, physicians, ancillary staff)
Target behaviour change Hand hygiene
Development and testing Not reported
Educational or behavioural 
theory
Not reported
Educational strategies and 
topics targeted
Focused education of all health-care workers:
One-hour group session educational classes: For all shifts every day for 1 week. All  
health-care workers were given a comprehensive infection control manual, and the 
Association for Professionals in Infection Control (APIC) hand hygiene guideline was 
used as an educational tool to reinforce classroom teaching. Attendance was voluntary 
and monitored; each health-care worker could attend the course as many times as 
desired. Theoretical and practical indications for the use of hand hygiene were reviewed. 
The guidelines were also posted at a strategic location in each ICU (display format and 
location not specified)
Post tests: To evaluate retention of educational material – were given 1 month later
Routine infection control review classes: Held by the primary investigator to provide 
an opportunity for infection control questions and sharing of infection and compliance 
surveillance data
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Infection surveillance 
feedback approach 
Not part of the intervention: standardised NNIS data collection methods (reference 
cited) were used during baseline as well as intervention periods. Surveillance data were 
shared via: routine infection control review classes; reports to the ICU manager and 
administrator; and feedback data posted in the ICUs (no details of format given). Stated 
that feedback was ‘frequent’ but the timing was not specified. Validity and reliability of 
the data collection were not reported
Performance feedback 
approach 
Pre- and post-intervention data on compliance of health-care workers with hand hygiene 
before contact with patients were collected in the ICUs by a trained infection control 
practitioner, who covertly observed the hand washing techniques of the health-care 
workers (physicians, nursing staff, and technicians) at random times twice a week, 
including all shifts, for 30-minute intervals. Data were recorded on a specially designed 
form and shared via routine infection control review classes; graphic presentations 
of hand hygiene rates in the form of bar charts were displayed in monthly meetings; 
reports to the ICU manager and administrator; and feedback data in the form of bar 
charts were posted in the ICUs. Validity and reliability of the data collection method were 
not reported. Health-care workers were informed that their hand hygiene practices were 
being monitored but were not aware of precisely when these observations were being 
made
Concentration of education Timing of group sessions was one hour per day for 1 week for all shifts. Timing of 
infection review classes not reported. Performance feedback on compliance was 
monthly. Timing and duration of post tests not reported
Non-educational 
intervention components 
Interventions for reducing CVC-associated BSI and for reducing urinary catheter-
associated UTIs overlapped with the current intervention by 7 of 21 months and 17 of 
21 months, respectively
Costs reported Not reported, but described as ‘relatively low-cost approach’
Outcome characteristics
Catheter-BSI definition
Reference cited:  
Garner et al.147
Laboratory-confirmed CABSI
A patient with a CVC has a recognised pathogen cultured from one or more 
percutaneous blood cultures, after 48 hours of vascular catheterisation, and the 
pathogen cultured from the blood is not related to an infection at another site and 
patient has at least one of the following signs or symptoms: fever (≥ 38 °C), chills 
or hypotension. With common skin commensals (e.g. diphtheroids, Bacillus spp., 
Propionibacterium spp., coagulase-negative staphylococci or micrococci), the organism is 
cultured from two or more blood cultures drawn on separate occasions
Outcomes reported Not stated explicitly as primary or secondary
Focus of a priori hypothesis:
 z Compliance with hand hygiene
 z Reduction in overall nosocomial infection incidence
Other outcomes:
 z Incidence of nosocomial infections by type
 z Central vascular catheter-associated BSI
 z Peripheral vascular catheter-associated BSI
Also included, but not data extracted:
 z Central vascular catheter-suspected BSI (clinical sepsis)
 z Peripheral vascular-suspected BSI (clinical sepsis)
 z VAP
 z Non-ventilator pneumonia
 z Catheter-associated UTI
 z Non-catheter UTI
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Results data
Primary outcomes
Outcome
Baseline  
(4 months; 2000) 
(2187 bed-days)
Intervention 
(17 months; 2001–2) 
(7409 bed-days)
Difference in 
compliance between 
baseline and 
intervention 
Device duration Not reported Not reported Statistical comparison 
(relative risk) reported 
only for the total 
nosocomial infections 
per 1000 bed-days; 
number of catheters  
not reported
Total device utilisation Not reported Not reported
No. of devices/patient Not reported Not reported
Central catheter-associated  
laboratory-confirmed BSI incidence rate
15 (3.75 per montha) 12 (0.71 per montha)
Peripheral catheter-associated 
laboratory-confirmed BSI incidence rate
3 (0.75 per montha) 4 (0.24 per montha)
Total CABSI incidencea 18 (4.5 per month) 16 (0.94 per month)
CABSI incidence per 1000 catheter-days Not reported Not reported
CABSI incidence per 1000 patient-days Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
a Not reported; estimated by reviewers.
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Secondary outcomes 
Compliance with hand 
hygiene
Baseline (4 months; 2000) 
(n = 1160)
Intervention  
(17 months; 2001–2)
(n = 3187)
Difference in compliance 
between baseline and 
intervention [relative risk 
(RR) (95% CI); p-value]
Total observed hand washing 
episodes, number (%)
268 (23.1) 2056 (64.5) RR = 2.79 (2.46 to 3.17); 
p < 0.0001
Observed hand washing 
episodes by  
post-intervention study 
period (baseline = period 1),a 
number (%)
1. 268 (23.1)
2. January to June 2001 724 (53.5) (n = 1353)b Period 2 vs. period 1: 
RR = 2.32 (2.01 to 2.66); 
p = 0.0001
3. July to December 2001 828 (72.1) (n = 1148)b Period 3 vs. period 2: 
RR = 1.35 (1.22 to 1.49); 
p = 0.0001
4. January to May 2002 518 (73.8) (n = 701)b Period 4 vs. period 3: 
RR = 1.02 (0.92 to 1.14); 
p = 0.665
n, number of opportunities for hand hygiene.
Further information on compliance. Compliance was assessed and compared for different subgroups of health-care 
workers (nurses, physicians, ancillary staff), men and women, different types of procedures (superficial, invasive), times of 
shift work (morning, afternoon, night), and the different ICUs (medical surgical, coronary). Data on per cent adherence to 
hand hygiene are presented but it is unclear to which study periods they refer (in table 3 the data for each subgroup sum 
to 2564 (in one case 2563) opportunities for hand hygiene, which is less than the 3187 post-intervention opportunities 
reported in table 2). Compliance data ranged from a minimum of 30.8% adherence (physicians subgroup) to a maximum 
of 66.0% adherence (night period subgroup). It is unclear if the study was powered for this type of comparison (statistics 
were reported only for comparisons within subgroups (e.g. men vs. women), not for pre- versus post-intervention 
implementation)
Reaction to education Not a study outcome
Attitudes Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not reported other than compliance as detailed above
a The post-intervention study periods appear arbitrary as they do not coincide with the implementation of specific 
intervention components (education in January 2001 and performance feedback in May 2001).
b The number of hand washing opportunities in separate study periods sums to 3202, which is a discrepancy of 15 
compared with the reported total number of opportunities (3187); the number of observed hand washing episodes 
in separate study periods sum to 2070, which is a discrepancy of 14 compared with the reported total number of 
observed episodes (2056).
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NOT REPORTED – no 
data reported on the population and only limited information given on the critical care characteristics 
and devices
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? YES. Reported that interventions for reducing CVC-associated BSI and for reducing 
urinary catheter-associated UTIs overlapped with the current intervention by 7 of 21 months and 17 of 
21 months, respectively
Was the effect of educational practice separable from effects of non-educational practice? UNCLEAR. 
Possible confounding owing to two other overlapping interventions
Were the intervention component(s) implemented as planned? UNCLEAR. Stated that attendance 
at education sessions while voluntary was monitored, but no attendance data were reported. Post-
evaluation test results also not reported (education was aimed at enhancing compliance with hand 
hygiene, which statically significantly increased but did not reach 100%)
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. There are discrepancies in both the data for the number of hand washing opportunities and 
the number of observed hand washing episodes. Numbers of patients and catheters were not reported
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? UNCLEAR. Observations of hand washing were done covertly but blinding of data collection 
for infection surveillance was not reported
Other possible 
sources of bias
The authors acknowledged that the Hawthorne effect must be taken into account – i.e. observed 
effects may have resulted from the ICU staff being observed (staff were aware they were being 
monitored but not precisely when)
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. The nature of the education 
sessions was poorly described. However, the educational material is available as published guidelines 
which could be reproduced, disseminated and discussed
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Compliance data were collected by a trained infection 
control practitioner and data were recorded on a specially designed form (no further details provided)
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? PARTIALLY. The authors hypothesised that they could increase hand 
hygiene compliance to 70% with a reduction in nosocomial infection of 30%. Compliance with hand 
hygiene did not reach this target when the overall 17 months of intervention were taken together but 
did reach the target for arbitrary time periods covering the last 11 months of the intervention period 
(possibly selective definition of monitoring periods?). Compliance with hand hygiene was significantly 
increased from 23.1% to 64.5%. Nosocomial infection reductions exceeded the target reduction but 
this outcome does not capture device-related infections
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 14
289
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
SHERERTZ (2000)135
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Sherertz (2000)135
Summary of approach Single hospital, multiple-unit, 1-day hands-on course on infection control practices and 
procedures given in June 1996 and June 1997 for third-year medical students and physicians 
completing their first postgraduate year 
Location USA, North Carolina
Language English
Critical care specialty General MICUs/SICUs and associated step-down unit 
No. of critical care units Six ICUs and one step-down unit (data pooled)
No. of hospitals 1
Hospital name (unless 
multicentre); city
Wake Forest University Baptist Medical Center, Winston-Salem 
Study design Single-cohort before-and-after study
Study time periods Baseline: July 1995 to June 1996
Intervention, course 1: 3 days in June 1996
Intervention, course 2: 3 days in June 1997
Follow-up: June 1997 to December 1997
Funding source Not reported
Conflicts of interest Not reported
SICU, surgical intensive care unit.
Population and setting
Critical care unit 
characteristics
CVC and arterial catheter insertions were performed by physicians in training
The hospital’s infection control policy on vascular catheters did not change substantially 
during the study period, with the exception of the educational intervention
Stated that the seven study units did not differ between the baseline and post-intervention 
periods in number of admissions or severity of illness (data not shown)
No other information provided
Patient population 
characteristics
None reported
Device characteristics Included CVCs, PICCs and arterial catheters. Antibiotic-coated catheters were not used.  
No other details reported
Insertion site  
antisepsis used
Povidone–iodine; avoidance of antibiotic ointment
Dressing type and 
duration/frequency
Clear plastic dressing
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Intervention characteristics
Objective To improve standardisation of infection control practices and techniques during invasive 
procedures
Main focus of 
education 
CVC insertion, specifically the use of full sterile drapes and other barrier precautions
Trainers (providers) Infection control practitioners and a hospital epidemiologist taught 1 hour of basic infection 
control principles
One to three faculty members oversaw training at hands-on rotation stations. Staff teaching the 
hands-on sessions were:
Oncology catheter care nurses: Blood draws through vascular lines
Respiratory therapists: Arterial puncture for analysis of blood gas
Critical care medicine faculty and fellows and trauma faculty: Insertion of arterial catheters and 
CVCs
Nurse instructors: Urinary catheter insertion and peripheral venous catheter insertion (PICC)
Oncologist: Lumbar puncture
Faculty from the School of Medical Technology: Phlebotomy
Training of trainers Not reported
Learners (recipients) Third-year medical students and physicians completing their PGY-1
Target behaviour 
change
Principal focus was to determine whether the intervention could increase the use of full-size 
sterile drapes for CVC insertion
Development and 
testing
Not reported. Informal surveys indicated physicians in training at the study hospital had poor 
compliance with maximal barrier precautions when inserting CVCs, despite conventional bedside 
and didactic instruction by critical care medicine faculty over 2 years. Unpublished observations 
also suggested CVC insertion practices varied widely
Educational or 
behavioural theory
Not reported
Educational 
strategies and topics 
targeted
1-hour session on basic infection control principles: Content included hand washing, 
isolation, appropriate use of barrier garments, handling of patients with resistant organisms and 
varicella
1-hour session on Occupational Safety and Health Administration (OSHA) considerations for 
blood and body fluids and tuberculosis – taught on a different day
7 × 1-hour rotation stations (7–16 participants per group): Each had 5–15 minutes of 
didactic instruction (in year 2 this was done mostly by videotape), followed by hands-on skills 
practice overseen by one to three faculty members. The hands-on sessions were delivered by 
various trainers (see above):
(1) blood draws through vascular lines; (2) arterial puncture for obtaining arterial blood gas;  
(3) insertion of arterial catheters and CVCs; (4) urinary catheter insertion; (5) lumbar puncture; 
(6) PICC insertion; and (7) phlebotomy
Simulation with mannequins was used in all hands-on sessions for skills practice. Phlebotomy 
skills were practised on fellow students. PICCs were started first on a mannequin and later on a 
fellow student
A member of the infection control department reviewed the content of each didactic session to 
ensure consistency with existing infection control policies. To ensure appropriate content delivery, 
the course director observed each rotation station instructor for an entire session
Courses on vascular catheters covered: use of povidone–iodine for skin preparation; avoidance 
of antibiotic ointment at the insertion site; use of clear plastic dressings; regular changes of 
intravenous tubing every 3 days; and instruction not to adhere to fixed schedules for  
changing CVCs
Infection surveillance 
feedback approach 
Not included in the intervention
Performance 
feedback approach 
Not included in the intervention
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Concentration of 
education 
A 1-day course run on 3 days in June in 1996 and on 3 days in June 1997 (different participants 
each year). In each year the course was for medical students (1 day) and for two groups of  
PGY-1 physicians (1 day each, with about 50 physicians per group). The physician education was 
part of the orientation for new interns. The course comprised 7 × 1-hour hands-on sessions, 
with 15-minute morning and afternoon breaks and a 1-hour lunch break. Two 1-hour sessions 
on basic infection control principles and OSHA were also reported but it is unclear how they 
relate to the 1-day course (stated that the OSHA session was on a different day). Authors 
mention when considering costs that there were eight hands-on stations, not seven (see below)
No. of participants was:
 z 1996: 110 PGY-1 physicians, 107 medical students
 z 1997: 95 PGY-1 physicians, 94 medical students, 46 physician assistant students
Non-educational 
intervention 
components 
None: educational intervention only
Costs reported During year 1, supplies cost approximately US$25,000, largely because of the mannequins 
and CVC kits. Year 2 supplies cost approximately US$12,000. Almost all physicians teaching 
the course were fellows; most other faculty were nurses or had salaries equivalent to those of 
nurses. Using a yearly salary plus benefits (US$50,000) as an average cost for the participating 
faculty, it was estimated that each day of participation time cost approximately US$200 
(excluding faculty preparation time or lost opportunity). Assuming eight stations with two faculty 
each for three different course days, the total cost for faculty time was approximately US$9600 
per year (total for 2 years US$19,200). The 2021 full-size drapes used cost US$9.28 each 
(total US$18,755). In the baseline year the sterile sheets cost approximately US$874 (US$1.00 
per reprocessed drape for 874 drapes). The overall course cost was therefore US$74,081 
[= US$25,000 + US$12,000 + US$19,200 + (US$18,755 to US$874)]
PGY-1, first postgraduate year. 
Outcome characteristics
Catheter-BSI 
definition
Reference cited: 
Garner et al.147
Primary bloodstream infections: a pathogen is isolated from one or more blood cultures and is 
not related to an infection at another site, unless that site is a catheter
Catheter-related infections were defined as meeting definition 3 of the CDC Cardiovascular 
System Infection Criteria for arterial or venous infection (reference, left). Fulfilment of this 
definition required the presence of fever (temperature > 38 °C), pain, erythema or heat at the 
catheter site plus the presence of a negative blood culture or absence of any blood cultures and 
the presence of a positive roll-plate culture of the catheter (method reported). Blood cultures 
(method reported) were predominantly drawn through only a peripheral vein, or as paired 
cultures through a peripheral vein and through a catheter
Outcomes reported Not stated whether primary or secondary:
 z Physician perceptions of need for full drapes, towels, povidone–iodine, gowns, gloves, masks
 z Frequency of use of full sterile drapes
 z CRBSI incidence
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Results data
Primary outcomes 
Outcome Baseline (12 months)
Post–intervention 
(18 months)
Difference between 
baseline and post 
intervention 
Device duration Not reported Not reported Not reported
Total device utilisation Not reported Not reported Not reported
 Total no. of CVCs inserted 2009 3090
CRBSI incidence rate (CVCs and 
arterial catheters):a
 July to December 1995 19 Not tested statistically
 January to June 1996 13
 July to December 1996 14
 January to June 1997 8
 July to December 1997 8
CRBSI incidence per 1000  
catheter-days
Not reported Not reported Not reported
CRBSI incidence per 1000  
patient-days:b
Baseline vs. time after 
first course:
 July to December 1995
 January to June 1996
 July to December 1996
 January to June 1997
 July to December 1997
1.4 (3.0)
0.9 (3.5)
1.0 (2.4)
0.6 (2.6)
1.3 (1.6)
CRBSI not tested 
statistically
Total number 
of infections 
(CRBSI + primary BSI); 
p = 0.01
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Stated that blood cultures were negative or were not done; definition appears to be for CABSI, not CRBSI as stated.
b Data extracted from graph by reviewer using Engauge software.
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Secondary outcomes 
Outcome [in relation to first (June 
1996) training course only]
Immediately 
before course 
(baseline)
Immediately 
after course
Six months after 
course
Difference 
relative to 
baseline 
Reaction to education Not assessed as an outcome
Attitudes: % of physicians 
(n = 109) who perceived a need for
 Full drapes 33 99 73 p < 0.01a,b
 Towels 88 25 53 p < 0.01a,b
 Povidone–iodine 97 99 96 Not significant
 Gowns 80 98 82 Not significant
 Gloves 96 99 98 Not significant
 Masks 82 98 91 p < 0.01a
Compliance: % of CVC insertions 
for which sterile drapes used 
44
65
p < 0.001
Knowledge Not assessed as an outcome
Skills Not assessed as an outcome
Process evaluation At the end of each 1-day course participants were asked to rate various factors, 
including each instructor on a scale of 1 (poor) to 5 (excellent). In both years, all 
mean evaluation scores for course instructors ranged from 4.4 to 4.8 (no further 
data provided)
a Footnote for Table 2 stated that the difference between pre-course and post-course scores was significant: p < 0.01 
immediately post intervention.
b For 6 months’ follow up, p < 0.001.
Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NOT REPORTED 
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Stated that hospital’s infection control policy on vascular catheters did not 
change substantially during the study period, and the seven study units did not differ between the 
baseline and post-intervention periods in number of admissions or severity of illness. However, no 
quantitative data were provided and no information at all was given about the patient population
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention (although catheter kits and drapes were provided, these were standard 
hospital practice)
Were the intervention component(s) implemented as planned? PARTIALLY. The number of staff who 
took the intervention was reported for each year, but it was not reported whether all staff in the ICU 
took all components of the intervention
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. For attitudes, the same sample size was reported for pre-intervention and post-intervention 
results. For other outcomes, it was not indicated or discernible whether there were any missing data
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Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. The definition 
and microbiological culture approach for infections were the same pre-and post-intervention, but no 
information was provided on the staff diagnosing infections. Information on sterile drape and CVC 
use was provided by the purchasing department, but the person(s) responsible for transcribing and 
analysing this information were not reported
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
The authors acknowledged that other unmeasured effects may have affected outcomes, and because 
faculty participated in the course, they may have changed their approach to care of patients and 
subsequent supervision of physicians-in-training. Only processes that are routinely performed by 
physicians were monitored (i.e. excluding arterial punctures, urinary catheter insertions, blood draws 
through lines, peripheral line insertions, and phlebotomy)
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? YES. The numbers, duration, content, and 
cost of sessions were reported, although it is unclear whether the training course comprised 7- or 
8-hour-long sessions and whether a session on OSHA was included
Justification given for sample size? NO
Data collection process reported? NOT REPORTED. Methods for assessing outcomes were reported but 
no information was provided on who collected the outcomes data or how the data were managed
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT APPLICABLE
Statistical tests described? YES
Results Educational significance or effect size assessed? NO. Significance discussed but no effect size provided
Target behaviour change achieved? PARTIALLY. Reported briefly the proportion of CVC insertions for 
which sterile drapes were used immediately before and in the 6 months after an education course. 
There was a statistically significant increase in compliance with the use of drapes; before and after the 
education course compliance was 44% and 65% respectively (p < 0.001)
Additional comments
 z Stated that use of CVCs in the seven study units was high (central-line days/patient-days × 
100 = 73%). Because of this, the authors concluded that patient-days could serve as a surrogate of 
device-days (even though the latter would probably be more accurate under other circumstances).
 z Authors refer to catheter related infections inconsistently in the text, in some cases to describe 
the total number of (catheter related + primary BSI) infections. The definition of ‘catheter related’ 
infections given is consistent with catheter-associated infections (blood cultures negative or not done).
 z Surveys (data reported but not extracted) showed that most physicians had little experience 
performing procedures during medical school (1 of 3 PGY-1 physicians had never inserted a CVC 
during medical school).
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SPEROFF (2011)136
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Speroff (2011)136
Summary of approach Multicentre, cluster RCT in ≥ 60 ICUs (number not stated) comparing virtual collaborative and 
toolkit QI approaches for preventing CLABSI and VAP
Location USA, multistate (primarily southern states)
Language English
Critical care specialty Not reported (multiple ICUs) 
No. of critical care units Not reported (≥ 60 assuming at least one per hospital)
No. of hospitals 60 in total (29 and 31 per group)
Hospital name (unless 
multicentre); city
Multicentre (hospital names not reported)
Study design Cluster RCT (Clinicaltrials.gov registration number NCT 00975923)
Study time periods Baseline surveys: July to November 2005
Randomised December 2005
Intervention: January 2006 to September 2007 (18 months)
Follow-up: September 2007 to January 2008; outcomes survey January to April 2008 (data 
not reported)
Note: Reported that study was 18 months with follow-up thereafter: unclear whether any 
embedding of QI practices continued into the follow-up period
Funding source Supported by a grant from the Partnerships in Implementing Patient Safety (PIPS) from the 
Agency for Healthcare Research and Quality (AHRQ)
Conflicts of interest Stated no disclosure to report: AHRQ provided funding only
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Population and setting
Median hospital size = 117 beds; median ICU size = 16 beds; medical centres: rural (11%), inner city 
(28%) and suburban (61%). At baseline 45% of the facilities reported having a CLABSI programme 
and 62% a VAP programme (not stated whether facilities refer to hospitals or ICUs; number of ICUs per 
hospital not reported).
Baseline data
Critical care unit 
characteristics
Group 1: Toolkit  
(29 hospitals)
Group 2: Virtual 
collaborative  
(31 hospitals)
Difference  
Group 1 vs. Group 2 
Median (IQR) ICU patient 
volume per year
578 (244–1077) 568 (294–904) p = 0.93
Median (IQR) ICU LOS, days 4228 (1645–6725)a 3882 (1758–5718)a p = 0.95
Mean (SD)% ICU mortality 
rateb
7.1 (3.6) 5.7 (3.1) p = 0.13
Mean (SD)% patients 
admitted to ICU from 
emergency departmentb
67 (20) 71 (15) p = 0.27
Mean (SD)% Medicare/
Medicaidb
68.5 (10.1) 68.6 (9.5) p = 0.95
% hospitalist ICU 
management
40 47 p = 0.61
Patient population characteristics
Mean (SD)% femaleb 50.3 (7.7) 49.7 (5.7) p = 0.79
Age, ethnicity, health status, 
socioeconomic status, oral 
or i.v. antimicrobial use
Not reported Not reported Not reported
Device characteristics None reported None reported Not reported
Insertion site antisepsis used Not reported Not reported Not reported
Dressing type and duration/
frequency 
Not reported Not reported Not reported
a Interpretation unclear: reported LOS appears excessive; time period of data not stated.
b Not explicitly stated, but presumed to be mean (as SD reported).
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Intervention characteristics
Objective To determine if a QI virtual collaborative intervention would perform better than a 
toolkit-only approach at preventing CLABSI and VAP
Main focus of education Not explicitly stated, but the key interventions for preventing CLABSI were routine 
hand hygiene, site selection, barrier precautions, chlorhexidine skin preparation, 
and catheter need review. Education also covered epidemiology and prevention of 
infections, teamwork and QI approaches. Education also included in intervention 
for preventing VAP
Trainers (providers) Not reported; appears to be ICU nurse and quality managers 
Training of trainers Not reported; appears to be co-ordinated by the Hospital Corporation of America 
(HCA) corporate office of Quality, Safety, and Performance Improvement
Learners (recipients) ICU teams; no details reported
Target behaviour change Not explicitly stated: interventions address multiple possible behaviours associated 
with prevention of CLABSI and VAP
Development and testing Drew upon existing research in QI approaches; intervention components were 
iteratively developed by teams based on plan-do-study-act cycles
Educational or behavioural theory Not reported
Educational strategies and topics 
targeted
For the hospitals owned and 
operated by the HCA, stated203 
that 130/133 infection control 
programmes (97.7%) conducted 
surveillance in accordance with the 
CDC definitions for BSI
Both groups:
Both groups were offered interactive web seminars: five were on clinical subject 
matter, and five were on patient safety, charting use of statistical process control 
and QI methods (total number of seminars not stated)
Group 1 (toolkit)
Hospitals received a toolkit containing a set of evidence based guidelines and fact 
sheets for preventing CLABSI and VAP, a review of QI and teamwork methods, 
and standardised data collection and charting tools. HCA website provided nurse 
and quality managers with access to all educational seminars, clinical and QI tools. 
Education was provided to standardise outcome measurement (online tutorial, 
Talbot TR, November 2005). Other aspects of QI for preventing CLABSI and VAP 
were left to the discretion of the ICU to develop and implement
Group 2 (virtual collaborative)
Teams attended web seminars and teleconferences for reporting back to the larger 
group. Supported by monthly educational and troubleshooting conference calls, 
individual coaching co-ordinated by the HCA corporate office of quality, safety and 
performance improvement, and an e-mail Listserv designed to stimulate interaction 
among teams
Intervention components reportedly used in both interventions included BSI 
checklists; daily catheter review; seminars; continuing education classes for 
BSI; written education; BSI surveillance guide; QI efforts to prevent CLABSI; 
and statistical process control
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Infection surveillance feedback 
approach
Self-reported. Stated that data collection and surveillance methods varied across 
hospitals (reference cited203). Survey203 indicated that hospital acquired infection 
(HAI) reports were routinely provided to ICU staff and other stakeholders during 
the baseline period (September 2005). Web application data registry created 
and infection data reporting by the infection control personnel mandated from 
first quarter of 2006. To verify electronic data and correct missing information, 
infection control personnel were requested to complete a retrospective data 
collection sheet providing quarterly reports from January 2005 to December 2007 
(i.e. part baseline, part intervention period). Validity and reliability of data collection 
not reported. Stated ‘Nearly all ICPs provided HAI reports to senior hospital leaders, 
nurse management of the ICU, and institutional committees. Feedback of data 
was less frequent for front-line health-care workers, such as nurses, physicians, 
respiratory therapists, and support staff
Performance feedback approach Self-reported. Referred to as provider performance feedback for BSI and VAP but 
method of feedback not reported. Stated that validity of data collection method 
was not assessed
Concentration of education Not reported and not discernible owing to the large-scale nature of the 
intervention with multiple educational activities, site-to-site variation and iterative 
implementation.
Non-educational intervention 
components
Infrastructural changes (team development);
IHI care bundles for CLABSI and VAP (not described but reference cited);
Concurrent intervention to prevent VAP
Costs reported Not reported
Outcome characteristics
Catheter-BSI definition
From online HCA webcast at 
Vanderbilt Medical School (TR Talbot, 
2005)
Stated that although most hospitals 
defined CLABSI using CDC 
definitions, data collection and 
surveillance methods varied across 
hospitals (reference cited203)
CDC NNIS laboratory-confirmed CVC-related bloodstream infection. Must meet at 
least one of the following criteria:
Criterion 1: Patient with CVC has a recognised pathogen cultured from one 
or more blood cultures and organism cultured from blood is not related to an 
infection at another site
Criterion 2: Patient with CVC has at least one of the following signs or symptoms: 
fever, chills, or hypotension, and at least one of the following: (a) common skin 
contaminant (e.g. coagulase-negative staphylococci) is cultured from two or 
more blood cultures drawn on separate occasions; (b) common skin contaminant 
is cultured from at least one blood culture from a patient with CVC, and the 
physician institutes appropriate antimicrobial therapy; and signs and symptoms and 
positive laboratory results are not related to an infection at another site
Outcomes reported Not stated whether primary or secondary (study power based on  
hospital-acquired infections, not specifically mentioned whether CLABSI or VAP):
CLABSI per 1000 catheter-days;
VAP per 1000 ventilator days (data not extracted);
Process implementation
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Results data
Primary outcomes
Outcome
Group 1: Toolkit  
(29 hospitals)
Group 2: Virtual 
collaborative  
(31 hospitals)
Difference between 
Groups 1 and 2
Hospital-wide outcomes 
data (data pooled per 
hospital; not reported for 
separate ICUs)
Device duration Not reported Not reported Not reported
Device-days (not reported; e-mailed by the author)
 Baseline 26,599 22,172 Not reported
 3 months 25,257 22,202
 6 months 24,618 22,951
 9 months 27,821 23,268
 12 months 29,066 26,211
 15 months 29,818 25,646
 18 months 24,245 19,276
No. of devices/patient Not reported Not reported Not reported
CLAB incidence rate (not reported; e-mailed by the author)
 Baseline 81 37 Not reported
 3 months 72 52
 6 months 76 54
 9 months 72 53
 12 months 75 45
 15 months 62 65
 18 months 66 53
Median (IQR) CLABSI incidence per 1000 catheter-days per hospital
 Baseline 2.42 (0.65–6.80) 1.18 (0.00–3.83) 2.24 
(0.54–4.69)
Baseline: p = 0.24
Baseline vs. 12 months: 
p = 0.13
Baseline vs. 18 months: 
p = 0.95
Overall trend: p = 0.71a
 3 months 2.47 (1.48–5.35) 2.28 (0.00–3.73)
 6 months 2.54 (0.00–4.98) 1.76 (0.00–3.74)
 9 months 1.23 (0.00–3.93) 1.18 (0.00–2.71)
 12 months 1.17 (0.00–3.61) 2.04 (0.00–4.91)
 15 months 1.77 (0.00–3.30) 2.76 (0.00–4.67)
 18 months 1.16 (0.00–5.46) 1.18 (0.00–3.83) 2.24  
(0.54–4.69)
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Outcome
Group 1: Toolkit  
(29 hospitals)
Group 2: Virtual 
collaborative  
(31 hospitals)
Difference between 
Groups 1 and 2
Hospital-wide outcomes 
data (data pooled per 
hospital; not reported for 
separate ICUs)
CLABSI incidence per 1000 catheter-days per hospital calculated by reviewers from authors’ device-days and 
incidence datab
 Baseline 3.0 1.7
 3 months 2.9 2.3
 6 months 3.1 2.4
 9 months 2.6 2.3
 12 months 2.6 1.7
 15 months 2.1 2.5
 18 months 2.7 2.7
CLAB incidence per 1000 
patient-days
Not reported Not reported Not reported
LOS Not reported Not reported Not reported
Mortality Not reported Not reported Not reported
a Hierarchical negative binomial regression modelling of change in CLABSI rate over time.
b Data for calculating risk ratios with CIs (presented in the main report) were not reported in the primary publication but 
were obtained by contacting the author.
Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation 
Group 1: Toolkit  
(29 hospitals)
Group 2: Virtual 
collaborative  
(31 hospitals)
Difference between 
Groups 1 and 2 
No. (%) of hospitals responding to survey 19 (66) 27 (87)
No. of ICUs responding to survey 25 36
Clinical tool usea 49% 61% p = 0.23
BSI surveillance guide 13/25 (52%) 22/36 (61%) p = 0.60
BSI checklist 16/25 (64%) 31/36 (86%) p = 0.06
Data tool usea 30% 56% p = 0.004
QI implementation tools 6/25 (24%) 19/36 (53%) p = 0.03
BSI statistical process control 5/25 (20%) 23/36 (64%) p = 0.001
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Process evaluation 
Group 1: Toolkit  
(29 hospitals)
Group 2: Virtual 
collaborative  
(31 hospitals)
Difference between 
Groups 1 and 2 
All tools used
Median no. of tools downloaded 7 10 p = 0.051
Strategy usea 54% 69% p = 0.017
Protocols for BSI 19/25 (76%) 24/36 (67%) p = 0.57
Computer documentation for BSI 13/25 (52%) 24/36 (67%) p = 0.29
Increased staffing 0/25 (0%) 3/36 (8%) p = 0.26
Written education for BSI 19/25 (76%) 31/36 (86%) p = 0.33
Continuing education classes for BSI 16/25 (64%) 28/36 (78%) p = 0.26
QI teams 14/25 (56%) 27/36 (75%) p = 0.16
Provider performance feedback for BSI 11/25 (44%) 23/36 (64%) p = 0.18
Implementation
QI efforts to prevent CLABSI 88% 97% p = 0.99
Implemented hand hygieneb 93% 100% Not reported
Implemented site selectionb 72% 86% Not reported
Implemented barrier precautionsb 97% 100% Not reported
Implemented chlorhexidineb 100% 100% Not reported
Implemented daily assessmentb,c 68% 92% Not reported 
Implemented daily catheter reviewc Less often (no data) More often (no data) p = 0.04
Implemented all components of BSI interventions 64% 100% p = 0.13
Implemented BSI checklist 15/25 (60%) 28/36 (78%) p = 0.16
Participation in education
Participated in seminars 39% 57% p = 0.014
Attended the clinical topics 56% 64% p = 0.37
Participated in data and method topics 22% 50% p < 0.001
Other
Hospitals found seminars useful to QI efforts 30% 49% p = 0.017
a Tools and strategies reported for CLABSI (extracted) and VAP (not extracted).
b Data extracted by reviewers from graph (figure 1) using Engauge software.
c Unclear whether ‘daily assessment’ refers to ‘catheter need review’ or whether these are distinct variables.
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Critical appraisal
Potential for bias 
Group selectiona Were there systematic differences between the study groups? UNCLEAR. Very limited demographic 
information reported; unable to rule out selective presentation of data, as no justification provided for 
the focus on those variables presented
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE (note that part of analysis 
included adjustment for covariates, but the covariates were not specified)
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Limited information on staffing, infrastructure and care policy reported 
(staffing of infection control programmes varied among hospitals203). The study authors noted that the 
study was implemented during the IHI’s 100,000 Lives Campaign, which may have influenced regional 
infection rates (baseline incidence rate was noted to be low) 
Was the effect of educational practice separable from effects of non-educational practice? NO. 
Although many aspects of the interventions were educational, there were other non-educational 
components, e.g. provision of QI teams
Were the intervention component(s) implemented as planned? PARTIALLY. The intervention 
components varied across hospitals but implementation was reported only for hospitals who 
responded to surveys (see Process Evaluation section for details)
Missing dataa Were there systematic differences between the study groups in data availability? NOT REPORTED. 
The number of hospitals was specified for each study group but no indication was given of whether 
any hospitals did not provide follow-up data. The number of ICUs was given only for those reporting 
follow-up data; the number of ICUs in each study group was not stated
Outcome 
measurementa
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. Stated that data 
collection and surveillance methods varied across hospitals in the baseline period. Education aimed to 
improve standardisation of outcome definitions but it appears that same education may have been 
common to both study groups
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
1. Data were dependent on self-reports and were not verified by independent assessment
2. Implementation was at the level of ICUs, but the number of ICUs in the study was not reported, 
and only hospital-wide outcomes data were provided
3. Parts of the educational interventions appear to have been shared by both study groups but it is 
not possible to identify which intervention components were unique to the study groups
Risk of 
selection bias 
in randomised 
studies 
Risk of bias: reviewer 
judgement (low/high/unclear) Support for judgement
Random 
sequence 
generation
UNCLEAR No information given. Stated that hospitals willing to participate 
were matched on geographic location and ICU volume and then 
randomised but method of achieving this randomisation approach 
not stated
Allocation 
concealment
UNCLEAR No information given
a Assessment criteria for this RCT differ slightly from assessment criteria used for single-cohort studies (differences are 
compared between parallel study groups rather than sequential before-and-after groups).
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Other critical appraisal criteria
Methods Intervention described in sufficient detail to be replicated? NO. A large-scale study that did not mandate fixed 
specific intervention components, with each centre free to tailor its use of tools and change ideas. Many 
education components appear to have been common to both study groups, but this was not clearly reported, 
hence although numerous online supporting resources were provided, it is difficult to establish which are 
relevant to each study group. Although implementation was at the level of ICUs, the number of ICUs in the 
study, the number per hospital, and their specialties were not reported
Justification given for sample size? YES. Power of 82–91% for testing group differences calculated a priori 
with one-tailed α = 0.05 and group size of 30, assuming a 50% decrease in hospital-associated infection rates 
for the collaborative group vs. a 10–15% decrease for the toolkit group
Data collection process reported? PARTIALLY. Limited information given on infection surveillance feedback; no 
information given on performance feedback methods
If YES or PARTIALLY, was the data collection process shown to be valid? NO. Stated that data were not verified 
by independent assessment
If YES or PARTIALLY, was the data collection process shown to be reliable? NO. Stated that data were not 
verified by independent assessment
Statistical tests described? PARTIALLY. Stated that trend analysis was adjusted for clustering of ICUs within 
hospitals and adjusted for covariates but no intraclass correlation coefficient to account for clustering was 
reported. The covariates were not specified (limited baseline variables reported). Not stated whether analysis 
was by intention to treat (missing data not reported)
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED. Implementation of infection-prevention practices is 
reported through a post-study survey but unclear whether these practices had changed relative to baseline
Additional comments
 z Medical centres included were those of the HCA, a network of hospitals located primarily in the 
southern USA. Stated that to minimise contamination bias between study groups within the same 
facility, the unit of randomisation was the hospital and implementation was at the level of the ICU.
 z Stated that outcomes were reported hospital-wide, but appears to present data from ICUs.
 z A related paper by Talbot and colleagues203 (cited) indicated that nearly half of 126 hospitals in the 
HCA system surveyed from September 2005 reported difficulty in obtaining denominator data needed 
to determine BSI rates, with nearly one-quarter of the 126 hospitals unable to provide BSI rates for 
some months. Unclear whether these figures are representative for the 60 hospitals included in the 
present study.
 z Speroff and colleagues136 stated that data collection and surveillance methods varied across hospitals, 
citing evidence from Talbot and colleagues203 but unclear how representative the latter data from  
162 hospitals are for the 60 hospitals included in the present study.
 z Stated that the 60 participating sites did not differ from 113 non-participating sites (data not shown).
 z The study population consisted of hospitals that were part of a larger health-care system owned by a 
specific corporation. This may influence generalisability.
 z Correspondence with the main author confirmed that, while the majority of ICUs were adult based, 
there were two paediatric ICUs per study arm.
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WALL (2005)138
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Wall (2005)138
Summary of approach Single-unit, continuous QI programme involving real-time feedback of CRBSI rates and 
compliance with insertion practice, based on data collected by nurses using a standard 
checklist
Location USA: Tennessee
Language English
Critical care specialty Adult MICU
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Vanderbilt University Medical Center, Nashville
Study design Single cohort before-and-after study
Study time periods Baseline: January 2000 to October 2002 (CRBSI data reported for November 2000 to 
October 2002) (2 years)
Intervention: November 2002 to October 2004 (2 years)
Follow-up: None (continuous QI programme)
Funding source Lead author (Wall) was supported by the Office of Academic affiliations, Department of 
Veterans Affairs, VA National Quality Scholars Program, and with resources at the VA 
Tennessee Valley Healthcare System, Nashville, TN. Co-author (Ely) received the Paul Beeson 
Faculty Scholar Award from the Alliance for Aging Research and received a K23 from the 
National Institute of Health
Conflicts of interest Stated no competing interests declared
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Population and setting
Critical care unit 
characteristics
14 MICU beds in a 640-bed tertiary teaching hospital
Approximately 600 MICU admissions per year
Most CVCs in the medical MICU were inserted by trainees (house staff). Details of the 
staff who inserted catheters were reported only for the intervention period:
Medical student = 19 (3%)
Intern (postgraduate year 1) = 357 (57%)
Resident (postgraduate year 2) = 176 (28%)
Fellow/attending = 78 (12%)
Total insertions = 630 (100%)
Patient population 
characteristics
Patients with conditions including acute respiratory distress syndrome, asthma, chronic 
obstructive pulmonary disease, respiratory failure, pneumonia, sepsis, poisoning, drug 
overdose and gastrointestinal bleeding. Also critically ill solid organ and bone marrow 
transplant patients
Device characteristics Only devices placed by MICU staff were included (the authors implied that dialysis 
catheters were excluded but the numbers given below for the 630 catheters inserted by 
MICU staff during the intervention period include dialysis catheters). Catheter types and 
insertion sites were reported only for the intervention period:
Catheter type (total = 630):
 z Triple lumen = 372 (59%)
 z Introducer = 191 (30%)
 z Dialysis catheter = 38 (6%)
 z Swan–Ganz = 21 (3%)
 z Other = 8 (1%)
Venous insertion site (total = 630):
 z Internal jugular = 180 (29%)
 z Subclavian = 245 (39%)
 z Femoral = 171 (27%)
 z Other = 34 (5%)
Insertion circumstances (total = 630):
 z Non-emergency = 481 (76%)
 z Emergency = 149 (24%)
Not reported whether antiseptic or antimicrobial coated catheters were used. 
Insertion site antisepsis used Not reported
Dressing type and duration/
frequency 
Not reported
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Intervention characteristics
Objective The primary goal was to show that real-time measurement of CVC care was feasible in 
the MICU and that process measurements would guide continuous QI and thereby lead to 
a reduced CRBSI rate
Main focus of education Catheter insertion. Real-time feedback of compliance with insertion practices and data on 
infections based on checklists completed by nurses
Trainers (providers) Voluntary interdisciplinary team
Training of trainers Not reported
Learners (recipients) MICU house staff (proceduralists) and MICU nursing staff (as observers of procedures)
Target behaviour change Sterile catheter insertion procedure
Development and testing A voluntary interdisciplinary team of leaders (nurse manager, MICU director),  
front-line staff (MICU nurses and physicians), infectious diseases experts (chief hospital 
epidemiologist, infection control practitioners) and improvement experts developed 
a system for measuring the process of CVC care in real time based on review of the 
published literature and observation of MICU practice to identify risk factors during 
catheter insertion and maintenance
Priority areas for measurement established by the multidisciplinary team included provider 
education, trainee supervision, insertion site, hand hygiene, skin antisepsis, and use of 
maximal sterile barriers. Nursing checklist for CVC insertion was pilot tested for 1 week 
with two MICU nurses and revised before being implemented across the MICU
Educational or behavioural 
theory
Not reported
Educational strategies and 
topics targeted
Nursing checklist for CVC insertion. The checklist recorded through check boxes 
whether providers used hand hygiene; used barrier precautions (gloves, gown, mask, 
patient drape; using all four together being defined as maximal barrier precautions); 
maintained a sterile field; used chlorhexidine skin antisepsis; and were properly 
supervised. ‘Supervision’ was defined as the proceduralist having successfully completed 
five CVC insertions or if another provider with experience of at least five CVC insertions 
supervised them during the procedure. Nurses obtained this information for the checklist 
but had the option of recording ‘didn’t ask’. Providers were not obliged to follow 
infection reducing steps if a life-threatening situation mandated immediate CVC insertion
Web-based tutorial. This discussed catheter-related infections, described the checklist 
and explained the evidence base. House staff were requested by letter to complete the 
tutorial before their rotation. Nursing staff were requested by letter to complete the 
tutorial as part of their annual competencies curriculum. The website recorded whether 
each provider completed a self-assessment examination. Reminder letters were re-sent 
after 3 months if necessary, and MICU leadership personally approached non-compliers
Infection surveillance 
feedback approach 
Pre-intervention: Monthly infection incidence reports were provided by infection control 
practitioners to the MICU staff
Intervention period: To better account for the rarity of infections, infection surveillance 
data were fed back to MICUs as the time interval between infections rather than as 
incidence rates. This approach followed the principles of statistical process control, with 
g-charts displaying the time interval between infections. Formal validity and reliability 
analyses for data capture using the checklist were not undertaken
Performance feedback 
approach 
Completed checklists were dropped in a secure lock box then collected daily by infection 
control practitioners who scanned the de-identified information into a spreadsheet 
database using automatic scanning software. Data were held on a central computer at 
the Centre for Clinical Improvement. Process measurements obtained from the checklists 
were ‘bundled’ with the monthly infection surveillance reports and fed back to front-line 
MICU staff (feedback presentation method not reported). Formal validity and reliability 
analyses for data capture using the checklist were not undertaken. Competence in 
completing the online tutorial (knowledge) was assessed but the method of feeding back 
the results to staff (e.g. identifying learning goals) was not reported
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Concentration of education Checklist was applied daily and could be completed in 1 minute
Feedback on infections and compliance with insertion practice was reported as in ‘real 
time’ but the way MICU staff accessed the information was not reported. The time 
required for training and assessment was not reported
Non-educational 
intervention components 
None (all components including checklist, infection surveillance feedback and 
performance feedback are considered educational for the purposes of this systematic 
review)
Costs reported No
Outcome characteristics
Catheter-BSI definition
Reference cited:  
O’Grady et al.196
NNIS definition (reference cited). Laboratory-confirmed bacteraemia (or fungaemia) is 
attributed to a patient with a CVC if they have been in the MICU for at least 48 hours, 
provided that the infection is not related to another distal source. Patients with a CVC 
who develop a BSI within 48 hours of MICU discharge also have CR-BSI
Outcomes reported Not referred to as primary or secondary:
CRBSI rate and the time between CRBSI events
Compliance with CVC insertion practices
Results data
Primary outcomes
Outcome
Baseline: 24 months 
(November 2000 to 
October 2002)
Intervention: 24 months 
(November 2002 to 
October 2004)
Difference between 
baseline and intervention 
Device duration Not reported Not reported
Total device-days (not 
reported; e-mailed by  
the author)
3571 during 24 months 1132 during 24 months
No. of devices/patient Not reported Not reported
CRBSI number 25 during 24 months 6 during 24 months 76% reduction
CRBSI incidence per 1000 
catheter-days (a) reported 
and also confirmed by the 
author; (b) not reported; 
e-mailed by the author
(a) 7.0 during 24 months (a) 3.8 during final 6 months
(b) 5.3 during 24 months
No statistical comparison 
reported
CRBSI incidence per 1000 
patient-days
Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
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Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Compliance: Percentage of insertions compliant. Data extracted by reviewer from line graph using Engauge software
Month of 
intervention Hand hygiene
Chlorhexidine skin 
preparation Maximal barriers
Guidewire 
exchange
1–3 73 57 68 18
4–6 87 76 49 13
7–9 91 88 62 15
10–12 92 95 70 16
13–15 95 91 75 18
16–18 91 96 69 25
19–21 94 96 70 13
22–24 89 100 86 20
Process evaluation
The checklist generated real-time measurements for the CVC insertion process. These data were used for cycles of 
continuous QI in which the reasons for certain provider behaviours were explored
A decline in adherence to maximal barrier precautions during December 2002 to February 2003 was found to have been 
caused by lack of use of patient drapes (data presented but not extracted by reviewers). Adherence to maximal barrier 
precautions improved after the team purchased new sterile kits pre-packaged with drapes, and confirmed providers had 
completed the tutorial
Use of the femoral insertion site compared with other insertion sites was associated with statistically significantly lower 
adherence to hand washing, chlorhexidine skin preparation and maximal sterile barriers (data presented but not extracted 
by reviewers)
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? UNCLEAR. The 
authors stated that mortality rates, admission diagnoses, ventilator days, and lengths of stay were 
similar for patients admitted during the pre-intervention and intervention periods. However, other 
patient characteristics (e.g. age, gender, health acuity) were not reported
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. The authors acknowledged that it is possible that some undetected case mix 
variable or change in catheter duration may have contributed to the decreased CRBSI rate and that 
while the checklist specifically targeted catheter insertion, unmeasured improvements during catheter 
maintenance may also have contributed to the reduced CRBSI rate
Was the effect of educational practice separable from effects of non-educational practice? YES. All 
components of this intervention (checklist, infection surveillance feedback and process feedback) are 
classed as educational
Were the intervention component(s) implemented as planned? PARTIALLY. Stated in the methods 
section that the checklist was introduced to all nursing staff and implemented throughout the entire 
MICU. Letters were sent requesting ICU staff to complete the tutorial. If individuals still did not 
complete the tutorial, the MICU leadership approached them privately. Stated that a total of 630 CVCs 
were inserted using the new checklist
Missing data Were there systematic differences between the baseline and intervention groups in attrition or 
exclusions (includes withdrawal due to mortality; missing outcome data)? UNCLEAR. The authors 
stated that admissions, admission diagnoses, and mortality did not differ between the baseline and 
intervention groups; however, no quantitative data were reported
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? UNCLEAR. The MICU used 
a standard definition of CRBSI which appears to have applied both in the baseline and intervention 
periods. However, no information was given on the staff diagnosing infections
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on the 
information presented
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated?
NO. Although the principles and practices are mostly well described, only a summary of the 
checklist content is reported. The training module is general and covers topics relevant to 
infection prevention beyond those described by the authors; the scope of the knowledge 
assessment based on the tutorial is not reported
Justification given for sample size? NOT REPORTED
Data collection process reported? PARTIALLY. Stated that upon completing the checklist, a 
nurse detached the top page (with all items readable) and dropped it in a secure lockbox. 
The second page remained on the patient’s chart with the sensitive items blacked out. The 
infection control practitioners collected the checklists daily and scanned the de-identified 
forms into a pre-established computerised database using scanning software which scanned 
pre-established fields on the checklist and imported the information into a spreadsheet 
database. These data were stored on a secure computer at the Center for Clinical 
Improvement for future statistical analyses
If YES or PARTIALLY, was the data collection process shown to be valid? NO. Formal validity 
and reliability analyses for data capture using the checklist were not undertaken
If YES or PARTIALLY, was the data collection process shown to be reliable? NO. Formal validity 
and reliability analyses for data capture using the checklist were not undertaken
Statistical tests described? YES. Statistical process control approach
Results Educational significance or effect size assessed? NOT REPORTED
Target behaviour change achieved? PARTIALLY. Some aspects of catheter insertion procedure 
were complied with more extensively than others. Failure to use patient drapes was identified 
as a problem and steps were taken to improve compliance
Additional comments
The data reported above are from the primary research publication138 and web-based tutorial available at 
www.mc.vanderbilt.edu/cvctutorial.
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WARREN (2003)139
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Warren (2003)139
Summary of approach Ten-page self-study module, lectures and posters on the prevention of CABSIs given in two 
ICUs during 3 months in a non-teaching hospital
Location USA, Missouri
Language English
Critical care specialty Medical and SICU
No. of critical care units 2
No. of hospitals 1
Hospital name (unless 
multicentre); city
Missouri Baptist Medical Center, St Louis
Study design Single-cohort before-and-after study combining data from two ICUs
Study time periods Baseline: 1 March 1998 to 30 June 1999 (16 months)
Intervention: 1 July to 30 September 1999 (3 months)
Follow-up: 1 October 1999 to 31 July 2000 (10 months)
Data on anatomical insertion site of CVCs were collected from 1 August 1998
Funding source Supported in part by a CDC Cooperative Agreement and the National Foundation for 
Infectious Diseases (NFID) postdoctoral fellowship in Nosocomial Infection Research and 
Training (to lead author)
Conflicts of interest Not reported
SICU, surgical intensive care unit.
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Population and setting
Critical care unit characteristics:
500-bed non-teaching private community hospital affiliated to a 13-hospital integrated health-care system
Each ICU: 10 beds (total 20 beds); combined admission approximately 150 patients per month
No medical students or house staff; only registered nurses provided patient care
Four hospital-employed, board-certified critical care physicians staffed both ICUs and were responsible for central catheter 
insertion and critical care management
Patient population characteristics: 1215 of 
3943 of patients admitted to the ICU during the 
study (30%) had a CVC
Baseline 
(16 months)
Post intervention 
(10 months)
Difference between 
baseline and post 
intervention 
Total no. of patients 674 541 Not reported
No. (%) in MICU 310 (46) 239 (44) p = 0.56
No. (%) in SICU 364 (54) 302 (56%) Not reported
Male gender, n (%) 351 (52) 280 (52) p = 0.91
Median age, years 71 71 p = 0.62
Caucasian, n (%) 630 (94) 499 (92) p = 0.65
Congestive heart failure, n (%) 280 (42) 248 (46) p = 0.13
COPD, n (%) 226 (34) 180 (33) p = 0.92
Malignancy, n (%) 113 (17) 106 (20) p = 0.20
Diabetes mellitus, n (%) 200 (30) 170 (31) p = 0.51
HIV infection, n (%) 1 (0.1) 0 (0) p = 1.0
Mean APACHE II score 25.2 25.1 p = 0.86
Haemodialysis, n (%) 91 (14) 69 (13) p = 0.70
Corticosteroid use, n (%) 231 (34) 197 (36) p = 0.44
Immunocompromised, n (%) 84 (13) 51 (9) p = 0.09
Mechanically ventilated, n (%) 389 (58) 305 (56) p = 0.64
Mean no. of ventilator days 9.1 9.0 p = 0.28
Tracheostomy, n (%) 49 (7) 45 (8) p = 0.50
Re-intubation, n (%) 70 (10)a 64 (12) p = 0.95
Device characteristics Antimicrobial (chlorhexidine and silver sulfadiazine)-coated CVCs were 
used routinely during the entire study period
CVC supplies were kept in a supply room within the unit; no changes 
in the accessibility of supplies were made during the intervention
Insertion site data were available for 651 of the patients (54%) who 
had 941 non-tunnelled CVCs:
Proportion inserted in subclavian vein:
Baseline: 124 (25%) of 487 CVCs (in 318 patients)
Intervention: 188 (41%) of 454 CVCs (in 333 patients)
Difference: p < 0.001
Insertion site antisepsis used Not reported
Dressing type and duration/frequency Not reported
SICU, surgical intensive care unit.
a Authors reported 12%.
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Intervention characteristics
Objective To evaluate the effectiveness of an evidence-based intervention to prevent CABSIs among 
intensive care unit patients at a non-teaching, community hospital
Main focus of 
education 
Covered catheter insertion and maintenance and the collection of blood cultures, also infection 
epidemiology
Trainers (providers) Not explicitly stated. Mentioned in the acknowledgements section that two registered 
nurses from the Department of Infection Control and one from the Department of Nursing 
implemented the educational programme among the ICU staff
Training of trainers Not reported
Learners (recipients) Nurses and physicians in the ICUs
Target behaviour 
change
Education appears to target multiple behaviours, including aseptic technique; use of maximal 
barrier precautions during CVC insertion; selection of the subclavian vein as an insertion site; 
routine CVC site care; proper technique for obtaining blood cultures; and changing intravenous 
tubing and administration sets
Development and 
testing
Not reported
Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
10-page self-study module: Based on 1996 Hospital Infection Control Practices Advisory 
Committee guidelines (reference cited). Required to be completed by all ICU nurses and 
physicians. After the intervention period the self-study module was mandatory for all  
newly-hired ICU nurses
45 minute lectures: given to nursing and medical personnel
Grand rounds: Presented to hospital staff on the prevention of CABSI
Posters: distributed around the ICUs
Fact sheets: distributed around the ICUs
Topics in the teaching module included: the epidemiology of CABSI; aseptic technique and the 
use of maximal barrier precautions during CVC insertion; preference for the subclavian vein 
as an insertion site; routine CVC site care; proper technique for obtaining blood cultures; and 
guidelines for changing intravenous tubing and administration sets
Not reported how the topics were allocated among the educational strategies
Infection surveillance 
feedback approach 
Stated that all the ICU staff received reports of CABSI rates as part of the intervention. 
However, this process was already in place before the intervention. The time of initiation of 
the feedback and methodological details were not reported. While it appears that infection 
surveillance feedback was an ongoing activity, authors specifically stated that it was part of the 
intervention and it is unclear if the existing process was modified as part of the educational 
intervention
Performance feedback 
approach 
A 20-question pre-test was given before receiving the study module; the same questions were 
given as a post-test at the end of the module. The post-test was mandatory for all ICU nurses; 
the pre-test was optional. However, it was not reported whether staff were aware of their test 
results, i.e. unclear whether performance feedback occurred
Concentration of 
education 
The module with pre- and post-tests took an average of 1 hour to complete. After the 
intervention period, the module was mandatory for all newly hired ICU nurses. However, it 
is unclear whether all nurses were recruited solely during the specified intervention period or 
whether some recruitment – and hence education – continued in the follow-up period
Non-educational 
intervention 
components 
None (purely educational intervention)
Costs reported Authors estimated that the intervention cost US$3500 in personnel time and US$500 in printed 
material to implement in the two study ICUs. Cost-effectiveness was not investigated
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Outcome characteristics
Catheter-BSI infection 
definition
Reference cited: National 
Nosocomial Infections 
Surveillance 186
CABSI was defined by using National Nosocomial Infections Surveillance (NNIS) system criteria. 
CABSI defined as concordant growth between cultures obtained from the catheter tip; hub, 
infusate, or insertion site exudate and percutaneously drawn blood cultures; or a recognised 
pathogen isolated from blood culture that is not related to infection at another site.  
A CABSI was considered ICU related if it occurred > 24 hours after admission to the ICU.  
For low-virulence organisms, two or more positive blood cultures obtained on separate 
occasions had to be noted for the isolate to be considered a true pathogen, and at least one of 
the blood cultures had to be from a peripheral venepuncture
Outcomes reported Not stated whether primary or secondary:
CABSI incidence and incidence density
Time to infection
LOS
Mortality
Completion of pre- and post-intervention tests
Results data
Primary outcomes 
Outcome
Baseline 
(16 months, 
674 patients) 
Post intervention 
(10 months,  
541 patients)
Difference 
between 
baseline and post 
intervention 
Device duration Not reported Not reported Not reported
Total device utilisation, 
catheter-days
Total 6110 5210 p = 0.46
Mean per patient 9.1 9.6
No. of devices/patient Not reported Not reported Not reported
CABSI incidence, n (% of patients)
(a) Overall 30 (4) 11 (2) p = 0.02
(b) For specific post-intervention time periods
 1 July to 30 September 1999 1
 1 October to 31 December 1999 4
 1 January to 31 March 2000 4
 1 April to 31 July 2000 2
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Outcome
Baseline 
(16 months, 
674 patients) 
Post intervention 
(10 months,  
541 patients)
Difference 
between 
baseline and post 
intervention 
CABSI incidence per 1000 catheter-days 0
(a) Overall 4.9 2.1 Relative risk = 0.43 
(95% CI 0.22 to 
0.84) (57% decrease)(b) For specific post-intervention time periods
 1 July to 30 September 1999 0.9
 1 October to 31 December 1999 3.1
 1 January to 31 March 2000 2.7
 1 April to 31 July 2000 1.6
CABSI incidence per 1000 patient-days Not reported Not reported Not reported
Median time to infection among patients with  
CABSI, days
9 6 p = 0.70
Mean LOS, days ICU 7.8 8.0 p = 0.09
Hospital 19.0 19.3 p = 0.37
Mortality, n (%) 182 (27) 128 (24) p = 0.18
Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance with pre-and post-tests:
Total no. of nurses staffing both ICUs 110
 Were distributed the pre-test, n (%) 71 (65%)
 Completed the pre-test, n (%) 64 (58%)
 Completed the post-test, n (%) 103 (94%)
Total no. of physicians staffing both ICUs 4
 Completed the pre-test, n (%) 4 (100)
 Completed the post-test, n (%) 4 (100)
 Knowledge Not a study outcome
 Skills Not a study outcome
Process evaluation Not included in the study, other than compliance with tests 
noted above
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NO. Data showed 
that the study periods were similar in terms of patients’ gender, age, ethnicity, major disease, APACHE 
score, frequency of haemodialysis, immune incompetence, corticosteroid use, mechanical ventilation, 
ventilator days, tracheostomy and re-intubation
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT APPLICABLE
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Stated that antimicrobial catheters and CVC supplies did not differ between 
the baseline and intervention periods and that no formal education programme was in place before 
or after the adoption of the antimicrobial catheters hospital-wide in the early 1990s. However, data 
on markers of changes in processes of care (i.e. systematic observations of CVC insertion and care 
techniques, and appearances of insertion site dressing) were not collected, apart from the insertion site
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention
Were the intervention component(s) implemented as planned? PARTIALLY. Exposure to education was 
not explicitly reported and it is unclear whether test participation is reflective of education exposure. 
However, post-tests described as mandatory were completed by 94% of nurses and 100% of 
physicians, exposing nearly all the staff to part of the intervention
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
UNCLEAR. For most outcomes, data were for all patients who had a CVC. However, data for insertion 
site were reported to be available for 381 patients (47%) in the baseline period and 333 patients 
(62%) in the intervention period (reason for the missing data not reported)
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
The authors acknowledged that staff behaviour might have changed as a result of observation alone, 
independent of the intervention; this can neither be ruled out nor confirmed
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? NO. The educational topics were described 
superficially and it was not reported how the topics were allocated among the educational strategies. 
The test questions were not reported
Justification given for sample size? NO. Authors commented that the study was not powered to 
determine the impact of the intervention on lengths of stay, but they did not comment on whether it 
was powered to detect differences in infection incidence rates
Data collection process reported? PARTIALLY. Stated only that trained data collectors, including 
infection control and research nurses, collected data prospectively on all admissions to both ICUs
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES. Data were initially analysed separately for each ICU and found to be 
homogeneous (Breslow–Day test), so were pooled in the final analysis
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED
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Additional comments
 z Stated that the intervention was similar to that reported by Coopersmith (2002).50
 z In this hospital a dedicated team of intensivists performed catheter insertion in the ICUs. This may not 
reflect practice in other hospitals.
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WARREN (2004)51
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Warren (2004)51
Summary of approach 10-page self-study module on the prevention of CABSIs, lectures and posters and an 
awareness campaign given during 1 month in one ICU in a teaching hospital 
Location USA, Missouri
Language English
Critical care specialty MICU
No. of critical care units 1
No. of hospitals 1
Hospital name (unless 
multicentre); city
Barnes-Jewish Hospital, St Louis
Study design Single-cohort before-and-after study
Study time periods Baseline: January 2000 to December 2001 (24 months)
Intervention: January 2002
Follow-up: January 2002 to December 2003 (23 months)
Authors reported data for 2002 and 2003 (24 months) as post intervention, although this 
period included the intervention itself (January 2002). Newly hired nurses received education 
but it was not reported when or how many nurses were hired during the study period
Funding source Work supported by funding from a Centers for Disease Control and Prevention Cooperative 
Agreement and the Barnes-Jewish Hospital Foundation
Conflicts of interest Not reported
Population and setting
Critical care unit 
characteristics
ICU had 19 beds; located in a 1400-bed university-affiliated teaching hospital
Patient care was provided by a multidisciplinary team directed by attending physicians who 
were board certified in critical care medicine
Nurse to patient ratio 1 : 2.
CVCs were usually inserted by resident physicians (i.e. physicians in training)
Stated that patient care policies and protocols in the MICU remained unchanged during the 
study period, except for a new policy for prevention of VAP (introduced October 2000 during 
the baseline period)
Patient population 
characteristics
No details of the patients were provided. All patients admitted to the MICU during the study 
period were prospectively followed up by members of the hospital infection control team and 
surveyed for occurrence of CVC-associated bloodstream infection
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Device characteristics Included CVCs, dialysis catheters, pulmonary artery catheters but excluded arterial catheters
All were standard catheters without antimicrobial or antiseptic coatings
Mean ± SD monthly % of CVCs placed in the femoral vein:
Baseline: 26.3 ± 5.8%
Post-intervention: 20.4 ± 6.6%
Difference: p = 0.002 
Insertion site antisepsis 
used
Not reported
Dressing type and 
duration/frequency 
Not reported
Intervention characteristics
Objective To determine whether an educational programme could decrease the rate of  
catheter-associated bloodstream infection in the MICU of a teaching hospital
Main focus of education Covered catheter insertion and maintenance and the collection of blood cultures, also 
infection epidemiology
Trainers (providers) Not explicitly reported; probably provided by registered infection control nurses (as in Warren 
2003138) who were among the study authors and contributed to programme development
Training of trainers Development and testing (see below) involved information exchange among infection control 
professionals
Learners (recipients) All nurses in the ICU received the intervention by the end of January 2002. Newly-hired 
nurses were required to complete the education module as part of their job orientation. 
Physicians (interns, residents, fellows, attending physicians) completed the module during the 
first 3 days of their ICU rotation
Target behaviour 
change
Education appears to target multiple behaviours, including: aseptic technique; use of maximal 
barrier precautions during CVC insertion; selection of the subclavian vein as an insertion 
site; routine CVC site care; proper technique for obtaining blood cultures; and changing 
intravenous tubing and administration sets
Development  
and testing
The education programme was developed by a multidisciplinary task force in 1998 by 
infection control practitioners representing nine hospitals in the Barnes-Jewish-Christian 
Health System (Coopersmith (2002)50 cited). The local implementation plan was developed 
during monthly meetings of the MICU infection control community from July to December 
2001. The committee comprised two ICU infection control nurses, two medical directors 
of the hospital infection control group, two physicians from the ICU, the unit clinical nurse 
specialist (all named authors), and members of the nursing staff. Objectives of the meetings 
were: educate the ICU leadership on the problem of CABSI; review in detail the optimal 
practices for catheter insertion and maintenance in the ICU; describe components of the 
education programme and their local implementation; foster team building; develop a 
strategy for educating resident and attending physicians; and have a feedback mechanism 
for reporting problems during implementation. Additional meetings were held by members 
of the ICU infection control committee to revise CVC insertion and maintenance policies and 
procedures. Flow charts for all aspects of CVC care were developed and approved by the 
committee
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Educational or 
behavioural theory
Not reported
Educational strategies 
and topics targeted
Approach was similar to that of Warren (2003)139
10-page self-study module: Based on guidelines of the Hospital Infection Control Practices 
Advisory Committee as updated in 2002 (reference cited). Five major sections: (1) Goal of the 
Self-study Module; (2) Risk Factors; (3) Causes of CABSI; (4) Definition of CABSI; and (5) How 
to Decrease CABSI Risk
In-services at scheduled staff meetings: No details provided (mentioned only in the 
abstract)
45-minute lectures: No details provided
Group discussions: No details provided, but implied that group discussions occurred 
between taking the self-study module and post-test
Posters and fact sheets: Distributed at each patient computer terminal located directly 
outside of the patient room (unclear whether these were the same posters and fact sheets 
referred to in the promotional campaign)
Promotional campaign: Involved regular administration of lapel buttons to a staff member 
promoting the education programme, fact sheets and posters displayed throughout the ICU 
describing the programme, and photographic guidelines at each bedside computer station 
illustrating correct CVC insertion and maintenance, including dressing of the insertion site
Topics in the education module and tests: The epidemiology of CABSI; aseptic technique and 
the use of maximal barrier precautions during CVC insertion; preference for the subclavian 
vein as an insertion site; routine CVC site care; proper technique for obtaining blood cultures; 
and guidelines for changing intravenous tubing and administration sets. Specific topics listed 
were: (1) hand hygiene before and after patient contact; (2) sterile gloves when changing 
dressing; (3) avoidance of femoral insertion site where possible; (4) wear sterile gown, gloves, 
mask and cap when inserting a catheter; (5) remove hair around insertion site only with 
scissors or clippers; (6) use appropriate insertion site antiseptic; (7) use full sterile drape;  
(8) use sterile technique to apply transparent dressing; (9) do not use antimicrobial ointment 
at insertion site except for dialysis catheters; (10) avoid catheter changes over a guidewire; 
(11) change dressing only when necessary; and (12) follow hospital protocol for changing  
i.v. fluid administration and cleaning of injection ports
Infection surveillance 
feedback approach 
A monthly update of the CABSI was posted in the ICU in multiple locations for feedback 
to ICU staff. Not reported whether this system was already in place before the educational 
intervention
Performance feedback 
approach 
Tests were based on the same guidelines as used in the self-study module
The same 20-question test was conducted before and after implementation of the self-study 
module and group discussion. Score required to pass the test was 85%; if necessary the  
self-study module and post-test were repeated until a pass score was achieved
Validity and reliability of the assessment approach were not reported
Concentration of 
education 
Not reported other than that the lecture was 45 minutes. More detailed information on the 
time and staff resources required for a similar intervention were reported by Warren (2003)139 
but unclear whether they are applicable to this intervention
Non-educational 
intervention 
components 
A new policy for prevention of VAP was introduced in October 2000 (during the baseline 
period) and was in place for > 1 year before the educational intervention started
Costs reported Not reported (crude estimate of cost savings presented based on assumed infection 
incidence) 
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Outcome characteristics
Catheter-BSI definition
Reference cited: National 
Nosocomial Infections 
Surveillance186
Bloodstream infections were classified as primary or secondary according to CDC NNIS 
surveillance definitions. Primary BSI (bacteraemia) was defined employing either of the 
following two criteria:
(a)  Isolation of a recognised pathogen from blood culture (Staphylococcus aureus, 
Enterococcus spp., Candida spp.) not related to infection at another site; and [sic]
(b) Fever of ≥ 38.0 °C, chills, or hypotension, and either of the following:
–  common skin contaminant (e.g. diphtheroids, Bacillus spp, Propionibacterium spp, 
coagulase-negative staphylococci, or micrococci) isolated from two blood cultures drawn 
on separate occasions, within 24 hours, unrelated to infection at another site;
–  common skin contaminant isolated from a blood culture from a patient with an 
intravascular device and the physician institutes appropriate antimicrobial therapy
Specifically, requirements for a definition of CABSI were given in the education  
programme as:
1. Presence of a vascular catheter within the last 48 hours;
2. Either of criteria (a) or (b) above
Details of the technique for collecting and culturing blood samples were reported (not 
extracted by reviewers)
Outcomes reported Specified as the main outcome measure:
CABSI incidence and incidence per 1000 catheter-days
Results data
Primary outcomes 
Outcome Baseline (24 months)
Post intervention 
(23 months)
Difference between baseline and 
post intervention – only reported for 
incidence per 1000 CVC-days
Device duration Not reported Not reported
Total device utilisation, 
catheter-days 
7876a 7455
No. of devices/patient Not reported Not reported
CABSI incidence rate, n 74 41
CABSI incidence per 
1000 catheter-days
9.4 5.5
3.9 (95% CI 1.2 to 6.6); 41.5% decrease; 
p = 0.019 (risk ratio not reported)
CABSI incidence per 
1000 patient-days
Not reported Not reported
LOS Not reported Not reported
Mortality Not reported Not reported
a Data from the results section; reported in the abstract as 7879 catheter-days.
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Additional CVC incidence density data per month (data extracted from graph 
by reviewer using Engauge software)
Monthly CVC rate per 1000 CVC-days 
Baseline Post intervention
2000 2001 2002 2003
January 5.3 7.5 0 0
February 18.5 18.9 3.9 0
March 7.8 12.1 18.6 3.4
April 14.2 15.6 4.3 3.3
May 11.6 2.8 8.4 9.6
June 6.4 0 13.3 0
July 12.6 6.8 14.3 5.7
August 12.7 16.6 0 7.8
September 15.4 0 9.0 5.3
Octobera 6.0 12.6 3.3 5.0
November 6.9 0 5.9 10.6
December 5.7 6.6 0 0
a Intervention for prevention of VAP introduced in October 2000.
Secondary outcomes 
Reaction to 
education 
Not a study outcome
Attitudes Not a study outcome
Compliance Not a study outcome
Knowledge Not a study outcome
Skills Not a study outcome
Process 
evaluation
Not included in the study other than recording the frequency of insertions in the femoral vein (noted 
above)
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? NOT REPORTED.  
No data were given on the patient population
If YES, were the differences between the groups adjusted for in statistical analyses (e.g. as covariates 
or subgroups, or stratification by propensity scores)? NOT REPORTED
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the overall 
intervention? UNCLEAR. Stated that patient care policies and protocols in the MICU remained 
unchanged during the study period, except for a new policy for prevention of VAP (introduced  
October 2000 – during the baseline period). However, data on markers of changes in processes of care 
(i.e. systematic observations of CVC insertion and care techniques, device duration, and appearances 
of insertion site dressing) were not collected, apart from the insertion site
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention
Were the intervention component(s) implemented as planned? NOT REPORTED
Missing data Were there systematic differences between the baseline and intervention groups in data availability? 
NOT REPORTED. The number of patients in the ICU and the proportion of those that had a CVC were 
not specified
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how outcomes 
were determined (including differences in how outcomes were defined)? NOT REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO. The authors stated that the ICU staff was not blinded to either the presence of or the 
recipients of the education intervention
Other possible 
sources of bias
The authors acknowledged that other sources of potential bias may have influenced their results. 
These would include unrecognised differences in ascertainment or reporting of CABSI between the 
two study periods
Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? PARTIALLY. The self-study module was 
described well enough for the main educational topics to be reproduced in a similar strategy. However, 
the test questions were not reported and the nature of other educational elements (lectures, in-service 
and group discussions) was not reported
Justification given for sample size? NOT REPORTED
Data collection process reported? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be valid? NOT APPLICABLE 
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT APPLICABLE
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? NOT REPORTED
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Additional comments
 z Unclear whether infection surveillance feedback approach changed during the study period.
 z The majority of CVCs in this ICU were placed by physicians in training.
 z Related studies: Coopersmith (2002)50 study was in the SICU of the same hospital; Warren (2003)139 
applied a nearly identical programme within two ICUs of a community hospital.
 z Stated that the 20-question post test at the end of the module was to reinforce the topic and 
group discussion; the authors planned to reinforce the education by repeating the programme at 
2-year intervals.
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ZINGG (2009)144
Methods
Study characteristics
Lead author, publication 
year(s) and reference(s)
Zingg (2009)144
Summary of approach Educational programme targeting hand hygiene and catheter care in five ICUs at a single 
hospital
Location Switzerland
Language English
Critical care specialty Medical, cardiovascular, trauma, general surgery and neurosurgery ICUs
No. of critical care units 5
No. of hospitals 1
Hospital name (unless 
multicentre); city
University Hospital, Zurich
Study design Single-cohort before-and-after study that combined data from five ICUs into a single cohort 
(data also presented also separately for two of the five ICUs)
Study time periods Baseline: September to December 2003 (4 months)
Intervention: March to July 2004 (5 months)
Follow-up: None (monitoring during intervention only) 
Funding source Not reported
Conflicts of interest Authors disclosed no potential conflicts of interest
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Population and setting 
Critical care unit characteristics
Total for the five ICUs:
 z Beds = 52, sited in a 960-bed tertiary referral centre
 z Nursing staff = 395 (head nurses, teaching nurses, assistant nurses, trainee nurses)
 z Medical staff = 34
Internal guidelines recommended the use of maximal barrier precautions – but not stated whether the guidelines applied 
equally to baseline and intervention periods
Patient population characteristics: all adult 
patients hospitalised in any of the ICUs and 
with one or more CVCs in place were eligible 
for study entry; there were no exclusion criteria
Baseline (4 months) Intervention 
(5 months)
Difference between 
baseline and 
intervention
Total no. of patients 499 500
Cumulative no. of ICU-days 2944 3705 Not reported
Median (IQR) age, years 62 (49–71) 61 (48–73) p = 0.75
Male sex, n (%) 320 (64) 334 (67) p = 0.35
McCabe fatality score < 6 months, n (%) 187 (37) 223 (45) p = 0.01
Median (IQR) SAPSa II score 23 (16–31) 24 (18–34) p = 0.11
Charlson score > 3, n (%) 67 (13) 63 (13) p = 0.73
Cardiovascular surgery, n 208 196 p = 0.42
Diabetes, n 71 60 p = 0.30
Trauma, n (%) 10 (2) 55 (11) p < 0.001
Stay on MICU, n (%) 62 (12) 74 (15) p = 0.26
Intubation, n (%) 130 (26) 131 (26) p = 0.96
Non-CRBSI nosocomial infections, n (%) 129 (26) 131 (26) p = 0.90
Device characteristics Baseline (4 months)
Intervention 
(5 months)
Difference between 
baseline and 
intervention
Insertion vein
 Subclavian 494 477 p = 0.10
 Jugular 370 398 p = 0.56
 Femoral 110 139 p = 0.10
(1 missing data)
Catheter type
CVC 626 673 p = 0.34
Pulmonary CVC 211 175 p = 0.01
Other 137 167 p = 0.14
Lumens
Single lumen 100 121 p = 0.21
Multi (> 1) lumen 868 878 p = 0.21
(6 missing data) (16 missing data)
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Device characteristics Baseline (4 months)
Intervention 
(5 months)
Difference between 
baseline and 
intervention
Insertion venue:
Emergency room 39 31 p = 0.25
Operating room 644 636 p = 0.11
ICU 290 347 p = 0.03
(1 missing data) (1 missing data)
Insertion site antisepsis used Povidone-iodine (three 
SICUs) and octenidine 
(medical and 
neurosurgical ICUs)
Same as baseline 
practice
Quantitative data not 
reported
Dressing type and duration/frequency Not reported Not reported Not reported
SICU, surgical intensive care unit.
a Simplified Acute Physiology Score.
Intervention characteristics
Objective To study the impact of a teaching intervention on the rate of central venous CRBSIs in intensive 
care patients
Main focus of 
education 
Hand hygiene, dressing of the insertion site, manipulation of tubing and stopcocks, and 
aseptic preparation of infusates; explicitly stated that CVC insertion was not the focus of the 
intervention and was not observed
Trainers (providers) Two infection control nurses were responsible for teaching phases 1 and 2 (details of phases 
below). Two additional infection control nurses from the infection control unit participated 
in the bedside teaching sessions of phase 3. An infection control physician and an infection 
control nurse conducted teaching phase 4. (Note that the authors described teaching phases 
and content modules but mixed up the terminology – the above interpretation provided by the 
reviewers)
Training of trainers Not stated explicitly but appears that phase 1 (training of nurses) was conducted by two 
infection control nurses.
Learners (recipients) Nurses and physicians in the ICU (different emphasis of education for each group)
Target behaviour 
change
Hand hygiene, dressing of the insertion site, manipulation of tubing and stopcocks, and aseptic 
preparation of infusates
Development and 
testing
Not reported, except that teaching phase 1 was very helpful to build trust and learn from 
nurses’ (i.e. the learners’) experiences, and that procedure proposals were adapted to everyday 
situations which changed the modules significantly
Educational or 
behavioural theory
Not reported
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Educational strategies 
and topics targeted
Four sequential teaching phases within each of which four sequential content modules were 
provided (in the order below)
Teaching phases:
1. Training of head nurses and nurse instructors: A total of 12 interactive training sessions, 
organised to discuss discrepancies in existing CVC practice, evidence-based CVC care 
procedures, and feasibility in the units, and to achieve agreement for uniform hospital-wide 
procedures
2. General teaching sessions to all ICU nurses: Five 45-minute ex cathedra teaching 
interventions in the auditorium that comprised a short review of the literature, followed by 
practical demonstrations onsite and by video
3. Small group bedside teaching sessions for nurses: A total of 80 sessions of 15 minutes 
each, referred to as practical teaching workshops; stratified into the four modules, with only 
one module discussed per session
4. Teaching of medical staff: Physicians participated in a separate teaching programme 
focusing mainly on hand hygiene, although information about the content of the other 
modules was provided as well. Compared with the nurses’ teaching the theoretical 
background was more detailed, with a thorough discussion of the literature. Furthermore, 
they were confronted with findings on perceptions and beliefs of health-care workers about 
hand hygiene in the literature (references cited)
Content modules:
1. Hand hygiene
2. Dressing of the insertion site
3. Manipulation of tubing and stopcocks
4. Aseptic preparation of infusates
Detailed specification of the topic content for each module is reported in a table (data not 
extracted by reviewers)
Infection surveillance 
feedback approach 
Not included in the intervention
Performance feedback 
approach 
Not included in the intervention
Concentration of 
education 
The intervention comprised 47 hours of teaching by two infection control nurses (total 94 staff 
working hours), divided as follows:
 z Phase 1: 18 hours (three courses of 90 minutes for each of the four modules)
 z Phase 2: Five 45-minute ex cathedra teachings; total 3 hours and 45 minutes
 z Phase 3: Eighty 15-minute bedside sessions; total 20 hours
 z Phase 4: Five 1-hour interactive sessions with physicians; total 5 hours
Non-educational 
intervention 
components 
None (intervention purely educational)
Costs reported Not reported
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Outcome characteristics
Catheter-BSI 
definition
Reference cited: Garner 
et al.147
Primary bloodstream infection was defined as bacteraemia (or fungaemia) without any other 
documented source. For coagulase-negative staphylococci, two positive blood cultures or 
a complete antibiotic therapy adjusted for susceptibility testing was required. All patients 
were monitored for the development of CRBSI until 48 hours after ICU discharge. CRBSI was 
considered as ICU acquired if diagnosed ≥ 48 hours after admission or within 48 hours after 
discharge from the ICU. Patients with CRBSI > 48 hours after discharge were excluded from the 
risk analysis
Outcomes reported Primary (study powered to detect 2% change):
CRBSI incidence and incidence density
Secondary:
Compliance with hand hygiene
Other outcomes:
Device duration
Time to CRBSI
LOS
Mortality
Results data
Primary outcomes
Baseline (4 months)  
(974 CVCs) (499 patients) 
(2944 ICU-days)
Intervention (5 months) 
(1015 CVCs) (500 patients) 
(3705 ICU-days)
Difference between 
baseline and 
intervention 
Median (range) device 
duration, catheter-days 
5 (1–39) 6 (1–44) p < 0.001
Total device utilisation,  
catheter-days 
6200 7279 Not reported
No. of devices/patient Not reported Not reported Not reported
Median (IQR) and [mean] 
catheter-days per patient
5 (3–8) [6.4] 6 (3–9) [7.2] p < 0.001
CRBSI incidence rate 24 7 p < 0.001
CRBSI incidence per  
1000 catheter-days
 Overall (5 ICUs) 3.9 1.0 p < 0.001
 MICU 9.0a 3.9a Not reported
 SICU 3.0a 0.2a Not reported
 Other 3 ICUs Not reported Not reported Not reported
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Baseline (4 months)  
(974 CVCs) (499 patients) 
(2944 ICU-days)
Intervention (5 months) 
(1015 CVCs) (500 patients) 
(3705 ICU-days)
Difference between 
baseline and 
intervention 
Median (IQR) time to CRBSI, 
days
6.5 (3–19) 9 (7–16) p = 0.02
No. of blood cultures obtained 
per 1000 catheter-days
190 225 Not reported
CRBSI incidence per 1000 
patient-days
Not reported Not reported Not reported
Median (IQR) and [mean] length 
of ICU stay, daysb 
3 (2–7) [5.9] 4 (2–9) [7.5] p < 0.001
Mortality 44 44 p = 0.99
SICU, surgical intensive care unit.
a Difference between MICU and SICU statistically significant (p < 0.001); differences between other ICUs not reported.
b Median (IQR) LOS was 15.5 (10–25) days in patients with CRBSI and 5 (3–12) days in patients without CRBSI 
(difference reported as 10.5 days).
Secondary outcomes 
Reaction to education Not a study outcome
Attitudes Not a study outcome
Compliance Overall compliance with hand hygiene:
 z Baseline 59.1%; intervention 65% (difference: p = 0.466)
Rate of correctly performed hand disinfection procedures:
 z Baseline 22.5%; intervention 42.6% (difference: p = 0.003)
Hand hygiene performed before patient contact:
 z Baseline 26%; intervention 45% (difference: p = 0.007)
Hand hygiene performed after patient contact:
 z Baseline 21%; intervention 56% (difference: p < 0.001)
Knowledge Not a study outcome
Skills Not a study outcome
Process evaluation Not included in the study, apart from the observations on compliance noted above
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Critical appraisal
Potential for bias 
Group selection Were there systematic differences between the baseline and intervention groups? YES. The 
number of ICU-days, McCabe rapid fatality score, number of trauma patients and number who 
had a CVC inserted in the ICU were statistically significantly higher in the intervention than 
the baseline period. LOS in the MICU was also significantly longer in the intervention period, 
by around 10 days. The converse applied to the number of patients with pulmonary CVCs. 
Significantly fewer patients had pulmonary CVCs in the intervention period. The data suggest 
that patients in the intervention period were sicker than in the baseline period but data for  
non-CRBSI infections and mortality were identical for both periods
If YES, were the differences between the groups adjusted for in statistical analyses? NO
Intervention 
administration
Were any confounding variables identified that could influence the effect estimate for the 
overall intervention? NOT REPORTED. The staffing and staff to patient ratios were not reported 
separately for baseline and intervention periods. It was not reported whether any care policies 
other than those in the intervention changed during the study period
Was the effect of educational practice separable from effects of non-educational practice? YES. 
Education-only intervention
Were the intervention component(s) implemented as planned? UNCLEAR. All of the teaching 
models appear to have been implemented, but it is unclear if participation was mandatory 
or how many staff took part in all or some of the modules (compliance for hand hygiene 
statistically significantly increased, but did not reach 100%)
Missing data Were there systematic differences between the baseline and intervention groups in data 
availability? NO. Missing data were reported and appear to represent a small proportion of the 
total data for the outcomes in question (insertion vein, lumen number, and insertion venue). 
Specified that the population was all patients in the ICUs who had a CVC
Outcome 
measurement
Were there systematic differences between the baseline and intervention groups in how 
outcomes were determined (including differences in how outcomes were defined)? NOT 
REPORTED
Was any blinding of personnel and/or outcome assessors reported (including assessors of blood 
cultures)? NO
Other possible 
sources of bias
No other sources of bias were reported by the authors or identified by the reviewers based on 
the information presented
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Other critical appraisal criteria 
Methods Intervention described in sufficient detail to be replicated? YES. The structure, content and time 
resources required were reported in detail
Justification given for sample size? YES. Stated that a minimum of 870 catheters was needed  
to prove a significant CRBSI reduction from 3% (baseline) to 1% (intervention) (80% power, 
0.05 significance level)
Data collection process reported? PARTIALLY. CVC surveillance was conducted by a trained 
infection control nurse who visited all ICUs daily and recorded relevant information in 
a surveillance protocol for each patient. All protocols were reviewed and checked for 
completeness and plausibility by two study physicians
If YES or PARTIALLY, was the data collection process shown to be valid? NOT REPORTED
If YES or PARTIALLY, was the data collection process shown to be reliable? NOT REPORTED
Statistical tests described? YES
Results Educational significance or effect size assessed? NO
Target behaviour change achieved? PARTIALLY. Compliance was only reported for one of the 
behaviour changes (hand hygiene); compliance with hand hygiene was not 100%, although 
there were improvements
Additional comments
 z Not reported whether the participants were aware that they were being studied.
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Appendix 6 Lists of records not included in the 
data syntheses
Conference abstracts (n = 67) excluded from the evidence map
These abstracts either met the inclusion criteria or were of unclear relevance at the title and abstract 
screening step but were excluded as they provided insufficient information for inclusion in the keyword 
mapping exercise.
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Full-text records (n = 62) excluded from the evidence map
Note that for most records only the most apparent exclusion criteria agreed by the reviewers are listed. 
Records may have also failed to meet other criteria that are not listed below.
Reference
Reason for exclusion
Population criteria 
not met
Design criteria not 
met
Intervention 
criteria not met
Relevant outcomes 
not reported
Agra Varela (2009)63
Agvald-Ohman (2010)74
Berg (1995)204
Bezzio (2009)205
Bijma (1999)206
Chien (2001)207
Clancy (2009)208
Collignon (1985)209
Cooley (2009)210
DuBose (2010)211
Eggimann (2004)212
Elder (2008)201
Gnass (2004)213
Goeschel (2010)214
Goeschel (2011)215
Gurskis (2009)216
Halton (2010)151
Harnage (2008)217
Jeffries (2009)218
Joshi (2005)219
Kilbride (2003)220
Kilbride (2003)221  
Lindsey (2007)222  
Lisboa (2008)66  
Lolom (2009)72
Meier (1998)223
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Reference
Reason for exclusion
Population criteria 
not met
Design criteria not 
met
Intervention 
criteria not met
Relevant outcomes 
not reported
Moureau (2005)224
Moureau (2009)225
Nelson (2005)226
Northway (2005)227
O’Grady (2007)228
Palomar (2010)67
Papadimos (2008)229
Penne (2002)4
Plouffe (2010)230
Pronovost (2005)231
Render (2006)200
Riel-Roberge (2010)71
Rizzo (2005)232
Rodriguez-Paz (2008)233
Rosenthal (2008)234
Rosenthal (2010)235
Scales (2011)181
Schelonka (2006)236
Schindler (2007)73
Schuerer (2007)237
Schulman (2009)238
Seguin (2010)239
Sherertz (2004)240
Sherman (1988)241
Smith (2006)242
Smith (2007)243
Stewart (2008)244
Tsuchida (2007)245
Vandijck (2009)246
Verdier (2006)247
Warye (2009)248
Watson (2009)249
Weber (2010)250
Yilmaz (2007)251
Young (2006)252
Zack (2009)253
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Studies (n = 50) excluded from the clinical effectiveness 
systematic review
Study 
Reason for exclusion from systematic review
Population not adult
Design unclear or not 
prospective
Catheter-BSI definition 
not reported
Anguera Saperas64
Barsuk75/Cohen76
Berenholtz77
Berriel-Cass79
Bhutta78
Bishop-Kurylo80
Bizzarro81
Bonello82
Buttes84
CDC85
Chua86
Costello88
Curchoe89
Curry90
DePalo91
Duane92
Esteve65
Frankel96
Harnage100
Harrigan101
Hatler102
Jain104
Joy-Joseph105
Khouli145
Koll106
Koll107
Leboucher70
Maas111
Marra112
McKee113
Miller114
Miller115
Miller-Hoover116
AppENDIx 6
340
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Study 
Reason for exclusion from systematic review
Population not adult
Design unclear or not 
prospective
Catheter-BSI definition 
not reported
Moreira118
Northway119
Orsi120
Peredo121
Racco125
Rey127
Rogers128
Sannoh131
Santana132
Schulman133
Shannon134
Urrea Ayala69
Venkatram137
Warren140
Wirtschafter141
Yoo142
Zack143
Excluded studies from the systematic review  
of cost-effectiveness
Study Reason for exclusion
Moureau NL. Reducing the cost of catheter-related bloodstream infections. 
Nursing 2009;39:14–15
Not cost-effectiveness study (review)
Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to 
prevent central venous catheter-associated bloodstream infections: a  
systems-based intervention. Am J Infect Control 2006;34:503–6
Not economic analysis (not full-cost study)
Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ.  
Attributable cost of catheter-associated bloodstream infections among 
intensive care patients in a non-teaching hospital. Crit Care Med 
2006;34:2084–9
Not economic analysis (not full-cost study)
Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, 
et al. Effect of an education program on decreasing catheter-related  
bloodstream infections in the surgical intensive care unit. Crit Care Med 
2002;30:59–64
Not economic analysis (not full-cost study)
Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream 
infections through the use of a central venous line bundle: epidemiologic and 
economic consequences. Am J Infect Control 2011;39:640–6
Not economic analysis (not full-cost study)
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Clinical effectiveness full-text records (n = 19) identified in 
search updates (March 2012) (excluded from data synthesis but 
discussed in report)
Abramczyk ML, Carvalho WB, Medeiros EA. Preventing catheter-associated infections in the Pediatric 
Intensive Care Unit: impact of an educational program surveying policies for insertion and care of central 
venous catheters in a Brazilian teaching hospital. Braz J Infect Dis 2011;15:573–7.
Espiau M, Pujol M, Campins-Marti M, Planes AM, Pena Y, Balcells J, et al. [Incidence of central  
line-associated bloodstream infection in an intensive care unit.] An Pediatr 2011;75:188–93.
Esteban E, Ferrer R, Jordan I, Urrea M, Palomeque A. Educational intervention to reduce nosocomial 
infection rates in the pediatric intensive care unit. Intensive Care Med 2011;S175.
Gozu A, Clay C, Younus F. Hospital-wide reduction in central line-associated bloodstream infections:  
a tale of two small community hospitals. Infect Control Hosp Epidemiol 2011;32:619–22.
Harris BD, Hanson C, Christy C, Adams T, Banks A, Willis TS, et al. Strict hand hygiene and other 
practices shortened stays and cut costs and mortality in a pediatric intensive care unit. Health Affairs 
2011;30:1751–61.
Jacob J, Sims D, Van de Rostyne C, Schmidt G, O’Leary K. Toward the elimination of  
catheter-related bloodstream infections in a newborn intensive care unit (NICU). Jt Comm J Qual Patient 
Saf 2011;37:211–16.
Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use 
of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 
2011;39(8):640–6.
Kime T, Mohsini K, Nwankwo MU, Turner B. Central line ‘attention’ is their best prevention. Adv Neonatal 
Care 2011;11:242–8.
McLaughlin GE, Nares MA, Smith LJ, Feinroth CA. Preventing central-line-associated bloodstream 
infections in pediatric specialized care units: a case study of successful quality improvement. Progress 
Pediatr Cardiol 2012;33:47–52.
McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit 
Care Med 2012;40:388–93.
Miller MR, Niedner MF, Huskins WC, Colantuoni E, Yenokyan G, Moss M, et al. Reducing PICU central 
line-associated bloodstream infections: 3-year results. Pediatrics 2011;128:e1077–83.
Ong A, Dysert K, Herbert C, Laux L, Granato J, Crawford J, et al. Trends in central line-associated 
bloodstream infections in a trauma-surgical intensive care unit. Arch Surg 2011;146:302–7.
Payne NR, Barry J, Berg W, Brasel DE, Hagen EA, Matthews D, et al. Sustained reduction in neonatal 
nosocomial infections through quality improvement efforts. Pediatrics 2012;129:e165–73.
Render ML, Hasselbeck R, Freyberg RW, Hofer TP, Sales AE, Almenoff PL, et al. Reduction of central 
line infections in Veterans Administration intensive care units: an observational cohort using a central 
infrastructure to support learning and improvement. BMJ Qual Saf 2011;20:725–32.
Resende DS, do OJ, de Brito DD, Abdallah VO, Gontijo Filho PP. Reduction of catheter-associated 
bloodstream infections through procedures in newborn babies admitted in a university hospital intensive 
care unit in Brazil. Revista Da Sociedade Brasileira de Medicina Tropical 2011;44:731–4.
Seddon ME, Hocking CJ, Mead P, Simpson C. Aiming for zero: decreasing central line associated 
bacteraemia in the intensive care unit. N Z Med J 2011;124:9–21.
Shannon RP. Eliminating hospital acquired infections: is it possible? Is it sustainable? Is it worth it? Trans 
Am Clin Climatol Assoc 2011;122:103–14.
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Vigorito MC, McNicoll L, Adams L, Sexton B. Improving safety culture results in Rhode Island ICUs: lessons 
learned from the development of action-oriented plans. Jt Comm J Qual Patient Saf 2011;37:509–14.
Weiss CH, Moazed F, Mcevoy CA, Singer BD, Szleifer I, Amaral LAN, et al. Prompting Physicians to Address 
a Daily Checklist and Process of Care and Clinical Outcomes A Single-Site Study. Am J Respir Crit Care Med 
2011;184:680–6.
Clinical effectiveness conference abstracts (n = 12) identified in 
search updates (March 2012) (excluded from data synthesis)
Caswell H. Utilizing a proactive approach to preventing device associated infections in a new pediatric 
medical ICU. Pediatr Crit Care Med 2011;12(3).
Eggimann P, Joseph C, Thevenin M-J, Bellini C, Voirol P, Revelly J-P. Reduction of primary bacteremia 
following the introduction of chlorhexidine-impregnated sponges combined with transparent dressings on 
central venous catheters in a mixed ICU. J Vasc Access 2011;12(1).
Fleming A, Harris B. Strive toward elimination of catheter-related blood stream infections. Pediatr Crit Care 
Med 2011;12(3).
Guner R, Hasanoglu I, Keske S, Tasyaran MA. Educational approach to reduce catheter-related bloodstream 
infections and catheter-related urinary tract infection rates in intensive care unit. Clin Microbiol Infect 
2011;17(Suppl. 4):S775.
Kaye G, Mateo C. Multifaceted initiatives to eliminate central catheter-associated blood stream infections 
in the intensive care unit. Crit Care Nurse 2011;31(2):E35.
Kellie S, Scott M, Saad M, Cavallazzi R, Wiemken T. Procedural and educational interventions reduce 
ventilator associated pneumonia (VAP) and central line associated bloodstream infections (CLABSI).  
Chest 2011;140(4).
Palomar M, Lopez Pueyo M, Alvarez Lerma F, Olaechea P, Otal J, Insausti J. ICU-Acquired Infections.  
Do We Need Bundles? Abstr Intersci Conf Antimicrob Agents Chemother 2010;50.
Perez AJ, Monge FJC, Vivas AM. Effect of a program to improve prevention measures of catheter-related 
bloodstream infections in a medical ICU. Intensive Care Med 2011;37(1)(Suppl.):S172.
Ritter G. A central venous catheter line protocol by the continuum of care decreases complications in 
hospitalized patients: two steps beyond a checklist. Chest 2011;140(4).
Rooney KD, Sundaram R, Gibson L, Price RJ. Safety programme reduces ICU mortality. Crit Care 
2011;15:S173–4.
Szakmany T, Pain T, Beckett P, Jerrett H, Hermon A. Eliminating catheter related bloodstream infection on 
the intensive care unit: Not a Myth! Intensive Care Med 2011;37(1)(Suppl.):S16.
Zack JE, Spence D, Lamb B, Martin RS, Striker DA, Krettek JE, et al. Creating a culture of zero tolerance for 
central line associated bacteraemia. The National Database of Nursing Quality Indicators 2010.
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Appendix 7 Data for clinical effectiveness 
forest plots
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Data for forest plot: regional-scale interventions (see Figure 4)
Study Comparison
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline  
device-days
Intervention 
incidence 
density
Baseline 
incidence 
density RR SE of log RR
95% confidence 
limits of RR
Lower Upper
Burrell 
201183
INT months 4–6 vs. INT months 1–3 (20) (7684) (28) (9308) [2.6] [3.0] [0.87] [0.293] [0.49] [1.54]
INT months 7–9 vs. INT months 1–3 (13) (9634) (28) (9308) [1.3] [3.0] [0.45] [0.336] [0.23] [0.87]
INT months 10–12 vs. INT months 1–3 (18) (9725) (28) (9308) [1.9] [3.0] [0.63] [0.302] [0.34] [1.11]
INT months 13–15 vs. INT months 1–3 (10) (9589) (28) (9308) [1.0] [3.0] [0.33] [0.368] [0.17] [0.71]
INT months 16–18 vs. INT months 1–3 (11) (8773) (28) (9308) [1.3] [3.0] [0.43] [0.356] [0.21] [0.84]
Palomar 
Martinez 
201068
INT (3 months) vs. B (2006 data) 44 11432 59 9164 3.85 6.44 [0.60] [0.199] [0.41] [0.89]
Control (3 months) vs. B (2006 data) 28 8453 59 4644 3.31 12.70 [0.26] [0.229] [0.17] [0.41]
Pronovost 
2006, 
2008, 
2010 
34,123,124
INT months 0–3 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.62 Not reported 0.47 0.81
INT months 4–6 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.56 Not reported 0.38 0.84
INT months 7–9 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.47 Not reported 0.34 0.65
INT months 10–12 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.42 Not reported 0.28 0.63
INT months 13–15 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.37 Not reported 0.20 0.68
INT months 16–18 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.23 0.50
INT months 19–21 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.23 0.50
INT months 22–24 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.33 Not reported 0.23 0.48
INT months 25–27 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.44 Not reported 0.34 0.57
INT months 28–30 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.40 Not reported 0.30 0.53
INT months 31–33 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.31 Not reported 0.21 0.45
INT months 34–36 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.24 0.48
Render 
2006126
INT vs. B (timing unclear) Not reported Not reported Not reported Not reported 0.4 1.7 0.24 Not reported (not calculable)
INT (9 months) vs. B (5) (7830) (11) (7593) [0.6] [1.4] [0.44] [0.539] [0.15] [1.27]
Speroff 
2011136
Toolkit months 1–3 vs. B (72) (25257) (81) (26599) [2.9] [3.0] [0.97] [0.162] [0.68] [1.29]
Toolkit months 4–6 vs. B (76) (24618) (81) (26599) [3.1] [3.0] [1.03] [0.160] [0.74] [1.39]
Toolkit months 7–9 vs. B (72) (27821) (81) (26599) [2.6] [3.0] [0.87] [0.162] [0.62] [1.17]
Toolkit months 10–12 vs. B (75) (29066) (81) (26599) [2.6] [3.0] [0.87] [0.160] [0.62] [1.16]
Toolkit months 13–15 vs. B (62) (29818) (81) (26599) [2.1] [3.0] [0.7] [0.169] [0.49] [0.95]
Toolkit months 16–18 vs. B (66) (24245) (81) (26599) [2.7] [3.0] [0.9] [0.166] [0.65] [1.24]
Virtual collab. months 1–3 vs. B (52) (22202) (37) (22172) [2.3] [1.7] [1.35] [0.215] [0.92] [2.14]
Virtual collab. months 4–6 vs. B (54) (22951) (37) (22172) [2.4] [1.7] [1.41] [0.213] [0.93] [2.14]
Virtual collab. months 7–9 vs. B (53) (23268) (37) (22172) [2.3] [1.7] [1.36] [0.214] [0.90] [2.08]
Virtual collab. months 10–12 vs. B (45) (26211) (37) (22172) [1.7] [1.7] [1.0] [0.222] [0.67] [1.59]
Virtual collab. months 13–15 vs. B (65) (25646) (37) (22172) [2.5] [1.7] [1.47] [0.206] [1.01] [2.27]
Virtual collab. months 16–18 vs. B (53) (19276) (37) (22172) [2.7] [1.7] [1.59] [0.214] [1.08] [2.51]
B, baseline; INT, intervention.
Note: Data in parentheses were obtained from primary study authors (not reported in the publications); data in square 
brackets were calculated by reviewers.
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Data for forest plot: regional-scale interventions (see Figure 4)
Study Comparison
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline  
device-days
Intervention 
incidence 
density
Baseline 
incidence 
density RR SE of log RR
95% confidence 
limits of RR
Lower Upper
Burrell 
201183
INT months 4–6 vs. INT months 1–3 (20) (7684) (28) (9308) [2.6] [3.0] [0.87] [0.293] [0.49] [1.54]
INT months 7–9 vs. INT months 1–3 (13) (9634) (28) (9308) [1.3] [3.0] [0.45] [0.336] [0.23] [0.87]
INT months 10–12 vs. INT months 1–3 (18) (9725) (28) (9308) [1.9] [3.0] [0.63] [0.302] [0.34] [1.11]
INT months 13–15 vs. INT months 1–3 (10) (9589) (28) (9308) [1.0] [3.0] [0.33] [0.368] [0.17] [0.71]
INT months 16–18 vs. INT months 1–3 (11) (8773) (28) (9308) [1.3] [3.0] [0.43] [0.356] [0.21] [0.84]
Palomar 
Martinez 
201068
INT (3 months) vs. B (2006 data) 44 11432 59 9164 3.85 6.44 [0.60] [0.199] [0.41] [0.89]
Control (3 months) vs. B (2006 data) 28 8453 59 4644 3.31 12.70 [0.26] [0.229] [0.17] [0.41]
Pronovost 
2006, 
2008, 
2010 
34,123,124
INT months 0–3 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.62 Not reported 0.47 0.81
INT months 4–6 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.56 Not reported 0.38 0.84
INT months 7–9 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.47 Not reported 0.34 0.65
INT months 10–12 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.42 Not reported 0.28 0.63
INT months 13–15 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.37 Not reported 0.20 0.68
INT months 16–18 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.23 0.50
INT months 19–21 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.23 0.50
INT months 22–24 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.33 Not reported 0.23 0.48
INT months 25–27 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.44 Not reported 0.34 0.57
INT months 28–30 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.40 Not reported 0.30 0.53
INT months 31–33 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.31 Not reported 0.21 0.45
INT months 34–36 vs. B Reported as summary statistics and ranges (see data extraction form) Reported as summary statistics and ranges (see data extraction form) 0.34 Not reported 0.24 0.48
Render 
2006126
INT vs. B (timing unclear) Not reported Not reported Not reported Not reported 0.4 1.7 0.24 Not reported (not calculable)
INT (9 months) vs. B (5) (7830) (11) (7593) [0.6] [1.4] [0.44] [0.539] [0.15] [1.27]
Speroff 
2011136
Toolkit months 1–3 vs. B (72) (25257) (81) (26599) [2.9] [3.0] [0.97] [0.162] [0.68] [1.29]
Toolkit months 4–6 vs. B (76) (24618) (81) (26599) [3.1] [3.0] [1.03] [0.160] [0.74] [1.39]
Toolkit months 7–9 vs. B (72) (27821) (81) (26599) [2.6] [3.0] [0.87] [0.162] [0.62] [1.17]
Toolkit months 10–12 vs. B (75) (29066) (81) (26599) [2.6] [3.0] [0.87] [0.160] [0.62] [1.16]
Toolkit months 13–15 vs. B (62) (29818) (81) (26599) [2.1] [3.0] [0.7] [0.169] [0.49] [0.95]
Toolkit months 16–18 vs. B (66) (24245) (81) (26599) [2.7] [3.0] [0.9] [0.166] [0.65] [1.24]
Virtual collab. months 1–3 vs. B (52) (22202) (37) (22172) [2.3] [1.7] [1.35] [0.215] [0.92] [2.14]
Virtual collab. months 4–6 vs. B (54) (22951) (37) (22172) [2.4] [1.7] [1.41] [0.213] [0.93] [2.14]
Virtual collab. months 7–9 vs. B (53) (23268) (37) (22172) [2.3] [1.7] [1.36] [0.214] [0.90] [2.08]
Virtual collab. months 10–12 vs. B (45) (26211) (37) (22172) [1.7] [1.7] [1.0] [0.222] [0.67] [1.59]
Virtual collab. months 13–15 vs. B (65) (25646) (37) (22172) [2.5] [1.7] [1.47] [0.206] [1.01] [2.27]
Virtual collab. months 16–18 vs. B (53) (19276) (37) (22172) [2.7] [1.7] [1.59] [0.214] [1.08] [2.51]
B, baseline; INT, intervention.
Note: Data in parentheses were obtained from primary study authors (not reported in the publications); data in square 
brackets were calculated by reviewers.
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Data for forest plot: local-scale interventions of duration up to  
12 months (see Figure 5)
Study Comparison
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline 
device-days
Intervention 
incidence density
Baseline 
incidence density RR SE of log risk ratio
95% confidence limits of RR
Lower Upper
Coopersmith 200250 INT (6 months) vs. B 26 7044 74 6874 3.7 10.8 [0.34] [0.228] [0.22] [0.54]
DuBose 200893 INT (1 month) vs. B Not reported Not reported Not reported Not reported 5.8 Unclear Not reported  
(not calculable)
Not reported  
(not calculable)
Guerin 201098 INT (12 months) vs. B 3 2825 25 4415 1.1 5.7 0.19 [0.611] 0.06 0.63
Higuera 2005103 Total, INT (9 months) vs. B 55 2824 28 605 19.5 46.3 0.42 [0.232] 0.27 0.66
Medical-surgical ICU, INT vs. B Not reported Not reported Not reported Not reported 22.1 57.4 0.38 Not reported 0.22 0.68
Neurosurgical ICU, INT vs. B Not reported Not reported Not reported Not reported 17.1 32.8 0.52 Not reported 0.24 1.11
Lobo 2005108 INT (8 months) vs. B 16 1481 48 2450 10.8 19.6 [0.55] [0.289] [0.31] [0.97]
F (12 months) vs. B 22 1701 48 2450 12.9 19.6 [0.66] [0.257] [0.40] [1.09]
F vs. INT 22 1701 16 1481 12.9 10.8 [1.19] [0.329] [0.63] [2.28]
Lobo 2010109 ICU ‘A,’ INT (9 months) vs. B 8.94 843 11.28 940 10.6 12.0 [0.88] [0.448] [0.37] [2.13]
ICU ‘B’, INT (9 months) vs. B 21.85 1694 35.24 2175 12.9 16.2 [0.80] [0.272] [0.47] [1.36]
Perez Parra 2010122 Total (three ICUs), INT (9 months) vs. B 34 11582 45 10661 2.9 4.2 [0.70] [0.227] [0.45] [1.09]
General ICU, INT (9 months) vs. B 14 4064 18 3403 3.4 5.3 [0.65] [0.356] [0.32] [1.31]
Cardiac ICU, INT (9 months) vs. B 8 2981 12 2842 2.7 4.2 [0.64] [0.456] [0.26] [1.55]
MICU, INT (9 months) vs. B 12 4537 15 4416 2.6 3.4 [0.76] [0.387] [0.36] [1.66]
Rosenthal 2003129 Education (1–2 months) vs. B 10 586 56 1219 17.1 45.9 0.37 [0.343] 0.19 0.73
PF (7–8 months) vs. education 41 4140 10 586 9.9 17.1 0.58 [0.353] 0.29 1.18
PF + education (8–10 months) vs. B 51 4726 56 1219 10.8 45.9 0.24 [0.194] 0.17 0.36
Sherertz 2000135 F (18 months) vs. B (12 months) 30 Not reporteda 32 Not reporteda Not reported Not reported Not reported  
(not calculable)
Not reported  
(not calculable)
Warren 2003139 INT (10 months) vs. B 11 5210 30 6110 2.1 4.9 0.43 [0.352] 0.22 0.84
Warren 200451 INT (1 month) + F (23 months) vs. B 41 7455 74 7879 5.5 9.4 [0.59] [0.195] [0.40] [0.86]
Zingg 2009144 Total (5 ICUs), INT (5 months) vs. B 7 7279 24 6200 1.0 3.9 [0.26] [0.430] [0.11] [0.58]
MICU, INT (5 months) vs. B Not reported Not reported 24 6200 3.9 9 [0.43] Not reported  
(not calculable)
Not reported  
(not calculable)
SICU, INT (5 months) vs. B Not reported Not reported 24 6200 0.2 3 [0.07] Not reported  
(not calculable)
Not reported  
(not calculable)
B, baseline; F, follow-up; INT, intervention; PF, performance feedback; SICU, surgical intensive care unit.
a The author confirmed these data were not recorded during the study.
Data in square brackets were calculated by reviewers.
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Data for forest plot: local-scale interventions of duration up to  
12 months (see Figure 5)
Study Comparison
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline 
device-days
Intervention 
incidence density
Baseline 
incidence density RR SE of log risk ratio
95% confidence limits of RR
Lower Upper
Coopersmith 200250 INT (6 months) vs. B 26 7044 74 6874 3.7 10.8 [0.34] [0.228] [0.22] [0.54]
DuBose 200893 INT (1 month) vs. B Not reported Not reported Not reported Not reported 5.8 Unclear Not reported  
(not calculable)
Not reported  
(not calculable)
Guerin 201098 INT (12 months) vs. B 3 2825 25 4415 1.1 5.7 0.19 [0.611] 0.06 0.63
Higuera 2005103 Total, INT (9 months) vs. B 55 2824 28 605 19.5 46.3 0.42 [0.232] 0.27 0.66
Medical-surgical ICU, INT vs. B Not reported Not reported Not reported Not reported 22.1 57.4 0.38 Not reported 0.22 0.68
Neurosurgical ICU, INT vs. B Not reported Not reported Not reported Not reported 17.1 32.8 0.52 Not reported 0.24 1.11
Lobo 2005108 INT (8 months) vs. B 16 1481 48 2450 10.8 19.6 [0.55] [0.289] [0.31] [0.97]
F (12 months) vs. B 22 1701 48 2450 12.9 19.6 [0.66] [0.257] [0.40] [1.09]
F vs. INT 22 1701 16 1481 12.9 10.8 [1.19] [0.329] [0.63] [2.28]
Lobo 2010109 ICU ‘A,’ INT (9 months) vs. B 8.94 843 11.28 940 10.6 12.0 [0.88] [0.448] [0.37] [2.13]
ICU ‘B’, INT (9 months) vs. B 21.85 1694 35.24 2175 12.9 16.2 [0.80] [0.272] [0.47] [1.36]
Perez Parra 2010122 Total (three ICUs), INT (9 months) vs. B 34 11582 45 10661 2.9 4.2 [0.70] [0.227] [0.45] [1.09]
General ICU, INT (9 months) vs. B 14 4064 18 3403 3.4 5.3 [0.65] [0.356] [0.32] [1.31]
Cardiac ICU, INT (9 months) vs. B 8 2981 12 2842 2.7 4.2 [0.64] [0.456] [0.26] [1.55]
MICU, INT (9 months) vs. B 12 4537 15 4416 2.6 3.4 [0.76] [0.387] [0.36] [1.66]
Rosenthal 2003129 Education (1–2 months) vs. B 10 586 56 1219 17.1 45.9 0.37 [0.343] 0.19 0.73
PF (7–8 months) vs. education 41 4140 10 586 9.9 17.1 0.58 [0.353] 0.29 1.18
PF + education (8–10 months) vs. B 51 4726 56 1219 10.8 45.9 0.24 [0.194] 0.17 0.36
Sherertz 2000135 F (18 months) vs. B (12 months) 30 Not reporteda 32 Not reporteda Not reported Not reported Not reported  
(not calculable)
Not reported  
(not calculable)
Warren 2003139 INT (10 months) vs. B 11 5210 30 6110 2.1 4.9 0.43 [0.352] 0.22 0.84
Warren 200451 INT (1 month) + F (23 months) vs. B 41 7455 74 7879 5.5 9.4 [0.59] [0.195] [0.40] [0.86]
Zingg 2009144 Total (5 ICUs), INT (5 months) vs. B 7 7279 24 6200 1.0 3.9 [0.26] [0.430] [0.11] [0.58]
MICU, INT (5 months) vs. B Not reported Not reported 24 6200 3.9 9 [0.43] Not reported  
(not calculable)
Not reported  
(not calculable)
SICU, INT (5 months) vs. B Not reported Not reported 24 6200 0.2 3 [0.07] Not reported  
(not calculable)
Not reported  
(not calculable)
B, baseline; F, follow-up; INT, intervention; PF, performance feedback; SICU, surgical intensive care unit.
a The author confirmed these data were not recorded during the study.
Data in square brackets were calculated by reviewers.
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Data for forest plot: local-scale interventions of duration of  
> 12 months (see Figure 6)
Study Comparison 
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline 
device-days
Intervention 
incidence density
Baseline 
incidence density RR SE of log risk ratio
95% confidence limits of RR
Lower Upper
Coopersmith 200487 INT (15 months) vs. B 17 6152 32 9353 2.8 3.4 [0.82] [0.300] [0.45] [1.45]
Eggimann 2000;94 
200595 
INT months 1–8 vs. B (5) (2174) (28) (4243) (2.3) (6.6) [0.35] [0.486] [0.13] [0.90]
INT months 1–8 vs. Ba Not reported Not reported Not reported Not reported 0.8 2.4 0.31 Not reported 0.09 0.53
INT months 24–36 vs. B (8) (3333) (28) (4243) (2.4) (6.6) [0.36] [0.401] [0.17] [0.80]
INT months 37–41 vs. B (4) (1481) (28) (4243) (2.7) (6.6) [0.41] [0.535] [0.14] [1.17]
INT months 51–60 vs. B (5) (2941) (28) (4243) (1.7) (6.6) [0.26] [0.486] [0.10] [0.67]
INT months 61–72 vs. B (11) (3235) (28) (4243) (3.4) (6.6) [0.52] [0.356] [0.26] [1.03]
Galpern 200897 INT (19 months) vs. B (7) (7345) (12) (2593) [1.0] [4.6] [0.22] [0.476] [0.08] [0.52]
Longmate 2011110 INT months 1–12 vs. B 7 1981 9 1918 3.5 4.7 [0.74] [0.504] [0.28] [2.02]
INT months 12–24 vs. B 1 1786 9 1918 0.6 4.7 [0.1] [1.054] [0.02] [0.94]
INT months 24–36 vs. B 0 Not reported 9 1918 0.0 4.7 0.00 Not reported  
(not calculable)
Not reported  
(not calculable)
INT months 1–12 vs. Ba 7 2613 9 2660 2.7 3.4 0.79 0.504 0.29 2.13
INT months 12–24 vs. Ba 1 2155 9 2660 0.5 3.4 0.14 1.054 0.02 1.08
INT months 24–36 vs. Ba 0 2138 9 2660 0.0 3.4 0.00 Not reported 0.00 0.63
Misset 2004117 INT years 2–5 vs. INT year 1 14 Not reported 7 Not reported 0–2.9 3.5 Not reported  
(not calculable)
Not reported  
(not calculable)
Rosenthal 2005130 INT (17 months) vs. B (4 months) [18] Not reported [16] Not reported Not reported Not reported Not reported  
(not calculable)
Not reported  
(not calculable)
Wall 2005138 INT (24 months) vs. B 6 [1132] 25 [3571] (5.3) 7.0 [0.76] [0.455] [0.31] [1.85]
INT (last 6 months) vs. B Not reported Not reported 25 [3571] (3.8) 7.0 [0.54] Not reported  
(not calculable)
Not reported  
(not calculable)
a Multiple concurrent vascular catheters per patient counted separately in the calculation of device-days.
Data in parentheses were obtained from primary study authors (not reported in the publications); data in square brackets 
were calculated by reviewers.
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
349
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Data for forest plot: local-scale interventions of duration of  
> 12 months (see Figure 6)
Study Comparison 
Intervention 
incidence
Intervention 
device-days
Baseline 
incidence
Baseline 
device-days
Intervention 
incidence density
Baseline 
incidence density RR SE of log risk ratio
95% confidence limits of RR
Lower Upper
Coopersmith 200487 INT (15 months) vs. B 17 6152 32 9353 2.8 3.4 [0.82] [0.300] [0.45] [1.45]
Eggimann 2000;94 
200595 
INT months 1–8 vs. B (5) (2174) (28) (4243) (2.3) (6.6) [0.35] [0.486] [0.13] [0.90]
INT months 1–8 vs. Ba Not reported Not reported Not reported Not reported 0.8 2.4 0.31 Not reported 0.09 0.53
INT months 24–36 vs. B (8) (3333) (28) (4243) (2.4) (6.6) [0.36] [0.401] [0.17] [0.80]
INT months 37–41 vs. B (4) (1481) (28) (4243) (2.7) (6.6) [0.41] [0.535] [0.14] [1.17]
INT months 51–60 vs. B (5) (2941) (28) (4243) (1.7) (6.6) [0.26] [0.486] [0.10] [0.67]
INT months 61–72 vs. B (11) (3235) (28) (4243) (3.4) (6.6) [0.52] [0.356] [0.26] [1.03]
Galpern 200897 INT (19 months) vs. B (7) (7345) (12) (2593) [1.0] [4.6] [0.22] [0.476] [0.08] [0.52]
Longmate 2011110 INT months 1–12 vs. B 7 1981 9 1918 3.5 4.7 [0.74] [0.504] [0.28] [2.02]
INT months 12–24 vs. B 1 1786 9 1918 0.6 4.7 [0.1] [1.054] [0.02] [0.94]
INT months 24–36 vs. B 0 Not reported 9 1918 0.0 4.7 0.00 Not reported  
(not calculable)
Not reported  
(not calculable)
INT months 1–12 vs. Ba 7 2613 9 2660 2.7 3.4 0.79 0.504 0.29 2.13
INT months 12–24 vs. Ba 1 2155 9 2660 0.5 3.4 0.14 1.054 0.02 1.08
INT months 24–36 vs. Ba 0 2138 9 2660 0.0 3.4 0.00 Not reported 0.00 0.63
Misset 2004117 INT years 2–5 vs. INT year 1 14 Not reported 7 Not reported 0–2.9 3.5 Not reported  
(not calculable)
Not reported  
(not calculable)
Rosenthal 2005130 INT (17 months) vs. B (4 months) [18] Not reported [16] Not reported Not reported Not reported Not reported  
(not calculable)
Not reported  
(not calculable)
Wall 2005138 INT (24 months) vs. B 6 [1132] 25 [3571] (5.3) 7.0 [0.76] [0.455] [0.31] [1.85]
INT (last 6 months) vs. B Not reported Not reported 25 [3571] (3.8) 7.0 [0.54] Not reported  
(not calculable)
Not reported  
(not calculable)
a Multiple concurrent vascular catheters per patient counted separately in the calculation of device-days.
Data in parentheses were obtained from primary study authors (not reported in the publications); data in square brackets 
were calculated by reviewers.
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Appendix 8 Data extraction forms for 
cost - effectiveness analyses
Cohen and colleagues
This record was compiled by the Southampton Health Technology Assessments Centre (SHTAC) following 
the format used by the NHS CRD Economic Evaluation Database.
Study characteristics
Reference
Cohen et al. (2010).76
Health technology
Simulation-based education for prevention of CRBSIs in an ICU.
Interventions and comparators
Simulation-based education training in CVC insertion versus no training.
Was a no-treatment/supportive care strategy included?
Yes.
Describe interventions/strategies
Simulation-based education with training in CVC insertion. The training consisted of two 2-hour 
educational sessions of a lecture, ultrasound training, and deliberate practice with the CVC simulator and 
instructor feedback. The CVC simulator features a realistic tissue with ultrasound compatibility, an arterial 
tube, and self-sealing veins and skins.
Research question
To estimate cost savings related to a reduction in CRBSI after simulation training.
Study type
Cost–consequence analysis.
Study population
A total of 477 patients had a CVC inserted in the MICU during the study period.
Institutional setting
Intensive Care Unit.
Country/currency
United States of America; US dollars 2008.
Funding source
Not stated.
Analytical perspective
United States health-care payer.
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AppENDIx 8 – COHEN (2010)
Effectiveness
Before simulation-based intervention, the average infection rate was 4.2/100 (11 infections in 239 CVC 
patients). After the intervention, the infection rate was reduced to 0.42/100 admission (one infection in 
238 CVC patients). Thus, preventing an estimated 9.95 CRBSI cases.
Intervention costs
Intervention costs stated in the analysis includes hospital costs, obtained from the hospital finance 
department. The stated costs included both direct and indirect costs estimates and are listed as follows.
Item Units Cost (US$)/unit Total cost (US$)
Ultrasounda 1 19,475.07 19,475.07 
Central line simulatora 1 1353.40 1353.40 
CVC kits 210 35.73 7429.80 
Simulator supplies 16 439.35 6960.00 
Ultrasound cover probes 90 14.10 1256.40 
Sterile gowns 150 2.98 442.50 
Sterile drapes 15 50.08 743.70 
Supply carta 1 1633.20 1633.20 
Supplies total 39,294.07
Other expenses Hour Cost/hour Total cost
Simulator facility rental 330 45.00 14,850.00 
Salary support
Instructor 50,500.00 
Research assistant 7272.00
Total costs 111,916.07 
a One-time cost.
Indirect costs
Were indirect costs included?
No.
Health-state valuations/utilities
None included.
List the utility values used in the evaluation
None.
Modelling
The study developed a trial-based economic model based on a non-randomised trial for the intervention. 
Two statistical methods were used: the propensity score match case–control comparison method and 
linear regression models. The trial data were analysed and regression models were used to derive estimates 
of cost and LOS for the intervention and control group, controlling for age, sex and Charlson score (an 
indicator of the severity of the disease). In order to give the intervention and the control group the same 
infection risk, a regression-based propensity score was used. Estimates of cost differences between the 
matched cases and controls were then derived.
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Extract transition probabilities for the model and show sources
The model does not use transition probabilities but reported propensity score quartiles based on predicted 
probabilities of infection in relation to LOS in the hospital and MICU.
What is the model time horizon?
12 months.
What, if any, discount rates have been applied in the model? Same rate for 
costs and outcomes?
Not applicable.
Results/analysis
What measure(s) of benefit were reported in the evaluation?
Average LOS:
Quartile
No. non–CRBSI 
patients 
Hospital MICU
Non-CRBSI 
patients 
CRBSI 
patients Difference 
Non-CRBSI 
patients 
CRBSI 
patients Difference
1.2–1.4 42 12.98 25.67 12.69 6.39 23.00 16.61
1.5–3.4 267 16.18 38.67 22.49 7.69 27.33 19.64
3.5–4.2 39 18.21 34.00 15.79 8.79 13.33 4.54
> 4.2 49 16.33 22.00 5.67 8.43 16.00 7.57
Average total 397 15.93 30.09 14.16 7.83 19.92 12.09
Comparison between MICU patients with CVCs with and without a CRBSI.
Provide a summary of the costs estimated for each intervention/strategy 
assessed in the evaluation
Quartile No. of non-CRBSI patients Non-CRBSI patients (US$) CRBSI patients (US$) Difference (US$)
1.2–1.4 42 51,829 152,678 100,849
1.5–3.4 267 58,335 155,878 97,543
3.5–4.2 39 63,057 108,581 45,524
> 4.2 49 57,465 144,468 87,003
Average total 397 57,671 140,401 82,730
Comparison between MICU patients with CVCs with and without a CRBSI.
Synthesis of costs and benefits: are the costs and outcomes reported 
together? If so, provide a summary of the results
9.95 CRBSI prevented, total annual savings were US$704,034 and US$711,248 and 137 patients hospital 
days and 120 and 121 MICU days.
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Give results of any statistical analysis of the results of the evaluation
Not applicable.
Was any sensitivity analysis performed?
No.
What scenarios were tested in the sensitivity analysis?
None.
Give a summary of the results of the sensitivity analysis
None.
Conclusions/implications
Give a brief summary of the author’s conclusions from their analysis
The results of the analyses show that simulation-based educational intervention is highly cost-effective.
Southampton Health Technology Assessments Centre Commentary
Selection of comparators
Appropriate.
Validity of estimate of measure of benefit
Appropriate.
Validity of estimate of costs
Acceptable.
AppENDIx 8 – COHEN (2010)
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Halton and colleagues
This record was compiled by SHTAC following the format used by the NHS CRD Economic 
Evaluation Database.
Study characteristics
Reference
Halton et al. (2010).151
Health technology
Central venous catheter care bundle.
Interventions and comparators
A bundle approach to CVC care compared with non-bundled approach.
Was a no-treatment/supportive care strategy included?
Yes.
Describe interventions/strategies
Intervention: optimal hand hygiene, chlorhexidine skin antiseptic, maximal barrier precautions for catheter 
insertion, choice of optimal insertion site and prompt catheter removal.
Research question
To estimate cost-effectiveness of catheter care bundle in the prevention of CRBSIs in intensive care.
Study type
Cost-effectiveness and cost–utility.
Study population
Patients aged 50–80+ years in ICUs.
Institutional setting
ICU.
Country/currency
2006 Australian dollars (A$).
Funding source
Medical Research Council.
Analytical perspective
Australian health-care payer perspective.
Effectiveness
The effectiveness data were derived from the study by Pronovost et al.34 The bundle was comprised five 
elements. The intervention reduced the rate of CRBSI from 7.7 to 1.4 per 1000 line-days over a 18-month 
period, a reduction in the relative risk of 0.34 (95% CI 0.23 to 0.5). Effect estimates for each type of 
commercially available antimicrobial central venous catheter, relative to uncoated catheters, were taken 
from the results of a meta-analysis: chlorhexidine/silver sulfadiazine (CH/SSD)-coated catheters (RR = 0.66) 
and minocycline and rifampicin (MR)-coated catheters (RR = 0.39).
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Intervention costs
The costs for the intervention were unknown.
List the direct intervention costs and other direct costs used in the evaluation.
Parameters Estimate Source Ref. Level of evidence
ICU bed-days (2006 A$) 3021 Costing study 161 4
Hospital bed-day (2006 A$) 843 Prior economic evaluation 162 3
Diagnostics CRBSI (2006 A$) 101.7 Health system database – 1
Treatment CRBSI (2006 A$) 591.3
Were the methods for deriving these data adequately described?
Yes.
Indirect costs
No.
Health state valuations/utilities
Preference-based utility weights were taken from a study with participant demographics similar to the 
modelled cohort. These weights were assigned to patients in ICU and 6 months post discharge. Australian 
population QoL norms were used for long-term survival.
Were the methods for deriving these data adequately described?
Yes
List the utility values used in the evaluation:
The utilities are as follows:
Parameters Age, years Estimate
ICU 0.66
Population norms 50–59 0.80
60–69 0.79
70–79 0.75
80+ 0.66
Modelling
A Markov state transition model was used. The model was adapted from a previously reported model.155 
Patients were assumed to receive a CVC on entry to the ICU. Over subsequent cycles the catheter was either 
removed as no longer necessary, or retained owing to the patient developing CRBSI. The model consists of six 
health states as follows: ICU patient with CVC; ICU patient recently infected with CRBSI; ICU patient without 
CRBSI and with CVC being removed; hospital ward patient with previous history of CRBSI; remaining ward 
patient without CRBSI; and recently discharged patient with or without previous history of CRBSI.
What was the purpose of the model?
To evaluate the cost-effectiveness of CVC care bundle.
AppENDIx 8 – HALTON (2010)
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What are the main components of the model (e.g. health states within a 
Markov model)?
The main components are as follows:
Patients were assumed to receive a CVC on entry to ICU, and over subsequent daily cycles either retained 
their catheter, had it removed, or developed a CRBSI. Patient faced an underlying risk of mortality while in 
the ICU and a further risk if they developed CRBSI. The surviving cohorts were modelled for the remainder of 
their life time in monthly cycles. The estimated risk of mortality due to hospital acquired CRBSI was 1.06.
Extract transition probabilities for [natural history/disease progression] model and show sources (or refer to 
table in text).
Parameters Estimates Sources
Daily probabilities of CRBSI Day 1–5 0.4% Table 1
Day 6–15 0.9%
Day 16–30 2%
Daily probability of catheter removal Not stated (varied)
Baseline mortality (probabilities)
ICU 0.098
Hospital 0.069
Parameters Estimates Sources
Annual post discharge Year 1 0.050
Year 2–3 0.027
Year 4–5 0.028
Year 6–10 0.037
Year 11–15 0.042
Underlying annual mortality 45–64 years 0.004
65–84 years 0.030
85+ years 0.140
What is the model time horizon?
The patients were followed for the remaining part of their lifetime in monthly cycles.
What, if any, discount rates have been applied in the model?
Three per cent applied to both costs and outcomes
Results/analysis
What measure(s) of benefit were reported in the evaluation?
The measure of benefit reported was QALYs and number of bed-days gained for the catheter care bundle 
relative to current practice.
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Provide a summary of the costs estimated for each intervention/strategy 
assessed in the evaluation
Not applicable.
Synthesis of costs and benefits
As the cost of implementing a bundle in Australia was unknown, deterministic threshold analyses were 
conducted. The maximum cost for the bundle was identified at which it would remain cost-effective (i.e. 
if the cost per QALY was less than A$64,000) assuming it would reduce the risk of CRBSI by 0.34. The 
baseline analyses show the benefits for the bundle or standard practice under different scenarios. The 
bundle at an implementation cost of A$4,349,730 was shown to be cost-effective for the whole 18-month 
period compared with current practice alone. For the strategy that includes CH/SSD catheters, the 
implementation cost over the same period was estimated to be A$2,287,400. MR catheter would result in 
a total implementation cost of A$1,144,465.
Halton and colleagues151 also estimated the maximum cost for the bundle at which it would remain 
cost-effective assuming it would effectively eliminate infection (RR CRBSI = 0.001). According to this 
assumption, the maximum nationwide implementation cost would be below A$6.6M if the A-CVCs are 
not considered a good alternative.
Give results of any statistical analysis of the results of the evaluation.
Not applicable.
Was any sensitivity analysis performed? If yes, what type(s)?
Yes, deterministic (one-way).
What scenarios were tested in the sensitivity analysis?
Threshold analyses were used to determine the effectiveness and implementation cost of different types 
of bundle that would be more cost-effective relative to the current practice. The analyses were undertaken 
in three different ways; where three separate comparisons were made one after the other. An initial 
comparison was between the current practice and the bundle. A subsequent comparison includes a  
three-way comparison; where current practice was compared with the bundle and then with CH/SSD 
catheters. The final stage of the analysis, involved a four-way comparison of current practice against the 
bundle, CH/SSD catheters and MR catheters.
Give a summary of the results of the sensitivity analysis.
See above.
Conclusions/implications
Give a brief summary of the author’s conclusions from their analysis
Implementation of catheter care bundles is cost-effective in the intensive care setting, if the  
decision-makers are willing to spend more on infection intervention control.
Southampton Health Technology Assessments Centre commentary
Selection of comparators
Comparator selection is adequate.
Validity of estimate of measure of benefit
Valid.
Validity of estimate of costs
Reasonable but no costs estimated for the intervention.
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Bond and King
This record was compiled by SHTAC following the format used by the NHS CRD Economic 
Evaluation Database.
Study characteristics
Reference
Bond and King (2011).152
Health technology
Educational intervention to improve the safety of CVC insertion.
Interventions and comparators
Educational intervention vs. no educational intervention.
Was a no treatment/supportive care strategy included?
Yes.
Describe interventions/strategies
The educational intervention consists of a CVC education course. It is a day-long programme with 
brief introductory lectures followed by hands-on procedural simulation in CVC insertion, using training 
mannequins, appropriate sterile procedures, ultrasound imaging and receiving feedback from instructors. 
In addition, residents and nurses are taught the Institute for Healthcare bundle of barrier precautions and 
new processes to encourage, ensure and track compliance.
Research question
To model the cost and mortality outcomes of CVC placement with respect to an educational intervention 
that attempts to reduce both infectious and mechanical complications.
Study type
Cost-effectiveness analysis.
Study population
Baseline cohort was 600 patients who had CVCs placed outside the operating room setting in the hospital 
setting each year. The proposed setting was described as a health-care system that includes a tertiary care 
center, a community hospital, and a free-standing emergency department. There are three emergency 
departments and 12 ICUs in the system.
Institutional setting
ICU.
Country/currency
United States of America; US dollars. Cost year not stated.
Funding source
None.
Analytical perspective
Not stated.
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Effectiveness
The evaluation assumes that the educational intervention would reduce the rate of the infectious 
complication CLAB by 50% and reduce the rate of the mechanical complications by 25%. The study does 
not discuss the sources that these are based upon nor the rationale behind their use.
Intervention costs
The intervention costs are detailed although it is not stated where these costs were collected.
Item
No. item/
hours per year
Cost per 
item/hour Programme Year 1 Programme Year 2–5
Acquisition of training mannequins 5 US$2000 US$10,000 US$0
Acquisition of ultrasound technology 3 US$18,000 US$54,000 US$0
Trainer time 10 US$150 US$1500 US$1500
Trainee time (nurses) 1900 US$25 US$47,500 US$4750
Trainee time EM residents (14/year) 112 US$20 US$2240 US$2240
Transitional interns (12/year) 96 US$20 US$1920 US$1920
Trainee time IM residents (16/year) 128 US$20 US$2560 US$2560
Trainee time surgery residents (4/year) 32 US$20 US$640 US$640
Chart review 0.5 FTE 2000 US$30,000 US$30,000
Data analysis 40 US$100 US$4000 US$4000
Programme oversight 400 US$40 US$16,000 US$16,000
Total per programme year US$170,360 US$63,610a
EM, emergency medicine; FTE, full-time equivalent; IM, internal medicine.
a Total cost for years 2–5 is US$254,440.
The cost per CLAB case was US$16,350 based upon those reported by Institute of Healthcare (full reference 
not supplied). The mean excess cost of mechanical complication was US$17,312.
Indirect costs
None included.
Health-state valuations/utilities
None included.
List the utility values used in the evaluation
None.
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Modelling
A decision-analytic model was compiled in TreeAge. The model began with the need for a CVC, with 
a focus on non-emergent cases, defines as those where there was sufficient time to follow sterile 
precautions in CVC insertion. One cohort of patients received the education intervention and the other did 
not. In each cohort, a proportion received the CVC in the internal jugular, subclavian and femoral. Patients 
then either had no complications, mechanical complication or CLAB. Patients who suffered a CLAB or a 
mechanical complication had corresponding higher costs and mortality than those without.
Extract transition probabilities for the model and show sources:
 z Location of CVC: internal jugular 0.35; subclavian 0.6, femoral 0.05.
 z Probability of CLAB line infection 0.7%.
 z Baseline mortality risk for an ICU patient: 10.
 z Mortality risk for patients with CLAB: 12.
 z Excess mortality of mechanical complications associated with iatrogenic pneumothorax: 7.
What is the model time horizon?
The duration of the hospital stay.
What, if any, discount rates have been applied in the model?
None applied.
Results/analysis
What measure(s) of benefit were reported in the evaluation?
Survival with education (per patient) 0.899; survival without education 0.898.
Provide a summary of the costs estimated for each intervention/strategy 
assessed in the evaluation
Cost with education (per patient) US$546; cost without education US$392. Additional cost of education 
intervention US$154. Using programme cost of US$170,360 per year.
Synthesis of costs and benefits: are the costs and outcomes reported 
together? If so, provide a summary of the results
Yearly annual additional cost of US$92,400 to a large health-care system is the cost to reduce the number 
of CLAB infections from 4 to 2. (No discussion in the text on the reduction in mortality.)
Give results of any statistical analysis of the results of the evaluation
Not applicable.
Was any sensitivity analysis performed? If yes, what type(s)? [i.e. 
deterministic (one-way, two-way, etc.) or probabilistic]
One-way sensitivity analyses.
What scenarios were tested in the sensitivity analysis?
The programme cost, CLAB baseline rate, intervention effectiveness on CLAB rate were varied.
Give a summary of the results of the sensitivity analysis
For lower programme cost of US$63,610 per year, additional cost of education intervention (per patient) 
US$44*. Raising CLAB infection rate to 5%* gives a net monetary benefit of US$158 (i.e. cost saving) with 
an additional survival of 0.003.
(*Note that neither of the sensitivity analyses had a reduction in mechanical complications).
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Conclusions/implications
Give a brief summary of the author’s conclusions from their analysis
If the educational intervention is effective, a small increase in costs can reduce complications.
Southampton Health Technology Assessments Centre commentary
Selection of comparators
Appropriate.
Validity of estimate of measure of benefit
Appropriate, although rationale for selection not given.
Validity of estimate of costs
Uncertain. Derivation of cost associated with CLAB is unclear.
AppENDIx 8 – bOND AND kING (2011)
DOI: 10.3310/hta18150 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 15
363
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Frampton et al. under the terms of a commissioning contract issued by the Secretary of State for  
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be 
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science 
Park, Southampton SO16 7NS, UK.
Appendix 9 The model parameters and their 
distributions included in the probabilistic sensitivity 
analysis
Name
Base 
case
Upper 
value
Lower 
value SE Distribution Alpha Beta
Catheter-BSI incidence rate, per 1000  
catheter-days
3.7 5.0 1.3 1.22 Log-normal 1.6 0.3
Critical care mortality, no catheter-BSI 0.169 0.203 0.135 0.02 Beta 79.6 391.6
RR for critical care mortality due to catheter-BSI 3.25 3.6 2.7 0.28 Log-normal 1.3 1.0
Catheter utilisation 0.71 0.96 0.49 0.13 Beta 8.3 3.4
Costs
Ward bed-day, £ 246 295.2 196.8 25.10 Gamma 96.0 2.6
Critical care bed-day, £ 1440 1171 1657 –110.93 Gamma 168.5 8.5
Treatment for catheter-BSI 518 622 415 52.89 Gamma 96.0 5.4
Standard care (per patient in critical care) 0
Bundle (per patient in critical care) 15.48 20.13 10.84 2.37 Gamma 42.7 0.4
Clinical effectiveness
Bundle effectiveness 0.4 0.67 0.22 0.10 Log-normal –0.5 –1.6
Additional LOS for catheter-BSI, critical care 1.5 2.5 0.0 0.30 Triangle 2.0 0.5
Additional LOS for catheter-BSI, ward 5.13 8.68 1.58 1.81 Log-normal 2.2 0.5
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Appendix 10 Calculating the cost of the central 
venous catheter care bundle
The cost of the bundle consists of the national programme and local implementation costs. The programme grant for implementing Matching Michigan in England was £1,750,000 for a 2-year period. 
Thus the annual cost would be £875,000 per annum.
The local training costs were calculated based on advice on implementation of Matching Michigan in one 
local centre. In this centre, one Band 6 nurse trained and monitored critical care staff in three critical care 
units and this took 20% whole time equivalent (WTE).
Using the assumptions above, the costs were estimated per patient attending ICU and these are shown in 
the table below.
Parameter Value Source
National ICU data
No. of patients attending critical care per year in England 89,618 ICNARC163
No. of critical care units 188 ICNARC163
Average no. of patients per critical care unit 477 ICNARC163
National programme costs
National programme costs/year £875,000 Matching Michigan162
National programme costs per patient in critical care £9.76 Matching Michigan162
Local unit costs
Annual salary of a band 6 nurse £40,917 Agenda for Changea
Proportion of time allocated to staff training 20% Assumption
No. of critical care units covered 3 Assumption
No. of patients admitted to critical care 1431 ICNARC
Local training costs per patient in critical care (expert opinion, Matching Michigan162) £5.72
Total cost of bundle £15.48
ICNARC, Intensive Care National Audit & Research Centre.
a See: www.nhscareers.nhs.uk/working-in-the-nhs/pay-and-benefits/agenda-for-change-pay-rates/ (accessed  
October 2012).
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